data_1yji_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1yji _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.501 ' OG ' ' SD ' ' A' ' 90' ' ' MET . 67.9 p . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.1 mmtt -75.94 115.39 15.6 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 45.1 t -116.3 108.1 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.16 -0.963 . . . . 0.0 111.952 -177.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 28.2 t -103.38 134.89 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 CA-C-O 121.687 0.756 . . . . 0.0 110.247 178.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -108.42 118.8 37.72 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 177.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 64.7 t -98.17 113.53 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 120.846 -1.159 . . . . 0.0 108.516 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.401 ' OG ' ' N ' ' A' ' 8' ' ' HIS . 5.3 p -79.6 -153.63 0.08 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.486 -0.759 . . . . 0.0 110.261 -179.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.722 ' ND1' ' H ' ' A' ' 8' ' ' HIS . 0.4 OUTLIER -91.84 -52.67 4.63 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.8 p30 -62.41 -2.0 0.92 Allowed 'General case' 0 N--CA 1.483 1.189 0 O-C-N 120.865 -1.147 . . . . 0.0 111.364 -178.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.65 0.43 64.54 Favored Glycine 0 N--CA 1.498 2.811 0 O-C-N 120.67 -1.269 . . . . 0.0 110.575 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -77.02 141.55 40.28 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.98 -1.306 . . . . 0.0 109.101 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.43 ' CD ' ' N ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -119.43 164.38 15.82 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.387 -0.82 . . . . 0.0 112.486 -178.139 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.89 111.69 7.39 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -98.35 122.67 41.81 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.197 -0.939 . . . . 0.0 109.589 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.0 mt -117.47 -164.48 1.0 Allowed 'General case' 0 N--CA 1.503 2.205 0 CA-C-O 122.747 1.26 . . . . 0.0 109.968 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -137.74 99.6 3.96 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 104.558 -2.386 . . . . 0.0 104.558 176.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.8 t -102.31 121.13 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.321 0 O-C-N 121.238 -0.914 . . . . 0.0 109.022 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.71 -178.67 5.48 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.237 -0.914 . . . . 0.0 111.547 -178.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -67.72 131.2 45.12 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 122.078 0.942 . . . . 0.0 111.584 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.78 -18.84 48.6 Favored Glycine 0 N--CA 1.493 2.433 0 N-CA-C 111.121 -0.791 . . . . 0.0 111.121 178.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 62.3 t -79.65 132.81 31.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 120.689 -1.477 . . . . 0.0 108.478 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.464 ' O ' ' N ' ' A' ' 25' ' ' GLN . 18.0 p -88.2 145.59 25.82 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.962 -1.086 . . . . 0.0 108.666 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 70.4 mt -45.64 -39.8 8.23 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 120.594 -1.316 . . . . 0.0 109.864 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 10.5 ttt -64.51 -27.67 69.13 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.549 -0.719 . . . . 0.0 109.255 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.464 ' N ' ' O ' ' A' ' 22' ' ' SER . 52.3 mt-30 -72.78 -58.62 3.2 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.173 -0.954 . . . . 0.0 109.053 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.82 -27.48 69.35 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.768 -1.207 . . . . 0.0 110.89 -179.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.05 -22.02 64.19 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.653 -1.279 . . . . 0.0 108.793 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 89.6 t -84.66 -21.63 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-O 121.492 0.663 . . . . 0.0 109.41 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.18 -28.0 32.31 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.391 -0.818 . . . . 0.0 109.491 -179.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 . . . . . 0 N--CA 1.485 1.306 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.886 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 13.9 m . . . . . 0 N--CA 1.484 1.265 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.529 ' SG ' ' O ' ' A' ' 48' ' ' CYS . 13.8 p -96.42 46.84 1.07 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.887 -1.133 . . . . 0.0 110.224 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.489 ' NE2' ' OH ' ' A' ' 51' ' ' TYR . 38.7 t60 -75.32 109.98 9.28 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.045 -1.034 . . . . 0.0 108.347 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -143.49 164.65 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.152 -0.968 . . . . 0.0 109.36 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.561 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 58.1 m-85 -108.81 110.71 22.14 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-O 121.9 0.857 . . . . 0.0 109.477 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.5 t -87.77 132.89 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.625 ' C ' ' H ' ' A' ' 55' ' ' ALA . 21.6 t-20 -47.58 126.21 9.59 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.959 -1.088 . . . . 0.0 109.556 179.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -58.19 15.26 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.638 -0.664 . . . . 0.0 111.193 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.625 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -103.39 -18.75 14.7 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.697 -1.252 . . . . 0.0 109.577 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -113.0 -12.71 13.19 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.104 -0.998 . . . . 0.0 109.172 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 13.6 p -68.08 -37.38 81.18 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.455 -0.778 . . . . 0.0 109.882 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -88.95 13.24 13.27 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.49 -0.757 . . . . 0.0 109.424 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.3 mtpt -124.46 -39.3 2.33 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -81.18 161.74 61.6 Favored Pre-proline 0 N--CA 1.497 1.909 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -56.23 92.74 0.05 OUTLIER 'Trans proline' 0 N--CA 1.49 1.31 0 C-N-CA 121.584 1.522 . . . . 0.0 113.401 -177.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.37 102.63 5.2 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 178.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.729 ' N ' HH22 ' A' ' 83' ' ' ARG . . . -50.16 151.82 1.92 Allowed 'General case' 0 C--N 1.288 -2.08 0 CA-C-O 122.742 1.258 . . . . 0.0 112.596 -177.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -59.31 -165.38 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.372 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -68.76 -5.22 19.31 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.254 -0.904 . . . . 0.0 112.783 -177.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.4 mtt180 -60.91 -38.41 85.66 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.154 -1.591 . . . . 0.0 108.997 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -80.74 -39.04 27.65 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.973 -1.08 . . . . 0.0 110.05 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 84.5 mt -46.65 -28.93 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.33 -0.856 . . . . 0.0 110.105 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -82.84 -30.41 32.18 Favored Glycine 0 N--CA 1.498 2.786 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 25.3 mtt -76.56 -34.21 58.5 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 178.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.3 mt -59.05 -24.27 62.72 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -92.26 30.38 1.47 Allowed 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -134.89 19.4 3.49 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.533 -0.729 . . . . 0.0 110.487 -179.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.4 m -97.74 167.42 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 120.809 -1.182 . . . . 0.0 110.214 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.546 ' OG1' ' CD1' ' A' ' 106' ' ' TRP . 6.8 m -101.59 -0.16 35.32 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.385 -0.822 . . . . 0.0 109.789 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -107.18 169.29 8.65 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.242 -0.911 . . . . 0.0 110.465 -178.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.561 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -61.21 110.32 1.37 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.741 -0.6 . . . . 0.0 109.839 -179.343 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.3 tp -68.6 158.01 34.89 Favored 'General case' 0 C--N 1.294 -1.811 0 O-C-N 120.26 -1.525 . . . . 0.0 108.753 178.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.443 ' N ' ' OG ' ' A' ' 82' ' ' SER . 41.5 mmtt -128.25 153.38 78.83 Favored Pre-proline 0 C--N 1.294 -1.818 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 -178.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -55.32 -28.29 61.97 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 121.54 1.494 . . . . 0.0 109.52 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -112.27 29.74 7.65 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.722 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.443 ' OG ' ' N ' ' A' ' 79' ' ' LYS . 4.3 m -61.89 164.64 6.19 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.673 -1.267 . . . . 0.0 109.159 178.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.729 HH22 ' N ' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -164.93 146.24 7.73 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 118.564 -1.254 . . . . 0.0 112.012 -178.6 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.508 ' CD2' ' N ' ' A' ' 84' ' ' LEU . 3.2 mm? -92.72 95.35 9.51 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 177.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -31.77 -46.21 0.11 Allowed 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -177.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.467 ' SG ' ' N ' ' A' ' 87' ' ' GLN . 30.3 p -58.22 -45.75 87.13 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 119.856 -1.777 . . . . 0.0 111.956 -177.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.467 ' N ' ' SG ' ' A' ' 86' ' ' CYS . 10.4 tp60 -74.79 39.58 0.13 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.481 -1.387 . . . . 0.0 111.494 -178.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 31.6 mt -131.35 145.71 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 O-C-N 120.86 -1.15 . . . . 0.0 108.715 178.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.6 mp -121.6 127.84 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.501 ' SD ' ' OG ' ' A' ' 1' ' ' SER . 0.0 OUTLIER -88.33 162.05 16.79 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -178.881 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 45.5 p -152.1 148.4 21.32 Favored Pre-proline 0 N--CA 1.49 1.551 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.1 -32.98 98.3 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 121.69 1.594 . . . . 0.0 111.298 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -66.63 -32.81 74.38 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.126 -0.984 . . . . 0.0 109.502 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.6 mt -90.85 31.39 1.07 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.149 -0.969 . . . . 0.0 109.229 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -60.21 133.31 55.98 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.878 -1.139 . . . . 0.0 110.45 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 110.67 11.33 19.53 Favored Glycine 0 N--CA 1.507 3.416 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 178.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -64.07 124.17 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.19 0 O-C-N 120.997 -1.296 . . . . 0.0 110.297 -177.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.5 t -101.69 121.92 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.505 -0.747 . . . . 0.0 109.32 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.1 t -108.5 133.53 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 120.977 -1.077 . . . . 0.0 110.109 -178.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.96 118.32 36.39 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.901 0.858 . . . . 0.0 109.113 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 14.9 t -107.74 124.59 34.45 Favored Pre-proline 0 N--CA 1.497 1.909 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -82.57 178.45 6.14 Favored 'Trans proline' 0 N--CA 1.5 1.886 0 C-N-CA 122.315 2.01 . . . . 0.0 113.497 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -83.03 -14.03 54.69 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.32 87.32 2.72 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 -178.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -87.56 -32.59 19.28 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . 0.546 ' CD1' ' OG1' ' A' ' 75' ' ' THR . 45.3 t-105 . . . . . 0 C--N 1.302 -1.486 0 CA-C-O 117.735 -1.126 . . . . 0.0 109.564 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' A' ' 17' ' ' VAL . 51.9 p . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.51 109.66 12.9 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.563 -0.855 . . . . 0.0 108.953 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.4 ' CG1' ' CZ ' ' A' ' 5' ' ' TYR . 22.9 t -107.48 108.55 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 O-C-N 121.237 -0.915 . . . . 0.0 110.489 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.0 t -99.04 98.81 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.089 -1.007 . . . . 0.0 111.405 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.4 ' CZ ' ' CG1' ' A' ' 3' ' ' VAL . 68.9 m-85 -73.08 115.13 12.03 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 75.2 t -98.81 111.6 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 61.3 p -72.3 -159.66 0.06 Allowed 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 121.666 0.746 . . . . 0.0 109.867 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.744 ' ND1' ' H ' ' A' ' 8' ' ' HIS . 0.2 OUTLIER -90.58 -50.87 5.69 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.309 -0.869 . . . . 0.0 108.709 -179.966 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.495 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 15.1 p30 -66.34 5.23 0.58 Allowed 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.752 -179.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.433 ' H ' ' C ' ' A' ' 8' ' ' HIS . . . 92.11 -1.83 74.4 Favored Glycine 0 N--CA 1.499 2.887 0 O-C-N 120.879 -1.138 . . . . 0.0 110.895 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -65.27 129.67 40.56 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.89 -1.359 . . . . 0.0 108.541 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 2.2 mtt85 -108.76 160.64 15.8 Favored 'General case' 0 N--CA 1.502 2.126 0 CA-C-O 121.68 0.752 . . . . 0.0 110.58 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.15 115.38 5.42 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 179.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -98.72 127.12 44.54 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-O 121.829 0.823 . . . . 0.0 110.342 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.416 ' CD1' ' H ' ' A' ' 16' ' ' ASP . 0.3 OUTLIER -113.44 -174.33 2.44 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 123.203 1.478 . . . . 0.0 111.032 -177.797 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.416 ' H ' ' CD1' ' A' ' 15' ' ' LEU . 0.8 OUTLIER -136.14 99.97 4.28 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 104.654 -2.35 . . . . 0.0 104.654 176.48 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.433 ' O ' ' OG ' ' A' ' 1' ' ' SER . 13.0 t -108.22 116.39 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.81 -179.72 2.33 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.311 -0.868 . . . . 0.0 111.409 -178.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 19' ' ' ASP . 3.8 p-10 -70.0 136.75 50.75 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 122.012 0.91 . . . . 0.0 110.724 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.01 -18.2 41.74 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 178.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.5 t -80.1 138.52 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 120.616 -1.52 . . . . 0.0 109.432 -178.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.27 153.97 21.06 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.164 -0.96 . . . . 0.0 109.126 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.419 ' CD2' ' N ' ' A' ' 23' ' ' LEU . 1.8 mm? -56.26 -64.05 0.99 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.612 -0.68 . . . . 0.0 109.178 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.515 ' O ' ' SD ' ' A' ' 24' ' ' MET . 6.6 tpt -49.46 -16.28 0.2 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.009 -1.057 . . . . 0.0 109.123 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.418 ' N ' ' C ' ' A' ' 23' ' ' LEU . 7.7 tm0? -78.35 -68.1 0.67 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.104 -0.998 . . . . 0.0 109.47 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.24 -21.7 15.17 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.929 -1.107 . . . . 0.0 110.418 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.78 -19.35 65.78 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 120.844 -1.16 . . . . 0.0 108.809 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 96.5 t -86.98 -23.87 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.472 -0.767 . . . . 0.0 109.381 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.53 -26.43 45.79 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.529 -0.732 . . . . 0.0 109.054 -179.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.407 ' N ' HD21 ' A' ' 30' ' ' ASN . 1.8 m-80 . . . . . 0 C--N 1.304 -1.408 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 9.7 m . . . . . 0 N--CA 1.487 1.395 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.516 ' SG ' ' O ' ' A' ' 48' ' ' CYS . 17.8 p -87.44 54.66 3.22 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.695 -1.253 . . . . 0.0 110.071 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.527 ' CE1' ' OH ' ' A' ' 51' ' ' TYR . 43.6 t60 -76.52 109.97 10.69 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.955 -1.091 . . . . 0.0 109.024 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -146.06 168.17 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 120.796 -1.19 . . . . 0.0 109.697 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.601 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 37.2 m-85 -116.7 114.86 24.62 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-O 122.051 0.929 . . . . 0.0 109.58 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.456 ' O ' ' OD1' ' A' ' 81' ' ' ASN . 78.7 t -91.31 131.64 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.611 ' C ' ' H ' ' A' ' 55' ' ' ALA . 1.1 t30 -46.95 127.65 10.31 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -57.38 13.9 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.63 -0.669 . . . . 0.0 111.441 -178.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.611 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -103.45 -19.8 14.28 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.57 -1.331 . . . . 0.0 109.8 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.41 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 30.2 m-85 -109.59 -9.78 14.87 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.708 -1.245 . . . . 0.0 108.859 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.0 p -71.18 -37.51 72.17 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.565 -0.71 . . . . 0.0 110.141 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 9.5 p-10 -87.84 10.51 18.33 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.229 -0.919 . . . . 0.0 109.913 -178.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.43 ' CE ' ' O ' ' A' ' 55' ' ' ALA . 9.1 mttm -121.21 -40.04 2.63 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -78.73 162.09 66.67 Favored Pre-proline 0 N--CA 1.498 1.953 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -53.97 94.19 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 121.877 1.718 . . . . 0.0 113.939 -176.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.0 98.5 3.62 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 177.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.895 ' H ' HH22 ' A' ' 83' ' ' ARG . . . -61.05 169.34 2.04 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-O 122.559 1.171 . . . . 0.0 111.953 -178.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -65.18 -175.02 0.19 Allowed 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 122.204 1.002 . . . . 0.0 111.954 -178.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -70.33 3.31 3.0 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.813 -0.555 . . . . 0.0 111.409 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.2 mtm180 -59.95 -41.76 92.58 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.669 -1.269 . . . . 0.0 110.143 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.478 ' N ' ' CD ' ' A' ' 67' ' ' GLU . 23.7 mp0 -80.29 -37.0 33.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.021 -1.049 . . . . 0.0 110.029 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.444 ' CD1' ' N ' ' A' ' 68' ' ' ILE . 1.3 mp -46.88 -34.13 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 C-N-CA 119.731 -0.788 . . . . 0.0 109.142 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.3 -28.36 62.08 Favored Glycine 0 N--CA 1.498 2.791 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.421 ' N ' ' O ' ' A' ' 67' ' ' GLU . 25.1 mtt -79.97 -35.6 37.31 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 178.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 74.9 mt -66.81 -24.69 66.2 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -77.48 5.83 8.18 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.732 -1.23 . . . . 0.0 108.032 178.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -124.42 30.17 6.1 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.752 -0.592 . . . . 0.0 110.981 -177.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 28.9 m -96.35 169.54 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.42 0 O-C-N 120.652 -1.28 . . . . 0.0 110.723 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.531 ' OG1' ' CG ' ' A' ' 106' ' ' TRP . 3.1 m -102.41 -9.93 19.86 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.342 -0.849 . . . . 0.0 111.281 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.413 ' HB2' ' HE2' ' A' ' 49' ' ' HIS . . . -104.58 176.13 5.26 Favored 'General case' 0 N--CA 1.507 2.405 0 O-C-N 120.627 -1.296 . . . . 0.0 110.411 -178.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.601 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -59.64 105.33 0.36 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.613 -0.679 . . . . 0.0 110.255 -178.528 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.9 tp -73.96 147.35 43.14 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 119.502 -1.999 . . . . 0.0 110.338 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 27.0 mmtm -109.58 155.52 41.2 Favored Pre-proline 0 C--N 1.291 -1.962 0 CA-C-N 114.756 -1.111 . . . . 0.0 108.83 -178.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.47 -23.02 73.96 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 121.964 1.776 . . . . 0.0 109.331 178.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.456 ' OD1' ' O ' ' A' ' 52' ' ' VAL . 2.1 p30 -115.55 23.22 12.53 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.832 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.1 m -47.21 165.66 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.672 -1.268 . . . . 0.0 109.409 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.895 HH22 ' H ' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -161.58 141.99 10.71 Favored 'General case' 0 N--CA 1.5 2.046 0 C-N-CA 118.259 -1.376 . . . . 0.0 111.96 -177.531 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 95.5 mt -86.32 111.16 20.21 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 177.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.464 ' N ' ' SG ' ' A' ' 48' ' ' CYS . 0.1 OUTLIER -56.2 -35.14 66.94 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -176.106 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.547 ' SG ' ' N ' ' A' ' 87' ' ' GLN . 31.6 p -63.51 -49.06 75.05 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 119.678 -1.889 . . . . 0.0 112.343 -177.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.67 HE22 ' NH1' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -79.61 33.8 0.26 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.841 -1.162 . . . . 0.0 111.425 -177.709 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.42 ' CG2' ' N ' ' A' ' 89' ' ' ILE . 71.5 mt -113.17 160.76 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 177.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.42 ' N ' ' CG2' ' A' ' 88' ' ' ILE . 35.6 mm -136.5 121.85 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.147 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 3.2 tpt -87.28 160.87 18.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.792 -1.193 . . . . 0.0 108.799 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 39.4 p -151.06 148.67 23.2 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -56.03 -32.37 85.97 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 121.379 1.386 . . . . 0.0 111.634 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.503 ' CD ' ' H ' ' A' ' 93' ' ' GLU . 2.3 pm0 -68.11 -31.52 71.18 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.062 -1.024 . . . . 0.0 110.006 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.2 mt -94.43 27.99 2.75 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 120.72 -1.237 . . . . 0.0 108.956 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -61.86 138.03 58.31 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.023 -1.048 . . . . 0.0 110.324 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 107.83 9.77 27.81 Favored Glycine 0 N--CA 1.499 2.866 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 178.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 14.4 tt -64.99 133.25 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 120.925 -1.338 . . . . 0.0 111.365 -177.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.3 t -103.06 114.59 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.5 t -103.72 135.75 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.729 -1.232 . . . . 0.0 108.558 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.1 116.17 31.44 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.809 0.814 . . . . 0.0 109.172 -179.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.2 t -103.34 125.01 36.24 Favored Pre-proline 0 N--CA 1.498 1.933 0 O-C-N 121.845 -0.534 . . . . 0.0 109.565 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -80.6 167.24 19.09 Favored 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 122.193 1.929 . . . . 0.0 113.735 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -73.11 -14.98 61.49 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 21.5 mtm180 -123.82 92.32 3.65 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 2.7 pp0? -82.61 -19.51 38.23 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.628 -0.67 . . . . 0.0 109.716 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . 0.531 ' CG ' ' OG1' ' A' ' 75' ' ' THR . 63.5 t-105 . . . . . 0 C--N 1.304 -1.373 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.537 178.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.488 ' OG ' ' SD ' ' A' ' 90' ' ' MET . 83.9 p . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 25.4 mmtt -75.38 111.71 10.93 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.31 -0.869 . . . . 0.0 109.157 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.446 ' CG2' ' SD ' ' A' ' 90' ' ' MET . 17.2 t -109.49 109.19 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.343 -0.848 . . . . 0.0 109.499 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 38.5 t -99.57 96.49 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.127 -0.983 . . . . 0.0 111.345 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -70.54 111.76 6.3 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 76.1 t -98.46 117.36 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 80.8 p -76.51 -158.6 0.1 Allowed 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.346 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.711 ' ND1' ' H ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -90.33 -49.65 6.41 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.089 -1.007 . . . . 0.0 109.466 -179.646 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.485 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 22.9 p-10 -66.39 2.06 1.39 Allowed 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.264 -0.897 . . . . 0.0 110.355 -178.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.01 -0.54 62.47 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -65.05 127.94 33.7 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.9 -1.353 . . . . 0.0 108.227 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' A' ' 12' ' ' ARG . 2.3 mtt85 -108.12 160.67 15.63 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 122.156 0.979 . . . . 0.0 110.796 -178.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -150.99 115.19 5.06 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 178.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.466 ' N ' ' OE2' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -99.19 128.46 45.32 Favored 'General case' 0 N--CA 1.508 2.436 0 CA-C-O 122.504 1.145 . . . . 0.0 110.613 -178.144 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.462 ' CD1' ' H ' ' A' ' 16' ' ' ASP . 0.2 OUTLIER -115.13 -173.86 2.39 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 123.072 1.415 . . . . 0.0 110.575 -178.475 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.462 ' H ' ' CD1' ' A' ' 15' ' ' LEU . 32.6 t0 -136.36 104.39 5.6 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 176.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.2 t -112.9 122.92 67.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 O-C-N 121.525 -0.734 . . . . 0.0 109.604 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.82 179.78 5.9 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.919 0.866 . . . . 0.0 111.519 -178.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -69.31 138.82 54.11 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 122.025 0.917 . . . . 0.0 110.913 -179.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.83 -17.09 37.94 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 62.0 t -81.9 139.13 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 O-C-N 120.51 -1.583 . . . . 0.0 109.122 -178.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 16.0 p -92.68 149.19 21.48 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.158 -0.964 . . . . 0.0 108.588 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 27.0 mt -50.01 -36.15 27.51 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 121.093 -1.004 . . . . 0.0 110.007 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 7.5 tpt -68.11 -24.37 65.02 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.319 -0.863 . . . . 0.0 109.474 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -76.94 -63.22 1.41 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.143 -0.973 . . . . 0.0 109.622 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.95 -28.54 24.06 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.123 -0.986 . . . . 0.0 110.599 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.14 -20.96 29.17 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.749 -1.22 . . . . 0.0 108.756 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.5 t -88.57 -23.85 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.485 -0.759 . . . . 0.0 110.585 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.485 ' OG ' ' ND2' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -75.3 -31.11 60.56 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.303 -0.873 . . . . 0.0 109.99 -179.287 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.485 ' ND2' ' OG ' ' A' ' 29' ' ' SER . 1.7 m-80 . . . . . 0 C--N 1.304 -1.37 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 75.5 p . . . . . 0 N--CA 1.482 1.127 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 20.8 p -97.28 54.21 1.21 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.214 -0.928 . . . . 0.0 109.586 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.483 ' CE1' ' OH ' ' A' ' 51' ' ' TYR . 39.5 t60 -76.2 96.11 3.84 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -133.65 164.58 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 121.151 -0.968 . . . . 0.0 109.748 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.568 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 45.8 m-85 -113.54 113.25 24.85 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 122.073 0.94 . . . . 0.0 110.192 -179.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.423 ' O ' ' OD1' ' A' ' 81' ' ' ASN . 47.1 t -87.25 131.13 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.621 ' C ' ' H ' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -48.0 128.19 13.29 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.92 -1.113 . . . . 0.0 108.902 179.834 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -55.85 9.96 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.284 -0.885 . . . . 0.0 111.515 -178.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.621 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -98.19 -18.42 18.46 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.892 -1.13 . . . . 0.0 110.137 -179.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -114.66 -7.45 12.73 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 120.707 -1.246 . . . . 0.0 108.855 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.3 p -71.61 -41.18 69.22 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.083 -1.01 . . . . 0.0 109.858 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -85.48 10.17 13.74 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.435 -0.791 . . . . 0.0 110.006 -178.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 17.3 mttt -120.11 -38.46 2.93 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -82.51 164.14 48.79 Favored Pre-proline 0 N--CA 1.493 1.705 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.563 ' O ' ' NH2' ' A' ' 83' ' ' ARG . 5.6 Cg_endo -58.31 99.33 0.1 OUTLIER 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 121.773 1.649 . . . . 0.0 114.714 -176.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.27 102.97 1.48 Allowed 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -56.77 155.33 7.88 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-O 122.304 1.049 . . . . 0.0 112.51 -178.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.444 ' ND2' ' NH1' ' A' ' 66' ' ' ARG . 3.0 p30 -59.3 -178.2 0.06 Allowed 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.721 0.772 . . . . 0.0 111.148 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -70.1 2.19 3.88 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.669 -0.644 . . . . 0.0 112.354 -178.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.444 ' NH1' ' ND2' ' A' ' 64' ' ' ASN . 51.4 mtt85 -67.57 -40.97 84.87 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 120.68 -1.263 . . . . 0.0 109.679 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.484 ' N ' ' CD ' ' A' ' 67' ' ' GLU . 23.0 mp0 -72.26 -41.06 67.17 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.08 -1.013 . . . . 0.0 108.609 178.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.479 ' CD1' ' N ' ' A' ' 68' ' ' ILE . 1.4 mp -48.31 -30.26 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -70.15 -74.9 0.63 Allowed Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 9.0 ptp -46.38 -33.89 4.21 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.875 -1.368 . . . . 0.0 109.144 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.0 mt -58.04 -28.56 64.6 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.536 ' N ' ' O ' ' A' ' 69' ' ' GLY . 39.6 tt0 -79.71 5.11 14.22 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.368 -0.833 . . . . 0.0 108.771 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -122.99 31.57 5.98 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.555 -0.716 . . . . 0.0 110.122 -178.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.4 m -92.09 166.77 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 120.797 -1.189 . . . . 0.0 110.006 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.513 ' OG1' ' CG ' ' A' ' 106' ' ' TRP . 4.8 m -99.56 -8.08 25.02 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.806 -0.558 . . . . 0.0 110.249 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -107.36 169.74 8.39 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.113 -0.992 . . . . 0.0 110.354 -178.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.568 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -60.91 108.52 0.87 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.815 -0.553 . . . . 0.0 109.67 -179.553 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.5 tp -72.93 155.78 39.52 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 120.011 -1.681 . . . . 0.0 110.118 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 25.3 mmtm -117.15 153.54 49.78 Favored Pre-proline 0 C--N 1.292 -1.916 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 -178.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.4 -22.16 70.37 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 C-N-CA 121.173 1.249 . . . . 0.0 109.77 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.431 ' OD1' ' O ' ' A' ' 81' ' ' ASN . 1.1 p30 -111.77 19.66 17.8 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.867 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 21.6 m -58.24 162.69 3.39 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.542 -1.349 . . . . 0.0 109.746 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.563 ' NH2' ' O ' ' A' ' 61' ' ' PRO . 0.7 OUTLIER -171.72 146.28 2.09 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 118.32 -1.352 . . . . 0.0 111.169 179.447 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.444 ' CD1' ' N ' ' A' ' 84' ' ' LEU . 5.3 mp -76.62 116.01 16.9 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -57.51 -16.96 11.25 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.446 -0.784 . . . . 0.0 112.922 -176.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 30.5 p -85.85 -33.16 21.37 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 119.81 -1.806 . . . . 0.0 111.207 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.406 ' OE1' ' CD ' ' A' ' 67' ' ' GLU . 34.2 tt0 -87.53 32.05 0.73 Allowed 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.261 -1.525 . . . . 0.0 110.403 -179.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 41.3 mm -117.61 157.93 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 O-C-N 121.022 -1.049 . . . . 0.0 108.423 178.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 35.2 mm -130.5 122.7 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.488 ' SD ' ' OG ' ' A' ' 1' ' ' SER . 0.0 OUTLIER -86.54 155.84 20.32 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.137 -0.977 . . . . 0.0 108.622 -178.888 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 57.0 p -147.81 148.02 28.98 Favored Pre-proline 0 N--CA 1.492 1.663 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -58.08 -32.71 96.16 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 121.286 1.324 . . . . 0.0 111.018 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -64.82 -28.54 69.63 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.13 -0.981 . . . . 0.0 109.262 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.4 mt -99.37 27.59 5.11 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.401 -0.812 . . . . 0.0 109.492 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -58.9 138.45 57.36 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.876 -1.14 . . . . 0.0 109.361 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 107.22 9.75 29.01 Favored Glycine 0 N--CA 1.501 3.028 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 178.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 16.4 tt -65.09 130.05 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.842 -1.387 . . . . 0.0 111.113 -178.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.494 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 4.8 t -103.5 115.36 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.446 -0.784 . . . . 0.0 109.077 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.5 t -102.65 134.81 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 120.922 -1.112 . . . . 0.0 109.366 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -108.39 124.05 49.78 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.799 0.809 . . . . 0.0 109.661 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.1 t -111.11 124.12 33.58 Favored Pre-proline 0 N--CA 1.495 1.816 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -83.06 175.53 8.41 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 122.678 2.252 . . . . 0.0 113.37 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -83.5 -17.34 42.25 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -109.74 80.92 1.36 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.447 ' O ' ' OXT' ' A' ' 106' ' ' TRP . 39.5 tt0 -82.95 -33.27 26.77 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.116 -0.99 . . . . 0.0 109.177 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . 0.548 ' CG ' ' O ' ' A' ' 106' ' ' TRP . 57.3 t-105 . . . . . 0 C--N 1.301 -1.522 0 CA-C-O 118.294 -0.86 . . . . 0.0 109.788 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.447 ' OG ' ' O ' ' A' ' 17' ' ' VAL . 68.0 p . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 19.1 mmtm -76.96 113.88 15.14 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.98 -1.075 . . . . 0.0 108.534 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 49.5 t -115.0 109.91 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.442 -0.786 . . . . 0.0 110.076 -179.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.6 t -102.64 134.88 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 CA-C-O 121.749 0.785 . . . . 0.0 110.389 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -106.12 114.5 28.68 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 177.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 67.0 t -97.82 115.21 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 27.7 p -77.92 -160.28 0.19 Allowed 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.426 0.631 . . . . 0.0 109.674 -178.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.75 ' ND1' ' H ' ' A' ' 8' ' ' HIS . 0.2 OUTLIER -87.13 -47.23 9.06 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.563 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.459 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 17.8 p30 -70.52 -2.53 14.36 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.088 -1.007 . . . . 0.0 110.973 -178.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.12 0.0 57.26 Favored Glycine 0 N--CA 1.499 2.863 0 O-C-N 120.854 -1.154 . . . . 0.0 110.953 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -66.31 131.15 45.45 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.628 -1.513 . . . . 0.0 108.847 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.84 156.03 23.61 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.579 0.704 . . . . 0.0 110.979 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.3 mmm-85 -142.76 112.75 7.03 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 177.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.442 ' CD ' ' H ' ' A' ' 14' ' ' GLU . 2.6 mp0 -98.37 127.33 44.26 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.863 -1.148 . . . . 0.0 109.819 -178.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 19.4 mt -117.88 -165.19 1.07 Allowed 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 122.738 1.256 . . . . 0.0 110.0 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -137.13 99.77 4.09 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 104.942 -2.244 . . . . 0.0 104.942 176.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.447 ' O ' ' OG ' ' A' ' 1' ' ' SER . 12.8 t -102.63 115.36 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.33 177.17 4.05 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 122.359 1.076 . . . . 0.0 111.312 -178.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -65.69 133.34 50.88 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.975 0.893 . . . . 0.0 110.709 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.03 -18.4 53.83 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.3 t -85.36 138.64 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.585 -1.538 . . . . 0.0 109.175 -178.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.478 ' HG ' ' H ' ' A' ' 25' ' ' GLN . 59.9 p -93.38 146.35 23.8 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.266 -0.896 . . . . 0.0 109.458 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.5 mt -48.11 -34.17 9.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.001 -1.062 . . . . 0.0 109.406 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.49 ' O ' ' SD ' ' A' ' 24' ' ' MET . 4.3 tpt -67.55 -29.07 68.35 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.478 ' H ' ' HG ' ' A' ' 22' ' ' SER . 14.5 mm100 -73.74 -59.83 2.53 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.104 -0.997 . . . . 0.0 109.637 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.48 -24.42 65.26 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.878 -1.139 . . . . 0.0 111.22 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.4 -24.58 67.9 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.941 -1.099 . . . . 0.0 108.967 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 88.7 t -80.78 -23.52 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 CA-C-O 121.555 0.693 . . . . 0.0 109.148 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.25 -27.54 35.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.4 -0.812 . . . . 0.0 109.28 -179.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 . . . . . 0 C--N 1.303 -1.449 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 178.695 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 42.7 p . . . . . 0 N--CA 1.482 1.14 0 CA-C-O 121.159 0.504 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.497 ' SG ' ' O ' ' A' ' 48' ' ' CYS . 15.0 p -91.37 48.11 1.45 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.795 -1.191 . . . . 0.0 109.996 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.536 ' NE2' ' OH ' ' A' ' 51' ' ' TYR . 53.8 t60 -77.99 113.14 15.62 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.969 -1.082 . . . . 0.0 109.026 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -146.05 165.12 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.107 -0.996 . . . . 0.0 109.214 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.536 ' OH ' ' NE2' ' A' ' 49' ' ' HIS . 52.0 m-85 -114.03 111.57 21.86 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 121.667 0.746 . . . . 0.0 109.788 -178.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.444 ' O ' ' OD1' ' A' ' 81' ' ' ASN . 81.9 t -86.12 135.02 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.609 ' C ' ' H ' ' A' ' 55' ' ' ALA . 3.3 t30 -49.7 128.09 17.22 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.91 -1.119 . . . . 0.0 108.973 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -56.09 12.13 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.592 -0.692 . . . . 0.0 111.566 -178.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.609 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -101.06 -19.62 15.72 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.892 -1.13 . . . . 0.0 109.8 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.4 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 46.3 m-85 -110.78 -11.59 14.37 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.767 -1.208 . . . . 0.0 109.596 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.5 p -70.59 -38.3 74.03 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.81 -1.181 . . . . 0.0 110.012 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -85.85 9.71 15.93 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.184 -0.948 . . . . 0.0 110.092 -178.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.437 ' CE ' ' O ' ' A' ' 55' ' ' ALA . 9.6 mttm -121.11 -37.93 2.88 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -81.84 159.0 67.06 Favored Pre-proline 0 N--CA 1.494 1.748 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -48.7 101.96 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.029 1.819 . . . . 0.0 112.247 -178.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.9 101.44 4.41 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -49.63 144.05 6.44 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-O 121.878 0.847 . . . . 0.0 111.504 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -53.56 -175.17 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.658 0.742 . . . . 0.0 110.121 -179.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -69.5 -1.44 8.62 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.697 -0.627 . . . . 0.0 111.136 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.507 ' O ' ' SD ' ' A' ' 70' ' ' MET . 8.8 mtt85 -63.85 -39.92 95.36 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.769 -1.207 . . . . 0.0 109.439 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.441 ' N ' ' CD ' ' A' ' 67' ' ' GLU . 10.2 mp0 -78.18 -40.68 37.0 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.174 -0.953 . . . . 0.0 109.868 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.47 ' CD1' ' N ' ' A' ' 68' ' ' ILE . 1.4 mp -46.72 -25.33 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.49 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -76.66 -67.81 1.62 Allowed Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.066 -1.614 . . . . 0.0 109.066 179.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.507 ' SD ' ' O ' ' A' ' 66' ' ' ARG . 4.7 mpp? -49.28 -39.42 30.74 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.054 -1.262 . . . . 0.0 108.599 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.5 mt -55.2 -21.71 14.86 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.49 ' N ' ' O ' ' A' ' 69' ' ' GLY . 27.0 tt0 -91.08 12.46 19.8 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -124.93 31.04 5.74 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.446 -0.784 . . . . 0.0 110.085 -179.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -98.61 175.5 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.287 0 O-C-N 121.375 -0.828 . . . . 0.0 109.215 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.526 ' OG1' ' CD1' ' A' ' 106' ' ' TRP . 4.2 m -109.71 -0.61 18.46 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.342 -0.849 . . . . 0.0 110.026 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -107.45 167.44 9.93 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.053 -1.029 . . . . 0.0 109.882 -179.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.459 ' O ' ' CG ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -58.07 106.8 0.4 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.616 -0.677 . . . . 0.0 110.935 -178.767 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.2 tp -70.29 147.67 49.41 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 120.106 -1.621 . . . . 0.0 109.562 178.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.1 mmtp -112.78 156.04 43.13 Favored Pre-proline 0 C--N 1.29 -2.003 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -178.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -54.22 -22.14 25.02 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 121.349 1.366 . . . . 0.0 109.862 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.444 ' OD1' ' O ' ' A' ' 52' ' ' VAL . 0.1 OUTLIER -126.99 37.81 4.21 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.955 -0.465 . . . . 0.0 110.426 -179.887 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 37.5 m -60.49 175.46 0.45 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.365 -1.46 . . . . 0.0 108.445 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.433 ' HE ' HG12 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -166.24 159.86 15.43 Favored 'General case' 0 N--CA 1.504 2.227 0 C-N-CA 118.28 -1.368 . . . . 0.0 111.583 -178.183 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.413 ' C ' ' SG ' ' A' ' 48' ' ' CYS . 50.0 mt -105.75 95.35 5.74 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 178.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.52 ' C ' ' H ' ' A' ' 87' ' ' GLN . 0.1 OUTLIER -39.78 -44.34 1.57 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.553 -0.717 . . . . 0.0 112.848 -176.718 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 13.9 p -60.65 5.94 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 119.972 -1.705 . . . . 0.0 110.938 -177.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.52 ' H ' ' C ' ' A' ' 85' ' ' CYS . 13.6 mt-30 -136.02 45.39 2.39 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 120.937 -1.102 . . . . 0.0 111.664 -178.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.433 HG12 ' HE ' ' A' ' 83' ' ' ARG . 3.7 mt -131.77 156.18 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 O-C-N 121.074 -1.016 . . . . 0.0 108.602 177.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 38.3 mm -129.7 126.48 62.9 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.427 0 O-C-N 121.31 -0.869 . . . . 0.0 109.524 -178.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.434 ' SD ' HG22 ' A' ' 97' ' ' ILE . 4.1 tpt -91.05 163.51 14.28 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.106 -0.996 . . . . 0.0 110.38 -179.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 70.6 p -151.93 147.24 19.59 Favored Pre-proline 0 N--CA 1.488 1.469 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -56.35 -30.08 79.63 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 121.259 1.306 . . . . 0.0 111.568 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -68.96 -31.21 69.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.105 -0.997 . . . . 0.0 110.334 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.7 mt -95.58 32.72 1.75 Allowed 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.209 -0.932 . . . . 0.0 109.488 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -62.45 138.6 58.49 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.71 -1.244 . . . . 0.0 110.159 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 109.86 9.75 24.03 Favored Glycine 0 N--CA 1.504 3.187 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 178.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.434 HG22 ' SD ' ' A' ' 90' ' ' MET . 0.0 OUTLIER -65.04 129.89 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 120.996 -1.297 . . . . 0.0 111.555 -177.708 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.9 t -106.99 118.97 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.2 -0.937 . . . . 0.0 109.393 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.1 t -101.84 133.27 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.014 -1.054 . . . . 0.0 109.283 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.68 115.51 30.37 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 18.0 t -103.73 122.89 43.08 Favored Pre-proline 0 N--CA 1.494 1.736 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -82.16 177.8 6.9 Favored 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 121.975 1.784 . . . . 0.0 113.111 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -85.75 -13.78 47.26 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.7 86.89 2.65 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -178.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -85.05 -28.76 25.45 Favored 'General case' 0 C--N 1.308 -1.207 0 O-C-N 121.115 -0.99 . . . . 0.0 109.312 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . 0.526 ' CD1' ' OG1' ' A' ' 75' ' ' THR . 62.5 t-105 . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.611 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.448 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.69 110.66 17.95 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 53.6 t -108.59 108.58 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.268 -0.895 . . . . 0.0 110.058 -179.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 62.9 t -99.11 126.31 52.39 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-O 121.97 0.89 . . . . 0.0 110.278 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -103.45 112.95 26.08 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 177.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 64.7 t -99.63 120.88 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.567 ' HG ' ' N ' ' A' ' 8' ' ' HIS . 3.7 p -82.44 -153.28 0.12 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.238 -0.913 . . . . 0.0 109.319 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.703 ' ND1' ' H ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -91.14 -44.35 9.31 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.458 -0.776 . . . . 0.0 109.393 -179.908 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 0.5 OUTLIER -66.93 -0.87 3.4 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.217 -0.927 . . . . 0.0 111.317 -178.444 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.5 0.52 69.78 Favored Glycine 0 N--CA 1.498 2.826 0 O-C-N 120.427 -1.421 . . . . 0.0 110.618 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.1 t -72.46 135.7 45.8 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.938 -1.331 . . . . 0.0 108.31 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.29 163.9 12.64 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 122.204 1.002 . . . . 0.0 111.048 -178.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 -151.02 112.77 4.47 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -100.24 127.77 46.45 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-O 122.561 1.172 . . . . 0.0 111.127 -178.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.63 -174.97 2.58 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-O 122.811 1.291 . . . . 0.0 110.301 -177.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -134.26 100.62 4.74 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 176.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.6 t -111.21 115.79 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.15 177.14 3.4 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.884 0.85 . . . . 0.0 111.495 -177.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -66.02 138.55 57.87 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 122.014 0.911 . . . . 0.0 110.325 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.42 -18.11 35.13 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 178.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 51.9 t -83.79 140.68 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 120.704 -1.468 . . . . 0.0 109.326 -178.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 51.5 p -93.58 147.69 22.77 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.231 -0.918 . . . . 0.0 109.131 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.9 mt -50.23 -31.9 15.16 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.193 -0.942 . . . . 0.0 109.477 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.448 ' SD ' ' C ' ' A' ' 24' ' ' MET . 1.4 tmt? -68.64 -29.58 68.1 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 52.5 mm-40 -72.05 -63.76 1.07 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.063 -1.023 . . . . 0.0 109.355 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.35 -25.6 62.16 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.996 -1.065 . . . . 0.0 110.374 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.27 -20.47 59.15 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.974 -1.079 . . . . 0.0 108.981 179.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 84.1 t -86.54 -22.62 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.637 -0.664 . . . . 0.0 109.636 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.484 ' OG ' ' ND2' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -79.74 -26.74 40.66 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.443 -0.786 . . . . 0.0 109.075 -179.525 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.484 ' ND2' ' OG ' ' A' ' 29' ' ' SER . 2.4 m-80 . . . . . 0 N--CA 1.484 1.249 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 11.1 m . . . . . 0 N--CA 1.483 1.181 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.525 ' SG ' ' N ' ' A' ' 85' ' ' CYS . 31.9 p -80.11 53.76 1.8 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 120.944 -1.098 . . . . 0.0 109.605 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.512 ' NE2' ' OH ' ' A' ' 51' ' ' TYR . 39.3 t60 -77.64 105.61 8.91 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -143.62 164.83 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 120.859 -1.151 . . . . 0.0 109.889 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.565 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 36.4 m-85 -111.56 111.01 21.71 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.921 0.867 . . . . 0.0 110.101 -179.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.44 ' O ' ' OD1' ' A' ' 81' ' ' ASN . 15.2 t -85.9 130.62 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.617 ' C ' ' H ' ' A' ' 55' ' ' ALA . 17.8 t-20 -47.11 126.18 8.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.783 -1.198 . . . . 0.0 109.566 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -57.32 13.99 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.737 -0.602 . . . . 0.0 111.291 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.617 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -100.7 -18.99 16.25 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.729 -1.232 . . . . 0.0 109.781 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -113.85 -10.93 12.92 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.098 -1.001 . . . . 0.0 109.078 -178.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 13.1 p -68.99 -43.18 75.39 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.37 -0.831 . . . . 0.0 109.952 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -81.47 4.64 20.36 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.575 -0.703 . . . . 0.0 109.743 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 21.1 mtpt -113.19 -38.29 4.49 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.403 HG11 HH12 ' A' ' 83' ' ' ARG . 0.5 OUTLIER -82.8 158.57 65.0 Favored Pre-proline 0 N--CA 1.497 1.879 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 179.701 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.556 ' O ' ' NH2' ' A' ' 83' ' ' ARG . 1.1 Cg_endo -51.33 84.93 0.02 OUTLIER 'Trans proline' 0 N--CA 1.501 1.939 0 C-N-CA 122.405 2.07 . . . . 0.0 113.792 -176.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.79 105.17 0.28 Allowed 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -56.86 150.76 15.79 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-O 122.235 1.017 . . . . 0.0 112.667 -178.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.434 ' H ' ' ND2' ' A' ' 64' ' ' ASN . 0.6 OUTLIER -61.61 -172.84 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.032 -179.847 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -71.07 1.9 5.19 Favored 'General case' 0 N--CA 1.503 2.198 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -178.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.2 mtm180 -73.77 -46.74 43.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.386 -1.446 . . . . 0.0 109.087 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.443 ' N ' ' CD ' ' A' ' 67' ' ' GLU . 9.2 mp0 -64.39 -25.14 67.89 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.234 -0.916 . . . . 0.0 109.054 178.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.525 ' CD1' ' N ' ' A' ' 68' ' ' ILE . 1.4 mp -68.3 -34.74 67.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.032 -1.042 . . . . 0.0 108.839 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.82 -23.8 59.39 Favored Glycine 0 N--CA 1.496 2.672 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.434 ' N ' ' SD ' ' A' ' 70' ' ' MET . 0.9 OUTLIER -88.81 -31.54 18.28 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.911 -1.347 . . . . 0.0 107.571 178.931 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 52.8 mt -67.74 -23.04 65.21 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -80.34 0.89 31.04 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -121.91 32.61 5.78 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.605 -0.684 . . . . 0.0 110.254 -178.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 29.3 m -94.69 167.21 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 O-C-N 121.126 -0.984 . . . . 0.0 110.796 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.479 ' OG1' ' CG ' ' A' ' 106' ' ' TRP . 3.4 m -104.24 -4.87 22.47 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.378 -0.826 . . . . 0.0 109.883 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -107.88 170.85 7.74 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.014 -1.053 . . . . 0.0 110.749 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.565 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -61.54 107.67 0.84 Allowed 'General case' 0 N--CA 1.5 2.037 0 CA-C-O 121.532 0.682 . . . . 0.0 110.034 -179.716 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.404 ' HG ' ' H ' ' A' ' 79' ' ' LYS . 8.6 tp -69.6 159.88 32.57 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 119.606 -1.934 . . . . 0.0 110.303 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.404 ' H ' ' HG ' ' A' ' 78' ' ' LEU . 18.7 mmtp -123.27 154.26 65.36 Favored Pre-proline 0 C--N 1.297 -1.715 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 -178.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -58.07 -23.6 61.72 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 121.537 1.491 . . . . 0.0 110.014 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 52' ' ' VAL . 1.5 p30 -117.07 27.72 8.95 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.99 -0.444 . . . . 0.0 109.837 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.0 m -58.48 166.68 1.67 Allowed 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.373 -1.455 . . . . 0.0 109.452 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.556 ' NH2' ' O ' ' A' ' 61' ' ' PRO . 0.5 OUTLIER -172.32 153.43 2.98 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.122 -1.031 . . . . 0.0 111.267 179.549 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.625 ' H ' ' CD1' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -83.34 129.04 34.97 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 177.887 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.525 ' N ' ' SG ' ' A' ' 48' ' ' CYS . 0.5 OUTLIER -75.2 -6.11 47.96 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.718 -1.239 . . . . 0.0 112.584 -176.601 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 27.7 p -89.41 -33.65 16.77 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.281 -1.512 . . . . 0.0 110.722 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -92.33 49.54 1.52 Allowed 'General case' 0 N--CA 1.504 2.226 0 O-C-N 120.979 -1.076 . . . . 0.0 110.467 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 30.6 mt -130.56 154.26 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 36.5 mm -129.19 127.79 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.348 0 O-C-N 121.249 -0.907 . . . . 0.0 109.7 -178.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 8.1 tpt -89.02 161.17 16.73 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.908 -1.12 . . . . 0.0 110.099 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.6 p -151.19 149.53 24.98 Favored Pre-proline 0 N--CA 1.491 1.62 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.6 -39.51 82.16 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 121.626 1.55 . . . . 0.0 111.754 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -64.16 -24.93 67.86 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.143 -0.973 . . . . 0.0 108.842 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 14.1 mt -99.52 23.99 8.74 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.434 -0.792 . . . . 0.0 109.577 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.442 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 18.7 p-10 -65.88 140.87 58.39 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.169 -0.957 . . . . 0.0 109.621 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 106.69 7.73 33.54 Favored Glycine 0 N--CA 1.506 3.338 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 178.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -61.71 127.65 21.89 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 O-C-N 121.707 -0.878 . . . . 0.0 110.346 -178.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.3 t -103.74 115.38 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.244 -0.91 . . . . 0.0 109.728 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.5 t -101.65 134.37 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.926 -1.109 . . . . 0.0 109.851 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.49 123.63 49.18 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 121.884 0.85 . . . . 0.0 108.722 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.3 t -112.97 126.37 28.35 Favored Pre-proline 0 N--CA 1.497 1.919 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -84.52 178.07 5.27 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.797 2.331 . . . . 0.0 113.031 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.424 ' OD2' ' CD2' ' A' ' 8' ' ' HIS . 1.0 OUTLIER -84.2 -17.99 38.08 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.57 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -107.68 83.15 1.76 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.582 ' H ' ' NE2' ' A' ' 105' ' ' GLN . 1.3 pm0 -84.69 -31.66 24.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.911 -1.118 . . . . 0.0 108.887 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . 0.479 ' CG ' ' OG1' ' A' ' 75' ' ' THR . 57.4 t-105 . . . . . 0 C--N 1.3 -1.568 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.145 178.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.456 ' H3 ' ' H ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 27.2 mmtt -76.19 107.14 8.21 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.403 -0.919 . . . . 0.0 108.718 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.7 t -107.09 109.97 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 O-C-N 121.176 -0.952 . . . . 0.0 109.201 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.9 t -98.82 94.19 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.039 -1.038 . . . . 0.0 110.59 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -68.06 114.65 6.76 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 71.5 t -98.75 112.07 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.115 -0.99 . . . . 0.0 108.434 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 63.6 p -72.7 -160.08 0.07 Allowed 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.554 0.692 . . . . 0.0 109.517 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.734 ' ND1' ' H ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -88.9 -50.93 5.9 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.183 -0.948 . . . . 0.0 108.625 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.504 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 10.1 p30 -64.94 2.71 0.67 Allowed 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 119.804 -0.759 . . . . 0.0 110.442 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.522 ' O ' ' NH1' ' A' ' 12' ' ' ARG . . . 93.83 -3.09 70.39 Favored Glycine 0 N--CA 1.496 2.693 0 O-C-N 120.731 -1.23 . . . . 0.0 110.08 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.09 128.04 34.22 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.932 -1.334 . . . . 0.0 108.438 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.522 ' NH1' ' O ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -108.63 159.54 16.65 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.51 -0.744 . . . . 0.0 111.197 -178.782 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.2 mtt85 -150.08 115.72 5.54 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 178.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -97.82 126.93 43.44 Favored 'General case' 0 N--CA 1.502 2.158 0 CA-C-O 122.633 1.206 . . . . 0.0 110.607 -178.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.516 ' CD1' ' H ' ' A' ' 16' ' ' ASP . 0.2 OUTLIER -111.9 -175.43 2.69 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 123.132 1.444 . . . . 0.0 111.589 -177.723 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.516 ' H ' ' CD1' ' A' ' 15' ' ' LEU . 11.1 t70 -137.06 101.57 4.59 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 104.548 -2.39 . . . . 0.0 104.548 176.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.456 ' H ' ' H3 ' ' A' ' 1' ' ' SER . 11.8 t -109.67 119.03 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.56 176.33 4.18 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.188 -0.945 . . . . 0.0 111.141 -177.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -65.64 137.08 57.09 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.953 0.882 . . . . 0.0 110.691 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.92 -17.07 23.99 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 178.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.8 t -77.64 139.8 18.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 O-C-N 120.428 -1.631 . . . . 0.0 108.479 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 25' ' ' GLN . 59.5 p -94.16 143.7 26.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.105 -0.997 . . . . 0.0 109.093 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 49.6 mt -45.45 -37.14 4.9 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.08 -1.013 . . . . 0.0 109.766 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.492 ' O ' ' SD ' ' A' ' 24' ' ' MET . 5.6 tpt -65.62 -26.43 67.82 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.388 -0.82 . . . . 0.0 109.355 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' A' ' 22' ' ' SER . 13.8 mm100 -75.31 -63.23 1.32 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.183 -0.948 . . . . 0.0 109.702 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.449 ' O ' ' OD1' ' A' ' 30' ' ' ASN . . . -59.94 -26.49 66.02 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.657 -1.277 . . . . 0.0 110.906 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.44 -20.39 66.14 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.585 -1.322 . . . . 0.0 109.011 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 70.6 t -86.51 -25.69 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.438 -0.789 . . . . 0.0 109.587 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.96 -24.55 60.81 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.362 -0.836 . . . . 0.0 109.042 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.449 ' OD1' ' O ' ' A' ' 26' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.303 -1.435 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 179.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.439 ' O ' ' OE1' ' A' ' 105' ' ' GLN . 3.1 m . . . . . 0 N--CA 1.483 1.181 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.592 ' SG ' ' N ' ' A' ' 85' ' ' CYS . 18.3 p -97.7 54.18 1.15 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.867 -1.146 . . . . 0.0 109.744 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.52 ' NE2' ' OH ' ' A' ' 51' ' ' TYR . 43.3 t60 -75.89 110.43 10.33 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.114 -0.991 . . . . 0.0 109.113 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -146.52 166.94 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 120.813 -1.179 . . . . 0.0 109.582 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.583 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 37.4 m-85 -115.85 115.38 26.15 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.857 0.837 . . . . 0.0 109.815 -179.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 13.3 t -89.46 129.48 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.592 ' C ' ' H ' ' A' ' 55' ' ' ALA . 19.0 t-20 -46.15 131.01 10.32 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.107 -0.996 . . . . 0.0 109.753 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.412 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 9.7 pt-20 -57.01 8.16 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.395 -0.816 . . . . 0.0 111.025 -179.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.592 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -95.96 -23.13 16.99 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.636 -1.29 . . . . 0.0 110.113 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -111.25 -6.71 14.5 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.901 -1.124 . . . . 0.0 108.894 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 25.3 p -70.87 -42.14 70.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.643 -0.661 . . . . 0.0 109.806 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -82.8 0.93 41.57 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.59 -0.694 . . . . 0.0 109.894 -179.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 15.7 mttt -109.99 -38.72 5.25 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -84.73 158.19 59.83 Favored Pre-proline 0 N--CA 1.496 1.835 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.41 ' O ' ' NH1' ' A' ' 83' ' ' ARG . 1.3 Cg_endo -54.49 110.97 0.59 Allowed 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 121.714 1.609 . . . . 0.0 113.698 -177.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.37 112.8 12.06 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.899 ' H ' ' NH1' ' A' ' 83' ' ' ARG . . . -53.81 144.33 18.68 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-O 122.286 1.041 . . . . 0.0 112.073 -178.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.439 HD22 ' NH2' ' A' ' 66' ' ' ARG . 1.3 p30 -66.37 -167.73 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.678 0.751 . . . . 0.0 110.636 -179.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -69.47 -6.67 32.0 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.667 -0.646 . . . . 0.0 112.127 -178.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.508 ' O ' ' SD ' ' A' ' 70' ' ' MET . 69.3 mtm-85 -65.03 -44.61 88.55 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 120.424 -1.422 . . . . 0.0 109.405 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -74.27 -39.53 62.93 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.153 -0.967 . . . . 0.0 109.35 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 39.5 mt -48.02 -25.33 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.335 -0.853 . . . . 0.0 109.574 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -82.29 -40.64 9.93 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.508 ' SD ' ' O ' ' A' ' 66' ' ' ARG . 4.3 mpp? -72.05 -34.59 68.88 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 178.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 46.1 mt -63.99 -27.75 69.34 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -79.14 2.79 19.64 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.042 -1.037 . . . . 0.0 108.472 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -120.86 28.14 8.09 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.74 -0.6 . . . . 0.0 110.713 -178.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.9 m -95.96 169.53 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 O-C-N 120.844 -1.16 . . . . 0.0 109.975 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.476 ' OG1' ' CD2' ' A' ' 106' ' ' TRP . 3.7 m -106.29 -6.78 18.14 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.435 -0.79 . . . . 0.0 111.957 -178.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.414 ' HB3' ' HE2' ' A' ' 49' ' ' HIS . . . -106.16 174.7 5.77 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 120.56 -1.338 . . . . 0.0 110.572 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.583 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -56.1 104.39 0.14 Allowed 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.833 -0.542 . . . . 0.0 111.26 -178.516 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.4 tp -69.98 149.44 47.73 Favored 'General case' 0 C--N 1.295 -1.794 0 O-C-N 120.186 -1.572 . . . . 0.0 109.366 178.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.451 ' NZ ' ' OE2' ' A' ' 77' ' ' GLU . 27.2 mmtm -115.31 156.57 45.51 Favored Pre-proline 0 C--N 1.287 -2.133 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -178.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -56.97 -21.51 41.8 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 121.358 1.372 . . . . 0.0 109.629 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -120.33 28.1 8.22 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.422 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 37.2 m -57.6 158.38 6.07 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 120.07 -1.644 . . . . 0.0 108.885 179.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.899 ' NH1' ' H ' ' A' ' 63' ' ' ALA . 1.6 mtp85 -169.47 159.6 8.65 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 118.763 -1.175 . . . . 0.0 111.042 -178.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.575 ' CD2' ' N ' ' A' ' 84' ' ' LEU . 2.7 mm? -84.21 123.83 30.53 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 179.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.592 ' N ' ' SG ' ' A' ' 48' ' ' CYS . 0.5 OUTLIER -64.11 -16.48 61.91 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.197 -0.94 . . . . 0.0 113.145 -176.556 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . 0.422 ' C ' ' H ' ' A' ' 88' ' ' ILE . 22.2 p -81.65 -43.46 18.51 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 119.708 -1.87 . . . . 0.0 110.955 -178.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.652 HE22 ' CZ ' ' A' ' 83' ' ' ARG . 5.2 pp0? -75.61 29.57 0.1 Allowed 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.972 -1.08 . . . . 0.0 111.169 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.422 ' H ' ' C ' ' A' ' 86' ' ' CYS . 38.4 mt -116.03 151.42 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.295 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 178.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.5 mp -131.44 125.52 56.71 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.235 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -178.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.449 ' CG ' ' HG ' ' A' ' 1' ' ' SER . 1.9 tpt -87.49 161.8 17.6 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.089 -1.007 . . . . 0.0 109.571 -179.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.6 p -152.08 149.32 23.08 Favored Pre-proline 0 N--CA 1.489 1.484 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -54.56 -39.29 89.06 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 121.74 1.626 . . . . 0.0 111.643 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -64.03 -24.21 67.62 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.169 -0.957 . . . . 0.0 109.49 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 13.9 mt -101.73 18.88 19.3 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.449 -0.782 . . . . 0.0 109.434 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -61.44 139.53 58.2 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.407 -0.808 . . . . 0.0 109.946 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 105.55 8.21 35.53 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 178.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.75 138.39 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.207 -1.172 . . . . 0.0 111.878 -177.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.5 t -106.48 117.81 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.665 -0.647 . . . . 0.0 109.328 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.8 t -102.74 136.91 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 120.761 -1.212 . . . . 0.0 108.568 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -108.16 114.75 28.88 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.76 0.791 . . . . 0.0 108.88 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.4 t -102.47 124.77 38.18 Favored Pre-proline 0 N--CA 1.495 1.813 0 O-C-N 121.883 -0.511 . . . . 0.0 109.78 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -81.71 169.61 14.98 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 122.515 2.143 . . . . 0.0 113.88 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -75.61 -15.47 60.34 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.187 0.517 . . . . 0.0 109.649 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 27.4 mtm180 -122.31 93.38 3.96 Favored 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.439 ' OE1' ' O ' ' A' ' 47' ' ' THR . 35.5 tt0 -82.26 -16.96 47.66 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.651 -0.656 . . . . 0.0 109.826 -178.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . 0.476 ' CD2' ' OG1' ' A' ' 75' ' ' THR . 61.3 t-105 . . . . . 0 C--N 1.304 -1.397 0 CA-C-O 117.948 -1.025 . . . . 0.0 110.45 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.8 mmtm -77.27 117.12 18.48 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 72.5 t -115.78 109.61 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.334 -0.854 . . . . 0.0 111.048 -178.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 33.6 t -98.9 93.17 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 CA-C-O 122.209 1.004 . . . . 0.0 111.178 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -67.8 113.71 5.77 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 177.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 99.7 t -99.0 116.7 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 120.991 -1.068 . . . . 0.0 108.939 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.427 ' OG ' ' OD1' ' A' ' 9' ' ' ASP . 79.3 p -75.38 -157.71 0.07 Allowed 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.692 ' ND1' ' H ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -92.13 -48.51 6.68 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.217 -0.927 . . . . 0.0 109.105 -179.672 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.487 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 8.5 p30 -65.39 1.75 1.05 Allowed 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.323 -0.861 . . . . 0.0 110.7 -178.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.403 ' H ' ' C ' ' A' ' 8' ' ' HIS . . . 94.96 -3.45 67.19 Favored Glycine 0 N--CA 1.495 2.606 0 O-C-N 120.717 -1.239 . . . . 0.0 110.262 179.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -65.6 129.05 38.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.779 -1.424 . . . . 0.0 108.25 179.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 29.8 mtm180 -108.25 145.19 34.67 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.879 -0.513 . . . . 0.0 110.986 -178.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.16 114.85 16.22 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 178.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -98.6 122.97 42.49 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.51 -0.744 . . . . 0.0 110.237 -178.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 30.4 mt -120.28 -166.04 1.26 Allowed 'General case' 0 N--CA 1.502 2.13 0 CA-C-O 122.746 1.26 . . . . 0.0 109.729 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -134.41 99.81 4.48 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 104.623 -2.362 . . . . 0.0 104.623 176.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.6 t -101.4 117.8 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.276 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.07 178.03 5.97 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 122.366 1.079 . . . . 0.0 112.116 -177.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -64.65 130.38 43.38 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-O 121.981 0.896 . . . . 0.0 111.117 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.74 -17.05 54.96 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 178.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 64.8 t -78.82 134.54 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 120.503 -1.586 . . . . 0.0 108.805 -179.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 25' ' ' GLN . 4.2 p -80.59 139.77 36.11 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.027 -1.046 . . . . 0.0 108.847 179.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 31.5 mt -45.06 -33.03 1.94 Allowed 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.013 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 9.7 ttt -77.61 -33.07 53.84 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.426 -0.796 . . . . 0.0 109.217 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.419 ' N ' ' O ' ' A' ' 22' ' ' SER . 39.6 mm-40 -59.34 -56.62 19.73 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.457 -0.897 . . . . 0.0 108.796 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.2 -26.55 62.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.829 -1.169 . . . . 0.0 110.512 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.74 -21.59 55.69 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.93 -1.106 . . . . 0.0 108.802 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 54.7 t -86.58 -23.47 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.49 -0.756 . . . . 0.0 109.819 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.443 ' HG ' HD21 ' A' ' 30' ' ' ASN . 0.0 OUTLIER -75.81 -29.79 58.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.281 -0.887 . . . . 0.0 108.728 -179.442 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.443 HD21 ' HG ' ' A' ' 29' ' ' SER . 4.8 m-80 . . . . . 0 C--N 1.303 -1.448 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 24.8 m . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.498 ' SG ' ' O ' ' A' ' 48' ' ' CYS . 14.1 p -90.77 47.96 1.48 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.862 -1.149 . . . . 0.0 109.533 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.529 ' NE2' ' OH ' ' A' ' 51' ' ' TYR . 24.5 t60 -76.21 99.64 4.79 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -133.62 170.7 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.15 -0.969 . . . . 0.0 110.254 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.567 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 36.9 m-85 -116.46 113.3 22.64 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 122.056 0.932 . . . . 0.0 110.057 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.7 t -86.87 129.15 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.622 ' C ' ' H ' ' A' ' 55' ' ' ALA . 16.2 t-20 -46.62 127.35 9.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.034 -1.042 . . . . 0.0 109.662 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -55.76 10.08 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.611 -0.681 . . . . 0.0 111.487 -178.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.622 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -98.65 -19.95 17.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.807 -1.183 . . . . 0.0 109.829 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.427 ' CD2' ' HB ' ' A' ' 97' ' ' ILE . 39.1 m-85 -113.85 -6.94 13.22 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.919 -1.113 . . . . 0.0 108.574 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.528 ' CA ' HH12 ' A' ' 83' ' ' ARG . 22.5 p -69.76 -43.7 71.68 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.654 0.74 . . . . 0.0 110.138 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -83.5 14.05 4.03 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.964 -0.694 . . . . 0.0 109.228 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.2 mtpt -124.76 -38.74 2.34 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -85.8 164.7 38.51 Favored Pre-proline 0 N--CA 1.5 2.06 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 179.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -59.56 105.0 0.24 Allowed 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 121.208 1.272 . . . . 0.0 114.001 -176.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.472 ' HA ' ' NH2' ' A' ' 83' ' ' ARG . . . -74.43 104.65 5.24 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 177.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -47.09 140.66 4.86 Favored 'General case' 0 C--N 1.287 -2.149 0 CA-C-O 122.061 0.934 . . . . 0.0 111.437 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.473 ' N ' ' OD1' ' A' ' 64' ' ' ASN . 2.6 p30 -58.62 -169.81 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.404 0.621 . . . . 0.0 110.486 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -65.31 0.35 1.47 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.292 -0.88 . . . . 0.0 111.197 -178.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.506 ' O ' ' SD ' ' A' ' 70' ' ' MET . 0.3 OUTLIER -69.44 -45.01 70.14 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.681 -1.262 . . . . 0.0 108.843 -179.913 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.446 ' O ' ' N ' ' A' ' 69' ' ' GLY . 2.5 tt0 -73.82 -49.11 26.75 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.389 -0.819 . . . . 0.0 110.107 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.477 ' CD1' ' N ' ' A' ' 68' ' ' ILE . 1.4 mp -45.43 -19.76 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.395 -0.816 . . . . 0.0 109.508 -179.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.543 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -81.12 -73.39 1.19 Allowed Glycine 0 N--CA 1.497 2.748 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.506 ' SD ' ' O ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -47.38 -39.18 14.65 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.013 -1.286 . . . . 0.0 108.402 179.576 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.511 ' C ' ' H ' ' A' ' 73' ' ' CYS . 24.0 mt -57.14 -34.02 67.99 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 177.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.543 ' N ' ' O ' ' A' ' 69' ' ' GLY . 6.6 tp10 -73.77 12.28 0.69 Allowed 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.106 -0.996 . . . . 0.0 108.331 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.511 ' H ' ' C ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -133.07 36.14 3.48 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.524 -0.735 . . . . 0.0 110.19 -178.463 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.7 m -97.76 174.5 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.363 0 O-C-N 120.951 -1.093 . . . . 0.0 109.741 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.539 ' OG1' ' CG ' ' A' ' 106' ' ' TRP . 5.5 m -104.4 -9.32 18.54 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.016 -1.053 . . . . 0.0 111.295 -179.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -106.55 170.09 8.14 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.764 -1.21 . . . . 0.0 110.315 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.567 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -53.45 105.28 0.12 Allowed 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.841 -0.537 . . . . 0.0 111.126 -179.083 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.0 tp -74.0 140.5 45.52 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 120.084 -1.635 . . . . 0.0 108.857 178.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.8 mmtp -102.07 157.21 34.13 Favored Pre-proline 0 C--N 1.289 -2.065 0 CA-C-N 114.876 -1.056 . . . . 0.0 108.588 -178.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -58.9 -19.3 46.78 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 121.631 1.554 . . . . 0.0 109.095 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.413 ' OD1' ' O ' ' A' ' 81' ' ' ASN . 2.7 p30 -121.99 27.68 7.94 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.076 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 44.3 m -58.42 169.18 0.93 Allowed 'General case' 0 C--N 1.307 -1.274 0 O-C-N 120.287 -1.508 . . . . 0.0 108.74 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.528 HH12 ' CA ' ' A' ' 57' ' ' THR . 0.7 OUTLIER -171.9 150.6 2.62 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 118.621 -1.231 . . . . 0.0 110.985 -179.477 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.441 ' C ' ' SG ' ' A' ' 48' ' ' CYS . 82.5 mt -88.83 96.27 10.62 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.45 ' N ' ' SG ' ' A' ' 48' ' ' CYS . 0.1 OUTLIER -34.19 -42.03 0.12 Allowed 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -177.431 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 28.5 p -64.58 -28.48 69.66 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 119.932 -1.73 . . . . 0.0 111.392 -178.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 12.7 tp60 -91.56 35.83 0.95 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.98 -1.075 . . . . 0.0 110.703 -179.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.412 ' CG2' ' N ' ' A' ' 89' ' ' ILE . 39.7 mm -130.14 161.19 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.308 0 O-C-N 121.282 -0.886 . . . . 0.0 109.192 179.011 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.412 ' N ' ' CG2' ' A' ' 88' ' ' ILE . 1.4 mp -133.87 128.59 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.32 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.422 ' SD ' HG22 ' A' ' 97' ' ' ILE . 4.9 tpt -90.54 164.21 14.32 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.311 -0.868 . . . . 0.0 109.347 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 38.4 p -148.89 145.63 20.08 Favored Pre-proline 0 C--N 1.3 -1.553 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.85 -37.86 91.57 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 121.278 1.319 . . . . 0.0 111.295 -178.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -59.37 -29.51 67.75 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.111 -0.993 . . . . 0.0 109.147 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.2 mt -93.75 35.96 1.12 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.555 -0.716 . . . . 0.0 109.819 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -65.49 136.29 56.24 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.684 -1.26 . . . . 0.0 110.319 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 111.94 8.52 22.04 Favored Glycine 0 N--CA 1.506 3.362 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 178.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.427 ' HB ' ' CD2' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -66.24 124.66 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.583 -0.951 . . . . 0.0 110.378 -178.043 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 6.5 t -104.72 116.06 47.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.162 -0.961 . . . . 0.0 109.967 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 t -100.08 135.17 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 120.756 -1.215 . . . . 0.0 109.458 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 51' ' ' TYR . 0.5 OUTLIER -109.68 122.82 48.32 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.494 -0.754 . . . . 0.0 109.169 -179.898 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 5.3 t -113.32 128.29 25.84 Favored Pre-proline 0 N--CA 1.499 2.014 0 O-C-N 121.643 -0.661 . . . . 0.0 109.802 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -81.42 174.03 10.98 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 122.417 2.078 . . . . 0.0 113.81 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 103' ' ' ASP . 1.6 p-10 -80.47 -12.63 59.52 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-O 121.683 0.754 . . . . 0.0 108.991 178.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.53 86.86 2.65 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 -177.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.441 ' O ' ' O ' ' A' ' 106' ' ' TRP . 12.8 pt20 -81.69 -32.38 31.75 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . 0.539 ' CG ' ' OG1' ' A' ' 75' ' ' THR . 61.9 t-105 . . . . . 0 C--N 1.301 -1.506 0 CA-C-O 118.354 -0.832 . . . . 0.0 110.063 178.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.511 ' HG ' ' CG ' ' A' ' 90' ' ' MET . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.39 117.64 32.07 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.446 -0.784 . . . . 0.0 109.278 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.2 t -115.91 109.75 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.301 -0.874 . . . . 0.0 109.691 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.2 t -99.77 130.07 49.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.162 -0.961 . . . . 0.0 110.188 178.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -103.59 116.63 32.72 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 78.8 t -98.71 115.69 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 30.9 p -75.56 -161.48 0.16 Allowed 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 121.584 0.707 . . . . 0.0 109.641 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.738 ' ND1' ' H ' ' A' ' 8' ' ' HIS . 0.1 OUTLIER -86.88 -47.62 8.86 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.652 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.491 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 17.3 p30 -71.06 1.97 5.07 Favored 'General case' 0 C--N 1.307 -1.249 0 O-C-N 121.148 -0.97 . . . . 0.0 110.928 -178.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.71 1.85 60.05 Favored Glycine 0 N--CA 1.498 2.773 0 O-C-N 120.852 -1.155 . . . . 0.0 110.868 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -67.87 127.37 32.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.809 -1.406 . . . . 0.0 108.913 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -105.03 157.07 17.49 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.597 -0.689 . . . . 0.0 110.059 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.52 116.04 5.47 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -99.67 124.24 44.71 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 122.626 1.203 . . . . 0.0 111.341 -178.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.425 ' CD1' ' H ' ' A' ' 16' ' ' ASP . 0.2 OUTLIER -110.05 -176.51 3.01 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-O 122.99 1.376 . . . . 0.0 110.875 -178.843 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.425 ' H ' ' CD1' ' A' ' 15' ' ' LEU . 24.8 t0 -134.67 100.38 4.61 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 105.181 -2.155 . . . . 0.0 105.181 176.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.4 t -108.71 115.3 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.339 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.81 174.91 3.94 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.312 -0.868 . . . . 0.0 111.609 -177.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.03 137.5 57.75 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.952 0.882 . . . . 0.0 110.91 -178.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.62 -13.93 53.73 Favored Glycine 0 N--CA 1.493 2.435 0 C-N-CA 120.519 -0.848 . . . . 0.0 111.182 178.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 94.8 t -80.82 142.25 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.344 -1.68 . . . . 0.0 109.455 -178.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.427 ' OG ' ' OE1' ' A' ' 25' ' ' GLN . 1.2 p -87.82 142.6 27.69 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.559 -0.856 . . . . 0.0 109.176 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -46.95 -40.85 15.1 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 121.247 -0.908 . . . . 0.0 109.507 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 5.8 tpt -65.36 -35.63 81.55 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.046 -1.034 . . . . 0.0 109.531 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.443 ' NE2' ' N ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -60.74 -61.17 2.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.052 -1.03 . . . . 0.0 109.075 -179.421 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.55 -27.55 66.32 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.569 -1.332 . . . . 0.0 110.522 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.99 -20.85 66.2 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.741 -1.225 . . . . 0.0 108.57 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 69.8 t -87.03 -27.79 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.613 -0.679 . . . . 0.0 109.654 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.446 ' HG ' HD21 ' A' ' 30' ' ' ASN . 0.0 OUTLIER -72.52 -23.56 61.03 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.843 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.446 HD21 ' HG ' ' A' ' 29' ' ' SER . 2.3 m-80 . . . . . 0 C--N 1.302 -1.477 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 32.2 p . . . . . 0 N--CA 1.482 1.174 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.497 ' SG ' ' O ' ' A' ' 48' ' ' CYS . 21.9 p -79.68 57.0 2.37 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.928 -1.108 . . . . 0.0 110.217 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.495 ' NE2' ' OH ' ' A' ' 51' ' ' TYR . 38.0 t60 -76.59 106.05 8.01 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -139.25 165.43 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 120.617 -1.302 . . . . 0.0 109.74 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.537 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 40.7 m-85 -111.97 112.23 23.73 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 122.149 0.976 . . . . 0.0 109.792 -179.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.426 ' O ' ' OD1' ' A' ' 81' ' ' ASN . 96.8 t -85.58 135.25 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.618 ' C ' ' H ' ' A' ' 55' ' ' ALA . 1.7 t30 -49.28 123.22 7.07 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.947 -1.095 . . . . 0.0 108.147 179.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -54.16 11.57 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.818 -0.551 . . . . 0.0 112.178 -177.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.618 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -100.71 -15.57 17.66 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.999 -1.063 . . . . 0.0 109.817 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -115.26 -10.43 12.09 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.774 -1.204 . . . . 0.0 109.078 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 12.5 p -71.45 -41.62 69.22 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.876 -1.14 . . . . 0.0 109.912 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -86.91 14.46 7.27 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.438 -0.789 . . . . 0.0 109.898 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.479 ' CD ' ' O ' ' A' ' 55' ' ' ALA . 9.6 mtpt -125.46 -39.73 2.16 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -78.34 167.28 36.78 Favored Pre-proline 0 N--CA 1.494 1.759 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 179.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -55.57 105.38 0.15 Allowed 'Trans proline' 0 N--CA 1.489 1.237 0 CA-C-N 120.206 1.109 . . . . 0.0 113.181 -176.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.39 102.38 2.62 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -53.71 146.41 13.54 Favored 'General case' 0 C--N 1.29 -1.991 0 O-C-N 121.207 -0.933 . . . . 0.0 111.29 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -61.81 -171.3 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.732 -0.605 . . . . 0.0 110.756 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -69.41 1.49 3.87 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.189 -0.944 . . . . 0.0 112.147 -178.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -64.63 -40.46 95.5 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.525 -1.359 . . . . 0.0 108.736 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.519 ' N ' ' CD ' ' A' ' 67' ' ' GLU . 27.8 mp0 -79.36 -47.24 16.11 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.655 -0.653 . . . . 0.0 110.133 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 36.3 mt -44.62 -22.67 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.136 -0.977 . . . . 0.0 110.041 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 67' ' ' GLU . . . -86.03 -28.85 27.3 Favored Glycine 0 N--CA 1.498 2.777 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.46 ' N ' ' O ' ' A' ' 67' ' ' GLU . 30.0 mtt -77.33 -34.18 55.37 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.402 ' C ' ' H ' ' A' ' 73' ' ' CYS . 33.1 mt -65.62 -22.17 66.64 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -85.34 18.85 2.49 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 178.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.402 ' H ' ' C ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -133.85 24.47 3.96 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.732 -0.605 . . . . 0.0 110.295 -178.703 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 17.0 m -97.48 171.9 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 120.772 -1.205 . . . . 0.0 110.58 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.455 ' OG1' ' CG ' ' A' ' 106' ' ' TRP . 2.8 m -105.47 -1.78 24.5 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.383 -0.823 . . . . 0.0 110.28 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -107.48 170.94 7.67 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 120.965 -1.084 . . . . 0.0 110.589 -178.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.537 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -62.87 111.61 2.21 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.474 -0.766 . . . . 0.0 109.845 -179.281 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.4 tp -70.92 160.11 33.44 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 120.031 -1.668 . . . . 0.0 110.312 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.2 mmtm -125.12 152.55 70.85 Favored Pre-proline 0 C--N 1.296 -1.748 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -178.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -56.53 -22.45 43.02 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 121.217 1.278 . . . . 0.0 109.771 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.433 ' OD1' ' O ' ' A' ' 81' ' ' ASN . 1.4 p30 -120.21 28.54 7.99 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.888 -0.508 . . . . 0.0 109.862 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.3 m -55.41 172.1 0.16 Allowed 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.416 -1.428 . . . . 0.0 108.532 178.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.69 ' HE ' ' CG1' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -170.78 163.64 7.89 Favored 'General case' 0 N--CA 1.5 2.047 0 C-N-CA 118.661 -1.215 . . . . 0.0 111.273 -178.81 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.501 ' CD2' ' N ' ' A' ' 84' ' ' LEU . 2.2 mm? -104.26 97.71 7.62 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 178.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.426 ' C ' ' O ' ' A' ' 84' ' ' LEU . 0.6 OUTLIER -31.94 -42.18 0.06 Allowed 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -177.414 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 17.6 p -76.52 -14.72 60.01 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.076 -1.64 . . . . 0.0 112.187 -177.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.465 ' NE2' ' CG ' ' A' ' 67' ' ' GLU . 25.3 mt-30 -94.48 37.86 1.11 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.676 -1.265 . . . . 0.0 110.113 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.69 ' CG1' ' HE ' ' A' ' 83' ' ' ARG . 22.7 mt -131.42 168.44 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.269 -0.895 . . . . 0.0 109.4 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.521 ' N ' ' CG2' ' A' ' 88' ' ' ILE . 36.2 mm -139.01 122.72 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.649 ' SD ' ' N ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -78.65 143.34 36.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.965 -1.084 . . . . 0.0 108.511 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.649 ' N ' ' SD ' ' A' ' 90' ' ' MET . 1.1 p -130.07 149.72 73.99 Favored Pre-proline 0 N--CA 1.495 1.785 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -62.96 -35.18 67.99 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 121.626 1.551 . . . . 0.0 110.854 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -68.82 -26.06 64.98 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 119.68 -0.808 . . . . 0.0 109.936 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.5 mt -104.26 29.67 5.84 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.508 -0.745 . . . . 0.0 110.076 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -63.65 146.42 53.83 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.799 -1.188 . . . . 0.0 109.856 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 105.22 12.27 27.64 Favored Glycine 0 N--CA 1.504 3.227 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 178.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 17.5 tt -65.57 129.7 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 121.113 -1.227 . . . . 0.0 111.31 -177.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.6 t -104.82 126.52 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 O-C-N 121.208 -0.932 . . . . 0.0 108.852 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.2 t -111.58 135.01 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.994 -1.066 . . . . 0.0 109.997 -178.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -107.85 121.72 45.32 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.343 -0.848 . . . . 0.0 109.065 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 24.7 t -108.99 123.59 36.54 Favored Pre-proline 0 N--CA 1.498 1.967 0 O-C-N 121.689 -0.632 . . . . 0.0 109.4 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.442 ' O ' ' NE2' ' A' ' 105' ' ' GLN . 69.4 Cg_endo -83.25 178.34 5.87 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.711 2.274 . . . . 0.0 113.427 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -84.71 -18.33 35.56 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -108.44 81.95 1.55 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.487 ' H ' ' CD ' ' A' ' 105' ' ' GLN . 13.2 mp0 -84.03 -31.03 25.64 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 119.156 -1.017 . . . . 0.0 108.489 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . 0.455 ' CG ' ' OG1' ' A' ' 75' ' ' THR . 62.9 t-105 . . . . . 0 C--N 1.299 -1.594 0 O-C-N 121.028 -1.045 . . . . 0.0 109.814 178.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 13.6 p . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.9 mmtt -77.22 108.74 10.55 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.435 -0.906 . . . . 0.0 108.563 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 36.5 t -108.68 109.33 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.26 -0.9 . . . . 0.0 110.28 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 23.9 t -102.16 127.09 56.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.502 -0.749 . . . . 0.0 110.341 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -102.15 117.54 35.01 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 176.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 81.0 t -97.9 113.94 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 34.0 p -74.54 -163.65 0.22 Allowed 'General case' 0 C--N 1.293 -1.863 0 CA-C-O 121.595 0.712 . . . . 0.0 109.623 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.811 ' ND1' ' H ' ' A' ' 8' ' ' HIS . 0.3 OUTLIER -81.98 -45.84 14.81 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.778 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 23.4 p-10 -74.31 2.36 9.44 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.3 -0.875 . . . . 0.0 111.571 -178.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.88 -4.31 65.6 Favored Glycine 0 N--CA 1.5 2.915 0 O-C-N 120.441 -1.412 . . . . 0.0 110.928 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.89 126.37 27.11 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.79 -1.418 . . . . 0.0 108.418 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.4 mtt85 -106.21 162.25 13.82 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.262 -0.899 . . . . 0.0 111.32 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 17.3 mtt85 -146.29 107.82 4.27 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 178.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -98.62 126.73 44.3 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.344 -0.847 . . . . 0.0 110.523 -178.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 31.6 mt -119.06 -164.7 1.06 Allowed 'General case' 0 N--CA 1.503 2.175 0 CA-C-O 122.786 1.279 . . . . 0.0 110.531 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -137.32 99.07 3.87 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 176.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.7 t -102.12 119.24 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 121.346 -0.846 . . . . 0.0 109.131 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.42 174.8 3.77 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.308 -0.87 . . . . 0.0 110.56 -178.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -69.95 141.39 53.05 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 122.053 0.93 . . . . 0.0 110.755 -179.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.24 -17.16 49.27 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.6 t -83.04 139.88 17.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 120.836 -1.391 . . . . 0.0 109.262 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 79.0 p -92.04 146.09 24.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.112 -0.993 . . . . 0.0 109.024 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 84.8 mt -46.38 -40.36 11.87 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.478 -0.764 . . . . 0.0 109.218 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 13.5 tpp -55.57 -43.12 75.64 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.427 -0.796 . . . . 0.0 108.953 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -62.26 -58.05 9.15 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.23 -0.919 . . . . 0.0 109.325 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.95 -33.33 24.07 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.675 -1.266 . . . . 0.0 111.743 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.84 -22.97 62.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.428 -1.42 . . . . 0.0 109.344 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 53.5 t -86.31 -19.85 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.189 -0.944 . . . . 0.0 109.857 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.87 -31.29 51.33 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.236 -0.915 . . . . 0.0 109.352 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 . . . . . 0 N--CA 1.487 1.387 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.815 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 8.1 m . . . . . 0 N--CA 1.482 1.161 0 CA-C-O 120.98 0.419 . . . . 0.0 110.154 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.546 ' SG ' ' N ' ' A' ' 85' ' ' CYS . 16.6 p -92.74 53.91 2.13 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.891 -1.13 . . . . 0.0 110.397 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.524 ' NE2' ' OH ' ' A' ' 51' ' ' TYR . 48.7 t60 -75.94 111.68 11.56 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.28 -0.887 . . . . 0.0 108.634 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -147.34 167.75 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 120.884 -1.135 . . . . 0.0 109.534 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.566 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 38.0 m-85 -115.68 111.24 20.3 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 121.788 0.804 . . . . 0.0 109.754 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 80.7 t -85.95 132.81 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.596 ' C ' ' H ' ' A' ' 55' ' ' ALA . 1.0 OUTLIER -47.96 126.6 10.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.103 -0.998 . . . . 0.0 108.545 179.359 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -56.67 14.13 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.369 -0.832 . . . . 0.0 111.648 -178.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.596 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -101.99 -19.91 15.02 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.56 -1.338 . . . . 0.0 109.681 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -111.54 -10.49 14.14 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.704 -1.247 . . . . 0.0 108.951 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 10.4 p -70.84 -37.39 73.15 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.126 -0.984 . . . . 0.0 110.353 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -84.42 0.33 49.91 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.235 -0.916 . . . . 0.0 110.268 -178.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.448 ' CE ' ' O ' ' A' ' 55' ' ' ALA . 9.0 mttt -112.61 -37.36 4.94 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.4 0.619 . . . . 0.0 109.512 -179.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.409 HG12 HH12 ' A' ' 83' ' ' ARG . 0.4 OUTLIER -81.56 161.67 60.9 Favored Pre-proline 0 N--CA 1.497 1.918 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 179.859 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.566 ' O ' ' NH2' ' A' ' 83' ' ' ARG . 5.0 Cg_endo -55.31 90.52 0.04 OUTLIER 'Trans proline' 0 N--CA 1.5 1.905 0 C-N-CA 122.381 2.054 . . . . 0.0 114.348 -176.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.61 104.31 0.64 Allowed 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 177.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -53.8 149.58 8.51 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.77 0.795 . . . . 0.0 112.561 -178.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.453 ' N ' ' ND2' ' A' ' 64' ' ' ASN . 0.1 OUTLIER -60.74 -172.1 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.308 0.575 . . . . 0.0 110.117 179.678 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -70.14 4.74 1.98 Allowed 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.727 -0.608 . . . . 0.0 112.11 -178.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.4 mtt85 -65.72 -40.28 92.02 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.65 -1.281 . . . . 0.0 108.928 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.441 ' N ' ' CD ' ' A' ' 67' ' ' GLU . 34.1 mp0 -80.05 -37.66 33.48 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.701 -1.249 . . . . 0.0 109.636 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.447 ' CD1' ' N ' ' A' ' 68' ' ' ILE . 1.3 mp -46.15 -35.6 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.219 -0.926 . . . . 0.0 109.055 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.39 -28.97 60.73 Favored Glycine 0 N--CA 1.495 2.599 0 C-N-CA 119.365 -1.398 . . . . 0.0 109.619 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.429 ' N ' ' O ' ' A' ' 67' ' ' GLU . 26.6 mtt -79.0 -35.41 42.86 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 178.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 74.2 mt -64.98 -24.74 67.6 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -80.88 5.48 15.98 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.782 -1.198 . . . . 0.0 108.036 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -122.73 25.97 8.46 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.764 -0.585 . . . . 0.0 110.504 -178.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.4 m -96.21 168.97 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.339 0 O-C-N 120.682 -1.261 . . . . 0.0 109.97 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.548 ' OG1' ' CD1' ' A' ' 106' ' ' TRP . 3.1 m -106.57 0.14 24.31 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.429 -0.794 . . . . 0.0 110.824 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -107.4 169.33 8.64 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.171 -0.956 . . . . 0.0 110.564 -178.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.566 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -59.76 106.14 0.45 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.569 -0.707 . . . . 0.0 109.478 -179.289 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.9 tp -70.13 152.25 44.53 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 119.933 -1.729 . . . . 0.0 110.303 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 46.3 mmtt -114.73 156.6 44.67 Favored Pre-proline 0 C--N 1.294 -1.828 0 CA-C-N 114.506 -1.225 . . . . 0.0 108.478 -178.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -57.56 -20.36 41.2 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 121.807 1.672 . . . . 0.0 110.4 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -125.22 31.91 5.49 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.734 -0.603 . . . . 0.0 110.775 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 33.4 m -59.44 169.85 1.15 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.653 -1.279 . . . . 0.0 110.473 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.566 ' NH2' ' O ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -171.91 171.52 5.08 Favored 'General case' 0 N--CA 1.503 2.219 0 CA-C-O 122.479 1.133 . . . . 0.0 111.864 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 47.3 mt -100.87 112.25 24.64 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 178.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.546 ' N ' ' SG ' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -56.7 -11.86 1.58 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.067 -1.02 . . . . 0.0 112.607 -176.554 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 28.3 p -87.54 -39.9 14.74 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 119.896 -1.752 . . . . 0.0 110.932 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -81.29 42.83 0.69 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.802 -1.186 . . . . 0.0 110.573 -178.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.8 mt -130.67 157.56 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 O-C-N 121.124 -0.985 . . . . 0.0 108.494 179.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 36.9 mm -132.46 128.52 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 O-C-N 121.391 -0.818 . . . . 0.0 109.763 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 3.6 tpt -88.62 161.54 16.84 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.969 -1.082 . . . . 0.0 109.657 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.5 p -155.04 148.83 18.83 Favored Pre-proline 0 C--N 1.3 -1.58 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -55.91 -37.7 95.59 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 121.651 1.567 . . . . 0.0 111.874 -178.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -65.13 -27.32 68.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.213 -0.929 . . . . 0.0 109.305 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 15.7 mt -96.66 24.73 5.73 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.322 -0.861 . . . . 0.0 109.459 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -64.2 138.06 58.26 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.651 -0.655 . . . . 0.0 110.055 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 108.03 8.87 29.02 Favored Glycine 0 N--CA 1.505 3.251 0 N-CA-C 110.669 -0.973 . . . . 0.0 110.669 178.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 16.0 tt -63.2 132.33 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 120.945 -1.326 . . . . 0.0 111.936 -177.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.0 t -104.91 115.33 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.1 t -103.12 133.32 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.898 -1.126 . . . . 0.0 109.01 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -104.71 114.77 29.19 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 23.5 t -102.4 122.18 47.42 Favored Pre-proline 0 N--CA 1.494 1.74 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.455 ' O ' ' NE2' ' A' ' 105' ' ' GLN . 68.5 Cg_endo -83.35 171.17 11.41 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.274 1.983 . . . . 0.0 113.18 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -79.13 -15.24 58.42 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -110.75 82.97 1.68 Allowed 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.459 ' CD ' ' N ' ' A' ' 105' ' ' GLN . 14.7 mp0 -83.09 -32.83 26.55 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 120.96 -1.087 . . . . 0.0 108.514 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . 0.548 ' CD1' ' OG1' ' A' ' 75' ' ' THR . 61.6 t-105 . . . . . 0 C--N 1.302 -1.476 0 CA-C-O 117.616 -1.183 . . . . 0.0 110.266 178.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.462 ' CB ' ' SD ' ' A' ' 90' ' ' MET . 1.5 p . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 25.2 mmtt -92.92 116.36 28.98 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.069 -1.019 . . . . 0.0 109.192 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.2 t -114.47 108.61 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 O-C-N 121.351 -0.843 . . . . 0.0 109.573 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.4 t -99.6 129.03 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.267 -0.896 . . . . 0.0 110.849 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -104.86 115.77 30.86 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 177.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 81.0 t -98.24 114.8 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 120.901 -1.125 . . . . 0.0 108.146 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.41 ' OG ' ' OD1' ' A' ' 9' ' ' ASP . 63.2 p -72.15 -159.92 0.06 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.708 -0.62 . . . . 0.0 109.682 -178.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.696 ' ND1' ' H ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -88.02 -46.93 8.92 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -179.882 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.519 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 13.4 p30 -70.75 4.63 2.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.344 -0.848 . . . . 0.0 110.755 -178.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.85 -4.63 65.94 Favored Glycine 0 N--CA 1.498 2.821 0 O-C-N 120.808 -1.182 . . . . 0.0 110.552 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -65.61 126.9 29.8 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.747 -1.443 . . . . 0.0 108.718 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.52 ' CG ' HH11 ' A' ' 12' ' ' ARG . 2.6 mtt-85 -105.52 160.95 14.77 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.474 -0.766 . . . . 0.0 110.84 -178.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -150.83 116.31 5.43 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -101.98 130.87 48.62 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.701 -0.624 . . . . 0.0 111.14 -178.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 30.7 mt -119.4 -165.29 1.13 Allowed 'General case' 0 N--CA 1.504 2.237 0 CA-C-O 122.737 1.256 . . . . 0.0 109.882 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -135.19 97.24 3.67 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 104.62 -2.363 . . . . 0.0 104.62 176.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.7 t -104.79 118.62 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.518 0 O-C-N 121.044 -1.035 . . . . 0.0 108.244 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.05 173.34 6.63 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 122.091 0.948 . . . . 0.0 111.693 -177.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -64.63 138.51 58.44 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.988 0.899 . . . . 0.0 111.166 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.9 -14.43 52.72 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 178.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 48.6 t -82.63 140.48 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 O-C-N 120.721 -1.458 . . . . 0.0 108.87 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.471 ' O ' ' N ' ' A' ' 25' ' ' GLN . 35.6 p -92.88 141.05 28.86 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.238 -0.914 . . . . 0.0 109.078 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 57.9 mt -44.48 -36.24 2.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.27 -0.894 . . . . 0.0 109.753 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.405 ' O ' ' SD ' ' A' ' 24' ' ' MET . 4.9 tpt -61.19 -37.84 84.39 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.471 ' N ' ' O ' ' A' ' 22' ' ' SER . 11.8 mm100 -66.82 -58.48 4.95 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.306 -0.871 . . . . 0.0 108.994 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.29 -30.07 59.44 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.785 -1.197 . . . . 0.0 110.749 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.92 -24.58 66.13 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.955 -1.091 . . . . 0.0 109.06 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 89.5 t -86.05 -23.88 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.393 -0.817 . . . . 0.0 109.709 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.34 -28.92 59.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.17 -0.956 . . . . 0.0 108.618 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 . . . . . 0 C--N 1.306 -1.29 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 178.748 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 7.3 m . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.752 0.31 . . . . 0.0 110.251 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.586 ' SG ' ' N ' ' A' ' 85' ' ' CYS . 17.7 p -82.3 54.42 2.56 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.756 -1.215 . . . . 0.0 110.15 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.457 ' CE1' ' OH ' ' A' ' 51' ' ' TYR . 35.8 t60 -77.45 109.67 11.58 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -143.7 164.94 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 120.679 -1.263 . . . . 0.0 109.664 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.546 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 42.4 m-85 -112.52 112.58 24.22 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-O 121.915 0.865 . . . . 0.0 109.747 -179.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.7 t -88.54 132.41 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.654 ' N ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -47.73 127.01 11.1 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.076 -1.015 . . . . 0.0 108.646 179.301 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -56.36 14.6 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.252 -0.905 . . . . 0.0 111.297 -178.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.642 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -99.67 -18.0 17.5 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.595 -1.315 . . . . 0.0 109.823 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.416 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 30.9 m-85 -116.18 -9.4 11.63 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.977 -1.077 . . . . 0.0 108.38 -179.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 31.2 p -68.44 -43.62 76.71 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.272 -0.893 . . . . 0.0 109.82 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -91.03 19.86 5.36 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 120.179 -0.608 . . . . 0.0 109.731 -179.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.6 mtpt -129.83 -40.83 1.34 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -81.06 168.17 26.92 Favored Pre-proline 0 N--CA 1.491 1.599 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 179.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -59.43 97.68 0.1 Allowed 'Trans proline' 0 N--CA 1.491 1.369 0 CA-C-N 120.123 1.08 . . . . 0.0 113.593 -176.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.84 99.56 3.81 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 178.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.544 ' H ' ' NH1' ' A' ' 83' ' ' ARG . . . -47.03 152.17 0.56 Allowed 'General case' 0 C--N 1.287 -2.121 0 CA-C-O 122.242 1.02 . . . . 0.0 113.129 -178.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -61.1 -169.81 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.618 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -67.68 -3.92 10.58 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.771 -0.58 . . . . 0.0 111.976 -178.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? -62.74 -42.49 99.7 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.539 -1.351 . . . . 0.0 108.442 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.536 ' OE1' ' N ' ' A' ' 67' ' ' GLU . 22.5 mp0 -75.55 -48.1 23.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.446 -0.784 . . . . 0.0 109.937 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 35.3 mt -44.21 -21.83 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.519 -0.738 . . . . 0.0 109.655 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -80.0 -79.54 0.85 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 9.9 ptp -47.56 -37.81 13.0 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.925 -1.338 . . . . 0.0 108.932 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.448 ' O ' ' CG2' ' A' ' 74' ' ' VAL . 2.5 tm? -56.93 -31.02 64.51 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' A' ' 69' ' ' GLY . 14.5 tt0 -81.88 14.52 2.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.09 -1.007 . . . . 0.0 109.256 178.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -125.51 36.62 4.52 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.225 -0.922 . . . . 0.0 110.083 -179.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.448 ' CG2' ' O ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -98.87 176.09 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 121.058 -1.026 . . . . 0.0 108.522 179.218 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.522 ' OG1' ' CD1' ' A' ' 106' ' ' TRP . 4.9 m -120.05 6.36 10.82 Favored 'General case' 0 N--CA 1.508 2.446 0 O-C-N 121.245 -0.91 . . . . 0.0 111.19 -178.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.429 ' CB ' ' NE2' ' A' ' 49' ' ' HIS . . . -105.78 171.94 7.07 Favored 'General case' 0 N--CA 1.506 2.362 0 O-C-N 120.979 -1.076 . . . . 0.0 109.674 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.546 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -59.0 102.66 0.13 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.23 -0.919 . . . . 0.0 109.641 -179.313 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.6 mp -71.81 141.54 49.66 Favored 'General case' 0 C--N 1.293 -1.875 0 O-C-N 120.132 -1.605 . . . . 0.0 110.665 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 45.2 mmtt -104.81 158.52 31.84 Favored Pre-proline 0 C--N 1.288 -2.081 0 CA-C-N 113.786 -1.552 . . . . 0.0 107.845 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -53.4 -16.24 7.06 Favored 'Trans proline' 0 C--N 1.302 -1.901 0 C-N-CA 121.248 1.298 . . . . 0.0 109.873 178.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -130.55 39.47 3.62 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.993 -0.442 . . . . 0.0 111.03 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.7 m -68.45 150.34 48.23 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 119.978 -1.701 . . . . 0.0 107.554 178.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.544 ' NH1' ' H ' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -165.68 169.47 15.17 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.533 -1.354 . . . . 0.0 110.121 -179.669 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.561 ' CD2' ' N ' ' A' ' 84' ' ' LEU . 1.1 mm? -85.73 119.78 26.44 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.586 ' N ' ' SG ' ' A' ' 48' ' ' CYS . 0.5 OUTLIER -57.26 -41.84 80.4 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.037 -1.039 . . . . 0.0 111.282 -177.875 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 30.6 p -60.56 -22.92 64.2 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 120.635 -1.29 . . . . 0.0 111.444 -177.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -91.18 33.04 0.98 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.009 -1.057 . . . . 0.0 111.16 -179.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.41 HG23 HD11 ' A' ' 88' ' ' ILE . 33.8 mt -130.27 144.79 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 O-C-N 120.966 -1.084 . . . . 0.0 108.226 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.7 mp -122.21 134.96 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.43 0 O-C-N 121.678 -0.639 . . . . 0.0 109.304 -179.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.628 ' SD ' ' N ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -81.16 144.5 31.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.234 -0.917 . . . . 0.0 108.851 -179.651 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.628 ' N ' ' SD ' ' A' ' 90' ' ' MET . 0.5 OUTLIER -129.46 152.54 79.77 Favored Pre-proline 0 N--CA 1.497 1.876 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 177.833 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.24 -34.75 26.66 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 121.671 1.58 . . . . 0.0 110.791 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -70.57 -23.29 62.57 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.584 -0.846 . . . . 0.0 109.8 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.7 mt -104.48 30.91 5.0 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.427 -0.796 . . . . 0.0 110.4 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -64.46 144.75 56.96 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.114 -1.616 . . . . 0.0 109.676 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 105.8 11.75 27.74 Favored Glycine 0 N--CA 1.503 3.112 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 178.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 15.3 tt -63.62 128.89 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.013 -1.286 . . . . 0.0 111.015 -177.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.482 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 6.6 t -103.84 123.7 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.225 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.2 t -111.44 135.06 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.067 -1.021 . . . . 0.0 109.688 -179.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -108.91 122.48 47.29 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-O 121.712 0.768 . . . . 0.0 109.055 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 35.0 t -110.3 123.27 36.34 Favored Pre-proline 0 N--CA 1.497 1.889 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.4 ' HG3' ' CD2' ' A' ' 49' ' ' HIS . 41.6 Cg_endo -85.94 -178.3 2.83 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.865 2.377 . . . . 0.0 113.486 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -87.01 -20.15 27.64 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -103.78 82.45 2.0 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -81.13 -23.3 38.42 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.444 -0.902 . . . . 0.0 109.68 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . 0.522 ' CD1' ' OG1' ' A' ' 75' ' ' THR . 11.1 t-105 . . . . . 0 C--N 1.305 -1.359 0 O-C-N 120.847 -1.158 . . . . 0.0 110.164 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 98.0 p . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -76.11 111.03 11.09 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.428 ' CG1' ' CE1' ' A' ' 5' ' ' TYR . 96.5 t -111.9 111.89 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.735 -0.603 . . . . 0.0 110.302 -178.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 24.4 t -98.89 98.85 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.222 -0.924 . . . . 0.0 111.764 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.428 ' CE1' ' CG1' ' A' ' 3' ' ' VAL . 29.0 m-85 -72.94 111.89 8.47 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 176.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 79.1 t -98.89 117.92 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 75.0 p -73.73 -155.83 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.492 -0.755 . . . . 0.0 109.513 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.703 ' ND1' ' H ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -91.54 -50.27 5.87 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.164 -0.96 . . . . 0.0 108.985 -179.727 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.492 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 22.0 p-10 -66.03 2.07 1.24 Allowed 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.509 -0.745 . . . . 0.0 110.734 -179.155 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.408 ' O ' ' NH1' ' A' ' 12' ' ' ARG . . . 96.74 -4.98 63.92 Favored Glycine 0 N--CA 1.501 3.013 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -62.6 126.52 27.62 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.117 -1.226 . . . . 0.0 108.179 179.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.432 ' NH1' ' CG ' ' A' ' 12' ' ' ARG . 0.5 OUTLIER -112.09 161.1 16.87 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 121.875 0.845 . . . . 0.0 111.577 -178.16 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.5 ttm105 -149.65 118.67 6.71 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -99.46 128.02 45.55 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.39 -0.819 . . . . 0.0 110.427 -178.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.6 mt -117.79 -165.54 1.1 Allowed 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 122.972 1.368 . . . . 0.0 109.978 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -138.0 101.73 4.5 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 176.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.2 t -104.69 117.07 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.67 179.9 4.5 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-O 122.046 0.927 . . . . 0.0 112.343 -177.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -65.89 134.13 52.37 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.849 0.833 . . . . 0.0 110.548 -179.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.94 -18.01 42.55 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 178.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.2 t -83.72 139.63 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 120.848 -1.384 . . . . 0.0 109.889 -178.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.511 ' O ' ' N ' ' A' ' 25' ' ' GLN . 51.4 p -94.84 141.26 28.84 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 178.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.1 mt -45.81 -33.86 3.37 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.362 -0.836 . . . . 0.0 109.611 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 2.3 tpt -68.53 -28.46 67.01 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 121.674 0.75 . . . . 0.0 109.165 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.511 ' N ' ' O ' ' A' ' 22' ' ' SER . 7.0 tp-100 -76.55 -62.72 1.53 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.138 -0.976 . . . . 0.0 109.959 -179.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.29 -24.17 53.17 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.689 -1.257 . . . . 0.0 109.995 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.94 -22.21 66.61 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.161 -0.962 . . . . 0.0 109.649 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 99.1 t -86.29 -17.93 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.374 -0.829 . . . . 0.0 109.41 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.97 -30.32 22.85 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.391 -0.818 . . . . 0.0 110.066 -178.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 . . . . . 0 N--CA 1.488 1.44 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.259 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 62.0 p . . . . . 0 N--CA 1.483 1.202 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.486 ' SG ' ' N ' ' A' ' 85' ' ' CYS . 30.1 p -73.46 54.85 0.46 Allowed 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.869 -1.145 . . . . 0.0 109.405 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.481 ' CE1' ' OH ' ' A' ' 51' ' ' TYR . 50.9 t60 -76.74 106.45 8.41 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -143.84 160.8 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 120.696 -1.253 . . . . 0.0 109.231 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.585 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 39.5 m-85 -108.52 111.42 23.27 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 122.241 1.019 . . . . 0.0 109.953 -179.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.9 t -85.94 133.29 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.606 ' C ' ' H ' ' A' ' 55' ' ' ALA . 1.0 OUTLIER -48.21 127.7 13.04 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.872 -1.143 . . . . 0.0 108.625 -179.852 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -56.35 9.15 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.467 -0.77 . . . . 0.0 111.471 -178.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.606 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -99.11 -17.38 18.24 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.805 -1.184 . . . . 0.0 109.9 -179.272 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.403 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 48.1 m-85 -115.61 -4.74 12.2 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.1 -1.0 . . . . 0.0 108.808 -179.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 24.8 p -72.95 -41.94 63.93 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.619 -0.676 . . . . 0.0 109.796 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -89.31 15.44 9.05 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 120.204 -0.599 . . . . 0.0 109.886 -179.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.1 mtpt -121.68 -40.86 2.51 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -78.86 158.33 75.41 Favored Pre-proline 0 N--CA 1.495 1.82 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -49.47 102.74 0.05 OUTLIER 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 122.222 1.948 . . . . 0.0 113.726 -177.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.432 ' HA ' HH22 ' A' ' 83' ' ' ARG . . . -75.66 101.62 5.05 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 177.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.779 ' H ' HH22 ' A' ' 83' ' ' ARG . . . -65.25 169.58 5.55 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-O 122.211 1.005 . . . . 0.0 112.58 -178.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.415 ' ND2' ' HE ' ' A' ' 66' ' ' ARG . 4.0 p30 -63.24 177.54 0.62 Allowed 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 122.103 0.954 . . . . 0.0 111.428 -178.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -72.23 5.34 2.89 Favored 'General case' 0 N--CA 1.503 2.214 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.523 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.415 ' HE ' ' ND2' ' A' ' 64' ' ' ASN . 10.2 mtm180 -74.16 -50.52 18.96 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 120.37 -1.456 . . . . 0.0 109.185 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.442 ' OE1' ' OE1' ' A' ' 87' ' ' GLN . 82.3 mt-10 -65.58 -16.71 63.97 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.525 -0.734 . . . . 0.0 109.655 179.114 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.525 ' CD1' ' N ' ' A' ' 68' ' ' ILE . 1.4 mp -75.54 -34.92 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.383 -0.823 . . . . 0.0 108.918 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.81 -20.51 48.21 Favored Glycine 0 N--CA 1.495 2.597 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 3.5 mmt -83.51 -35.42 24.85 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 178.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 59.8 mt -63.75 -21.98 66.68 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -83.82 11.7 7.16 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -131.26 28.13 4.74 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.446 -0.784 . . . . 0.0 109.774 -178.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 18.0 m -90.92 162.86 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.326 -0.859 . . . . 0.0 110.697 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.524 ' OG1' ' CD2' ' A' ' 106' ' ' TRP . 6.7 m -100.75 -8.7 22.5 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.321 -0.862 . . . . 0.0 109.983 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -107.55 175.33 5.53 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.807 -1.183 . . . . 0.0 110.723 -178.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.585 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -61.46 108.71 1.0 Allowed 'General case' 0 N--CA 1.503 2.21 0 CA-C-O 121.372 0.606 . . . . 0.0 110.967 -178.843 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 9.2 tp -72.92 156.67 38.62 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 119.547 -1.97 . . . . 0.0 110.101 179.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.6 mmtm -118.03 155.76 50.94 Favored Pre-proline 0 C--N 1.293 -1.856 0 CA-C-N 115.105 -0.952 . . . . 0.0 108.534 -178.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.99 -24.26 79.21 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 121.674 1.582 . . . . 0.0 109.261 178.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 81' ' ' ASN . 1.4 p30 -112.9 21.69 15.21 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.013 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.7 m -52.07 158.26 1.13 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 120.306 -1.496 . . . . 0.0 109.067 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.779 HH22 ' H ' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -156.69 148.22 22.48 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.061 -1.055 . . . . 0.0 111.924 -178.28 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.56 ' CD2' ' N ' ' A' ' 84' ' ' LEU . 2.2 mm? -85.48 121.66 28.51 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 177.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.486 ' N ' ' SG ' ' A' ' 48' ' ' CYS . 0.2 OUTLIER -70.64 -5.09 26.9 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.867 -1.146 . . . . 0.0 113.183 -175.708 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 27.9 p -93.93 -37.7 11.56 Favored 'General case' 0 N--CA 1.506 2.354 0 CA-C-N 120.438 1.472 . . . . 0.0 111.004 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.63 HE22 ' NH1' ' A' ' 83' ' ' ARG . 5.0 pp0? -84.91 24.74 1.02 Allowed 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.214 -0.929 . . . . 0.0 110.39 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 47.3 mt -108.09 148.3 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 O-C-N 121.131 -0.981 . . . . 0.0 108.651 179.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 33.5 mm -127.68 124.35 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.415 ' SD ' HG23 ' A' ' 97' ' ' ILE . 2.7 tpt -91.14 160.77 15.39 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.301 -0.874 . . . . 0.0 109.928 -178.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 70.9 p -149.38 147.61 23.86 Favored Pre-proline 0 N--CA 1.49 1.532 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -57.1 -29.58 83.71 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 121.46 1.44 . . . . 0.0 111.616 -179.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -67.83 -29.54 68.72 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.19 -0.944 . . . . 0.0 109.938 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.4 mt -98.1 31.04 2.85 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.578 -0.701 . . . . 0.0 109.863 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -62.63 138.51 58.51 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.169 -0.957 . . . . 0.0 110.17 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 111.8 9.1 21.49 Favored Glycine 0 N--CA 1.505 3.281 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 178.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.415 HG23 ' SD ' ' A' ' 90' ' ' MET . 0.1 OUTLIER -67.07 125.94 25.58 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 O-C-N 121.604 -0.939 . . . . 0.0 110.838 -178.213 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.6 t -101.97 121.51 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.367 -0.833 . . . . 0.0 109.594 178.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.3 t -105.88 134.02 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 120.894 -1.129 . . . . 0.0 108.849 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -108.16 119.83 40.59 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 121.864 0.84 . . . . 0.0 109.015 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 23.7 t -107.27 122.94 39.76 Favored Pre-proline 0 N--CA 1.496 1.846 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -83.57 177.69 6.15 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.703 2.269 . . . . 0.0 113.594 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -84.38 -15.26 46.96 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -112.05 80.4 1.32 Allowed 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.465 ' NE2' ' O ' ' A' ' 106' ' ' TRP . 2.2 pp0? -80.55 -20.43 43.46 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.724 -1.235 . . . . 0.0 109.659 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . 0.524 ' CD2' ' OG1' ' A' ' 75' ' ' THR . 67.4 t-105 . . . . . 0 C--N 1.302 -1.475 0 CA-C-O 117.83 -1.081 . . . . 0.0 110.24 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.501 ' OG ' ' SD ' ' A' ' 90' ' ' MET . 67.9 p . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.1 mmtt -75.94 115.39 15.6 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 45.1 t -116.3 108.1 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.16 -0.963 . . . . 0.0 111.952 -177.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 28.2 t -103.38 134.89 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 CA-C-O 121.687 0.756 . . . . 0.0 110.247 178.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -108.42 118.8 37.72 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 177.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 64.7 t -98.17 113.53 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 120.846 -1.159 . . . . 0.0 108.516 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.401 ' OG ' ' N ' ' A' ' 8' ' ' HIS . 5.3 p -79.6 -153.63 0.08 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.486 -0.759 . . . . 0.0 110.261 -179.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.722 ' ND1' ' H ' ' A' ' 8' ' ' HIS . 0.4 OUTLIER -91.84 -52.67 4.63 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.8 p30 -62.41 -2.0 0.92 Allowed 'General case' 0 N--CA 1.483 1.189 0 O-C-N 120.865 -1.147 . . . . 0.0 111.364 -178.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.65 0.43 64.54 Favored Glycine 0 N--CA 1.498 2.811 0 O-C-N 120.67 -1.269 . . . . 0.0 110.575 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -77.02 141.55 40.28 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.98 -1.306 . . . . 0.0 109.101 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.43 ' CD ' ' N ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -119.43 164.38 15.82 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.387 -0.82 . . . . 0.0 112.486 -178.139 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.89 111.69 7.39 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -98.35 122.67 41.81 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.197 -0.939 . . . . 0.0 109.589 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.0 mt -117.47 -164.48 1.0 Allowed 'General case' 0 N--CA 1.503 2.205 0 CA-C-O 122.747 1.26 . . . . 0.0 109.968 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -137.74 99.6 3.96 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 104.558 -2.386 . . . . 0.0 104.558 176.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.8 t -102.31 121.13 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.321 0 O-C-N 121.238 -0.914 . . . . 0.0 109.022 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.71 -178.67 5.48 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.237 -0.914 . . . . 0.0 111.547 -178.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -67.72 131.2 45.12 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 122.078 0.942 . . . . 0.0 111.584 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.78 -18.84 48.6 Favored Glycine 0 N--CA 1.493 2.433 0 N-CA-C 111.121 -0.791 . . . . 0.0 111.121 178.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 62.3 t -79.65 132.81 31.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 120.689 -1.477 . . . . 0.0 108.478 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.464 ' O ' ' N ' ' A' ' 25' ' ' GLN . 18.0 p -88.2 145.59 25.82 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.962 -1.086 . . . . 0.0 108.666 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 70.4 mt -45.64 -39.8 8.23 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 120.594 -1.316 . . . . 0.0 109.864 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 10.5 ttt -64.51 -27.67 69.13 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.549 -0.719 . . . . 0.0 109.255 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.464 ' N ' ' O ' ' A' ' 22' ' ' SER . 52.3 mt-30 -72.78 -58.62 3.2 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.173 -0.954 . . . . 0.0 109.053 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.82 -27.48 69.35 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.768 -1.207 . . . . 0.0 110.89 -179.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.05 -22.02 64.19 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.653 -1.279 . . . . 0.0 108.793 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 89.6 t -84.66 -21.63 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-O 121.492 0.663 . . . . 0.0 109.41 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.18 -28.0 32.31 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.391 -0.818 . . . . 0.0 109.491 -179.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -104.41 4.09 32.97 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 63.6 68.88 1.48 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.4 mt -124.47 -42.86 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.656 -0.908 . . . . 0.0 109.892 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.777 ' O ' ' N ' ' A' ' 35' ' ' ILE . 2.7 m-85 -89.1 7.52 34.61 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.015 -1.053 . . . . 0.0 110.488 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -38.11 72.96 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.3 0 CA-C-O 121.97 0.89 . . . . 0.0 111.473 -178.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.777 ' N ' ' O ' ' A' ' 33' ' ' TYR . 8.2 tp -156.04 20.21 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.57 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.2 t 56.76 171.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.07 -1.019 . . . . 0.0 109.278 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -138.85 135.58 7.46 Favored Glycine 0 N--CA 1.499 2.856 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.546 ' C ' ' H ' ' A' ' 40' ' ' GLY . 1.3 m-20 -73.74 -66.21 0.73 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.327 -1.102 . . . . 0.0 109.266 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.612 ' SG ' ' N ' ' A' ' 42' ' ' SER . 11.6 p -70.91 15.29 0.11 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.957 -1.089 . . . . 0.0 109.099 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.546 ' H ' ' C ' ' A' ' 38' ' ' ASP . . . 54.32 10.78 2.11 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 108.335 -1.906 . . . . 0.0 108.335 -179.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.501 ' H ' ' C ' ' A' ' 39' ' ' CYS . . . 93.92 22.77 24.73 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.612 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 51.1 m -99.04 39.94 1.24 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.397 -1.06 . . . . 0.0 109.519 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.501 ' O ' ' SD ' ' A' ' 70' ' ' MET . . . 42.34 77.68 0.06 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.296 -0.877 . . . . 0.0 110.315 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -166.63 15.56 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.986 -1.072 . . . . 0.0 109.649 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.491 ' O ' ' S1 ' ' A' ' 107' ' ' FES . 3.0 p -149.51 168.29 23.9 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.455 -0.778 . . . . 0.0 109.575 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.424 ' O ' ' OXT' ' A' ' 106' ' ' TRP . . . -102.34 14.76 31.09 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 13.9 m -62.5 -41.48 98.85 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.489 -0.757 . . . . 0.0 109.983 -179.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.529 ' SG ' ' O ' ' A' ' 48' ' ' CYS . 13.8 p -96.42 46.84 1.07 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.887 -1.133 . . . . 0.0 110.224 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.489 ' NE2' ' OH ' ' A' ' 51' ' ' TYR . 38.7 t60 -75.32 109.98 9.28 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.045 -1.034 . . . . 0.0 108.347 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -143.49 164.65 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.152 -0.968 . . . . 0.0 109.36 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.561 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 58.1 m-85 -108.81 110.71 22.14 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-O 121.9 0.857 . . . . 0.0 109.477 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.5 t -87.77 132.89 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.625 ' C ' ' H ' ' A' ' 55' ' ' ALA . 21.6 t-20 -47.58 126.21 9.59 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.959 -1.088 . . . . 0.0 109.556 179.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -58.19 15.26 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.638 -0.664 . . . . 0.0 111.193 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.625 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -103.39 -18.75 14.7 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.697 -1.252 . . . . 0.0 109.577 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -113.0 -12.71 13.19 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.104 -0.998 . . . . 0.0 109.172 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 13.6 p -68.08 -37.38 81.18 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.455 -0.778 . . . . 0.0 109.882 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -88.95 13.24 13.27 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.49 -0.757 . . . . 0.0 109.424 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.3 mtpt -124.46 -39.3 2.33 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -81.18 161.74 61.6 Favored Pre-proline 0 N--CA 1.497 1.909 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -56.23 92.74 0.05 OUTLIER 'Trans proline' 0 N--CA 1.49 1.31 0 C-N-CA 121.584 1.522 . . . . 0.0 113.401 -177.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.37 102.63 5.2 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 178.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.729 ' N ' HH22 ' A' ' 83' ' ' ARG . . . -50.16 151.82 1.92 Allowed 'General case' 0 C--N 1.288 -2.08 0 CA-C-O 122.742 1.258 . . . . 0.0 112.596 -177.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -59.31 -165.38 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.372 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -68.76 -5.22 19.31 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.254 -0.904 . . . . 0.0 112.783 -177.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.4 mtt180 -60.91 -38.41 85.66 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.154 -1.591 . . . . 0.0 108.997 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -80.74 -39.04 27.65 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.973 -1.08 . . . . 0.0 110.05 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 84.5 mt -46.65 -28.93 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.33 -0.856 . . . . 0.0 110.105 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -82.84 -30.41 32.18 Favored Glycine 0 N--CA 1.498 2.786 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.501 ' SD ' ' O ' ' A' ' 43' ' ' ALA . 25.3 mtt -76.56 -34.21 58.5 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 178.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.3 mt -59.05 -24.27 62.72 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -92.26 30.38 1.47 Allowed 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -134.89 19.4 3.49 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.533 -0.729 . . . . 0.0 110.487 -179.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.4 m -97.74 167.42 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 120.809 -1.182 . . . . 0.0 110.214 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.546 ' OG1' ' CD1' ' A' ' 106' ' ' TRP . 6.8 m -101.59 -0.16 35.32 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.385 -0.822 . . . . 0.0 109.789 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -107.18 169.29 8.65 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.242 -0.911 . . . . 0.0 110.465 -178.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.561 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -61.21 110.32 1.37 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.741 -0.6 . . . . 0.0 109.839 -179.343 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.3 tp -68.6 158.01 34.89 Favored 'General case' 0 C--N 1.294 -1.811 0 O-C-N 120.26 -1.525 . . . . 0.0 108.753 178.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.443 ' N ' ' OG ' ' A' ' 82' ' ' SER . 41.5 mmtt -128.25 153.38 78.83 Favored Pre-proline 0 C--N 1.294 -1.818 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 -178.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -55.32 -28.29 61.97 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 121.54 1.494 . . . . 0.0 109.52 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -112.27 29.74 7.65 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.722 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.443 ' OG ' ' N ' ' A' ' 79' ' ' LYS . 4.3 m -61.89 164.64 6.19 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.673 -1.267 . . . . 0.0 109.159 178.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.729 HH22 ' N ' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -164.93 146.24 7.73 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 118.564 -1.254 . . . . 0.0 112.012 -178.6 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.508 ' CD2' ' N ' ' A' ' 84' ' ' LEU . 3.2 mm? -92.72 95.35 9.51 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 177.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.5 ' SG ' ' OH ' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -31.77 -46.21 0.11 Allowed 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -177.156 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.467 ' SG ' ' N ' ' A' ' 87' ' ' GLN . 30.3 p -58.22 -45.75 87.13 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 119.856 -1.777 . . . . 0.0 111.956 -177.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.467 ' N ' ' SG ' ' A' ' 86' ' ' CYS . 10.4 tp60 -74.79 39.58 0.13 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.481 -1.387 . . . . 0.0 111.494 -178.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 31.6 mt -131.35 145.71 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 O-C-N 120.86 -1.15 . . . . 0.0 108.715 178.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.6 mp -121.6 127.84 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.501 ' SD ' ' OG ' ' A' ' 1' ' ' SER . 0.0 OUTLIER -88.33 162.05 16.79 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -178.881 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 45.5 p -152.1 148.4 21.32 Favored Pre-proline 0 N--CA 1.49 1.551 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.1 -32.98 98.3 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 121.69 1.594 . . . . 0.0 111.298 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -66.63 -32.81 74.38 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.126 -0.984 . . . . 0.0 109.502 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.6 mt -90.85 31.39 1.07 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.149 -0.969 . . . . 0.0 109.229 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -60.21 133.31 55.98 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.878 -1.139 . . . . 0.0 110.45 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 110.67 11.33 19.53 Favored Glycine 0 N--CA 1.507 3.416 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 178.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -64.07 124.17 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.19 0 O-C-N 120.997 -1.296 . . . . 0.0 110.297 -177.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.5 t -101.69 121.92 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.505 -0.747 . . . . 0.0 109.32 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.1 t -108.5 133.53 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 120.977 -1.077 . . . . 0.0 110.109 -178.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.96 118.32 36.39 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.901 0.858 . . . . 0.0 109.113 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 14.9 t -107.74 124.59 34.45 Favored Pre-proline 0 N--CA 1.497 1.909 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -82.57 178.45 6.14 Favored 'Trans proline' 0 N--CA 1.5 1.886 0 C-N-CA 122.315 2.01 . . . . 0.0 113.497 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -83.03 -14.03 54.69 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.32 87.32 2.72 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 -178.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -87.56 -32.59 19.28 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.546 ' CD1' ' OG1' ' A' ' 75' ' ' THR . 45.3 t-105 . . . . . 0 C--N 1.302 -1.486 0 CA-C-O 117.735 -1.126 . . . . 0.0 109.564 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' FES . . . . . 0.491 ' S1 ' ' O ' ' A' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' A' ' 17' ' ' VAL . 51.9 p . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.51 109.66 12.9 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.563 -0.855 . . . . 0.0 108.953 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.4 ' CG1' ' CZ ' ' A' ' 5' ' ' TYR . 22.9 t -107.48 108.55 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 O-C-N 121.237 -0.915 . . . . 0.0 110.489 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.0 t -99.04 98.81 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.089 -1.007 . . . . 0.0 111.405 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.4 ' CZ ' ' CG1' ' A' ' 3' ' ' VAL . 68.9 m-85 -73.08 115.13 12.03 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 75.2 t -98.81 111.6 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 61.3 p -72.3 -159.66 0.06 Allowed 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 121.666 0.746 . . . . 0.0 109.867 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.744 ' ND1' ' H ' ' A' ' 8' ' ' HIS . 0.2 OUTLIER -90.58 -50.87 5.69 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.309 -0.869 . . . . 0.0 108.709 -179.966 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.495 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 15.1 p30 -66.34 5.23 0.58 Allowed 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.752 -179.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.433 ' H ' ' C ' ' A' ' 8' ' ' HIS . . . 92.11 -1.83 74.4 Favored Glycine 0 N--CA 1.499 2.887 0 O-C-N 120.879 -1.138 . . . . 0.0 110.895 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -65.27 129.67 40.56 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.89 -1.359 . . . . 0.0 108.541 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 2.2 mtt85 -108.76 160.64 15.8 Favored 'General case' 0 N--CA 1.502 2.126 0 CA-C-O 121.68 0.752 . . . . 0.0 110.58 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.15 115.38 5.42 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 179.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -98.72 127.12 44.54 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-O 121.829 0.823 . . . . 0.0 110.342 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.416 ' CD1' ' H ' ' A' ' 16' ' ' ASP . 0.3 OUTLIER -113.44 -174.33 2.44 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 123.203 1.478 . . . . 0.0 111.032 -177.797 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.416 ' H ' ' CD1' ' A' ' 15' ' ' LEU . 0.8 OUTLIER -136.14 99.97 4.28 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 104.654 -2.35 . . . . 0.0 104.654 176.48 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.433 ' O ' ' OG ' ' A' ' 1' ' ' SER . 13.0 t -108.22 116.39 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.81 -179.72 2.33 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.311 -0.868 . . . . 0.0 111.409 -178.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 19' ' ' ASP . 3.8 p-10 -70.0 136.75 50.75 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 122.012 0.91 . . . . 0.0 110.724 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.01 -18.2 41.74 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 178.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.5 t -80.1 138.52 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 120.616 -1.52 . . . . 0.0 109.432 -178.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.27 153.97 21.06 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.164 -0.96 . . . . 0.0 109.126 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.419 ' CD2' ' N ' ' A' ' 23' ' ' LEU . 1.8 mm? -56.26 -64.05 0.99 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.612 -0.68 . . . . 0.0 109.178 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.515 ' O ' ' SD ' ' A' ' 24' ' ' MET . 6.6 tpt -49.46 -16.28 0.2 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.009 -1.057 . . . . 0.0 109.123 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.418 ' N ' ' C ' ' A' ' 23' ' ' LEU . 7.7 tm0? -78.35 -68.1 0.67 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.104 -0.998 . . . . 0.0 109.47 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.24 -21.7 15.17 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.929 -1.107 . . . . 0.0 110.418 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.78 -19.35 65.78 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 120.844 -1.16 . . . . 0.0 108.809 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 96.5 t -86.98 -23.87 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.472 -0.767 . . . . 0.0 109.381 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.53 -26.43 45.79 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.529 -0.732 . . . . 0.0 109.054 -179.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.407 ' N ' HD21 ' A' ' 30' ' ' ASN . 1.8 m-80 -106.92 -0.69 23.01 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.147 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 64.48 75.47 0.37 Allowed Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 56.4 mt -124.09 -52.07 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 O-C-N 121.629 -0.924 . . . . 0.0 109.563 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -91.24 122.43 33.86 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 177.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -106.91 65.59 0.66 Allowed 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 176.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 14.4 mt -149.48 148.25 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.297 0 O-C-N 120.649 -1.282 . . . . 0.0 110.317 -178.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.3 t -88.49 111.07 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -49.21 108.75 0.47 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.539 ' C ' ' H ' ' A' ' 40' ' ' GLY . 12.6 t0 -50.09 -59.48 3.87 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.137 -1.213 . . . . 0.0 109.258 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.613 ' SG ' ' N ' ' A' ' 42' ' ' SER . 17.1 p -71.31 16.68 0.09 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.251 -0.906 . . . . 0.0 108.997 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.539 ' H ' ' C ' ' A' ' 38' ' ' ASP . . . 59.27 9.09 7.52 Favored Glycine 0 N--CA 1.483 1.783 0 N-CA-C 107.226 -2.35 . . . . 0.0 107.226 -178.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.505 ' H ' ' C ' ' A' ' 39' ' ' CYS . . . 90.39 23.65 30.97 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 109.186 -1.566 . . . . 0.0 109.186 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.613 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 60.1 m -99.91 41.65 1.15 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.395 -1.062 . . . . 0.0 110.072 -179.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 43.71 76.09 0.09 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.278 -0.889 . . . . 0.0 109.934 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.22 23.54 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.143 -0.973 . . . . 0.0 109.488 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.502 ' SG ' ' OG1' ' A' ' 47' ' ' THR . 3.2 p -160.9 163.48 31.9 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.027 -1.046 . . . . 0.0 110.092 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -96.53 8.88 43.04 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.502 ' OG1' ' SG ' ' A' ' 45' ' ' CYS . 9.7 m -51.91 -51.45 56.8 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.798 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.516 ' SG ' ' O ' ' A' ' 48' ' ' CYS . 17.8 p -87.44 54.66 3.22 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.695 -1.253 . . . . 0.0 110.071 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.527 ' CE1' ' OH ' ' A' ' 51' ' ' TYR . 43.6 t60 -76.52 109.97 10.69 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.955 -1.091 . . . . 0.0 109.024 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -146.06 168.17 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 120.796 -1.19 . . . . 0.0 109.697 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.601 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 37.2 m-85 -116.7 114.86 24.62 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-O 122.051 0.929 . . . . 0.0 109.58 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.456 ' O ' ' OD1' ' A' ' 81' ' ' ASN . 78.7 t -91.31 131.64 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.611 ' C ' ' H ' ' A' ' 55' ' ' ALA . 1.1 t30 -46.95 127.65 10.31 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -57.38 13.9 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.63 -0.669 . . . . 0.0 111.441 -178.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.611 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -103.45 -19.8 14.28 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.57 -1.331 . . . . 0.0 109.8 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.41 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 30.2 m-85 -109.59 -9.78 14.87 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.708 -1.245 . . . . 0.0 108.859 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.0 p -71.18 -37.51 72.17 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.565 -0.71 . . . . 0.0 110.141 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 9.5 p-10 -87.84 10.51 18.33 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.229 -0.919 . . . . 0.0 109.913 -178.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.43 ' CE ' ' O ' ' A' ' 55' ' ' ALA . 9.1 mttm -121.21 -40.04 2.63 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -78.73 162.09 66.67 Favored Pre-proline 0 N--CA 1.498 1.953 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -53.97 94.19 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 121.877 1.718 . . . . 0.0 113.939 -176.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.0 98.5 3.62 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 177.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.895 ' H ' HH22 ' A' ' 83' ' ' ARG . . . -61.05 169.34 2.04 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-O 122.559 1.171 . . . . 0.0 111.953 -178.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -65.18 -175.02 0.19 Allowed 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 122.204 1.002 . . . . 0.0 111.954 -178.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -70.33 3.31 3.0 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.813 -0.555 . . . . 0.0 111.409 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.2 mtm180 -59.95 -41.76 92.58 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.669 -1.269 . . . . 0.0 110.143 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.478 ' N ' ' CD ' ' A' ' 67' ' ' GLU . 23.7 mp0 -80.29 -37.0 33.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.021 -1.049 . . . . 0.0 110.029 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.444 ' CD1' ' N ' ' A' ' 68' ' ' ILE . 1.3 mp -46.88 -34.13 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 C-N-CA 119.731 -0.788 . . . . 0.0 109.142 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.3 -28.36 62.08 Favored Glycine 0 N--CA 1.498 2.791 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.421 ' N ' ' O ' ' A' ' 67' ' ' GLU . 25.1 mtt -79.97 -35.6 37.31 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 178.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 74.9 mt -66.81 -24.69 66.2 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -77.48 5.83 8.18 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.732 -1.23 . . . . 0.0 108.032 178.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -124.42 30.17 6.1 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.752 -0.592 . . . . 0.0 110.981 -177.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 28.9 m -96.35 169.54 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.42 0 O-C-N 120.652 -1.28 . . . . 0.0 110.723 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.531 ' OG1' ' CG ' ' A' ' 106' ' ' TRP . 3.1 m -102.41 -9.93 19.86 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.342 -0.849 . . . . 0.0 111.281 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.413 ' HB2' ' HE2' ' A' ' 49' ' ' HIS . . . -104.58 176.13 5.26 Favored 'General case' 0 N--CA 1.507 2.405 0 O-C-N 120.627 -1.296 . . . . 0.0 110.411 -178.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.601 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -59.64 105.33 0.36 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.613 -0.679 . . . . 0.0 110.255 -178.528 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.9 tp -73.96 147.35 43.14 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 119.502 -1.999 . . . . 0.0 110.338 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 27.0 mmtm -109.58 155.52 41.2 Favored Pre-proline 0 C--N 1.291 -1.962 0 CA-C-N 114.756 -1.111 . . . . 0.0 108.83 -178.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.47 -23.02 73.96 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 121.964 1.776 . . . . 0.0 109.331 178.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.456 ' OD1' ' O ' ' A' ' 52' ' ' VAL . 2.1 p30 -115.55 23.22 12.53 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.832 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.1 m -47.21 165.66 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.672 -1.268 . . . . 0.0 109.409 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.895 HH22 ' H ' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -161.58 141.99 10.71 Favored 'General case' 0 N--CA 1.5 2.046 0 C-N-CA 118.259 -1.376 . . . . 0.0 111.96 -177.531 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 95.5 mt -86.32 111.16 20.21 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 177.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.464 ' N ' ' SG ' ' A' ' 48' ' ' CYS . 0.1 OUTLIER -56.2 -35.14 66.94 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -176.106 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.547 ' SG ' ' N ' ' A' ' 87' ' ' GLN . 31.6 p -63.51 -49.06 75.05 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 119.678 -1.889 . . . . 0.0 112.343 -177.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.67 HE22 ' NH1' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -79.61 33.8 0.26 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.841 -1.162 . . . . 0.0 111.425 -177.709 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.42 ' CG2' ' N ' ' A' ' 89' ' ' ILE . 71.5 mt -113.17 160.76 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 177.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.42 ' N ' ' CG2' ' A' ' 88' ' ' ILE . 35.6 mm -136.5 121.85 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.147 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 3.2 tpt -87.28 160.87 18.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.792 -1.193 . . . . 0.0 108.799 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 39.4 p -151.06 148.67 23.2 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -56.03 -32.37 85.97 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 121.379 1.386 . . . . 0.0 111.634 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.503 ' CD ' ' H ' ' A' ' 93' ' ' GLU . 2.3 pm0 -68.11 -31.52 71.18 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.062 -1.024 . . . . 0.0 110.006 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.2 mt -94.43 27.99 2.75 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 120.72 -1.237 . . . . 0.0 108.956 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -61.86 138.03 58.31 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.023 -1.048 . . . . 0.0 110.324 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 107.83 9.77 27.81 Favored Glycine 0 N--CA 1.499 2.866 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 178.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 14.4 tt -64.99 133.25 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 120.925 -1.338 . . . . 0.0 111.365 -177.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.3 t -103.06 114.59 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.5 t -103.72 135.75 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.729 -1.232 . . . . 0.0 108.558 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.1 116.17 31.44 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.809 0.814 . . . . 0.0 109.172 -179.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.2 t -103.34 125.01 36.24 Favored Pre-proline 0 N--CA 1.498 1.933 0 O-C-N 121.845 -0.534 . . . . 0.0 109.565 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -80.6 167.24 19.09 Favored 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 122.193 1.929 . . . . 0.0 113.735 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -73.11 -14.98 61.49 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 21.5 mtm180 -123.82 92.32 3.65 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 2.7 pp0? -82.61 -19.51 38.23 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.628 -0.67 . . . . 0.0 109.716 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.531 ' CG ' ' OG1' ' A' ' 75' ' ' THR . 63.5 t-105 . . . . . 0 C--N 1.304 -1.373 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.537 178.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' FES . . . . . 0.499 ' S1 ' ' O ' ' A' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.488 ' OG ' ' SD ' ' A' ' 90' ' ' MET . 83.9 p . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 25.4 mmtt -75.38 111.71 10.93 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.31 -0.869 . . . . 0.0 109.157 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.446 ' CG2' ' SD ' ' A' ' 90' ' ' MET . 17.2 t -109.49 109.19 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.343 -0.848 . . . . 0.0 109.499 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 38.5 t -99.57 96.49 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.127 -0.983 . . . . 0.0 111.345 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.432 ' CE2' ' CD1' ' A' ' 32' ' ' ILE . 93.9 m-85 -70.54 111.76 6.3 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 76.1 t -98.46 117.36 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 80.8 p -76.51 -158.6 0.1 Allowed 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.346 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.711 ' ND1' ' H ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -90.33 -49.65 6.41 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.089 -1.007 . . . . 0.0 109.466 -179.646 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.485 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 22.9 p-10 -66.39 2.06 1.39 Allowed 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.264 -0.897 . . . . 0.0 110.355 -178.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.01 -0.54 62.47 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -65.05 127.94 33.7 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.9 -1.353 . . . . 0.0 108.227 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' A' ' 12' ' ' ARG . 2.3 mtt85 -108.12 160.67 15.63 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 122.156 0.979 . . . . 0.0 110.796 -178.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -150.99 115.19 5.06 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 178.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.466 ' N ' ' OE2' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -99.19 128.46 45.32 Favored 'General case' 0 N--CA 1.508 2.436 0 CA-C-O 122.504 1.145 . . . . 0.0 110.613 -178.144 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.462 ' CD1' ' H ' ' A' ' 16' ' ' ASP . 0.2 OUTLIER -115.13 -173.86 2.39 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 123.072 1.415 . . . . 0.0 110.575 -178.475 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.462 ' H ' ' CD1' ' A' ' 15' ' ' LEU . 32.6 t0 -136.36 104.39 5.6 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 176.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.2 t -112.9 122.92 67.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 O-C-N 121.525 -0.734 . . . . 0.0 109.604 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.82 179.78 5.9 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.919 0.866 . . . . 0.0 111.519 -178.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -69.31 138.82 54.11 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 122.025 0.917 . . . . 0.0 110.913 -179.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.83 -17.09 37.94 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 62.0 t -81.9 139.13 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 O-C-N 120.51 -1.583 . . . . 0.0 109.122 -178.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 16.0 p -92.68 149.19 21.48 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.158 -0.964 . . . . 0.0 108.588 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 27.0 mt -50.01 -36.15 27.51 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 121.093 -1.004 . . . . 0.0 110.007 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.493 ' SD ' ' OD2' ' A' ' 34' ' ' ASP . 7.5 tpt -68.11 -24.37 65.02 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.319 -0.863 . . . . 0.0 109.474 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -76.94 -63.22 1.41 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.143 -0.973 . . . . 0.0 109.622 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.95 -28.54 24.06 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.123 -0.986 . . . . 0.0 110.599 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.14 -20.96 29.17 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.749 -1.22 . . . . 0.0 108.756 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.5 t -88.57 -23.85 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.485 -0.759 . . . . 0.0 110.585 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.485 ' OG ' ' ND2' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -75.3 -31.11 60.56 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.303 -0.873 . . . . 0.0 109.99 -179.287 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.485 ' ND2' ' OG ' ' A' ' 29' ' ' SER . 1.7 m-80 -104.54 0.09 28.35 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 64.4 59.03 8.84 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.872 ' O ' ' N ' ' A' ' 34' ' ' ASP . 25.3 mt -91.47 124.74 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.231 -1.159 . . . . 0.0 108.253 179.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -40.41 49.32 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.707 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -177.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.872 ' N ' ' O ' ' A' ' 32' ' ' ILE . 29.8 p-10 -94.17 -8.62 38.89 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.175 -0.953 . . . . 0.0 109.816 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.579 ' CG1' ' H ' ' A' ' 36' ' ' VAL . 9.5 tt -47.12 -177.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.451 -0.781 . . . . 0.0 110.693 -178.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.579 ' H ' ' CG1' ' A' ' 35' ' ' ILE . 42.8 t 60.63 91.48 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -178.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -148.87 151.51 23.67 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.537 ' C ' ' H ' ' A' ' 40' ' ' GLY . 26.4 m-20 -88.21 -68.4 0.76 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.126 -1.22 . . . . 0.0 109.956 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.625 ' SG ' ' N ' ' A' ' 42' ' ' SER . 4.7 p -69.81 15.7 0.08 Allowed 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 119.901 -0.72 . . . . 0.0 109.653 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.537 ' H ' ' C ' ' A' ' 38' ' ' ASP . . . 51.4 11.83 0.82 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.508 ' H ' ' C ' ' A' ' 39' ' ' CYS . . . 96.61 19.76 26.44 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.625 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 4.8 p -93.38 35.12 1.11 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.323 -1.104 . . . . 0.0 109.537 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 45.2 74.56 0.13 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.341 -0.849 . . . . 0.0 110.314 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -166.65 26.44 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.846 -1.159 . . . . 0.0 109.927 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.514 ' SG ' ' OG1' ' A' ' 47' ' ' THR . 3.0 p -161.59 -177.0 5.63 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.099 -1.001 . . . . 0.0 109.717 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -116.27 12.75 15.47 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.361 -0.837 . . . . 0.0 109.524 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.514 ' OG1' ' SG ' ' A' ' 45' ' ' CYS . 75.5 p -59.81 -28.5 67.51 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.226 -0.921 . . . . 0.0 109.483 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 20.8 p -97.28 54.21 1.21 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.214 -0.928 . . . . 0.0 109.586 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.483 ' CE1' ' OH ' ' A' ' 51' ' ' TYR . 39.5 t60 -76.2 96.11 3.84 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -133.65 164.58 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 121.151 -0.968 . . . . 0.0 109.748 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.568 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 45.8 m-85 -113.54 113.25 24.85 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 122.073 0.94 . . . . 0.0 110.192 -179.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.423 ' O ' ' OD1' ' A' ' 81' ' ' ASN . 47.1 t -87.25 131.13 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.621 ' C ' ' H ' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -48.0 128.19 13.29 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.92 -1.113 . . . . 0.0 108.902 179.834 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -55.85 9.96 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.284 -0.885 . . . . 0.0 111.515 -178.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.621 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -98.19 -18.42 18.46 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.892 -1.13 . . . . 0.0 110.137 -179.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -114.66 -7.45 12.73 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 120.707 -1.246 . . . . 0.0 108.855 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.3 p -71.61 -41.18 69.22 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.083 -1.01 . . . . 0.0 109.858 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -85.48 10.17 13.74 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.435 -0.791 . . . . 0.0 110.006 -178.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 17.3 mttt -120.11 -38.46 2.93 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -82.51 164.14 48.79 Favored Pre-proline 0 N--CA 1.493 1.705 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.563 ' O ' ' NH2' ' A' ' 83' ' ' ARG . 5.6 Cg_endo -58.31 99.33 0.1 OUTLIER 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 121.773 1.649 . . . . 0.0 114.714 -176.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.27 102.97 1.48 Allowed 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -56.77 155.33 7.88 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-O 122.304 1.049 . . . . 0.0 112.51 -178.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.444 ' ND2' ' NH1' ' A' ' 66' ' ' ARG . 3.0 p30 -59.3 -178.2 0.06 Allowed 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.721 0.772 . . . . 0.0 111.148 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -70.1 2.19 3.88 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.669 -0.644 . . . . 0.0 112.354 -178.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.444 ' NH1' ' ND2' ' A' ' 64' ' ' ASN . 51.4 mtt85 -67.57 -40.97 84.87 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 120.68 -1.263 . . . . 0.0 109.679 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.484 ' N ' ' CD ' ' A' ' 67' ' ' GLU . 23.0 mp0 -72.26 -41.06 67.17 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.08 -1.013 . . . . 0.0 108.609 178.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.479 ' CD1' ' N ' ' A' ' 68' ' ' ILE . 1.4 mp -48.31 -30.26 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -70.15 -74.9 0.63 Allowed Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 9.0 ptp -46.38 -33.89 4.21 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.875 -1.368 . . . . 0.0 109.144 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.0 mt -58.04 -28.56 64.6 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.536 ' N ' ' O ' ' A' ' 69' ' ' GLY . 39.6 tt0 -79.71 5.11 14.22 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.368 -0.833 . . . . 0.0 108.771 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -122.99 31.57 5.98 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.555 -0.716 . . . . 0.0 110.122 -178.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.4 m -92.09 166.77 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 120.797 -1.189 . . . . 0.0 110.006 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.513 ' OG1' ' CG ' ' A' ' 106' ' ' TRP . 4.8 m -99.56 -8.08 25.02 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.806 -0.558 . . . . 0.0 110.249 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -107.36 169.74 8.39 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.113 -0.992 . . . . 0.0 110.354 -178.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.568 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -60.91 108.52 0.87 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.815 -0.553 . . . . 0.0 109.67 -179.553 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.5 tp -72.93 155.78 39.52 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 120.011 -1.681 . . . . 0.0 110.118 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 25.3 mmtm -117.15 153.54 49.78 Favored Pre-proline 0 C--N 1.292 -1.916 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 -178.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.4 -22.16 70.37 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 C-N-CA 121.173 1.249 . . . . 0.0 109.77 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.431 ' OD1' ' O ' ' A' ' 81' ' ' ASN . 1.1 p30 -111.77 19.66 17.8 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.867 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 21.6 m -58.24 162.69 3.39 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.542 -1.349 . . . . 0.0 109.746 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.563 ' NH2' ' O ' ' A' ' 61' ' ' PRO . 0.7 OUTLIER -171.72 146.28 2.09 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 118.32 -1.352 . . . . 0.0 111.169 179.447 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.444 ' CD1' ' N ' ' A' ' 84' ' ' LEU . 5.3 mp -76.62 116.01 16.9 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -57.51 -16.96 11.25 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.446 -0.784 . . . . 0.0 112.922 -176.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 30.5 p -85.85 -33.16 21.37 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 119.81 -1.806 . . . . 0.0 111.207 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.406 ' OE1' ' CD ' ' A' ' 67' ' ' GLU . 34.2 tt0 -87.53 32.05 0.73 Allowed 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.261 -1.525 . . . . 0.0 110.403 -179.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 41.3 mm -117.61 157.93 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 O-C-N 121.022 -1.049 . . . . 0.0 108.423 178.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 35.2 mm -130.5 122.7 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.488 ' SD ' ' OG ' ' A' ' 1' ' ' SER . 0.0 OUTLIER -86.54 155.84 20.32 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.137 -0.977 . . . . 0.0 108.622 -178.888 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 57.0 p -147.81 148.02 28.98 Favored Pre-proline 0 N--CA 1.492 1.663 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -58.08 -32.71 96.16 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 121.286 1.324 . . . . 0.0 111.018 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -64.82 -28.54 69.63 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.13 -0.981 . . . . 0.0 109.262 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.4 mt -99.37 27.59 5.11 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.401 -0.812 . . . . 0.0 109.492 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -58.9 138.45 57.36 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.876 -1.14 . . . . 0.0 109.361 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 107.22 9.75 29.01 Favored Glycine 0 N--CA 1.501 3.028 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 178.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 16.4 tt -65.09 130.05 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.842 -1.387 . . . . 0.0 111.113 -178.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.494 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 4.8 t -103.5 115.36 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.446 -0.784 . . . . 0.0 109.077 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.5 t -102.65 134.81 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 120.922 -1.112 . . . . 0.0 109.366 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -108.39 124.05 49.78 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.799 0.809 . . . . 0.0 109.661 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.1 t -111.11 124.12 33.58 Favored Pre-proline 0 N--CA 1.495 1.816 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -83.06 175.53 8.41 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 122.678 2.252 . . . . 0.0 113.37 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -83.5 -17.34 42.25 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -109.74 80.92 1.36 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.447 ' O ' ' OXT' ' A' ' 106' ' ' TRP . 39.5 tt0 -82.95 -33.27 26.77 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.116 -0.99 . . . . 0.0 109.177 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.548 ' CG ' ' O ' ' A' ' 106' ' ' TRP . 57.3 t-105 . . . . . 0 C--N 1.301 -1.522 0 CA-C-O 118.294 -0.86 . . . . 0.0 109.788 179.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' FES . . . . . 0.489 ' S1 ' ' O ' ' A' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.447 ' OG ' ' O ' ' A' ' 17' ' ' VAL . 68.0 p . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 19.1 mmtm -76.96 113.88 15.14 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.98 -1.075 . . . . 0.0 108.534 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 49.5 t -115.0 109.91 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.442 -0.786 . . . . 0.0 110.076 -179.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.6 t -102.64 134.88 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 CA-C-O 121.749 0.785 . . . . 0.0 110.389 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -106.12 114.5 28.68 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 177.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 67.0 t -97.82 115.21 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 27.7 p -77.92 -160.28 0.19 Allowed 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.426 0.631 . . . . 0.0 109.674 -178.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.75 ' ND1' ' H ' ' A' ' 8' ' ' HIS . 0.2 OUTLIER -87.13 -47.23 9.06 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.563 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.459 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 17.8 p30 -70.52 -2.53 14.36 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.088 -1.007 . . . . 0.0 110.973 -178.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.12 0.0 57.26 Favored Glycine 0 N--CA 1.499 2.863 0 O-C-N 120.854 -1.154 . . . . 0.0 110.953 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -66.31 131.15 45.45 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.628 -1.513 . . . . 0.0 108.847 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.84 156.03 23.61 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.579 0.704 . . . . 0.0 110.979 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.3 mmm-85 -142.76 112.75 7.03 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 177.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.442 ' CD ' ' H ' ' A' ' 14' ' ' GLU . 2.6 mp0 -98.37 127.33 44.26 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.863 -1.148 . . . . 0.0 109.819 -178.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 19.4 mt -117.88 -165.19 1.07 Allowed 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 122.738 1.256 . . . . 0.0 110.0 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -137.13 99.77 4.09 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 104.942 -2.244 . . . . 0.0 104.942 176.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.447 ' O ' ' OG ' ' A' ' 1' ' ' SER . 12.8 t -102.63 115.36 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.33 177.17 4.05 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 122.359 1.076 . . . . 0.0 111.312 -178.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -65.69 133.34 50.88 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.975 0.893 . . . . 0.0 110.709 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.03 -18.4 53.83 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.3 t -85.36 138.64 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.585 -1.538 . . . . 0.0 109.175 -178.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.478 ' HG ' ' H ' ' A' ' 25' ' ' GLN . 59.9 p -93.38 146.35 23.8 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.266 -0.896 . . . . 0.0 109.458 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.5 mt -48.11 -34.17 9.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.001 -1.062 . . . . 0.0 109.406 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.49 ' O ' ' SD ' ' A' ' 24' ' ' MET . 4.3 tpt -67.55 -29.07 68.35 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.478 ' H ' ' HG ' ' A' ' 22' ' ' SER . 14.5 mm100 -73.74 -59.83 2.53 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.104 -0.997 . . . . 0.0 109.637 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.48 -24.42 65.26 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.878 -1.139 . . . . 0.0 111.22 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.4 -24.58 67.9 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.941 -1.099 . . . . 0.0 108.967 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 88.7 t -80.78 -23.52 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 CA-C-O 121.555 0.693 . . . . 0.0 109.148 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.25 -27.54 35.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.4 -0.812 . . . . 0.0 109.28 -179.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -103.21 1.31 32.87 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 178.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 63.68 70.55 1.03 Allowed Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 71.4 mt -124.4 -43.61 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.674 -0.898 . . . . 0.0 110.516 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.652 ' O ' ' N ' ' A' ' 35' ' ' ILE . 0.2 OUTLIER -80.33 15.36 1.62 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.777 -1.202 . . . . 0.0 109.979 -179.047 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -58.11 54.47 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.516 0.674 . . . . 0.0 110.521 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.652 ' N ' ' O ' ' A' ' 33' ' ' TYR . 40.4 mm -126.91 -86.63 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.461 ' CG1' ' N ' ' A' ' 37' ' ' GLY . 69.9 t -148.8 164.17 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.923 -1.11 . . . . 0.0 109.609 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.461 ' N ' ' CG1' ' A' ' 36' ' ' VAL . . . -166.01 109.63 0.37 Allowed Glycine 0 N--CA 1.483 1.808 0 N-CA-C 108.741 -1.743 . . . . 0.0 108.741 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -87.44 -91.93 0.11 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.16 -1.2 . . . . 0.0 109.764 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.431 ' SG ' ' N ' ' A' ' 42' ' ' SER . 0.5 OUTLIER -51.65 -28.77 15.5 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.047 -1.033 . . . . 0.0 108.642 -179.677 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 46.71 65.15 2.31 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 85.96 55.22 2.57 Favored Glycine 0 N--CA 1.497 2.755 0 C-N-CA 119.469 -1.348 . . . . 0.0 109.785 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.431 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 0.6 OUTLIER -155.9 14.12 0.34 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.348 -1.678 . . . . 0.0 110.368 179.583 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 42' ' ' SER . . . 42.42 70.0 0.33 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.271 -0.893 . . . . 0.0 109.957 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.7 t -162.57 22.21 0.1 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.92 -1.113 . . . . 0.0 109.861 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.528 ' SG ' ' N ' ' A' ' 46' ' ' ALA . 2.1 p -155.76 -156.25 0.63 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.047 -1.033 . . . . 0.0 109.975 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.528 ' N ' ' SG ' ' A' ' 45' ' ' CYS . . . -149.04 21.38 0.98 Allowed 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 42.7 p -71.35 -38.92 71.59 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.021 -1.05 . . . . 0.0 110.206 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.497 ' SG ' ' O ' ' A' ' 48' ' ' CYS . 15.0 p -91.37 48.11 1.45 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.795 -1.191 . . . . 0.0 109.996 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.536 ' NE2' ' OH ' ' A' ' 51' ' ' TYR . 53.8 t60 -77.99 113.14 15.62 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.969 -1.082 . . . . 0.0 109.026 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -146.05 165.12 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.107 -0.996 . . . . 0.0 109.214 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.536 ' OH ' ' NE2' ' A' ' 49' ' ' HIS . 52.0 m-85 -114.03 111.57 21.86 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 121.667 0.746 . . . . 0.0 109.788 -178.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.444 ' O ' ' OD1' ' A' ' 81' ' ' ASN . 81.9 t -86.12 135.02 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.609 ' C ' ' H ' ' A' ' 55' ' ' ALA . 3.3 t30 -49.7 128.09 17.22 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.91 -1.119 . . . . 0.0 108.973 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -56.09 12.13 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.592 -0.692 . . . . 0.0 111.566 -178.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.609 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -101.06 -19.62 15.72 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.892 -1.13 . . . . 0.0 109.8 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.4 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 46.3 m-85 -110.78 -11.59 14.37 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.767 -1.208 . . . . 0.0 109.596 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.5 p -70.59 -38.3 74.03 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.81 -1.181 . . . . 0.0 110.012 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -85.85 9.71 15.93 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.184 -0.948 . . . . 0.0 110.092 -178.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.437 ' CE ' ' O ' ' A' ' 55' ' ' ALA . 9.6 mttm -121.11 -37.93 2.88 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -81.84 159.0 67.06 Favored Pre-proline 0 N--CA 1.494 1.748 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -48.7 101.96 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.029 1.819 . . . . 0.0 112.247 -178.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.9 101.44 4.41 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -49.63 144.05 6.44 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-O 121.878 0.847 . . . . 0.0 111.504 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -53.56 -175.17 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.658 0.742 . . . . 0.0 110.121 -179.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -69.5 -1.44 8.62 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.697 -0.627 . . . . 0.0 111.136 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.507 ' O ' ' SD ' ' A' ' 70' ' ' MET . 8.8 mtt85 -63.85 -39.92 95.36 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.769 -1.207 . . . . 0.0 109.439 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.441 ' N ' ' CD ' ' A' ' 67' ' ' GLU . 10.2 mp0 -78.18 -40.68 37.0 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.174 -0.953 . . . . 0.0 109.868 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.47 ' CD1' ' N ' ' A' ' 68' ' ' ILE . 1.4 mp -46.72 -25.33 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.49 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -76.66 -67.81 1.62 Allowed Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.066 -1.614 . . . . 0.0 109.066 179.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.507 ' SD ' ' O ' ' A' ' 66' ' ' ARG . 4.7 mpp? -49.28 -39.42 30.74 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.054 -1.262 . . . . 0.0 108.599 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.5 mt -55.2 -21.71 14.86 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.49 ' N ' ' O ' ' A' ' 69' ' ' GLY . 27.0 tt0 -91.08 12.46 19.8 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -124.93 31.04 5.74 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.446 -0.784 . . . . 0.0 110.085 -179.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -98.61 175.5 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.287 0 O-C-N 121.375 -0.828 . . . . 0.0 109.215 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.526 ' OG1' ' CD1' ' A' ' 106' ' ' TRP . 4.2 m -109.71 -0.61 18.46 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.342 -0.849 . . . . 0.0 110.026 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -107.45 167.44 9.93 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.053 -1.029 . . . . 0.0 109.882 -179.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.459 ' O ' ' CG ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -58.07 106.8 0.4 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.616 -0.677 . . . . 0.0 110.935 -178.767 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.2 tp -70.29 147.67 49.41 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 120.106 -1.621 . . . . 0.0 109.562 178.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.1 mmtp -112.78 156.04 43.13 Favored Pre-proline 0 C--N 1.29 -2.003 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -178.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -54.22 -22.14 25.02 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 121.349 1.366 . . . . 0.0 109.862 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.444 ' OD1' ' O ' ' A' ' 52' ' ' VAL . 0.1 OUTLIER -126.99 37.81 4.21 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.955 -0.465 . . . . 0.0 110.426 -179.887 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 37.5 m -60.49 175.46 0.45 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.365 -1.46 . . . . 0.0 108.445 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.433 ' HE ' HG12 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -166.24 159.86 15.43 Favored 'General case' 0 N--CA 1.504 2.227 0 C-N-CA 118.28 -1.368 . . . . 0.0 111.583 -178.183 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.413 ' C ' ' SG ' ' A' ' 48' ' ' CYS . 50.0 mt -105.75 95.35 5.74 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 178.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.52 ' C ' ' H ' ' A' ' 87' ' ' GLN . 0.1 OUTLIER -39.78 -44.34 1.57 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.553 -0.717 . . . . 0.0 112.848 -176.718 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 13.9 p -60.65 5.94 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 119.972 -1.705 . . . . 0.0 110.938 -177.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.52 ' H ' ' C ' ' A' ' 85' ' ' CYS . 13.6 mt-30 -136.02 45.39 2.39 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 120.937 -1.102 . . . . 0.0 111.664 -178.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.433 HG12 ' HE ' ' A' ' 83' ' ' ARG . 3.7 mt -131.77 156.18 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 O-C-N 121.074 -1.016 . . . . 0.0 108.602 177.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 38.3 mm -129.7 126.48 62.9 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.427 0 O-C-N 121.31 -0.869 . . . . 0.0 109.524 -178.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.434 ' SD ' HG22 ' A' ' 97' ' ' ILE . 4.1 tpt -91.05 163.51 14.28 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.106 -0.996 . . . . 0.0 110.38 -179.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 70.6 p -151.93 147.24 19.59 Favored Pre-proline 0 N--CA 1.488 1.469 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -56.35 -30.08 79.63 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 121.259 1.306 . . . . 0.0 111.568 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -68.96 -31.21 69.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.105 -0.997 . . . . 0.0 110.334 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.7 mt -95.58 32.72 1.75 Allowed 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.209 -0.932 . . . . 0.0 109.488 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -62.45 138.6 58.49 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.71 -1.244 . . . . 0.0 110.159 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 109.86 9.75 24.03 Favored Glycine 0 N--CA 1.504 3.187 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 178.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.434 HG22 ' SD ' ' A' ' 90' ' ' MET . 0.0 OUTLIER -65.04 129.89 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 120.996 -1.297 . . . . 0.0 111.555 -177.708 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.9 t -106.99 118.97 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.2 -0.937 . . . . 0.0 109.393 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.1 t -101.84 133.27 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.014 -1.054 . . . . 0.0 109.283 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.68 115.51 30.37 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 18.0 t -103.73 122.89 43.08 Favored Pre-proline 0 N--CA 1.494 1.736 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -82.16 177.8 6.9 Favored 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 121.975 1.784 . . . . 0.0 113.111 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -85.75 -13.78 47.26 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.7 86.89 2.65 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -178.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -85.05 -28.76 25.45 Favored 'General case' 0 C--N 1.308 -1.207 0 O-C-N 121.115 -0.99 . . . . 0.0 109.312 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.526 ' CD1' ' OG1' ' A' ' 75' ' ' THR . 62.5 t-105 . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.611 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.448 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.69 110.66 17.95 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 53.6 t -108.59 108.58 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.268 -0.895 . . . . 0.0 110.058 -179.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 62.9 t -99.11 126.31 52.39 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-O 121.97 0.89 . . . . 0.0 110.278 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -103.45 112.95 26.08 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 177.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 64.7 t -99.63 120.88 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.567 ' HG ' ' N ' ' A' ' 8' ' ' HIS . 3.7 p -82.44 -153.28 0.12 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.238 -0.913 . . . . 0.0 109.319 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.703 ' ND1' ' H ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -91.14 -44.35 9.31 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.458 -0.776 . . . . 0.0 109.393 -179.908 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 0.5 OUTLIER -66.93 -0.87 3.4 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.217 -0.927 . . . . 0.0 111.317 -178.444 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.5 0.52 69.78 Favored Glycine 0 N--CA 1.498 2.826 0 O-C-N 120.427 -1.421 . . . . 0.0 110.618 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.1 t -72.46 135.7 45.8 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.938 -1.331 . . . . 0.0 108.31 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.29 163.9 12.64 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 122.204 1.002 . . . . 0.0 111.048 -178.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 -151.02 112.77 4.47 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -100.24 127.77 46.45 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-O 122.561 1.172 . . . . 0.0 111.127 -178.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.63 -174.97 2.58 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-O 122.811 1.291 . . . . 0.0 110.301 -177.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -134.26 100.62 4.74 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 176.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.6 t -111.21 115.79 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.15 177.14 3.4 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.884 0.85 . . . . 0.0 111.495 -177.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -66.02 138.55 57.87 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 122.014 0.911 . . . . 0.0 110.325 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.42 -18.11 35.13 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 178.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 51.9 t -83.79 140.68 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 120.704 -1.468 . . . . 0.0 109.326 -178.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 51.5 p -93.58 147.69 22.77 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.231 -0.918 . . . . 0.0 109.131 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.9 mt -50.23 -31.9 15.16 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.193 -0.942 . . . . 0.0 109.477 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.448 ' SD ' ' C ' ' A' ' 24' ' ' MET . 1.4 tmt? -68.64 -29.58 68.1 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 52.5 mm-40 -72.05 -63.76 1.07 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.063 -1.023 . . . . 0.0 109.355 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.35 -25.6 62.16 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.996 -1.065 . . . . 0.0 110.374 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.427 ' HB2' ' H ' ' A' ' 33' ' ' TYR . . . -60.27 -20.47 59.15 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.974 -1.079 . . . . 0.0 108.981 179.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 84.1 t -86.54 -22.62 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.637 -0.664 . . . . 0.0 109.636 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.484 ' OG ' ' ND2' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -79.74 -26.74 40.66 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.443 -0.786 . . . . 0.0 109.075 -179.525 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.484 ' ND2' ' OG ' ' A' ' 29' ' ' SER . 2.4 m-80 -113.14 -0.09 14.78 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 63.66 79.73 0.15 Allowed Glycine 0 N--CA 1.496 2.657 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 78.6 mt -124.53 -63.44 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 O-C-N 121.689 -0.889 . . . . 0.0 111.01 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.43 ' O ' ' C ' ' A' ' 34' ' ' ASP . 26.7 m-85 -92.66 -12.58 31.19 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.145 -0.972 . . . . 0.0 109.988 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 33' ' ' TYR . 10.6 p-10 -39.29 -50.07 1.97 Allowed 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.528 -0.733 . . . . 0.0 109.875 -178.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.424 ' O ' ' O ' ' A' ' 36' ' ' VAL . 19.9 tt -44.03 125.02 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.678 -0.638 . . . . 0.0 109.34 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.448 ' CG1' ' N ' ' A' ' 37' ' ' GLY . 94.0 t 55.73 163.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 CA-C-O 121.497 0.665 . . . . 0.0 109.905 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.448 ' N ' ' CG1' ' A' ' 36' ' ' VAL . . . 170.0 115.8 0.35 Allowed Glycine 0 N--CA 1.488 2.146 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.552 ' C ' ' H ' ' A' ' 40' ' ' GLY . 28.7 t70 -87.73 -83.58 0.2 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.947 -1.325 . . . . 0.0 110.039 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.552 ' SG ' ' N ' ' A' ' 42' ' ' SER . 11.9 p -69.73 15.84 0.07 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.087 -1.008 . . . . 0.0 109.51 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.552 ' H ' ' C ' ' A' ' 38' ' ' ASP . . . 52.42 13.4 1.85 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.46 -1.856 . . . . 0.0 108.46 -179.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.483 ' H ' ' C ' ' A' ' 39' ' ' CYS . . . 88.57 89.88 1.14 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.552 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 41.1 t -159.51 22.4 0.18 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.124 -1.221 . . . . 0.0 108.885 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.501 ' CB ' HE21 ' A' ' 87' ' ' GLN . . . 58.24 63.45 1.74 Allowed 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.296 -0.878 . . . . 0.0 109.837 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.8 t -160.81 23.12 0.14 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.99 -1.069 . . . . 0.0 110.399 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.497 ' SG ' ' OG1' ' A' ' 47' ' ' THR . 1.5 p -162.16 166.24 25.9 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.027 -1.046 . . . . 0.0 110.047 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -97.25 4.36 51.0 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.497 ' OG1' ' SG ' ' A' ' 45' ' ' CYS . 11.1 m -49.7 -54.0 21.32 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 120.911 -1.118 . . . . 0.0 109.539 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.525 ' SG ' ' N ' ' A' ' 85' ' ' CYS . 31.9 p -80.11 53.76 1.8 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 120.944 -1.098 . . . . 0.0 109.605 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.512 ' NE2' ' OH ' ' A' ' 51' ' ' TYR . 39.3 t60 -77.64 105.61 8.91 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -143.62 164.83 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 120.859 -1.151 . . . . 0.0 109.889 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.565 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 36.4 m-85 -111.56 111.01 21.71 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.921 0.867 . . . . 0.0 110.101 -179.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.44 ' O ' ' OD1' ' A' ' 81' ' ' ASN . 15.2 t -85.9 130.62 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.617 ' C ' ' H ' ' A' ' 55' ' ' ALA . 17.8 t-20 -47.11 126.18 8.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.783 -1.198 . . . . 0.0 109.566 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -57.32 13.99 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.737 -0.602 . . . . 0.0 111.291 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.617 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -100.7 -18.99 16.25 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.729 -1.232 . . . . 0.0 109.781 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -113.85 -10.93 12.92 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.098 -1.001 . . . . 0.0 109.078 -178.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 13.1 p -68.99 -43.18 75.39 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.37 -0.831 . . . . 0.0 109.952 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -81.47 4.64 20.36 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.575 -0.703 . . . . 0.0 109.743 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 21.1 mtpt -113.19 -38.29 4.49 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.403 HG11 HH12 ' A' ' 83' ' ' ARG . 0.5 OUTLIER -82.8 158.57 65.0 Favored Pre-proline 0 N--CA 1.497 1.879 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 179.701 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.556 ' O ' ' NH2' ' A' ' 83' ' ' ARG . 1.1 Cg_endo -51.33 84.93 0.02 OUTLIER 'Trans proline' 0 N--CA 1.501 1.939 0 C-N-CA 122.405 2.07 . . . . 0.0 113.792 -176.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.79 105.17 0.28 Allowed 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -56.86 150.76 15.79 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-O 122.235 1.017 . . . . 0.0 112.667 -178.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.434 ' H ' ' ND2' ' A' ' 64' ' ' ASN . 0.6 OUTLIER -61.61 -172.84 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.032 -179.847 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -71.07 1.9 5.19 Favored 'General case' 0 N--CA 1.503 2.198 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -178.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.2 mtm180 -73.77 -46.74 43.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.386 -1.446 . . . . 0.0 109.087 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.443 ' N ' ' CD ' ' A' ' 67' ' ' GLU . 9.2 mp0 -64.39 -25.14 67.89 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.234 -0.916 . . . . 0.0 109.054 178.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.525 ' CD1' ' N ' ' A' ' 68' ' ' ILE . 1.4 mp -68.3 -34.74 67.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.032 -1.042 . . . . 0.0 108.839 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.82 -23.8 59.39 Favored Glycine 0 N--CA 1.496 2.672 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.434 ' N ' ' SD ' ' A' ' 70' ' ' MET . 0.9 OUTLIER -88.81 -31.54 18.28 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.911 -1.347 . . . . 0.0 107.571 178.931 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 52.8 mt -67.74 -23.04 65.21 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -80.34 0.89 31.04 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -121.91 32.61 5.78 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.605 -0.684 . . . . 0.0 110.254 -178.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 29.3 m -94.69 167.21 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 O-C-N 121.126 -0.984 . . . . 0.0 110.796 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.479 ' OG1' ' CG ' ' A' ' 106' ' ' TRP . 3.4 m -104.24 -4.87 22.47 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.378 -0.826 . . . . 0.0 109.883 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -107.88 170.85 7.74 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.014 -1.053 . . . . 0.0 110.749 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.565 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -61.54 107.67 0.84 Allowed 'General case' 0 N--CA 1.5 2.037 0 CA-C-O 121.532 0.682 . . . . 0.0 110.034 -179.716 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.404 ' HG ' ' H ' ' A' ' 79' ' ' LYS . 8.6 tp -69.6 159.88 32.57 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 119.606 -1.934 . . . . 0.0 110.303 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.404 ' H ' ' HG ' ' A' ' 78' ' ' LEU . 18.7 mmtp -123.27 154.26 65.36 Favored Pre-proline 0 C--N 1.297 -1.715 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 -178.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -58.07 -23.6 61.72 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 121.537 1.491 . . . . 0.0 110.014 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 52' ' ' VAL . 1.5 p30 -117.07 27.72 8.95 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.99 -0.444 . . . . 0.0 109.837 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.0 m -58.48 166.68 1.67 Allowed 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.373 -1.455 . . . . 0.0 109.452 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.556 ' NH2' ' O ' ' A' ' 61' ' ' PRO . 0.5 OUTLIER -172.32 153.43 2.98 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.122 -1.031 . . . . 0.0 111.267 179.549 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.625 ' H ' ' CD1' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -83.34 129.04 34.97 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 177.887 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.525 ' N ' ' SG ' ' A' ' 48' ' ' CYS . 0.5 OUTLIER -75.2 -6.11 47.96 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.718 -1.239 . . . . 0.0 112.584 -176.601 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 27.7 p -89.41 -33.65 16.77 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.281 -1.512 . . . . 0.0 110.722 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.501 HE21 ' CB ' ' A' ' 43' ' ' ALA . 12.1 tt0 -92.33 49.54 1.52 Allowed 'General case' 0 N--CA 1.504 2.226 0 O-C-N 120.979 -1.076 . . . . 0.0 110.467 -179.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 30.6 mt -130.56 154.26 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 36.5 mm -129.19 127.79 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.348 0 O-C-N 121.249 -0.907 . . . . 0.0 109.7 -178.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 8.1 tpt -89.02 161.17 16.73 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.908 -1.12 . . . . 0.0 110.099 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.6 p -151.19 149.53 24.98 Favored Pre-proline 0 N--CA 1.491 1.62 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.6 -39.51 82.16 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 121.626 1.55 . . . . 0.0 111.754 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -64.16 -24.93 67.86 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.143 -0.973 . . . . 0.0 108.842 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 14.1 mt -99.52 23.99 8.74 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.434 -0.792 . . . . 0.0 109.577 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.442 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 18.7 p-10 -65.88 140.87 58.39 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.169 -0.957 . . . . 0.0 109.621 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 106.69 7.73 33.54 Favored Glycine 0 N--CA 1.506 3.338 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 178.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -61.71 127.65 21.89 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 O-C-N 121.707 -0.878 . . . . 0.0 110.346 -178.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.3 t -103.74 115.38 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.244 -0.91 . . . . 0.0 109.728 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.5 t -101.65 134.37 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.926 -1.109 . . . . 0.0 109.851 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.49 123.63 49.18 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 121.884 0.85 . . . . 0.0 108.722 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.3 t -112.97 126.37 28.35 Favored Pre-proline 0 N--CA 1.497 1.919 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -84.52 178.07 5.27 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.797 2.331 . . . . 0.0 113.031 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.424 ' OD2' ' CD2' ' A' ' 8' ' ' HIS . 1.0 OUTLIER -84.2 -17.99 38.08 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.57 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -107.68 83.15 1.76 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.582 ' H ' ' NE2' ' A' ' 105' ' ' GLN . 1.3 pm0 -84.69 -31.66 24.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.911 -1.118 . . . . 0.0 108.887 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.479 ' CG ' ' OG1' ' A' ' 75' ' ' THR . 57.4 t-105 . . . . . 0 C--N 1.3 -1.568 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.145 178.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' FES . . . . . 0.483 ' S1 ' ' O ' ' A' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.456 ' H3 ' ' H ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 27.2 mmtt -76.19 107.14 8.21 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.403 -0.919 . . . . 0.0 108.718 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.7 t -107.09 109.97 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 O-C-N 121.176 -0.952 . . . . 0.0 109.201 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.9 t -98.82 94.19 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.039 -1.038 . . . . 0.0 110.59 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -68.06 114.65 6.76 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 71.5 t -98.75 112.07 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.115 -0.99 . . . . 0.0 108.434 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 63.6 p -72.7 -160.08 0.07 Allowed 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.554 0.692 . . . . 0.0 109.517 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.734 ' ND1' ' H ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -88.9 -50.93 5.9 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.183 -0.948 . . . . 0.0 108.625 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.504 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 10.1 p30 -64.94 2.71 0.67 Allowed 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 119.804 -0.759 . . . . 0.0 110.442 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.522 ' O ' ' NH1' ' A' ' 12' ' ' ARG . . . 93.83 -3.09 70.39 Favored Glycine 0 N--CA 1.496 2.693 0 O-C-N 120.731 -1.23 . . . . 0.0 110.08 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.09 128.04 34.22 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.932 -1.334 . . . . 0.0 108.438 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.522 ' NH1' ' O ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -108.63 159.54 16.65 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.51 -0.744 . . . . 0.0 111.197 -178.782 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.2 mtt85 -150.08 115.72 5.54 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 178.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -97.82 126.93 43.44 Favored 'General case' 0 N--CA 1.502 2.158 0 CA-C-O 122.633 1.206 . . . . 0.0 110.607 -178.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.516 ' CD1' ' H ' ' A' ' 16' ' ' ASP . 0.2 OUTLIER -111.9 -175.43 2.69 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 123.132 1.444 . . . . 0.0 111.589 -177.723 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.516 ' H ' ' CD1' ' A' ' 15' ' ' LEU . 11.1 t70 -137.06 101.57 4.59 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 104.548 -2.39 . . . . 0.0 104.548 176.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.456 ' H ' ' H3 ' ' A' ' 1' ' ' SER . 11.8 t -109.67 119.03 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.56 176.33 4.18 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.188 -0.945 . . . . 0.0 111.141 -177.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -65.64 137.08 57.09 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.953 0.882 . . . . 0.0 110.691 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.92 -17.07 23.99 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 178.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.8 t -77.64 139.8 18.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 O-C-N 120.428 -1.631 . . . . 0.0 108.479 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 25' ' ' GLN . 59.5 p -94.16 143.7 26.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.105 -0.997 . . . . 0.0 109.093 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 49.6 mt -45.45 -37.14 4.9 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.08 -1.013 . . . . 0.0 109.766 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.54 ' SD ' ' CD2' ' A' ' 33' ' ' TYR . 5.6 tpt -65.62 -26.43 67.82 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.388 -0.82 . . . . 0.0 109.355 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' A' ' 22' ' ' SER . 13.8 mm100 -75.31 -63.23 1.32 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.183 -0.948 . . . . 0.0 109.702 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.449 ' O ' ' OD1' ' A' ' 30' ' ' ASN . . . -59.94 -26.49 66.02 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.657 -1.277 . . . . 0.0 110.906 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.43 ' O ' ' N ' ' A' ' 32' ' ' ILE . . . -64.44 -20.39 66.14 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.585 -1.322 . . . . 0.0 109.011 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 70.6 t -86.51 -25.69 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.438 -0.789 . . . . 0.0 109.587 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.96 -24.55 60.81 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.362 -0.836 . . . . 0.0 109.042 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.449 ' OD1' ' O ' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -107.38 -0.1 22.61 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 179.261 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 64.66 69.72 1.26 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 108.916 -1.674 . . . . 0.0 108.916 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.43 ' N ' ' O ' ' A' ' 27' ' ' ALA . 53.4 mt -123.85 -37.99 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.795 -0.826 . . . . 0.0 109.394 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.745 ' O ' ' N ' ' A' ' 35' ' ' ILE . 0.2 OUTLIER -89.3 6.87 38.45 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.885 -1.135 . . . . 0.0 109.886 -179.225 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -38.01 74.27 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.204 0 CA-C-O 122.076 0.941 . . . . 0.0 111.602 -177.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.745 ' N ' ' O ' ' A' ' 33' ' ' TYR . 3.3 tp -150.49 4.61 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.934 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.431 ' O ' ' O ' ' A' ' 35' ' ' ILE . 5.6 t 56.14 104.22 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 120.843 -1.161 . . . . 0.0 109.356 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -70.69 151.42 49.35 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.533 ' C ' ' H ' ' A' ' 40' ' ' GLY . 9.3 m-20 -80.69 -63.25 1.45 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.41 -1.053 . . . . 0.0 109.329 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.619 ' SG ' ' N ' ' A' ' 42' ' ' SER . 13.9 p -72.5 17.53 0.11 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.314 -0.866 . . . . 0.0 109.104 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.533 ' H ' ' C ' ' A' ' 38' ' ' ASP . . . 54.72 13.15 4.07 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 108.01 -2.036 . . . . 0.0 108.01 -178.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' A' ' 39' ' ' CYS . . . 89.47 23.14 34.83 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.619 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 34.6 t -94.22 38.07 1.09 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.137 -1.214 . . . . 0.0 109.731 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 44.47 72.54 0.19 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.342 -0.849 . . . . 0.0 110.318 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -166.26 27.7 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.728 -1.232 . . . . 0.0 110.426 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.527 ' O ' ' S1 ' ' A' ' 107' ' ' FES . 2.9 p -162.64 159.69 24.83 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.762 -1.211 . . . . 0.0 109.927 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -95.64 12.21 30.53 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.494 ' OG1' ' SG ' ' A' ' 45' ' ' CYS . 3.1 m -57.6 -39.0 75.85 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.29 -0.881 . . . . 0.0 109.648 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.592 ' SG ' ' N ' ' A' ' 85' ' ' CYS . 18.3 p -97.7 54.18 1.15 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.867 -1.146 . . . . 0.0 109.744 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.52 ' NE2' ' OH ' ' A' ' 51' ' ' TYR . 43.3 t60 -75.89 110.43 10.33 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.114 -0.991 . . . . 0.0 109.113 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -146.52 166.94 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 120.813 -1.179 . . . . 0.0 109.582 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.583 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 37.4 m-85 -115.85 115.38 26.15 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.857 0.837 . . . . 0.0 109.815 -179.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 13.3 t -89.46 129.48 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.592 ' C ' ' H ' ' A' ' 55' ' ' ALA . 19.0 t-20 -46.15 131.01 10.32 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.107 -0.996 . . . . 0.0 109.753 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.412 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 9.7 pt-20 -57.01 8.16 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.395 -0.816 . . . . 0.0 111.025 -179.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.592 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -95.96 -23.13 16.99 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.636 -1.29 . . . . 0.0 110.113 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -111.25 -6.71 14.5 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.901 -1.124 . . . . 0.0 108.894 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 25.3 p -70.87 -42.14 70.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.643 -0.661 . . . . 0.0 109.806 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -82.8 0.93 41.57 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.59 -0.694 . . . . 0.0 109.894 -179.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 15.7 mttt -109.99 -38.72 5.25 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -84.73 158.19 59.83 Favored Pre-proline 0 N--CA 1.496 1.835 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.41 ' O ' ' NH1' ' A' ' 83' ' ' ARG . 1.3 Cg_endo -54.49 110.97 0.59 Allowed 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 121.714 1.609 . . . . 0.0 113.698 -177.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.37 112.8 12.06 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.899 ' H ' ' NH1' ' A' ' 83' ' ' ARG . . . -53.81 144.33 18.68 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-O 122.286 1.041 . . . . 0.0 112.073 -178.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.439 HD22 ' NH2' ' A' ' 66' ' ' ARG . 1.3 p30 -66.37 -167.73 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.678 0.751 . . . . 0.0 110.636 -179.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -69.47 -6.67 32.0 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.667 -0.646 . . . . 0.0 112.127 -178.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.508 ' O ' ' SD ' ' A' ' 70' ' ' MET . 69.3 mtm-85 -65.03 -44.61 88.55 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 120.424 -1.422 . . . . 0.0 109.405 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -74.27 -39.53 62.93 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.153 -0.967 . . . . 0.0 109.35 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 39.5 mt -48.02 -25.33 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.335 -0.853 . . . . 0.0 109.574 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -82.29 -40.64 9.93 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.508 ' SD ' ' O ' ' A' ' 66' ' ' ARG . 4.3 mpp? -72.05 -34.59 68.88 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 178.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 46.1 mt -63.99 -27.75 69.34 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -79.14 2.79 19.64 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.042 -1.037 . . . . 0.0 108.472 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -120.86 28.14 8.09 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.74 -0.6 . . . . 0.0 110.713 -178.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.9 m -95.96 169.53 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 O-C-N 120.844 -1.16 . . . . 0.0 109.975 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.476 ' OG1' ' CD2' ' A' ' 106' ' ' TRP . 3.7 m -106.29 -6.78 18.14 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.435 -0.79 . . . . 0.0 111.957 -178.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.414 ' HB3' ' HE2' ' A' ' 49' ' ' HIS . . . -106.16 174.7 5.77 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 120.56 -1.338 . . . . 0.0 110.572 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.583 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -56.1 104.39 0.14 Allowed 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.833 -0.542 . . . . 0.0 111.26 -178.516 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.4 tp -69.98 149.44 47.73 Favored 'General case' 0 C--N 1.295 -1.794 0 O-C-N 120.186 -1.572 . . . . 0.0 109.366 178.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.451 ' NZ ' ' OE2' ' A' ' 77' ' ' GLU . 27.2 mmtm -115.31 156.57 45.51 Favored Pre-proline 0 C--N 1.287 -2.133 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -178.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -56.97 -21.51 41.8 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 121.358 1.372 . . . . 0.0 109.629 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -120.33 28.1 8.22 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.422 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 37.2 m -57.6 158.38 6.07 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 120.07 -1.644 . . . . 0.0 108.885 179.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.899 ' NH1' ' H ' ' A' ' 63' ' ' ALA . 1.6 mtp85 -169.47 159.6 8.65 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 118.763 -1.175 . . . . 0.0 111.042 -178.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.575 ' CD2' ' N ' ' A' ' 84' ' ' LEU . 2.7 mm? -84.21 123.83 30.53 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 179.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.592 ' N ' ' SG ' ' A' ' 48' ' ' CYS . 0.5 OUTLIER -64.11 -16.48 61.91 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.197 -0.94 . . . . 0.0 113.145 -176.556 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . 0.422 ' C ' ' H ' ' A' ' 88' ' ' ILE . 22.2 p -81.65 -43.46 18.51 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 119.708 -1.87 . . . . 0.0 110.955 -178.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.652 HE22 ' CZ ' ' A' ' 83' ' ' ARG . 5.2 pp0? -75.61 29.57 0.1 Allowed 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.972 -1.08 . . . . 0.0 111.169 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.422 ' H ' ' C ' ' A' ' 86' ' ' CYS . 38.4 mt -116.03 151.42 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.295 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 178.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.5 mp -131.44 125.52 56.71 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.235 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -178.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.449 ' CG ' ' HG ' ' A' ' 1' ' ' SER . 1.9 tpt -87.49 161.8 17.6 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.089 -1.007 . . . . 0.0 109.571 -179.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.6 p -152.08 149.32 23.08 Favored Pre-proline 0 N--CA 1.489 1.484 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -54.56 -39.29 89.06 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 121.74 1.626 . . . . 0.0 111.643 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -64.03 -24.21 67.62 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.169 -0.957 . . . . 0.0 109.49 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 13.9 mt -101.73 18.88 19.3 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.449 -0.782 . . . . 0.0 109.434 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -61.44 139.53 58.2 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.407 -0.808 . . . . 0.0 109.946 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 105.55 8.21 35.53 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 178.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.75 138.39 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.207 -1.172 . . . . 0.0 111.878 -177.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.5 t -106.48 117.81 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.665 -0.647 . . . . 0.0 109.328 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.8 t -102.74 136.91 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 120.761 -1.212 . . . . 0.0 108.568 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -108.16 114.75 28.88 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.76 0.791 . . . . 0.0 108.88 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.4 t -102.47 124.77 38.18 Favored Pre-proline 0 N--CA 1.495 1.813 0 O-C-N 121.883 -0.511 . . . . 0.0 109.78 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -81.71 169.61 14.98 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 122.515 2.143 . . . . 0.0 113.88 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -75.61 -15.47 60.34 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.187 0.517 . . . . 0.0 109.649 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 27.4 mtm180 -122.31 93.38 3.96 Favored 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.439 ' OE1' ' O ' ' A' ' 47' ' ' THR . 35.5 tt0 -82.26 -16.96 47.66 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.651 -0.656 . . . . 0.0 109.826 -178.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.476 ' CD2' ' OG1' ' A' ' 75' ' ' THR . 61.3 t-105 . . . . . 0 C--N 1.304 -1.397 0 CA-C-O 117.948 -1.025 . . . . 0.0 110.45 178.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' FES . . . . . 0.527 ' S1 ' ' O ' ' A' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.8 mmtm -77.27 117.12 18.48 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 72.5 t -115.78 109.61 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.334 -0.854 . . . . 0.0 111.048 -178.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 33.6 t -98.9 93.17 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 CA-C-O 122.209 1.004 . . . . 0.0 111.178 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -67.8 113.71 5.77 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 177.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 99.7 t -99.0 116.7 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 120.991 -1.068 . . . . 0.0 108.939 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.427 ' OG ' ' OD1' ' A' ' 9' ' ' ASP . 79.3 p -75.38 -157.71 0.07 Allowed 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.692 ' ND1' ' H ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -92.13 -48.51 6.68 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.217 -0.927 . . . . 0.0 109.105 -179.672 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.487 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 8.5 p30 -65.39 1.75 1.05 Allowed 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.323 -0.861 . . . . 0.0 110.7 -178.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.403 ' H ' ' C ' ' A' ' 8' ' ' HIS . . . 94.96 -3.45 67.19 Favored Glycine 0 N--CA 1.495 2.606 0 O-C-N 120.717 -1.239 . . . . 0.0 110.262 179.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -65.6 129.05 38.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.779 -1.424 . . . . 0.0 108.25 179.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 29.8 mtm180 -108.25 145.19 34.67 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.879 -0.513 . . . . 0.0 110.986 -178.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.16 114.85 16.22 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 178.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -98.6 122.97 42.49 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.51 -0.744 . . . . 0.0 110.237 -178.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 30.4 mt -120.28 -166.04 1.26 Allowed 'General case' 0 N--CA 1.502 2.13 0 CA-C-O 122.746 1.26 . . . . 0.0 109.729 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -134.41 99.81 4.48 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 104.623 -2.362 . . . . 0.0 104.623 176.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.6 t -101.4 117.8 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.276 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.07 178.03 5.97 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 122.366 1.079 . . . . 0.0 112.116 -177.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -64.65 130.38 43.38 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-O 121.981 0.896 . . . . 0.0 111.117 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.74 -17.05 54.96 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 178.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 64.8 t -78.82 134.54 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 120.503 -1.586 . . . . 0.0 108.805 -179.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 25' ' ' GLN . 4.2 p -80.59 139.77 36.11 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.027 -1.046 . . . . 0.0 108.847 179.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 31.5 mt -45.06 -33.03 1.94 Allowed 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.013 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 9.7 ttt -77.61 -33.07 53.84 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.426 -0.796 . . . . 0.0 109.217 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.419 ' N ' ' O ' ' A' ' 22' ' ' SER . 39.6 mm-40 -59.34 -56.62 19.73 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.457 -0.897 . . . . 0.0 108.796 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.2 -26.55 62.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.829 -1.169 . . . . 0.0 110.512 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.74 -21.59 55.69 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.93 -1.106 . . . . 0.0 108.802 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 54.7 t -86.58 -23.47 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.49 -0.756 . . . . 0.0 109.819 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.443 ' HG ' HD21 ' A' ' 30' ' ' ASN . 0.0 OUTLIER -75.81 -29.79 58.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.281 -0.887 . . . . 0.0 108.728 -179.442 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.443 HD21 ' HG ' ' A' ' 29' ' ' SER . 4.8 m-80 -104.65 -3.97 23.07 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 64.0 70.6 1.02 Allowed Glycine 0 N--CA 1.495 2.607 0 N-CA-C 109.171 -1.571 . . . . 0.0 109.171 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 70.8 mt -122.77 -63.71 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.276 -1.132 . . . . 0.0 110.705 -178.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.433 ' O ' ' C ' ' A' ' 34' ' ' ASP . 55.7 m-85 -97.67 2.57 49.9 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.15 -0.969 . . . . 0.0 110.716 178.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.544 ' O ' ' C ' ' A' ' 35' ' ' ILE . 8.8 p-10 -37.45 -37.63 0.21 Allowed 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.455 -0.778 . . . . 0.0 110.397 -178.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.544 ' C ' ' O ' ' A' ' 34' ' ' ASP . 96.2 mt -19.8 130.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.752 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.283 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.442 ' C ' ' O ' ' A' ' 35' ' ' ILE . 13.0 m -35.56 151.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 121.474 -0.766 . . . . 0.0 111.102 -178.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -139.33 172.98 22.98 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.408 ' C ' ' H ' ' A' ' 40' ' ' GLY . 2.8 m-20 -88.4 -76.53 0.39 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.258 -1.142 . . . . 0.0 110.754 -179.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.541 ' SG ' ' N ' ' A' ' 42' ' ' SER . 6.2 p -70.25 7.89 0.9 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.917 -1.114 . . . . 0.0 110.302 -178.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.408 ' H ' ' C ' ' A' ' 38' ' ' ASP . . . 53.19 8.18 0.66 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.528 ' H ' ' C ' ' A' ' 39' ' ' CYS . . . 102.78 81.27 1.53 Allowed Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.541 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 12.8 t -160.76 31.0 0.15 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.596 -0.944 . . . . 0.0 109.379 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 50.36 70.43 0.51 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.982 -1.074 . . . . 0.0 109.157 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -165.23 21.16 0.05 OUTLIER 'General case' 0 C--N 1.299 -1.596 0 O-C-N 120.916 -1.115 . . . . 0.0 110.184 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.491 ' SG ' ' OG1' ' A' ' 47' ' ' THR . 1.4 p -163.93 170.0 17.32 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.891 -1.13 . . . . 0.0 109.924 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -99.22 4.18 46.59 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.434 -0.791 . . . . 0.0 108.957 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.491 ' OG1' ' SG ' ' A' ' 45' ' ' CYS . 24.8 m -47.39 -54.13 12.05 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.346 -0.846 . . . . 0.0 109.582 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.498 ' SG ' ' O ' ' A' ' 48' ' ' CYS . 14.1 p -90.77 47.96 1.48 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.862 -1.149 . . . . 0.0 109.533 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.529 ' NE2' ' OH ' ' A' ' 51' ' ' TYR . 24.5 t60 -76.21 99.64 4.79 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -133.62 170.7 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.15 -0.969 . . . . 0.0 110.254 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.567 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 36.9 m-85 -116.46 113.3 22.64 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 122.056 0.932 . . . . 0.0 110.057 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.7 t -86.87 129.15 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.622 ' C ' ' H ' ' A' ' 55' ' ' ALA . 16.2 t-20 -46.62 127.35 9.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.034 -1.042 . . . . 0.0 109.662 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -55.76 10.08 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.611 -0.681 . . . . 0.0 111.487 -178.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.622 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -98.65 -19.95 17.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.807 -1.183 . . . . 0.0 109.829 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.427 ' CD2' ' HB ' ' A' ' 97' ' ' ILE . 39.1 m-85 -113.85 -6.94 13.22 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.919 -1.113 . . . . 0.0 108.574 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.528 ' CA ' HH12 ' A' ' 83' ' ' ARG . 22.5 p -69.76 -43.7 71.68 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.654 0.74 . . . . 0.0 110.138 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -83.5 14.05 4.03 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.964 -0.694 . . . . 0.0 109.228 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.2 mtpt -124.76 -38.74 2.34 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -85.8 164.7 38.51 Favored Pre-proline 0 N--CA 1.5 2.06 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 179.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -59.56 105.0 0.24 Allowed 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 121.208 1.272 . . . . 0.0 114.001 -176.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.472 ' HA ' ' NH2' ' A' ' 83' ' ' ARG . . . -74.43 104.65 5.24 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 177.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -47.09 140.66 4.86 Favored 'General case' 0 C--N 1.287 -2.149 0 CA-C-O 122.061 0.934 . . . . 0.0 111.437 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.473 ' N ' ' OD1' ' A' ' 64' ' ' ASN . 2.6 p30 -58.62 -169.81 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.404 0.621 . . . . 0.0 110.486 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -65.31 0.35 1.47 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.292 -0.88 . . . . 0.0 111.197 -178.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.506 ' O ' ' SD ' ' A' ' 70' ' ' MET . 0.3 OUTLIER -69.44 -45.01 70.14 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.681 -1.262 . . . . 0.0 108.843 -179.913 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.446 ' O ' ' N ' ' A' ' 69' ' ' GLY . 2.5 tt0 -73.82 -49.11 26.75 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.389 -0.819 . . . . 0.0 110.107 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.477 ' CD1' ' N ' ' A' ' 68' ' ' ILE . 1.4 mp -45.43 -19.76 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.395 -0.816 . . . . 0.0 109.508 -179.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.543 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -81.12 -73.39 1.19 Allowed Glycine 0 N--CA 1.497 2.748 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.506 ' SD ' ' O ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -47.38 -39.18 14.65 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.013 -1.286 . . . . 0.0 108.402 179.576 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.511 ' C ' ' H ' ' A' ' 73' ' ' CYS . 24.0 mt -57.14 -34.02 67.99 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 177.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.543 ' N ' ' O ' ' A' ' 69' ' ' GLY . 6.6 tp10 -73.77 12.28 0.69 Allowed 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.106 -0.996 . . . . 0.0 108.331 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.511 ' H ' ' C ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -133.07 36.14 3.48 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.524 -0.735 . . . . 0.0 110.19 -178.463 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.7 m -97.76 174.5 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.363 0 O-C-N 120.951 -1.093 . . . . 0.0 109.741 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.539 ' OG1' ' CG ' ' A' ' 106' ' ' TRP . 5.5 m -104.4 -9.32 18.54 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.016 -1.053 . . . . 0.0 111.295 -179.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -106.55 170.09 8.14 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.764 -1.21 . . . . 0.0 110.315 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.567 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -53.45 105.28 0.12 Allowed 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.841 -0.537 . . . . 0.0 111.126 -179.083 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.0 tp -74.0 140.5 45.52 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 120.084 -1.635 . . . . 0.0 108.857 178.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.8 mmtp -102.07 157.21 34.13 Favored Pre-proline 0 C--N 1.289 -2.065 0 CA-C-N 114.876 -1.056 . . . . 0.0 108.588 -178.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -58.9 -19.3 46.78 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 121.631 1.554 . . . . 0.0 109.095 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.413 ' OD1' ' O ' ' A' ' 81' ' ' ASN . 2.7 p30 -121.99 27.68 7.94 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.076 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 44.3 m -58.42 169.18 0.93 Allowed 'General case' 0 C--N 1.307 -1.274 0 O-C-N 120.287 -1.508 . . . . 0.0 108.74 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.528 HH12 ' CA ' ' A' ' 57' ' ' THR . 0.7 OUTLIER -171.9 150.6 2.62 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 118.621 -1.231 . . . . 0.0 110.985 -179.477 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.441 ' C ' ' SG ' ' A' ' 48' ' ' CYS . 82.5 mt -88.83 96.27 10.62 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.45 ' N ' ' SG ' ' A' ' 48' ' ' CYS . 0.1 OUTLIER -34.19 -42.03 0.12 Allowed 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -177.431 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 28.5 p -64.58 -28.48 69.66 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 119.932 -1.73 . . . . 0.0 111.392 -178.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 12.7 tp60 -91.56 35.83 0.95 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.98 -1.075 . . . . 0.0 110.703 -179.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.412 ' CG2' ' N ' ' A' ' 89' ' ' ILE . 39.7 mm -130.14 161.19 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.308 0 O-C-N 121.282 -0.886 . . . . 0.0 109.192 179.011 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.412 ' N ' ' CG2' ' A' ' 88' ' ' ILE . 1.4 mp -133.87 128.59 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.32 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.422 ' SD ' HG22 ' A' ' 97' ' ' ILE . 4.9 tpt -90.54 164.21 14.32 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.311 -0.868 . . . . 0.0 109.347 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 38.4 p -148.89 145.63 20.08 Favored Pre-proline 0 C--N 1.3 -1.553 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.85 -37.86 91.57 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 121.278 1.319 . . . . 0.0 111.295 -178.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -59.37 -29.51 67.75 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.111 -0.993 . . . . 0.0 109.147 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.2 mt -93.75 35.96 1.12 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.555 -0.716 . . . . 0.0 109.819 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -65.49 136.29 56.24 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.684 -1.26 . . . . 0.0 110.319 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 111.94 8.52 22.04 Favored Glycine 0 N--CA 1.506 3.362 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 178.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.427 ' HB ' ' CD2' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -66.24 124.66 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.583 -0.951 . . . . 0.0 110.378 -178.043 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 6.5 t -104.72 116.06 47.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.162 -0.961 . . . . 0.0 109.967 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 t -100.08 135.17 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 120.756 -1.215 . . . . 0.0 109.458 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 51' ' ' TYR . 0.5 OUTLIER -109.68 122.82 48.32 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.494 -0.754 . . . . 0.0 109.169 -179.898 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 5.3 t -113.32 128.29 25.84 Favored Pre-proline 0 N--CA 1.499 2.014 0 O-C-N 121.643 -0.661 . . . . 0.0 109.802 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -81.42 174.03 10.98 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 122.417 2.078 . . . . 0.0 113.81 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 103' ' ' ASP . 1.6 p-10 -80.47 -12.63 59.52 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-O 121.683 0.754 . . . . 0.0 108.991 178.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.53 86.86 2.65 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 -177.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.441 ' O ' ' O ' ' A' ' 106' ' ' TRP . 12.8 pt20 -81.69 -32.38 31.75 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.539 ' CG ' ' OG1' ' A' ' 75' ' ' THR . 61.9 t-105 . . . . . 0 C--N 1.301 -1.506 0 CA-C-O 118.354 -0.832 . . . . 0.0 110.063 178.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.511 ' HG ' ' CG ' ' A' ' 90' ' ' MET . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.39 117.64 32.07 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.446 -0.784 . . . . 0.0 109.278 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.2 t -115.91 109.75 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.301 -0.874 . . . . 0.0 109.691 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.2 t -99.77 130.07 49.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.162 -0.961 . . . . 0.0 110.188 178.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -103.59 116.63 32.72 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 78.8 t -98.71 115.69 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 30.9 p -75.56 -161.48 0.16 Allowed 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 121.584 0.707 . . . . 0.0 109.641 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.738 ' ND1' ' H ' ' A' ' 8' ' ' HIS . 0.1 OUTLIER -86.88 -47.62 8.86 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.652 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.491 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 17.3 p30 -71.06 1.97 5.07 Favored 'General case' 0 C--N 1.307 -1.249 0 O-C-N 121.148 -0.97 . . . . 0.0 110.928 -178.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.71 1.85 60.05 Favored Glycine 0 N--CA 1.498 2.773 0 O-C-N 120.852 -1.155 . . . . 0.0 110.868 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -67.87 127.37 32.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.809 -1.406 . . . . 0.0 108.913 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -105.03 157.07 17.49 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.597 -0.689 . . . . 0.0 110.059 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.52 116.04 5.47 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -99.67 124.24 44.71 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 122.626 1.203 . . . . 0.0 111.341 -178.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.425 ' CD1' ' H ' ' A' ' 16' ' ' ASP . 0.2 OUTLIER -110.05 -176.51 3.01 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-O 122.99 1.376 . . . . 0.0 110.875 -178.843 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.425 ' H ' ' CD1' ' A' ' 15' ' ' LEU . 24.8 t0 -134.67 100.38 4.61 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 105.181 -2.155 . . . . 0.0 105.181 176.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.4 t -108.71 115.3 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.339 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.81 174.91 3.94 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.312 -0.868 . . . . 0.0 111.609 -177.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.03 137.5 57.75 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.952 0.882 . . . . 0.0 110.91 -178.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.62 -13.93 53.73 Favored Glycine 0 N--CA 1.493 2.435 0 C-N-CA 120.519 -0.848 . . . . 0.0 111.182 178.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 94.8 t -80.82 142.25 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.344 -1.68 . . . . 0.0 109.455 -178.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.427 ' OG ' ' OE1' ' A' ' 25' ' ' GLN . 1.2 p -87.82 142.6 27.69 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.559 -0.856 . . . . 0.0 109.176 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -46.95 -40.85 15.1 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 121.247 -0.908 . . . . 0.0 109.507 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 5.8 tpt -65.36 -35.63 81.55 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.046 -1.034 . . . . 0.0 109.531 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.443 ' NE2' ' N ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -60.74 -61.17 2.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.052 -1.03 . . . . 0.0 109.075 -179.421 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.55 -27.55 66.32 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.569 -1.332 . . . . 0.0 110.522 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.99 -20.85 66.2 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.741 -1.225 . . . . 0.0 108.57 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 69.8 t -87.03 -27.79 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.613 -0.679 . . . . 0.0 109.654 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.446 ' HG ' HD21 ' A' ' 30' ' ' ASN . 0.0 OUTLIER -72.52 -23.56 61.03 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.843 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.446 HD21 ' HG ' ' A' ' 29' ' ' SER . 2.3 m-80 -110.74 -5.26 15.02 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 63.75 70.98 0.92 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.408 HD11 HG22 ' A' ' 32' ' ' ILE . 47.9 mt -121.35 -57.79 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.503 -0.998 . . . . 0.0 110.434 -178.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.421 ' O ' ' C ' ' A' ' 34' ' ' ASP . 1.0 OUTLIER -92.99 -10.9 34.65 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.833 -1.167 . . . . 0.0 109.906 178.904 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 33' ' ' TYR . 13.5 p-10 -38.93 -42.86 0.9 Allowed 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.833 -0.542 . . . . 0.0 110.275 -178.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.434 ' O ' ' O ' ' A' ' 36' ' ' VAL . 94.9 mt -44.33 120.66 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.672 -0.643 . . . . 0.0 109.413 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.434 ' O ' ' O ' ' A' ' 35' ' ' ILE . 65.9 t 56.95 160.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.447 -0.783 . . . . 0.0 110.007 -178.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 159.62 118.62 0.51 Allowed Glycine 0 N--CA 1.495 2.615 0 N-CA-C 108.906 -1.678 . . . . 0.0 108.906 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.554 ' C ' ' H ' ' A' ' 40' ' ' GLY . 15.0 t70 -87.67 -73.48 0.48 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.999 -1.295 . . . . 0.0 110.203 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.623 ' SG ' ' N ' ' A' ' 42' ' ' SER . 8.5 p -70.15 16.95 0.06 Allowed 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.435 -0.906 . . . . 0.0 109.848 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.554 ' H ' ' C ' ' A' ' 38' ' ' ASP . . . 49.85 15.41 0.93 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 108.817 -1.713 . . . . 0.0 108.817 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.471 ' H ' ' C ' ' A' ' 39' ' ' CYS . . . 92.04 21.73 32.28 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.021 -1.631 . . . . 0.0 109.021 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.623 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 6.4 m -93.9 36.07 1.13 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.638 -0.919 . . . . 0.0 109.848 -179.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 43.2 72.47 0.18 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.322 -0.861 . . . . 0.0 110.336 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.4 t -163.97 17.42 0.06 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.928 -1.107 . . . . 0.0 110.043 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.491 ' SG ' ' OG1' ' A' ' 47' ' ' THR . 1.8 p -153.7 -167.64 2.74 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.96 -1.088 . . . . 0.0 109.333 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -132.21 10.95 4.56 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.491 ' OG1' ' SG ' ' A' ' 45' ' ' CYS . 32.2 p -56.03 -41.9 75.67 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.25 -0.906 . . . . 0.0 109.276 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.497 ' SG ' ' O ' ' A' ' 48' ' ' CYS . 21.9 p -79.68 57.0 2.37 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.928 -1.108 . . . . 0.0 110.217 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.495 ' NE2' ' OH ' ' A' ' 51' ' ' TYR . 38.0 t60 -76.59 106.05 8.01 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -139.25 165.43 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 120.617 -1.302 . . . . 0.0 109.74 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.537 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 40.7 m-85 -111.97 112.23 23.73 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 122.149 0.976 . . . . 0.0 109.792 -179.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.426 ' O ' ' OD1' ' A' ' 81' ' ' ASN . 96.8 t -85.58 135.25 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.618 ' C ' ' H ' ' A' ' 55' ' ' ALA . 1.7 t30 -49.28 123.22 7.07 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.947 -1.095 . . . . 0.0 108.147 179.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -54.16 11.57 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.818 -0.551 . . . . 0.0 112.178 -177.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.618 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -100.71 -15.57 17.66 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.999 -1.063 . . . . 0.0 109.817 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -115.26 -10.43 12.09 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.774 -1.204 . . . . 0.0 109.078 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 12.5 p -71.45 -41.62 69.22 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.876 -1.14 . . . . 0.0 109.912 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -86.91 14.46 7.27 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.438 -0.789 . . . . 0.0 109.898 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.479 ' CD ' ' O ' ' A' ' 55' ' ' ALA . 9.6 mtpt -125.46 -39.73 2.16 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -78.34 167.28 36.78 Favored Pre-proline 0 N--CA 1.494 1.759 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 179.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -55.57 105.38 0.15 Allowed 'Trans proline' 0 N--CA 1.489 1.237 0 CA-C-N 120.206 1.109 . . . . 0.0 113.181 -176.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.39 102.38 2.62 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -53.71 146.41 13.54 Favored 'General case' 0 C--N 1.29 -1.991 0 O-C-N 121.207 -0.933 . . . . 0.0 111.29 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -61.81 -171.3 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.732 -0.605 . . . . 0.0 110.756 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -69.41 1.49 3.87 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.189 -0.944 . . . . 0.0 112.147 -178.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -64.63 -40.46 95.5 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.525 -1.359 . . . . 0.0 108.736 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.519 ' N ' ' CD ' ' A' ' 67' ' ' GLU . 27.8 mp0 -79.36 -47.24 16.11 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.655 -0.653 . . . . 0.0 110.133 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 36.3 mt -44.62 -22.67 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.136 -0.977 . . . . 0.0 110.041 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 67' ' ' GLU . . . -86.03 -28.85 27.3 Favored Glycine 0 N--CA 1.498 2.777 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.46 ' N ' ' O ' ' A' ' 67' ' ' GLU . 30.0 mtt -77.33 -34.18 55.37 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.402 ' C ' ' H ' ' A' ' 73' ' ' CYS . 33.1 mt -65.62 -22.17 66.64 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -85.34 18.85 2.49 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 178.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.402 ' H ' ' C ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -133.85 24.47 3.96 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.732 -0.605 . . . . 0.0 110.295 -178.703 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 17.0 m -97.48 171.9 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 120.772 -1.205 . . . . 0.0 110.58 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.455 ' OG1' ' CG ' ' A' ' 106' ' ' TRP . 2.8 m -105.47 -1.78 24.5 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.383 -0.823 . . . . 0.0 110.28 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -107.48 170.94 7.67 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 120.965 -1.084 . . . . 0.0 110.589 -178.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.537 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -62.87 111.61 2.21 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.474 -0.766 . . . . 0.0 109.845 -179.281 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.4 tp -70.92 160.11 33.44 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 120.031 -1.668 . . . . 0.0 110.312 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.2 mmtm -125.12 152.55 70.85 Favored Pre-proline 0 C--N 1.296 -1.748 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -178.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -56.53 -22.45 43.02 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 121.217 1.278 . . . . 0.0 109.771 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.433 ' OD1' ' O ' ' A' ' 81' ' ' ASN . 1.4 p30 -120.21 28.54 7.99 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.888 -0.508 . . . . 0.0 109.862 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.3 m -55.41 172.1 0.16 Allowed 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.416 -1.428 . . . . 0.0 108.532 178.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.69 ' HE ' ' CG1' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -170.78 163.64 7.89 Favored 'General case' 0 N--CA 1.5 2.047 0 C-N-CA 118.661 -1.215 . . . . 0.0 111.273 -178.81 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.501 ' CD2' ' N ' ' A' ' 84' ' ' LEU . 2.2 mm? -104.26 97.71 7.62 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 178.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.426 ' C ' ' O ' ' A' ' 84' ' ' LEU . 0.6 OUTLIER -31.94 -42.18 0.06 Allowed 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -177.414 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 17.6 p -76.52 -14.72 60.01 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.076 -1.64 . . . . 0.0 112.187 -177.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.465 ' NE2' ' CG ' ' A' ' 67' ' ' GLU . 25.3 mt-30 -94.48 37.86 1.11 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.676 -1.265 . . . . 0.0 110.113 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.69 ' CG1' ' HE ' ' A' ' 83' ' ' ARG . 22.7 mt -131.42 168.44 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.269 -0.895 . . . . 0.0 109.4 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.521 ' N ' ' CG2' ' A' ' 88' ' ' ILE . 36.2 mm -139.01 122.72 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.649 ' SD ' ' N ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -78.65 143.34 36.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.965 -1.084 . . . . 0.0 108.511 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.649 ' N ' ' SD ' ' A' ' 90' ' ' MET . 1.1 p -130.07 149.72 73.99 Favored Pre-proline 0 N--CA 1.495 1.785 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -62.96 -35.18 67.99 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 121.626 1.551 . . . . 0.0 110.854 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -68.82 -26.06 64.98 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 119.68 -0.808 . . . . 0.0 109.936 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.5 mt -104.26 29.67 5.84 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.508 -0.745 . . . . 0.0 110.076 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -63.65 146.42 53.83 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.799 -1.188 . . . . 0.0 109.856 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 105.22 12.27 27.64 Favored Glycine 0 N--CA 1.504 3.227 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 178.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 17.5 tt -65.57 129.7 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 121.113 -1.227 . . . . 0.0 111.31 -177.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.6 t -104.82 126.52 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 O-C-N 121.208 -0.932 . . . . 0.0 108.852 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.2 t -111.58 135.01 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.994 -1.066 . . . . 0.0 109.997 -178.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -107.85 121.72 45.32 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.343 -0.848 . . . . 0.0 109.065 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 24.7 t -108.99 123.59 36.54 Favored Pre-proline 0 N--CA 1.498 1.967 0 O-C-N 121.689 -0.632 . . . . 0.0 109.4 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.442 ' O ' ' NE2' ' A' ' 105' ' ' GLN . 69.4 Cg_endo -83.25 178.34 5.87 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.711 2.274 . . . . 0.0 113.427 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -84.71 -18.33 35.56 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -108.44 81.95 1.55 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.487 ' H ' ' CD ' ' A' ' 105' ' ' GLN . 13.2 mp0 -84.03 -31.03 25.64 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 119.156 -1.017 . . . . 0.0 108.489 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.455 ' CG ' ' OG1' ' A' ' 75' ' ' THR . 62.9 t-105 . . . . . 0 C--N 1.299 -1.594 0 O-C-N 121.028 -1.045 . . . . 0.0 109.814 178.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' FES . . . . . 0.486 ' S1 ' ' O ' ' A' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 13.6 p . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.9 mmtt -77.22 108.74 10.55 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.435 -0.906 . . . . 0.0 108.563 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 36.5 t -108.68 109.33 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.26 -0.9 . . . . 0.0 110.28 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 23.9 t -102.16 127.09 56.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.502 -0.749 . . . . 0.0 110.341 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -102.15 117.54 35.01 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 176.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 81.0 t -97.9 113.94 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 34.0 p -74.54 -163.65 0.22 Allowed 'General case' 0 C--N 1.293 -1.863 0 CA-C-O 121.595 0.712 . . . . 0.0 109.623 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.811 ' ND1' ' H ' ' A' ' 8' ' ' HIS . 0.3 OUTLIER -81.98 -45.84 14.81 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.778 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 23.4 p-10 -74.31 2.36 9.44 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.3 -0.875 . . . . 0.0 111.571 -178.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.88 -4.31 65.6 Favored Glycine 0 N--CA 1.5 2.915 0 O-C-N 120.441 -1.412 . . . . 0.0 110.928 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.89 126.37 27.11 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.79 -1.418 . . . . 0.0 108.418 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.4 mtt85 -106.21 162.25 13.82 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.262 -0.899 . . . . 0.0 111.32 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 17.3 mtt85 -146.29 107.82 4.27 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 178.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -98.62 126.73 44.3 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.344 -0.847 . . . . 0.0 110.523 -178.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 31.6 mt -119.06 -164.7 1.06 Allowed 'General case' 0 N--CA 1.503 2.175 0 CA-C-O 122.786 1.279 . . . . 0.0 110.531 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -137.32 99.07 3.87 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 176.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.7 t -102.12 119.24 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 121.346 -0.846 . . . . 0.0 109.131 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.42 174.8 3.77 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.308 -0.87 . . . . 0.0 110.56 -178.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -69.95 141.39 53.05 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 122.053 0.93 . . . . 0.0 110.755 -179.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.24 -17.16 49.27 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.6 t -83.04 139.88 17.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 120.836 -1.391 . . . . 0.0 109.262 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 79.0 p -92.04 146.09 24.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.112 -0.993 . . . . 0.0 109.024 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 84.8 mt -46.38 -40.36 11.87 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.478 -0.764 . . . . 0.0 109.218 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 13.5 tpp -55.57 -43.12 75.64 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.427 -0.796 . . . . 0.0 108.953 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -62.26 -58.05 9.15 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.23 -0.919 . . . . 0.0 109.325 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.95 -33.33 24.07 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.675 -1.266 . . . . 0.0 111.743 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.84 -22.97 62.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.428 -1.42 . . . . 0.0 109.344 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 53.5 t -86.31 -19.85 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.189 -0.944 . . . . 0.0 109.857 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.87 -31.29 51.33 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.236 -0.915 . . . . 0.0 109.352 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -108.06 -2.22 19.78 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 64.65 73.23 0.59 Allowed Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 74.9 mt -116.72 -47.24 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -90.26 131.94 35.8 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 105.127 -2.175 . . . . 0.0 105.127 175.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.9 p30 -103.58 67.01 0.89 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.618 -1.301 . . . . 0.0 107.621 177.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 20.0 tt -170.48 166.58 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 O-C-N 121.104 -0.998 . . . . 0.0 109.613 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.5 p -101.35 8.32 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.151 -0.968 . . . . 0.0 109.482 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.56 117.46 0.05 OUTLIER Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.534 ' C ' ' H ' ' A' ' 40' ' ' GLY . 30.5 t0 -48.95 -60.5 2.71 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.214 -1.168 . . . . 0.0 109.301 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.609 ' SG ' ' N ' ' A' ' 42' ' ' SER . 15.0 p -72.65 18.75 0.09 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.359 -0.838 . . . . 0.0 108.928 179.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.534 ' H ' ' C ' ' A' ' 38' ' ' ASP . . . 56.79 10.7 4.89 Favored Glycine 0 N--CA 1.485 1.904 0 N-CA-C 107.786 -2.126 . . . . 0.0 107.786 -178.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.476 ' H ' ' C ' ' A' ' 39' ' ' CYS . . . 89.82 23.77 32.09 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.609 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 17.7 p -98.55 40.6 1.18 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.406 -1.055 . . . . 0.0 109.826 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 42' ' ' SER . . . 42.98 75.79 0.09 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.342 -0.849 . . . . 0.0 110.172 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -166.54 26.01 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.696 -1.252 . . . . 0.0 109.753 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.502 ' O ' ' S1 ' ' A' ' 107' ' ' FES . 3.7 p -162.18 164.17 27.97 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.328 -0.858 . . . . 0.0 110.116 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -95.67 8.79 42.42 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.496 ' OG1' ' SG ' ' A' ' 45' ' ' CYS . 8.1 m -54.09 -48.37 70.75 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.124 -0.985 . . . . 0.0 110.154 -179.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.546 ' SG ' ' N ' ' A' ' 85' ' ' CYS . 16.6 p -92.74 53.91 2.13 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.891 -1.13 . . . . 0.0 110.397 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.524 ' NE2' ' OH ' ' A' ' 51' ' ' TYR . 48.7 t60 -75.94 111.68 11.56 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.28 -0.887 . . . . 0.0 108.634 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -147.34 167.75 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 120.884 -1.135 . . . . 0.0 109.534 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.566 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 38.0 m-85 -115.68 111.24 20.3 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 121.788 0.804 . . . . 0.0 109.754 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 80.7 t -85.95 132.81 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.596 ' C ' ' H ' ' A' ' 55' ' ' ALA . 1.0 OUTLIER -47.96 126.6 10.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.103 -0.998 . . . . 0.0 108.545 179.359 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -56.67 14.13 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.369 -0.832 . . . . 0.0 111.648 -178.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.596 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -101.99 -19.91 15.02 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.56 -1.338 . . . . 0.0 109.681 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -111.54 -10.49 14.14 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.704 -1.247 . . . . 0.0 108.951 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 10.4 p -70.84 -37.39 73.15 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.126 -0.984 . . . . 0.0 110.353 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -84.42 0.33 49.91 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.235 -0.916 . . . . 0.0 110.268 -178.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.448 ' CE ' ' O ' ' A' ' 55' ' ' ALA . 9.0 mttt -112.61 -37.36 4.94 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.4 0.619 . . . . 0.0 109.512 -179.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.409 HG12 HH12 ' A' ' 83' ' ' ARG . 0.4 OUTLIER -81.56 161.67 60.9 Favored Pre-proline 0 N--CA 1.497 1.918 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 179.859 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.566 ' O ' ' NH2' ' A' ' 83' ' ' ARG . 5.0 Cg_endo -55.31 90.52 0.04 OUTLIER 'Trans proline' 0 N--CA 1.5 1.905 0 C-N-CA 122.381 2.054 . . . . 0.0 114.348 -176.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.61 104.31 0.64 Allowed 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 177.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -53.8 149.58 8.51 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.77 0.795 . . . . 0.0 112.561 -178.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.453 ' N ' ' ND2' ' A' ' 64' ' ' ASN . 0.1 OUTLIER -60.74 -172.1 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.308 0.575 . . . . 0.0 110.117 179.678 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -70.14 4.74 1.98 Allowed 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.727 -0.608 . . . . 0.0 112.11 -178.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.4 mtt85 -65.72 -40.28 92.02 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.65 -1.281 . . . . 0.0 108.928 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.441 ' N ' ' CD ' ' A' ' 67' ' ' GLU . 34.1 mp0 -80.05 -37.66 33.48 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.701 -1.249 . . . . 0.0 109.636 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.447 ' CD1' ' N ' ' A' ' 68' ' ' ILE . 1.3 mp -46.15 -35.6 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.219 -0.926 . . . . 0.0 109.055 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.39 -28.97 60.73 Favored Glycine 0 N--CA 1.495 2.599 0 C-N-CA 119.365 -1.398 . . . . 0.0 109.619 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.429 ' N ' ' O ' ' A' ' 67' ' ' GLU . 26.6 mtt -79.0 -35.41 42.86 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 178.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 74.2 mt -64.98 -24.74 67.6 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -80.88 5.48 15.98 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.782 -1.198 . . . . 0.0 108.036 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -122.73 25.97 8.46 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.764 -0.585 . . . . 0.0 110.504 -178.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.4 m -96.21 168.97 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.339 0 O-C-N 120.682 -1.261 . . . . 0.0 109.97 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.548 ' OG1' ' CD1' ' A' ' 106' ' ' TRP . 3.1 m -106.57 0.14 24.31 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.429 -0.794 . . . . 0.0 110.824 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -107.4 169.33 8.64 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.171 -0.956 . . . . 0.0 110.564 -178.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.566 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -59.76 106.14 0.45 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.569 -0.707 . . . . 0.0 109.478 -179.289 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.9 tp -70.13 152.25 44.53 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 119.933 -1.729 . . . . 0.0 110.303 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 46.3 mmtt -114.73 156.6 44.67 Favored Pre-proline 0 C--N 1.294 -1.828 0 CA-C-N 114.506 -1.225 . . . . 0.0 108.478 -178.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -57.56 -20.36 41.2 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 121.807 1.672 . . . . 0.0 110.4 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -125.22 31.91 5.49 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.734 -0.603 . . . . 0.0 110.775 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 33.4 m -59.44 169.85 1.15 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.653 -1.279 . . . . 0.0 110.473 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.566 ' NH2' ' O ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -171.91 171.52 5.08 Favored 'General case' 0 N--CA 1.503 2.219 0 CA-C-O 122.479 1.133 . . . . 0.0 111.864 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 47.3 mt -100.87 112.25 24.64 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 178.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.546 ' N ' ' SG ' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -56.7 -11.86 1.58 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.067 -1.02 . . . . 0.0 112.607 -176.554 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 28.3 p -87.54 -39.9 14.74 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 119.896 -1.752 . . . . 0.0 110.932 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -81.29 42.83 0.69 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.802 -1.186 . . . . 0.0 110.573 -178.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.8 mt -130.67 157.56 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 O-C-N 121.124 -0.985 . . . . 0.0 108.494 179.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 36.9 mm -132.46 128.52 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 O-C-N 121.391 -0.818 . . . . 0.0 109.763 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 3.6 tpt -88.62 161.54 16.84 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.969 -1.082 . . . . 0.0 109.657 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.5 p -155.04 148.83 18.83 Favored Pre-proline 0 C--N 1.3 -1.58 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -55.91 -37.7 95.59 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 121.651 1.567 . . . . 0.0 111.874 -178.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -65.13 -27.32 68.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.213 -0.929 . . . . 0.0 109.305 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 15.7 mt -96.66 24.73 5.73 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.322 -0.861 . . . . 0.0 109.459 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -64.2 138.06 58.26 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.651 -0.655 . . . . 0.0 110.055 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 108.03 8.87 29.02 Favored Glycine 0 N--CA 1.505 3.251 0 N-CA-C 110.669 -0.973 . . . . 0.0 110.669 178.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 16.0 tt -63.2 132.33 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 120.945 -1.326 . . . . 0.0 111.936 -177.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.0 t -104.91 115.33 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.1 t -103.12 133.32 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.898 -1.126 . . . . 0.0 109.01 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -104.71 114.77 29.19 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 23.5 t -102.4 122.18 47.42 Favored Pre-proline 0 N--CA 1.494 1.74 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.455 ' O ' ' NE2' ' A' ' 105' ' ' GLN . 68.5 Cg_endo -83.35 171.17 11.41 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.274 1.983 . . . . 0.0 113.18 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -79.13 -15.24 58.42 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -110.75 82.97 1.68 Allowed 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.459 ' CD ' ' N ' ' A' ' 105' ' ' GLN . 14.7 mp0 -83.09 -32.83 26.55 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 120.96 -1.087 . . . . 0.0 108.514 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.548 ' CD1' ' OG1' ' A' ' 75' ' ' THR . 61.6 t-105 . . . . . 0 C--N 1.302 -1.476 0 CA-C-O 117.616 -1.183 . . . . 0.0 110.266 178.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' FES . . . . . 0.502 ' S1 ' ' O ' ' A' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.462 ' CB ' ' SD ' ' A' ' 90' ' ' MET . 1.5 p . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 25.2 mmtt -92.92 116.36 28.98 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.069 -1.019 . . . . 0.0 109.192 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.2 t -114.47 108.61 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 O-C-N 121.351 -0.843 . . . . 0.0 109.573 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.4 t -99.6 129.03 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.267 -0.896 . . . . 0.0 110.849 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -104.86 115.77 30.86 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 177.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 81.0 t -98.24 114.8 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 120.901 -1.125 . . . . 0.0 108.146 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.41 ' OG ' ' OD1' ' A' ' 9' ' ' ASP . 63.2 p -72.15 -159.92 0.06 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.708 -0.62 . . . . 0.0 109.682 -178.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.696 ' ND1' ' H ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -88.02 -46.93 8.92 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -179.882 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.519 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 13.4 p30 -70.75 4.63 2.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.344 -0.848 . . . . 0.0 110.755 -178.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.85 -4.63 65.94 Favored Glycine 0 N--CA 1.498 2.821 0 O-C-N 120.808 -1.182 . . . . 0.0 110.552 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -65.61 126.9 29.8 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.747 -1.443 . . . . 0.0 108.718 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.52 ' CG ' HH11 ' A' ' 12' ' ' ARG . 2.6 mtt-85 -105.52 160.95 14.77 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.474 -0.766 . . . . 0.0 110.84 -178.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -150.83 116.31 5.43 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -101.98 130.87 48.62 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.701 -0.624 . . . . 0.0 111.14 -178.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 30.7 mt -119.4 -165.29 1.13 Allowed 'General case' 0 N--CA 1.504 2.237 0 CA-C-O 122.737 1.256 . . . . 0.0 109.882 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -135.19 97.24 3.67 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 104.62 -2.363 . . . . 0.0 104.62 176.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.7 t -104.79 118.62 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.518 0 O-C-N 121.044 -1.035 . . . . 0.0 108.244 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.05 173.34 6.63 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 122.091 0.948 . . . . 0.0 111.693 -177.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -64.63 138.51 58.44 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.988 0.899 . . . . 0.0 111.166 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.9 -14.43 52.72 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 178.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 48.6 t -82.63 140.48 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 O-C-N 120.721 -1.458 . . . . 0.0 108.87 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.471 ' O ' ' N ' ' A' ' 25' ' ' GLN . 35.6 p -92.88 141.05 28.86 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.238 -0.914 . . . . 0.0 109.078 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 57.9 mt -44.48 -36.24 2.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.27 -0.894 . . . . 0.0 109.753 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.405 ' O ' ' SD ' ' A' ' 24' ' ' MET . 4.9 tpt -61.19 -37.84 84.39 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.471 ' N ' ' O ' ' A' ' 22' ' ' SER . 11.8 mm100 -66.82 -58.48 4.95 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.306 -0.871 . . . . 0.0 108.994 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.29 -30.07 59.44 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.785 -1.197 . . . . 0.0 110.749 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.434 ' HB2' ' H ' ' A' ' 33' ' ' TYR . . . -60.92 -24.58 66.13 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.955 -1.091 . . . . 0.0 109.06 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 89.5 t -86.05 -23.88 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.393 -0.817 . . . . 0.0 109.709 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.34 -28.92 59.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.17 -0.956 . . . . 0.0 108.618 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -108.07 -4.59 17.62 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 178.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 64.1 72.0 0.76 Allowed Glycine 0 N--CA 1.499 2.897 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.2 mt -124.51 -60.3 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.406 -1.056 . . . . 0.0 111.635 -178.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.437 ' O ' ' C ' ' A' ' 34' ' ' ASP . 0.2 OUTLIER -93.64 -15.19 25.6 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.307 -0.871 . . . . 0.0 109.2 179.267 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.437 ' C ' ' O ' ' A' ' 33' ' ' TYR . 6.8 p-10 -38.67 -43.81 0.93 Allowed 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -178.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.436 ' O ' ' O ' ' A' ' 36' ' ' VAL . 19.2 tt -41.76 122.8 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.436 ' O ' ' O ' ' A' ' 35' ' ' ILE . 93.4 t 57.46 159.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.309 -0.87 . . . . 0.0 109.577 -178.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 177.04 111.93 0.3 Allowed Glycine 0 N--CA 1.486 2.007 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.527 ' C ' ' H ' ' A' ' 40' ' ' GLY . 1.0 OUTLIER -88.42 -85.42 0.19 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.004 -1.292 . . . . 0.0 109.99 -178.895 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.531 ' C ' ' H ' ' A' ' 41' ' ' GLY . 11.8 p -65.76 10.36 0.1 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.843 -1.161 . . . . 0.0 110.118 -179.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.527 ' H ' ' C ' ' A' ' 38' ' ' ASP . . . 54.61 7.59 1.0 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 -179.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.531 ' H ' ' C ' ' A' ' 39' ' ' CYS . . . 100.83 84.2 1.79 Allowed Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.526 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 5.1 m -160.3 28.55 0.17 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.274 -1.133 . . . . 0.0 108.922 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 50.0 66.35 1.16 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.051 -1.03 . . . . 0.0 109.224 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.1 m -159.15 17.16 0.18 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.168 -0.957 . . . . 0.0 109.965 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.502 ' SG ' ' OG1' ' A' ' 47' ' ' THR . 1.5 p -156.49 160.94 40.0 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.2 -0.937 . . . . 0.0 109.899 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -95.28 16.74 15.9 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.502 ' OG1' ' SG ' ' A' ' 45' ' ' CYS . 7.3 m -65.43 -54.42 28.82 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.922 -1.111 . . . . 0.0 110.251 -179.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.586 ' SG ' ' N ' ' A' ' 85' ' ' CYS . 17.7 p -82.3 54.42 2.56 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.756 -1.215 . . . . 0.0 110.15 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.457 ' CE1' ' OH ' ' A' ' 51' ' ' TYR . 35.8 t60 -77.45 109.67 11.58 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -143.7 164.94 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 120.679 -1.263 . . . . 0.0 109.664 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.546 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 42.4 m-85 -112.52 112.58 24.22 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-O 121.915 0.865 . . . . 0.0 109.747 -179.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.7 t -88.54 132.41 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.654 ' N ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -47.73 127.01 11.1 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.076 -1.015 . . . . 0.0 108.646 179.301 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -56.36 14.6 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.252 -0.905 . . . . 0.0 111.297 -178.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.642 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -99.67 -18.0 17.5 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.595 -1.315 . . . . 0.0 109.823 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.416 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 30.9 m-85 -116.18 -9.4 11.63 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.977 -1.077 . . . . 0.0 108.38 -179.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 31.2 p -68.44 -43.62 76.71 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.272 -0.893 . . . . 0.0 109.82 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -91.03 19.86 5.36 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 120.179 -0.608 . . . . 0.0 109.731 -179.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.6 mtpt -129.83 -40.83 1.34 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -81.06 168.17 26.92 Favored Pre-proline 0 N--CA 1.491 1.599 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 179.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -59.43 97.68 0.1 Allowed 'Trans proline' 0 N--CA 1.491 1.369 0 CA-C-N 120.123 1.08 . . . . 0.0 113.593 -176.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.84 99.56 3.81 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 178.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.544 ' H ' ' NH1' ' A' ' 83' ' ' ARG . . . -47.03 152.17 0.56 Allowed 'General case' 0 C--N 1.287 -2.121 0 CA-C-O 122.242 1.02 . . . . 0.0 113.129 -178.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -61.1 -169.81 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.618 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -67.68 -3.92 10.58 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.771 -0.58 . . . . 0.0 111.976 -178.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? -62.74 -42.49 99.7 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.539 -1.351 . . . . 0.0 108.442 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.536 ' OE1' ' N ' ' A' ' 67' ' ' GLU . 22.5 mp0 -75.55 -48.1 23.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.446 -0.784 . . . . 0.0 109.937 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 35.3 mt -44.21 -21.83 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.519 -0.738 . . . . 0.0 109.655 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -80.0 -79.54 0.85 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 9.9 ptp -47.56 -37.81 13.0 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.925 -1.338 . . . . 0.0 108.932 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.448 ' O ' ' CG2' ' A' ' 74' ' ' VAL . 2.5 tm? -56.93 -31.02 64.51 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' A' ' 69' ' ' GLY . 14.5 tt0 -81.88 14.52 2.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.09 -1.007 . . . . 0.0 109.256 178.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -125.51 36.62 4.52 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.225 -0.922 . . . . 0.0 110.083 -179.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.448 ' CG2' ' O ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -98.87 176.09 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 121.058 -1.026 . . . . 0.0 108.522 179.218 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.522 ' OG1' ' CD1' ' A' ' 106' ' ' TRP . 4.9 m -120.05 6.36 10.82 Favored 'General case' 0 N--CA 1.508 2.446 0 O-C-N 121.245 -0.91 . . . . 0.0 111.19 -178.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.429 ' CB ' ' NE2' ' A' ' 49' ' ' HIS . . . -105.78 171.94 7.07 Favored 'General case' 0 N--CA 1.506 2.362 0 O-C-N 120.979 -1.076 . . . . 0.0 109.674 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.546 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -59.0 102.66 0.13 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.23 -0.919 . . . . 0.0 109.641 -179.313 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.6 mp -71.81 141.54 49.66 Favored 'General case' 0 C--N 1.293 -1.875 0 O-C-N 120.132 -1.605 . . . . 0.0 110.665 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 45.2 mmtt -104.81 158.52 31.84 Favored Pre-proline 0 C--N 1.288 -2.081 0 CA-C-N 113.786 -1.552 . . . . 0.0 107.845 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -53.4 -16.24 7.06 Favored 'Trans proline' 0 C--N 1.302 -1.901 0 C-N-CA 121.248 1.298 . . . . 0.0 109.873 178.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -130.55 39.47 3.62 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.993 -0.442 . . . . 0.0 111.03 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.7 m -68.45 150.34 48.23 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 119.978 -1.701 . . . . 0.0 107.554 178.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.544 ' NH1' ' H ' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -165.68 169.47 15.17 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.533 -1.354 . . . . 0.0 110.121 -179.669 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.561 ' CD2' ' N ' ' A' ' 84' ' ' LEU . 1.1 mm? -85.73 119.78 26.44 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.586 ' N ' ' SG ' ' A' ' 48' ' ' CYS . 0.5 OUTLIER -57.26 -41.84 80.4 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.037 -1.039 . . . . 0.0 111.282 -177.875 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 30.6 p -60.56 -22.92 64.2 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 120.635 -1.29 . . . . 0.0 111.444 -177.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -91.18 33.04 0.98 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.009 -1.057 . . . . 0.0 111.16 -179.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.41 HG23 HD11 ' A' ' 88' ' ' ILE . 33.8 mt -130.27 144.79 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 O-C-N 120.966 -1.084 . . . . 0.0 108.226 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.7 mp -122.21 134.96 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.43 0 O-C-N 121.678 -0.639 . . . . 0.0 109.304 -179.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.628 ' SD ' ' N ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -81.16 144.5 31.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.234 -0.917 . . . . 0.0 108.851 -179.651 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.628 ' N ' ' SD ' ' A' ' 90' ' ' MET . 0.5 OUTLIER -129.46 152.54 79.77 Favored Pre-proline 0 N--CA 1.497 1.876 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 177.833 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.24 -34.75 26.66 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 121.671 1.58 . . . . 0.0 110.791 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -70.57 -23.29 62.57 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.584 -0.846 . . . . 0.0 109.8 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.7 mt -104.48 30.91 5.0 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.427 -0.796 . . . . 0.0 110.4 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -64.46 144.75 56.96 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.114 -1.616 . . . . 0.0 109.676 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 105.8 11.75 27.74 Favored Glycine 0 N--CA 1.503 3.112 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 178.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 15.3 tt -63.62 128.89 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.013 -1.286 . . . . 0.0 111.015 -177.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.482 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 6.6 t -103.84 123.7 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.225 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.2 t -111.44 135.06 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.067 -1.021 . . . . 0.0 109.688 -179.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -108.91 122.48 47.29 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-O 121.712 0.768 . . . . 0.0 109.055 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 35.0 t -110.3 123.27 36.34 Favored Pre-proline 0 N--CA 1.497 1.889 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.4 ' HG3' ' CD2' ' A' ' 49' ' ' HIS . 41.6 Cg_endo -85.94 -178.3 2.83 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.865 2.377 . . . . 0.0 113.486 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -87.01 -20.15 27.64 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -103.78 82.45 2.0 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -81.13 -23.3 38.42 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.444 -0.902 . . . . 0.0 109.68 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.522 ' CD1' ' OG1' ' A' ' 75' ' ' THR . 11.1 t-105 . . . . . 0 C--N 1.305 -1.359 0 O-C-N 120.847 -1.158 . . . . 0.0 110.164 179.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 98.0 p . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -76.11 111.03 11.09 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.428 ' CG1' ' CE1' ' A' ' 5' ' ' TYR . 96.5 t -111.9 111.89 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.735 -0.603 . . . . 0.0 110.302 -178.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 24.4 t -98.89 98.85 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.222 -0.924 . . . . 0.0 111.764 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.428 ' CE1' ' CG1' ' A' ' 3' ' ' VAL . 29.0 m-85 -72.94 111.89 8.47 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 176.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 79.1 t -98.89 117.92 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 75.0 p -73.73 -155.83 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.492 -0.755 . . . . 0.0 109.513 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.703 ' ND1' ' H ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -91.54 -50.27 5.87 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.164 -0.96 . . . . 0.0 108.985 -179.727 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.492 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 22.0 p-10 -66.03 2.07 1.24 Allowed 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.509 -0.745 . . . . 0.0 110.734 -179.155 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.408 ' O ' ' NH1' ' A' ' 12' ' ' ARG . . . 96.74 -4.98 63.92 Favored Glycine 0 N--CA 1.501 3.013 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -62.6 126.52 27.62 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.117 -1.226 . . . . 0.0 108.179 179.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.432 ' NH1' ' CG ' ' A' ' 12' ' ' ARG . 0.5 OUTLIER -112.09 161.1 16.87 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 121.875 0.845 . . . . 0.0 111.577 -178.16 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.5 ttm105 -149.65 118.67 6.71 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -99.46 128.02 45.55 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.39 -0.819 . . . . 0.0 110.427 -178.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.6 mt -117.79 -165.54 1.1 Allowed 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 122.972 1.368 . . . . 0.0 109.978 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -138.0 101.73 4.5 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 176.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.2 t -104.69 117.07 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.67 179.9 4.5 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-O 122.046 0.927 . . . . 0.0 112.343 -177.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -65.89 134.13 52.37 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.849 0.833 . . . . 0.0 110.548 -179.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.94 -18.01 42.55 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 178.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.2 t -83.72 139.63 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 120.848 -1.384 . . . . 0.0 109.889 -178.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.511 ' O ' ' N ' ' A' ' 25' ' ' GLN . 51.4 p -94.84 141.26 28.84 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 178.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.1 mt -45.81 -33.86 3.37 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.362 -0.836 . . . . 0.0 109.611 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.512 ' SD ' ' OD1' ' A' ' 34' ' ' ASP . 2.3 tpt -68.53 -28.46 67.01 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 121.674 0.75 . . . . 0.0 109.165 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.511 ' N ' ' O ' ' A' ' 22' ' ' SER . 7.0 tp-100 -76.55 -62.72 1.53 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.138 -0.976 . . . . 0.0 109.959 -179.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.29 -24.17 53.17 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.689 -1.257 . . . . 0.0 109.995 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.94 -22.21 66.61 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.161 -0.962 . . . . 0.0 109.649 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 99.1 t -86.29 -17.93 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.374 -0.829 . . . . 0.0 109.41 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.97 -30.32 22.85 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.391 -0.818 . . . . 0.0 110.066 -178.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 -94.18 10.64 33.07 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 63.63 70.08 1.15 Allowed Glycine 0 N--CA 1.499 2.864 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 178.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.79 ' O ' ' N ' ' A' ' 34' ' ' ASP . 10.7 mt -124.95 121.64 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.454 -1.027 . . . . 0.0 109.76 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.541 ' O ' ' CD2' ' A' ' 33' ' ' TYR . 76.3 t80 -48.1 49.28 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.423 0 CA-C-O 120.891 0.377 . . . . 0.0 112.002 -177.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.79 ' N ' ' O ' ' A' ' 32' ' ' ILE . 4.2 p30 -96.27 -21.72 17.67 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.195 -0.941 . . . . 0.0 109.821 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.653 ' CG1' ' H ' ' A' ' 36' ' ' VAL . 3.4 tt -54.02 -167.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.422 -0.799 . . . . 0.0 109.996 -178.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.653 ' H ' ' CG1' ' A' ' 35' ' ' ILE . 13.4 t 58.84 99.88 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.285 -0.884 . . . . 0.0 108.729 -178.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -154.22 169.72 32.68 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.538 ' C ' ' H ' ' A' ' 40' ' ' GLY . 23.8 m-20 -87.97 -67.96 0.79 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.111 -1.229 . . . . 0.0 110.079 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.622 ' SG ' ' N ' ' A' ' 42' ' ' SER . 10.2 p -71.05 18.45 0.06 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.045 -1.034 . . . . 0.0 109.563 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.538 ' H ' ' C ' ' A' ' 38' ' ' ASP . . . 50.34 15.26 1.1 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.609 -1.796 . . . . 0.0 108.609 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.475 ' N ' ' C ' ' A' ' 39' ' ' CYS . . . 91.13 21.26 36.12 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 -179.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.622 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 57.9 m -93.77 35.98 1.12 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.437 -1.037 . . . . 0.0 109.991 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 44.72 70.58 0.33 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.379 -0.825 . . . . 0.0 110.252 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -163.47 26.6 0.08 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.897 -1.127 . . . . 0.0 110.133 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.455 ' SG ' ' N ' ' A' ' 46' ' ' ALA . 3.4 p -158.9 -159.44 0.78 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.886 -1.134 . . . . 0.0 109.95 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.455 ' N ' ' SG ' ' A' ' 45' ' ' CYS . . . -134.71 3.39 3.25 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.416 ' OG1' ' SG ' ' A' ' 45' ' ' CYS . 62.0 p -49.86 -51.06 43.1 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.434 -0.792 . . . . 0.0 109.458 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.486 ' SG ' ' N ' ' A' ' 85' ' ' CYS . 30.1 p -73.46 54.85 0.46 Allowed 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.869 -1.145 . . . . 0.0 109.405 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.481 ' CE1' ' OH ' ' A' ' 51' ' ' TYR . 50.9 t60 -76.74 106.45 8.41 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -143.84 160.8 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 120.696 -1.253 . . . . 0.0 109.231 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.585 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 39.5 m-85 -108.52 111.42 23.27 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 122.241 1.019 . . . . 0.0 109.953 -179.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.9 t -85.94 133.29 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.606 ' C ' ' H ' ' A' ' 55' ' ' ALA . 1.0 OUTLIER -48.21 127.7 13.04 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.872 -1.143 . . . . 0.0 108.625 -179.852 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -56.35 9.15 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.467 -0.77 . . . . 0.0 111.471 -178.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.606 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -99.11 -17.38 18.24 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.805 -1.184 . . . . 0.0 109.9 -179.272 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.403 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 48.1 m-85 -115.61 -4.74 12.2 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.1 -1.0 . . . . 0.0 108.808 -179.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 24.8 p -72.95 -41.94 63.93 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.619 -0.676 . . . . 0.0 109.796 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -89.31 15.44 9.05 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 120.204 -0.599 . . . . 0.0 109.886 -179.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.1 mtpt -121.68 -40.86 2.51 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -78.86 158.33 75.41 Favored Pre-proline 0 N--CA 1.495 1.82 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -49.47 102.74 0.05 OUTLIER 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 122.222 1.948 . . . . 0.0 113.726 -177.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.432 ' HA ' HH22 ' A' ' 83' ' ' ARG . . . -75.66 101.62 5.05 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 177.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.779 ' H ' HH22 ' A' ' 83' ' ' ARG . . . -65.25 169.58 5.55 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-O 122.211 1.005 . . . . 0.0 112.58 -178.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.415 ' ND2' ' HE ' ' A' ' 66' ' ' ARG . 4.0 p30 -63.24 177.54 0.62 Allowed 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 122.103 0.954 . . . . 0.0 111.428 -178.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -72.23 5.34 2.89 Favored 'General case' 0 N--CA 1.503 2.214 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.523 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.415 ' HE ' ' ND2' ' A' ' 64' ' ' ASN . 10.2 mtm180 -74.16 -50.52 18.96 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 120.37 -1.456 . . . . 0.0 109.185 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.442 ' OE1' ' OE1' ' A' ' 87' ' ' GLN . 82.3 mt-10 -65.58 -16.71 63.97 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.525 -0.734 . . . . 0.0 109.655 179.114 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.525 ' CD1' ' N ' ' A' ' 68' ' ' ILE . 1.4 mp -75.54 -34.92 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.383 -0.823 . . . . 0.0 108.918 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.81 -20.51 48.21 Favored Glycine 0 N--CA 1.495 2.597 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 3.5 mmt -83.51 -35.42 24.85 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 178.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 59.8 mt -63.75 -21.98 66.68 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -83.82 11.7 7.16 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -131.26 28.13 4.74 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.446 -0.784 . . . . 0.0 109.774 -178.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 18.0 m -90.92 162.86 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.326 -0.859 . . . . 0.0 110.697 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.524 ' OG1' ' CD2' ' A' ' 106' ' ' TRP . 6.7 m -100.75 -8.7 22.5 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.321 -0.862 . . . . 0.0 109.983 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -107.55 175.33 5.53 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.807 -1.183 . . . . 0.0 110.723 -178.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.585 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -61.46 108.71 1.0 Allowed 'General case' 0 N--CA 1.503 2.21 0 CA-C-O 121.372 0.606 . . . . 0.0 110.967 -178.843 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 9.2 tp -72.92 156.67 38.62 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 119.547 -1.97 . . . . 0.0 110.101 179.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.6 mmtm -118.03 155.76 50.94 Favored Pre-proline 0 C--N 1.293 -1.856 0 CA-C-N 115.105 -0.952 . . . . 0.0 108.534 -178.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.99 -24.26 79.21 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 121.674 1.582 . . . . 0.0 109.261 178.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 81' ' ' ASN . 1.4 p30 -112.9 21.69 15.21 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.013 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.7 m -52.07 158.26 1.13 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 120.306 -1.496 . . . . 0.0 109.067 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.779 HH22 ' H ' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -156.69 148.22 22.48 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.061 -1.055 . . . . 0.0 111.924 -178.28 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.56 ' CD2' ' N ' ' A' ' 84' ' ' LEU . 2.2 mm? -85.48 121.66 28.51 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 177.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.486 ' N ' ' SG ' ' A' ' 48' ' ' CYS . 0.2 OUTLIER -70.64 -5.09 26.9 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.867 -1.146 . . . . 0.0 113.183 -175.708 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 27.9 p -93.93 -37.7 11.56 Favored 'General case' 0 N--CA 1.506 2.354 0 CA-C-N 120.438 1.472 . . . . 0.0 111.004 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.63 HE22 ' NH1' ' A' ' 83' ' ' ARG . 5.0 pp0? -84.91 24.74 1.02 Allowed 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.214 -0.929 . . . . 0.0 110.39 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 47.3 mt -108.09 148.3 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 O-C-N 121.131 -0.981 . . . . 0.0 108.651 179.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 33.5 mm -127.68 124.35 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.415 ' SD ' HG23 ' A' ' 97' ' ' ILE . 2.7 tpt -91.14 160.77 15.39 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.301 -0.874 . . . . 0.0 109.928 -178.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 70.9 p -149.38 147.61 23.86 Favored Pre-proline 0 N--CA 1.49 1.532 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -57.1 -29.58 83.71 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 121.46 1.44 . . . . 0.0 111.616 -179.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -67.83 -29.54 68.72 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.19 -0.944 . . . . 0.0 109.938 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.4 mt -98.1 31.04 2.85 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.578 -0.701 . . . . 0.0 109.863 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -62.63 138.51 58.51 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.169 -0.957 . . . . 0.0 110.17 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 111.8 9.1 21.49 Favored Glycine 0 N--CA 1.505 3.281 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 178.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.415 HG23 ' SD ' ' A' ' 90' ' ' MET . 0.1 OUTLIER -67.07 125.94 25.58 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 O-C-N 121.604 -0.939 . . . . 0.0 110.838 -178.213 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.6 t -101.97 121.51 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.367 -0.833 . . . . 0.0 109.594 178.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.3 t -105.88 134.02 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 120.894 -1.129 . . . . 0.0 108.849 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -108.16 119.83 40.59 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 121.864 0.84 . . . . 0.0 109.015 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 23.7 t -107.27 122.94 39.76 Favored Pre-proline 0 N--CA 1.496 1.846 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -83.57 177.69 6.15 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.703 2.269 . . . . 0.0 113.594 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -84.38 -15.26 46.96 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -112.05 80.4 1.32 Allowed 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.465 ' NE2' ' O ' ' A' ' 106' ' ' TRP . 2.2 pp0? -80.55 -20.43 43.46 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.724 -1.235 . . . . 0.0 109.659 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.524 ' CD2' ' OG1' ' A' ' 75' ' ' THR . 67.4 t-105 . . . . . 0 C--N 1.302 -1.475 0 CA-C-O 117.83 -1.081 . . . . 0.0 110.24 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.462 ' OG ' ' SD ' ' A' ' 90' ' ' MET . 67.9 p . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.1 mmtt -75.94 115.39 15.6 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.558 HG21 ' CG2' ' A' ' 17' ' ' VAL . 45.1 t -116.3 108.1 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.16 -0.963 . . . . 0.0 111.952 -177.355 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 28.2 t -103.38 134.89 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 CA-C-O 121.687 0.756 . . . . 0.0 110.247 178.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -108.42 118.8 37.72 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 177.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 64.7 t -98.17 113.53 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 120.846 -1.159 . . . . 0.0 108.516 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.401 ' OG ' ' N ' ' A' ' 8' ' ' HIS . 5.3 p -79.6 -153.63 0.08 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.486 -0.759 . . . . 0.0 110.261 -179.167 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.569 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.4 OUTLIER -91.84 -52.67 4.63 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.8 p30 -62.41 -2.0 0.92 Allowed 'General case' 0 N--CA 1.483 1.189 0 O-C-N 120.865 -1.147 . . . . 0.0 111.364 -178.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.65 0.43 64.54 Favored Glycine 0 N--CA 1.498 2.811 0 O-C-N 120.67 -1.269 . . . . 0.0 110.575 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.408 HG23 HH11 ' A' ' 13' ' ' ARG . 1.0 OUTLIER -77.02 141.55 40.28 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.98 -1.306 . . . . 0.0 109.101 -179.597 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.43 ' CD ' ' N ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -119.43 164.38 15.82 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.387 -0.82 . . . . 0.0 112.486 -178.139 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.408 HH11 HG23 ' A' ' 11' ' ' THR . 0.0 OUTLIER -139.89 111.69 7.39 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.014 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -98.35 122.67 41.81 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.197 -0.939 . . . . 0.0 109.589 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.501 HD22 ' CG ' ' A' ' 30' ' ' ASN . 21.0 mt -117.47 -164.48 1.0 Allowed 'General case' 0 N--CA 1.503 2.205 0 CA-C-O 122.747 1.26 . . . . 0.0 109.968 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -137.74 99.6 3.96 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 104.558 -2.386 . . . . 0.0 104.558 176.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.558 ' CG2' HG21 ' A' ' 3' ' ' VAL . 16.8 t -102.31 121.13 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.321 0 O-C-N 121.238 -0.914 . . . . 0.0 109.022 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.71 -178.67 5.48 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.237 -0.914 . . . . 0.0 111.547 -178.057 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -67.72 131.2 45.12 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 122.078 0.942 . . . . 0.0 111.584 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.78 -18.84 48.6 Favored Glycine 0 N--CA 1.493 2.433 0 N-CA-C 111.121 -0.791 . . . . 0.0 111.121 178.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.407 ' HB ' HG12 ' A' ' 17' ' ' VAL . 62.3 t -79.65 132.81 31.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 120.689 -1.477 . . . . 0.0 108.478 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.425 ' O ' ' N ' ' A' ' 25' ' ' GLN . 18.0 p -88.2 145.59 25.82 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.962 -1.086 . . . . 0.0 108.666 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 70.4 mt -45.64 -39.8 8.23 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 120.594 -1.316 . . . . 0.0 109.864 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 10.5 ttt -64.51 -27.67 69.13 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.549 -0.719 . . . . 0.0 109.255 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.425 ' N ' ' O ' ' A' ' 22' ' ' SER . 52.3 mt-30 -72.78 -58.62 3.2 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.173 -0.954 . . . . 0.0 109.053 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.406 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -62.82 -27.48 69.35 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.768 -1.207 . . . . 0.0 110.89 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.05 -22.02 64.19 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.653 -1.279 . . . . 0.0 108.793 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 89.6 t -84.66 -21.63 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-O 121.492 0.663 . . . . 0.0 109.41 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.18 -28.0 32.31 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.391 -0.818 . . . . 0.0 109.491 -179.32 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.501 ' CG ' HD22 ' A' ' 15' ' ' LEU . 7.4 m-80 . . . . . 0 N--CA 1.485 1.306 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 13.9 m . . . . . 0 N--CA 1.484 1.265 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.529 ' SG ' ' O ' ' A' ' 48' ' ' CYS . 13.8 p -96.42 46.84 1.07 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.887 -1.133 . . . . 0.0 110.224 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.596 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 38.7 t60 -75.32 109.98 9.28 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.045 -1.034 . . . . 0.0 108.347 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -143.49 164.65 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.152 -0.968 . . . . 0.0 109.36 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.516 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 58.1 m-85 -108.81 110.71 22.14 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-O 121.9 0.857 . . . . 0.0 109.477 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.777 HG13 HD11 ' A' ' 97' ' ' ILE . 14.5 t -87.77 132.89 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.577 ' C ' ' H ' ' A' ' 55' ' ' ALA . 21.6 t-20 -47.58 126.21 9.59 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.959 -1.088 . . . . 0.0 109.556 179.113 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -58.19 15.26 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.638 -0.664 . . . . 0.0 111.193 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.577 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -103.39 -18.75 14.7 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.697 -1.252 . . . . 0.0 109.577 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.676 ' CD2' HD22 ' A' ' 94' ' ' LEU . 44.1 m-85 -113.0 -12.71 13.19 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.104 -0.998 . . . . 0.0 109.172 -178.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 13.6 p -68.08 -37.38 81.18 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.455 -0.778 . . . . 0.0 109.882 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -88.95 13.24 13.27 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.49 -0.757 . . . . 0.0 109.424 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.3 mtpt -124.46 -39.3 2.33 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.626 HG22 ' HD2' ' A' ' 61' ' ' PRO . 0.5 OUTLIER -81.18 161.74 61.6 Favored Pre-proline 0 N--CA 1.497 1.909 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 179.667 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.626 ' HD2' HG22 ' A' ' 60' ' ' VAL . 6.2 Cg_endo -56.23 92.74 0.05 OUTLIER 'Trans proline' 0 N--CA 1.49 1.31 0 C-N-CA 121.584 1.522 . . . . 0.0 113.401 -177.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.37 102.63 5.2 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 178.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.795 ' H ' HH22 ' A' ' 83' ' ' ARG . . . -50.16 151.82 1.92 Allowed 'General case' 0 C--N 1.288 -2.08 0 CA-C-O 122.742 1.258 . . . . 0.0 112.596 -177.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -59.31 -165.38 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.372 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.438 ' HA ' HD12 ' A' ' 68' ' ' ILE . 8.5 pt-20 -68.76 -5.22 19.31 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.254 -0.904 . . . . 0.0 112.783 -177.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.4 mtt180 -60.91 -38.41 85.66 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.154 -1.591 . . . . 0.0 108.997 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -80.74 -39.04 27.65 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.973 -1.08 . . . . 0.0 110.05 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.438 HD12 ' HA ' ' A' ' 65' ' ' GLU . 84.5 mt -46.65 -28.93 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.33 -0.856 . . . . 0.0 110.105 -179.335 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -82.84 -30.41 32.18 Favored Glycine 0 N--CA 1.498 2.786 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 25.3 mtt -76.56 -34.21 58.5 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 178.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.529 ' O ' HD13 ' A' ' 78' ' ' LEU . 6.3 mt -59.05 -24.27 62.72 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -92.26 30.38 1.47 Allowed 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -134.89 19.4 3.49 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.533 -0.729 . . . . 0.0 110.487 -179.247 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.4 m -97.74 167.42 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 120.809 -1.182 . . . . 0.0 110.214 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.546 ' OG1' ' CD1' ' A' ' 106' ' ' TRP . 6.8 m -101.59 -0.16 35.32 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.385 -0.822 . . . . 0.0 109.789 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.596 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -107.18 169.29 8.65 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.242 -0.911 . . . . 0.0 110.465 -178.106 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.516 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -61.21 110.32 1.37 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.741 -0.6 . . . . 0.0 109.839 -179.343 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.529 HD13 ' O ' ' A' ' 71' ' ' LEU . 4.3 tp -68.6 158.01 34.89 Favored 'General case' 0 C--N 1.294 -1.811 0 O-C-N 120.26 -1.525 . . . . 0.0 108.753 178.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.443 ' N ' ' OG ' ' A' ' 82' ' ' SER . 41.5 mmtt -128.25 153.38 78.83 Favored Pre-proline 0 C--N 1.294 -1.818 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 -178.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -55.32 -28.29 61.97 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 121.54 1.494 . . . . 0.0 109.52 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -112.27 29.74 7.65 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.722 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.443 ' OG ' ' N ' ' A' ' 79' ' ' LYS . 4.3 m -61.89 164.64 6.19 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.673 -1.267 . . . . 0.0 109.159 178.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.795 HH22 ' H ' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -164.93 146.24 7.73 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 118.564 -1.254 . . . . 0.0 112.012 -178.6 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.517 HD22 ' N ' ' A' ' 84' ' ' LEU . 3.2 mm? -92.72 95.35 9.51 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 177.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -31.77 -46.21 0.11 Allowed 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -177.156 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.467 ' SG ' ' N ' ' A' ' 87' ' ' GLN . 30.3 p -58.22 -45.75 87.13 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 119.856 -1.777 . . . . 0.0 111.956 -177.374 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.467 ' N ' ' SG ' ' A' ' 86' ' ' CYS . 10.4 tp60 -74.79 39.58 0.13 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.481 -1.387 . . . . 0.0 111.494 -178.221 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.556 ' C ' HD12 ' A' ' 89' ' ' ILE . 31.6 mt -131.35 145.71 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 O-C-N 120.86 -1.15 . . . . 0.0 108.715 178.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.556 HD12 ' C ' ' A' ' 88' ' ' ILE . 1.6 mp -121.6 127.84 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.462 ' SD ' ' OG ' ' A' ' 1' ' ' SER . 0.0 OUTLIER -88.33 162.05 16.79 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -178.881 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.415 ' H ' ' HE2' ' A' ' 90' ' ' MET . 45.5 p -152.1 148.4 21.32 Favored Pre-proline 0 N--CA 1.49 1.551 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.1 -32.98 98.3 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 121.69 1.594 . . . . 0.0 111.298 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -66.63 -32.81 74.38 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.126 -0.984 . . . . 0.0 109.502 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.676 HD22 ' CD2' ' A' ' 56' ' ' PHE . 7.6 mt -90.85 31.39 1.07 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.149 -0.969 . . . . 0.0 109.229 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -60.21 133.31 55.98 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.878 -1.139 . . . . 0.0 110.45 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 110.67 11.33 19.53 Favored Glycine 0 N--CA 1.507 3.416 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 178.059 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.777 HD11 HG13 ' A' ' 52' ' ' VAL . 0.3 OUTLIER -64.07 124.17 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.19 0 O-C-N 120.997 -1.296 . . . . 0.0 110.297 -177.583 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.5 t -101.69 121.92 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.505 -0.747 . . . . 0.0 109.32 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.1 t -108.5 133.53 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 120.977 -1.077 . . . . 0.0 110.109 -178.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.96 118.32 36.39 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.901 0.858 . . . . 0.0 109.113 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 14.9 t -107.74 124.59 34.45 Favored Pre-proline 0 N--CA 1.497 1.909 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.407 ' HG3' ' CD2' ' A' ' 49' ' ' HIS . 97.1 Cg_endo -82.57 178.45 6.14 Favored 'Trans proline' 0 N--CA 1.5 1.886 0 C-N-CA 122.315 2.01 . . . . 0.0 113.497 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -83.03 -14.03 54.69 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.32 87.32 2.72 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 -178.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -87.56 -32.59 19.28 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' TRP . . . . . 0.546 ' CD1' ' OG1' ' A' ' 75' ' ' THR . 45.3 t-105 . . . . . 0 C--N 1.302 -1.486 0 CA-C-O 117.735 -1.126 . . . . 0.0 109.564 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 51.9 p . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.51 109.66 12.9 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.563 -0.855 . . . . 0.0 108.953 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.497 HG21 HG21 ' A' ' 17' ' ' VAL . 22.9 t -107.48 108.55 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 O-C-N 121.237 -0.915 . . . . 0.0 110.489 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.0 t -99.04 98.81 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.089 -1.007 . . . . 0.0 111.405 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.484 ' CZ ' HG11 ' A' ' 3' ' ' VAL . 68.9 m-85 -73.08 115.13 12.03 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.062 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 75.2 t -98.81 111.6 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 61.3 p -72.3 -159.66 0.06 Allowed 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 121.666 0.746 . . . . 0.0 109.867 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.584 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.2 OUTLIER -90.58 -50.87 5.69 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.309 -0.869 . . . . 0.0 108.709 -179.966 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.495 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 15.1 p30 -66.34 5.23 0.58 Allowed 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.752 -179.105 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.11 -1.83 74.4 Favored Glycine 0 N--CA 1.499 2.887 0 O-C-N 120.879 -1.138 . . . . 0.0 110.895 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -65.27 129.67 40.56 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.89 -1.359 . . . . 0.0 108.541 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 2.2 mtt85 -108.76 160.64 15.8 Favored 'General case' 0 N--CA 1.502 2.126 0 CA-C-O 121.68 0.752 . . . . 0.0 110.58 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.15 115.38 5.42 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 179.203 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -98.72 127.12 44.54 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-O 121.829 0.823 . . . . 0.0 110.342 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.417 ' CD1' ' H ' ' A' ' 16' ' ' ASP . 0.3 OUTLIER -113.44 -174.33 2.44 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 123.203 1.478 . . . . 0.0 111.032 -177.797 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.417 ' H ' ' CD1' ' A' ' 15' ' ' LEU . 0.8 OUTLIER -136.14 99.97 4.28 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 104.654 -2.35 . . . . 0.0 104.654 176.48 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.497 HG21 HG21 ' A' ' 3' ' ' VAL . 13.0 t -108.22 116.39 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.81 -179.72 2.33 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.311 -0.868 . . . . 0.0 111.409 -178.093 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 19' ' ' ASP . 3.8 p-10 -70.0 136.75 50.75 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 122.012 0.91 . . . . 0.0 110.724 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.01 -18.2 41.74 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 178.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.434 ' HB ' HG12 ' A' ' 17' ' ' VAL . 57.5 t -80.1 138.52 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 120.616 -1.52 . . . . 0.0 109.432 -178.356 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.27 153.97 21.06 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.164 -0.96 . . . . 0.0 109.126 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.419 ' CD2' ' N ' ' A' ' 23' ' ' LEU . 1.8 mm? -56.26 -64.05 0.99 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.612 -0.68 . . . . 0.0 109.178 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.515 ' O ' ' SD ' ' A' ' 24' ' ' MET . 6.6 tpt -49.46 -16.28 0.2 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.009 -1.057 . . . . 0.0 109.123 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.418 ' N ' ' C ' ' A' ' 23' ' ' LEU . 7.7 tm0? -78.35 -68.1 0.67 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.104 -0.998 . . . . 0.0 109.47 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.427 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -55.24 -21.7 15.17 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.929 -1.107 . . . . 0.0 110.418 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.78 -19.35 65.78 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 120.844 -1.16 . . . . 0.0 108.809 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 96.5 t -86.98 -23.87 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.472 -0.767 . . . . 0.0 109.381 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.53 -26.43 45.79 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.529 -0.732 . . . . 0.0 109.054 -179.343 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.5 m120 . . . . . 0 C--N 1.304 -1.408 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.147 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 9.7 m . . . . . 0 N--CA 1.487 1.395 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.516 ' SG ' ' O ' ' A' ' 48' ' ' CYS . 17.8 p -87.44 54.66 3.22 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.695 -1.253 . . . . 0.0 110.071 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.796 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 43.6 t60 -76.52 109.97 10.69 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.955 -1.091 . . . . 0.0 109.024 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -146.06 168.17 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 120.796 -1.19 . . . . 0.0 109.697 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.601 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 37.2 m-85 -116.7 114.86 24.62 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-O 122.051 0.929 . . . . 0.0 109.58 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.456 ' O ' ' OD1' ' A' ' 81' ' ' ASN . 78.7 t -91.31 131.64 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.765 ' ND2' ' HB3' ' A' ' 55' ' ' ALA . 1.1 t30 -46.95 127.65 10.31 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -57.38 13.9 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.63 -0.669 . . . . 0.0 111.441 -178.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.765 ' HB3' ' ND2' ' A' ' 53' ' ' ASN . . . -103.45 -19.8 14.28 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.57 -1.331 . . . . 0.0 109.8 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.551 ' CD2' HD22 ' A' ' 94' ' ' LEU . 30.2 m-85 -109.59 -9.78 14.87 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.708 -1.245 . . . . 0.0 108.859 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.0 p -71.18 -37.51 72.17 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.565 -0.71 . . . . 0.0 110.141 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.421 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 9.5 p-10 -87.84 10.51 18.33 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.229 -0.919 . . . . 0.0 109.913 -178.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.536 ' HB2' HD21 ' A' ' 94' ' ' LEU . 9.1 mttm -121.21 -40.04 2.63 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.66 HG22 ' HD2' ' A' ' 61' ' ' PRO . 0.4 OUTLIER -78.73 162.09 66.67 Favored Pre-proline 0 N--CA 1.498 1.953 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 179.813 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.66 ' HD2' HG22 ' A' ' 60' ' ' VAL . 4.4 Cg_endo -53.97 94.19 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 121.877 1.718 . . . . 0.0 113.939 -176.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.0 98.5 3.62 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 177.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.967 ' H ' HH22 ' A' ' 83' ' ' ARG . . . -61.05 169.34 2.04 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-O 122.559 1.171 . . . . 0.0 111.953 -178.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -65.18 -175.02 0.19 Allowed 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 122.204 1.002 . . . . 0.0 111.954 -178.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -70.33 3.31 3.0 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.813 -0.555 . . . . 0.0 111.409 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.2 mtm180 -59.95 -41.76 92.58 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.669 -1.269 . . . . 0.0 110.143 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.478 ' N ' ' CD ' ' A' ' 67' ' ' GLU . 23.7 mp0 -80.29 -37.0 33.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.021 -1.049 . . . . 0.0 110.029 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.446 HD12 ' N ' ' A' ' 68' ' ' ILE . 1.3 mp -46.88 -34.13 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 C-N-CA 119.731 -0.788 . . . . 0.0 109.142 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.3 -28.36 62.08 Favored Glycine 0 N--CA 1.498 2.791 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.421 ' N ' ' O ' ' A' ' 67' ' ' GLU . 25.1 mtt -79.97 -35.6 37.31 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 178.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 74.9 mt -66.81 -24.69 66.2 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -77.48 5.83 8.18 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.732 -1.23 . . . . 0.0 108.032 178.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -124.42 30.17 6.1 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.752 -0.592 . . . . 0.0 110.981 -177.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 28.9 m -96.35 169.54 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.42 0 O-C-N 120.652 -1.28 . . . . 0.0 110.723 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.524 ' OG1' ' CG ' ' A' ' 106' ' ' TRP . 3.1 m -102.41 -9.93 19.86 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.342 -0.849 . . . . 0.0 111.281 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.796 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -104.58 176.13 5.26 Favored 'General case' 0 N--CA 1.507 2.405 0 O-C-N 120.627 -1.296 . . . . 0.0 110.411 -178.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.601 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -59.64 105.33 0.36 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.613 -0.679 . . . . 0.0 110.255 -178.528 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.9 tp -73.96 147.35 43.14 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 119.502 -1.999 . . . . 0.0 110.338 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 27.0 mmtm -109.58 155.52 41.2 Favored Pre-proline 0 C--N 1.291 -1.962 0 CA-C-N 114.756 -1.111 . . . . 0.0 108.83 -178.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.47 -23.02 73.96 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 121.964 1.776 . . . . 0.0 109.331 178.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.456 ' OD1' ' O ' ' A' ' 52' ' ' VAL . 2.1 p30 -115.55 23.22 12.53 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.832 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.1 m -47.21 165.66 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.672 -1.268 . . . . 0.0 109.409 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.967 HH22 ' H ' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -161.58 141.99 10.71 Favored 'General case' 0 N--CA 1.5 2.046 0 C-N-CA 118.259 -1.376 . . . . 0.0 111.96 -177.531 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 95.5 mt -86.32 111.16 20.21 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 177.042 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.604 ' HA ' HD12 ' A' ' 88' ' ' ILE . 0.1 OUTLIER -56.2 -35.14 66.94 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -176.106 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 86' ' ' CYS . . . . . 0.547 ' SG ' ' N ' ' A' ' 87' ' ' GLN . 31.6 p -63.51 -49.06 75.05 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 119.678 -1.889 . . . . 0.0 112.343 -177.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.683 HE22 ' NH1' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -79.61 33.8 0.26 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.841 -1.162 . . . . 0.0 111.425 -177.709 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.604 HD12 ' HA ' ' A' ' 85' ' ' CYS . 71.5 mt -113.17 160.76 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 177.336 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.484 ' N ' HG22 ' A' ' 88' ' ' ILE . 35.6 mm -136.5 121.85 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.147 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.4 ' SD ' HD21 ' A' ' 23' ' ' LEU . 3.2 tpt -87.28 160.87 18.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.792 -1.193 . . . . 0.0 108.799 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 39.4 p -151.06 148.67 23.2 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -56.03 -32.37 85.97 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 121.379 1.386 . . . . 0.0 111.634 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.57 ' CD ' ' H ' ' A' ' 93' ' ' GLU . 2.3 pm0 -68.11 -31.52 71.18 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.062 -1.024 . . . . 0.0 110.006 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.551 HD22 ' CD2' ' A' ' 56' ' ' PHE . 7.2 mt -94.43 27.99 2.75 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 120.72 -1.237 . . . . 0.0 108.956 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -61.86 138.03 58.31 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.023 -1.048 . . . . 0.0 110.324 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 107.83 9.77 27.81 Favored Glycine 0 N--CA 1.499 2.866 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 178.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 14.4 tt -64.99 133.25 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 120.925 -1.338 . . . . 0.0 111.365 -177.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.3 t -103.06 114.59 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.5 t -103.72 135.75 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.729 -1.232 . . . . 0.0 108.558 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.1 116.17 31.44 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.809 0.814 . . . . 0.0 109.172 -179.023 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.2 t -103.34 125.01 36.24 Favored Pre-proline 0 N--CA 1.498 1.933 0 O-C-N 121.845 -0.534 . . . . 0.0 109.565 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.424 ' HG3' ' CD2' ' A' ' 49' ' ' HIS . 85.2 Cg_endo -80.6 167.24 19.09 Favored 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 122.193 1.929 . . . . 0.0 113.735 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -73.11 -14.98 61.49 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 21.5 mtm180 -123.82 92.32 3.65 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 2.7 pp0? -82.61 -19.51 38.23 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.628 -0.67 . . . . 0.0 109.716 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' TRP . . . . . 0.524 ' CG ' ' OG1' ' A' ' 75' ' ' THR . 63.5 t-105 . . . . . 0 C--N 1.304 -1.373 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.537 178.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.408 ' OG ' ' O ' ' A' ' 17' ' ' VAL . 83.9 p . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.402 ' H ' ' HB2' ' A' ' 95' ' ' ASP . 25.4 mmtt -75.38 111.71 10.93 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.31 -0.869 . . . . 0.0 109.157 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.446 ' CG2' ' SD ' ' A' ' 90' ' ' MET . 17.2 t -109.49 109.19 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.343 -0.848 . . . . 0.0 109.499 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.473 HG22 ' OE1' ' A' ' 14' ' ' GLU . 38.5 t -99.57 96.49 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.127 -0.983 . . . . 0.0 111.345 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -70.54 111.76 6.3 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 76.1 t -98.46 117.36 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 80.8 p -76.51 -158.6 0.1 Allowed 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.346 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.602 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -90.33 -49.65 6.41 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.089 -1.007 . . . . 0.0 109.466 -179.646 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.485 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 22.9 p-10 -66.39 2.06 1.39 Allowed 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.264 -0.897 . . . . 0.0 110.355 -178.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.01 -0.54 62.47 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -65.05 127.94 33.7 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.9 -1.353 . . . . 0.0 108.227 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.447 HH11 ' HD2' ' A' ' 12' ' ' ARG . 2.3 mtt85 -108.12 160.67 15.63 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 122.156 0.979 . . . . 0.0 110.796 -178.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -150.99 115.19 5.06 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 178.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.473 ' OE1' HG22 ' A' ' 4' ' ' VAL . 0.2 OUTLIER -99.19 128.46 45.32 Favored 'General case' 0 N--CA 1.508 2.436 0 CA-C-O 122.504 1.145 . . . . 0.0 110.613 -178.144 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.459 ' CD1' ' H ' ' A' ' 16' ' ' ASP . 0.2 OUTLIER -115.13 -173.86 2.39 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 123.072 1.415 . . . . 0.0 110.575 -178.475 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.459 ' H ' ' CD1' ' A' ' 15' ' ' LEU . 32.6 t0 -136.36 104.39 5.6 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 176.51 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.538 HG22 ' CB ' ' A' ' 26' ' ' ALA . 25.2 t -112.9 122.92 67.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 O-C-N 121.525 -0.734 . . . . 0.0 109.604 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.82 179.78 5.9 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.919 0.866 . . . . 0.0 111.519 -178.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -69.31 138.82 54.11 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 122.025 0.917 . . . . 0.0 110.913 -179.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.83 -17.09 37.94 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 62.0 t -81.9 139.13 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 O-C-N 120.51 -1.583 . . . . 0.0 109.122 -178.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 16.0 p -92.68 149.19 21.48 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.158 -0.964 . . . . 0.0 108.588 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 27.0 mt -50.01 -36.15 27.51 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 121.093 -1.004 . . . . 0.0 110.007 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 7.5 tpt -68.11 -24.37 65.02 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.319 -0.863 . . . . 0.0 109.474 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -76.94 -63.22 1.41 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.143 -0.973 . . . . 0.0 109.622 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.538 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -52.95 -28.54 24.06 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.123 -0.986 . . . . 0.0 110.599 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.14 -20.96 29.17 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.749 -1.22 . . . . 0.0 108.756 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.5 t -88.57 -23.85 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.485 -0.759 . . . . 0.0 110.585 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.3 -31.11 60.56 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.303 -0.873 . . . . 0.0 109.99 -179.287 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.4 m120 . . . . . 0 C--N 1.304 -1.37 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.298 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 75.5 p . . . . . 0 N--CA 1.482 1.127 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 20.8 p -97.28 54.21 1.21 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.214 -0.928 . . . . 0.0 109.586 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.679 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 39.5 t60 -76.2 96.11 3.84 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -133.65 164.58 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 121.151 -0.968 . . . . 0.0 109.748 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.518 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 45.8 m-85 -113.54 113.25 24.85 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 122.073 0.94 . . . . 0.0 110.192 -179.05 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.465 HG12 HD22 ' A' ' 53' ' ' ASN . 47.1 t -87.25 131.13 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.609 ' N ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -48.0 128.19 13.29 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.92 -1.113 . . . . 0.0 108.902 179.834 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -55.85 9.96 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.284 -0.885 . . . . 0.0 111.515 -178.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.597 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -98.19 -18.42 18.46 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.892 -1.13 . . . . 0.0 110.137 -179.316 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.612 ' CD2' HD22 ' A' ' 94' ' ' LEU . 26.1 m-85 -114.66 -7.45 12.73 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 120.707 -1.246 . . . . 0.0 108.855 -179.448 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.3 p -71.61 -41.18 69.22 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.083 -1.01 . . . . 0.0 109.858 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -85.48 10.17 13.74 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.435 -0.791 . . . . 0.0 110.006 -178.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.507 ' HB2' HD21 ' A' ' 94' ' ' LEU . 17.3 mttt -120.11 -38.46 2.93 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.684 HG22 ' HD2' ' A' ' 61' ' ' PRO . 0.4 OUTLIER -82.51 164.14 48.79 Favored Pre-proline 0 N--CA 1.493 1.705 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.684 ' HD2' HG22 ' A' ' 60' ' ' VAL . 5.6 Cg_endo -58.31 99.33 0.1 OUTLIER 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 121.773 1.649 . . . . 0.0 114.714 -176.305 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.27 102.97 1.48 Allowed 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -56.77 155.33 7.88 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-O 122.304 1.049 . . . . 0.0 112.51 -178.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.444 ' ND2' ' NH1' ' A' ' 66' ' ' ARG . 3.0 p30 -59.3 -178.2 0.06 Allowed 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.721 0.772 . . . . 0.0 111.148 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -70.1 2.19 3.88 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.669 -0.644 . . . . 0.0 112.354 -178.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.444 ' NH1' ' ND2' ' A' ' 64' ' ' ASN . 51.4 mtt85 -67.57 -40.97 84.87 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 120.68 -1.263 . . . . 0.0 109.679 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.484 ' N ' ' CD ' ' A' ' 67' ' ' GLU . 23.0 mp0 -72.26 -41.06 67.17 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.08 -1.013 . . . . 0.0 108.609 178.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.499 HD12 ' N ' ' A' ' 68' ' ' ILE . 1.4 mp -48.31 -30.26 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -70.15 -74.9 0.63 Allowed Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 9.0 ptp -46.38 -33.89 4.21 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.875 -1.368 . . . . 0.0 109.144 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.488 HD22 HD11 ' A' ' 78' ' ' LEU . 12.0 mt -58.04 -28.56 64.6 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.389 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.536 ' N ' ' O ' ' A' ' 69' ' ' GLY . 39.6 tt0 -79.71 5.11 14.22 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.368 -0.833 . . . . 0.0 108.771 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -122.99 31.57 5.98 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.555 -0.716 . . . . 0.0 110.122 -178.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.562 HG21 HD13 ' A' ' 78' ' ' LEU . 16.4 m -92.09 166.77 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 120.797 -1.189 . . . . 0.0 110.006 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.47 ' OG1' ' CG ' ' A' ' 106' ' ' TRP . 4.8 m -99.56 -8.08 25.02 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.806 -0.558 . . . . 0.0 110.249 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.679 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -107.36 169.74 8.39 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.113 -0.992 . . . . 0.0 110.354 -178.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.518 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -60.91 108.52 0.87 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.815 -0.553 . . . . 0.0 109.67 -179.553 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.562 HD13 HG21 ' A' ' 74' ' ' VAL . 8.5 tp -72.93 155.78 39.52 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 120.011 -1.681 . . . . 0.0 110.118 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 25.3 mmtm -117.15 153.54 49.78 Favored Pre-proline 0 C--N 1.292 -1.916 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 -178.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.4 -22.16 70.37 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 C-N-CA 121.173 1.249 . . . . 0.0 109.77 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.431 ' OD1' ' O ' ' A' ' 81' ' ' ASN . 1.1 p30 -111.77 19.66 17.8 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.867 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 21.6 m -58.24 162.69 3.39 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.542 -1.349 . . . . 0.0 109.746 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.563 ' NH2' ' O ' ' A' ' 61' ' ' PRO . 0.7 OUTLIER -171.72 146.28 2.09 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 118.32 -1.352 . . . . 0.0 111.169 179.447 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.444 ' CD1' ' N ' ' A' ' 84' ' ' LEU . 5.3 mp -76.62 116.01 16.9 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -57.51 -16.96 11.25 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.446 -0.784 . . . . 0.0 112.922 -176.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 30.5 p -85.85 -33.16 21.37 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 119.81 -1.806 . . . . 0.0 111.207 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.406 ' OE1' ' CD ' ' A' ' 67' ' ' GLU . 34.2 tt0 -87.53 32.05 0.73 Allowed 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.261 -1.525 . . . . 0.0 110.403 -179.28 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.407 HG22 ' N ' ' A' ' 89' ' ' ILE . 41.3 mm -117.61 157.93 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 O-C-N 121.022 -1.049 . . . . 0.0 108.423 178.266 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.407 ' N ' HG22 ' A' ' 88' ' ' ILE . 35.2 mm -130.5 122.7 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.446 ' SD ' ' CG2' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -86.54 155.84 20.32 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.137 -0.977 . . . . 0.0 108.622 -178.888 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 57.0 p -147.81 148.02 28.98 Favored Pre-proline 0 N--CA 1.492 1.663 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -58.08 -32.71 96.16 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 121.286 1.324 . . . . 0.0 111.018 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -64.82 -28.54 69.63 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.13 -0.981 . . . . 0.0 109.262 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.612 HD22 ' CD2' ' A' ' 56' ' ' PHE . 6.4 mt -99.37 27.59 5.11 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.401 -0.812 . . . . 0.0 109.492 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.402 ' HB2' ' H ' ' A' ' 2' ' ' LYS . 9.2 p-10 -58.9 138.45 57.36 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.876 -1.14 . . . . 0.0 109.361 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 107.22 9.75 29.01 Favored Glycine 0 N--CA 1.501 3.028 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 178.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.446 HG13 HD21 ' A' ' 53' ' ' ASN . 16.4 tt -65.09 130.05 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.842 -1.387 . . . . 0.0 111.113 -178.063 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.8 t -103.5 115.36 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.446 -0.784 . . . . 0.0 109.077 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.5 t -102.65 134.81 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 120.922 -1.112 . . . . 0.0 109.366 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -108.39 124.05 49.78 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.799 0.809 . . . . 0.0 109.661 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.1 t -111.11 124.12 33.58 Favored Pre-proline 0 N--CA 1.495 1.816 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.415 ' HG3' ' CD2' ' A' ' 49' ' ' HIS . 75.6 Cg_endo -83.06 175.53 8.41 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 122.678 2.252 . . . . 0.0 113.37 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -83.5 -17.34 42.25 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -109.74 80.92 1.36 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.447 ' O ' ' OXT' ' A' ' 106' ' ' TRP . 39.5 tt0 -82.95 -33.27 26.77 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.116 -0.99 . . . . 0.0 109.177 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' TRP . . . . . 0.548 ' CG ' ' O ' ' A' ' 106' ' ' TRP . 57.3 t-105 . . . . . 0 C--N 1.301 -1.522 0 CA-C-O 118.294 -0.86 . . . . 0.0 109.788 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 68.0 p . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.414 ' H ' ' HB2' ' A' ' 95' ' ' ASP . 19.1 mmtm -76.96 113.88 15.14 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.98 -1.075 . . . . 0.0 108.534 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.532 HG21 ' CG2' ' A' ' 17' ' ' VAL . 49.5 t -115.0 109.91 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.442 -0.786 . . . . 0.0 110.076 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.6 t -102.64 134.88 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 CA-C-O 121.749 0.785 . . . . 0.0 110.389 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -106.12 114.5 28.68 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 177.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 67.0 t -97.82 115.21 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 27.7 p -77.92 -160.28 0.19 Allowed 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.426 0.631 . . . . 0.0 109.674 -178.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.58 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.2 OUTLIER -87.13 -47.23 9.06 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.563 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.459 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 17.8 p30 -70.52 -2.53 14.36 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.088 -1.007 . . . . 0.0 110.973 -178.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.12 0.0 57.26 Favored Glycine 0 N--CA 1.499 2.863 0 O-C-N 120.854 -1.154 . . . . 0.0 110.953 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -66.31 131.15 45.45 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.628 -1.513 . . . . 0.0 108.847 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.84 156.03 23.61 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.579 0.704 . . . . 0.0 110.979 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.3 mmm-85 -142.76 112.75 7.03 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 177.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.484 ' CD ' ' H ' ' A' ' 14' ' ' GLU . 2.6 mp0 -98.37 127.33 44.26 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.863 -1.148 . . . . 0.0 109.819 -178.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.497 HD22 ' CG ' ' A' ' 30' ' ' ASN . 19.4 mt -117.88 -165.19 1.07 Allowed 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 122.738 1.256 . . . . 0.0 110.0 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -137.13 99.77 4.09 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 104.942 -2.244 . . . . 0.0 104.942 176.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.532 ' CG2' HG21 ' A' ' 3' ' ' VAL . 12.8 t -102.63 115.36 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.33 177.17 4.05 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 122.359 1.076 . . . . 0.0 111.312 -178.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -65.69 133.34 50.88 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.975 0.893 . . . . 0.0 110.709 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.03 -18.4 53.83 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.431 ' HB ' HG12 ' A' ' 17' ' ' VAL . 61.3 t -85.36 138.64 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.585 -1.538 . . . . 0.0 109.175 -178.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.438 ' O ' ' N ' ' A' ' 25' ' ' GLN . 59.9 p -93.38 146.35 23.8 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.266 -0.896 . . . . 0.0 109.458 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.5 mt -48.11 -34.17 9.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.001 -1.062 . . . . 0.0 109.406 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.49 ' O ' ' SD ' ' A' ' 24' ' ' MET . 4.3 tpt -67.55 -29.07 68.35 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.438 ' N ' ' O ' ' A' ' 22' ' ' SER . 14.5 mm100 -73.74 -59.83 2.53 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.104 -0.997 . . . . 0.0 109.637 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.41 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -60.48 -24.42 65.26 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.878 -1.139 . . . . 0.0 111.22 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.4 -24.58 67.9 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.941 -1.099 . . . . 0.0 108.967 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 88.7 t -80.78 -23.52 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 CA-C-O 121.555 0.693 . . . . 0.0 109.148 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.25 -27.54 35.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.4 -0.812 . . . . 0.0 109.28 -179.14 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.497 ' CG ' HD22 ' A' ' 15' ' ' LEU . 7.0 m-80 . . . . . 0 C--N 1.303 -1.449 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 178.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 42.7 p . . . . . 0 N--CA 1.482 1.14 0 CA-C-O 121.159 0.504 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.497 ' SG ' ' O ' ' A' ' 48' ' ' CYS . 15.0 p -91.37 48.11 1.45 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.795 -1.191 . . . . 0.0 109.996 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.703 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 53.8 t60 -77.99 113.14 15.62 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.969 -1.082 . . . . 0.0 109.026 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -146.05 165.12 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.107 -0.996 . . . . 0.0 109.214 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.576 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 52.0 m-85 -114.03 111.57 21.86 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 121.667 0.746 . . . . 0.0 109.788 -178.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.584 HG13 HD11 ' A' ' 97' ' ' ILE . 81.9 t -86.12 135.02 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.578 ' C ' ' H ' ' A' ' 55' ' ' ALA . 3.3 t30 -49.7 128.09 17.22 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.91 -1.119 . . . . 0.0 108.973 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -56.09 12.13 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.592 -0.692 . . . . 0.0 111.566 -178.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.578 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -101.06 -19.62 15.72 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.892 -1.13 . . . . 0.0 109.8 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.559 ' CD2' HD22 ' A' ' 94' ' ' LEU . 46.3 m-85 -110.78 -11.59 14.37 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.767 -1.208 . . . . 0.0 109.596 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.549 HG21 ' OD1' ' A' ' 81' ' ' ASN . 9.5 p -70.59 -38.3 74.03 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.81 -1.181 . . . . 0.0 110.012 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -85.85 9.71 15.93 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.184 -0.948 . . . . 0.0 110.092 -178.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.437 ' CE ' ' O ' ' A' ' 55' ' ' ALA . 9.6 mttm -121.11 -37.93 2.88 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.605 HG22 ' HD2' ' A' ' 61' ' ' PRO . 0.5 OUTLIER -81.84 159.0 67.06 Favored Pre-proline 0 N--CA 1.494 1.748 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.796 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.605 ' HD2' HG22 ' A' ' 60' ' ' VAL . 3.1 Cg_exo -48.7 101.96 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.029 1.819 . . . . 0.0 112.247 -178.036 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.9 101.44 4.41 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.544 ' HB1' ' OE1' ' A' ' 67' ' ' GLU . . . -49.63 144.05 6.44 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-O 121.878 0.847 . . . . 0.0 111.504 -178.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -53.56 -175.17 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.658 0.742 . . . . 0.0 110.121 -179.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -69.5 -1.44 8.62 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.697 -0.627 . . . . 0.0 111.136 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.507 ' O ' ' SD ' ' A' ' 70' ' ' MET . 8.8 mtt85 -63.85 -39.92 95.36 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.769 -1.207 . . . . 0.0 109.439 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.544 ' OE1' ' HB1' ' A' ' 63' ' ' ALA . 10.2 mp0 -78.18 -40.68 37.0 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.174 -0.953 . . . . 0.0 109.868 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.484 HD12 ' N ' ' A' ' 68' ' ' ILE . 1.4 mp -46.72 -25.33 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.49 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -76.66 -67.81 1.62 Allowed Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.066 -1.614 . . . . 0.0 109.066 179.259 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.507 ' SD ' ' O ' ' A' ' 66' ' ' ARG . 4.7 mpp? -49.28 -39.42 30.74 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.054 -1.262 . . . . 0.0 108.599 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.566 ' O ' HD13 ' A' ' 78' ' ' LEU . 6.5 mt -55.2 -21.71 14.86 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.49 ' N ' ' O ' ' A' ' 69' ' ' GLY . 27.0 tt0 -91.08 12.46 19.8 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -124.93 31.04 5.74 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.446 -0.784 . . . . 0.0 110.085 -179.083 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -98.61 175.5 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.287 0 O-C-N 121.375 -0.828 . . . . 0.0 109.215 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.525 ' OG1' ' CD1' ' A' ' 106' ' ' TRP . 4.2 m -109.71 -0.61 18.46 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.342 -0.849 . . . . 0.0 110.026 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.703 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -107.45 167.44 9.93 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.053 -1.029 . . . . 0.0 109.882 -179.092 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.576 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -58.07 106.8 0.4 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.616 -0.677 . . . . 0.0 110.935 -178.767 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.566 HD13 ' O ' ' A' ' 71' ' ' LEU . 7.2 tp -70.29 147.67 49.41 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 120.106 -1.621 . . . . 0.0 109.562 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.1 mmtp -112.78 156.04 43.13 Favored Pre-proline 0 C--N 1.29 -2.003 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -178.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -54.22 -22.14 25.02 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 121.349 1.366 . . . . 0.0 109.862 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.549 ' OD1' HG21 ' A' ' 57' ' ' THR . 0.1 OUTLIER -126.99 37.81 4.21 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.955 -0.465 . . . . 0.0 110.426 -179.887 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.441 ' HG ' ' HE1' ' A' ' 51' ' ' TYR . 37.5 m -60.49 175.46 0.45 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.365 -1.46 . . . . 0.0 108.445 179.096 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.458 ' HE ' HG12 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -166.24 159.86 15.43 Favored 'General case' 0 N--CA 1.504 2.227 0 C-N-CA 118.28 -1.368 . . . . 0.0 111.583 -178.183 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.413 ' C ' ' SG ' ' A' ' 48' ' ' CYS . 50.0 mt -105.75 95.35 5.74 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 178.22 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.489 ' C ' ' H ' ' A' ' 87' ' ' GLN . 0.1 OUTLIER -39.78 -44.34 1.57 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.553 -0.717 . . . . 0.0 112.848 -176.718 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 13.9 p -60.65 5.94 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 119.972 -1.705 . . . . 0.0 110.938 -177.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.489 ' H ' ' C ' ' A' ' 85' ' ' CYS . 20.3 mt-30 -136.02 45.39 2.39 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 120.937 -1.102 . . . . 0.0 111.664 -178.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.458 HG12 ' HE ' ' A' ' 83' ' ' ARG . 3.7 mt -131.77 156.18 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 O-C-N 121.074 -1.016 . . . . 0.0 108.602 177.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 38.3 mm -129.7 126.48 62.9 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.427 0 O-C-N 121.31 -0.869 . . . . 0.0 109.524 -178.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.468 ' SD ' HG21 ' A' ' 97' ' ' ILE . 4.1 tpt -91.05 163.51 14.28 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.106 -0.996 . . . . 0.0 110.38 -179.436 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 70.6 p -151.93 147.24 19.59 Favored Pre-proline 0 N--CA 1.488 1.469 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -56.35 -30.08 79.63 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 121.259 1.306 . . . . 0.0 111.568 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -68.96 -31.21 69.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.105 -0.997 . . . . 0.0 110.334 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.559 HD22 ' CD2' ' A' ' 56' ' ' PHE . 5.7 mt -95.58 32.72 1.75 Allowed 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.209 -0.932 . . . . 0.0 109.488 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.414 ' HB2' ' H ' ' A' ' 2' ' ' LYS . 3.7 p30 -62.45 138.6 58.49 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.71 -1.244 . . . . 0.0 110.159 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 109.86 9.75 24.03 Favored Glycine 0 N--CA 1.504 3.187 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 178.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.685 HD13 ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -65.04 129.89 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 120.996 -1.297 . . . . 0.0 111.555 -177.708 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.685 ' N ' HD13 ' A' ' 97' ' ' ILE . 4.9 t -106.99 118.97 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.2 -0.937 . . . . 0.0 109.393 -179.249 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.1 t -101.84 133.27 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.014 -1.054 . . . . 0.0 109.283 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.68 115.51 30.37 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.273 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 18.0 t -103.73 122.89 43.08 Favored Pre-proline 0 N--CA 1.494 1.736 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.41 ' HG3' ' CD2' ' A' ' 49' ' ' HIS . 89.7 Cg_endo -82.16 177.8 6.9 Favored 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 121.975 1.784 . . . . 0.0 113.111 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -85.75 -13.78 47.26 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.471 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -120.7 86.89 2.65 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -178.086 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -85.05 -28.76 25.45 Favored 'General case' 0 C--N 1.308 -1.207 0 O-C-N 121.115 -0.99 . . . . 0.0 109.312 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' TRP . . . . . 0.525 ' CD1' ' OG1' ' A' ' 75' ' ' THR . 62.5 t-105 . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.611 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.448 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.412 ' H ' ' HB2' ' A' ' 95' ' ' ASP . 0.2 OUTLIER -82.69 110.66 17.95 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.614 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.492 HG21 ' CG2' ' A' ' 17' ' ' VAL . 53.6 t -108.59 108.58 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.268 -0.895 . . . . 0.0 110.058 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 62.9 t -99.11 126.31 52.39 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-O 121.97 0.89 . . . . 0.0 110.278 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -103.45 112.95 26.08 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 177.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 64.7 t -99.63 120.88 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.7 p -82.44 -153.28 0.12 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.238 -0.913 . . . . 0.0 109.319 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.589 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -91.14 -44.35 9.31 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.458 -0.776 . . . . 0.0 109.393 -179.908 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.93 -0.87 3.4 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.217 -0.927 . . . . 0.0 111.317 -178.444 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.5 0.52 69.78 Favored Glycine 0 N--CA 1.498 2.826 0 O-C-N 120.427 -1.421 . . . . 0.0 110.618 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.1 t -72.46 135.7 45.8 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.938 -1.331 . . . . 0.0 108.31 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.29 163.9 12.64 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 122.204 1.002 . . . . 0.0 111.048 -178.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 -151.02 112.77 4.47 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -100.24 127.77 46.45 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-O 122.561 1.172 . . . . 0.0 111.127 -178.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.431 HD21 ' CB ' ' A' ' 30' ' ' ASN . 0.2 OUTLIER -114.63 -174.97 2.58 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-O 122.811 1.291 . . . . 0.0 110.301 -177.954 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.429 ' H ' HD13 ' A' ' 15' ' ' LEU . 18.2 t70 -134.26 100.62 4.74 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 176.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.492 ' CG2' HG21 ' A' ' 3' ' ' VAL . 7.6 t -111.21 115.79 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.15 177.14 3.4 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.884 0.85 . . . . 0.0 111.495 -177.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -66.02 138.55 57.87 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 122.014 0.911 . . . . 0.0 110.325 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.42 -18.11 35.13 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 178.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.485 ' HB ' HG12 ' A' ' 17' ' ' VAL . 51.9 t -83.79 140.68 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 120.704 -1.468 . . . . 0.0 109.326 -178.645 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 51.5 p -93.58 147.69 22.77 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.231 -0.918 . . . . 0.0 109.131 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.405 ' N ' HD23 ' A' ' 23' ' ' LEU . 7.9 mt -50.23 -31.9 15.16 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.193 -0.942 . . . . 0.0 109.477 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.448 ' SD ' ' C ' ' A' ' 24' ' ' MET . 1.4 tmt? -68.64 -29.58 68.1 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 52.5 mm-40 -72.05 -63.76 1.07 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.063 -1.023 . . . . 0.0 109.355 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.439 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -58.35 -25.6 62.16 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.996 -1.065 . . . . 0.0 110.374 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.27 -20.47 59.15 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.974 -1.079 . . . . 0.0 108.981 179.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 84.1 t -86.54 -22.62 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.637 -0.664 . . . . 0.0 109.636 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.74 -26.74 40.66 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.443 -0.786 . . . . 0.0 109.075 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.431 ' CB ' HD21 ' A' ' 15' ' ' LEU . 4.9 m120 . . . . . 0 N--CA 1.484 1.249 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 11.1 m . . . . . 0 N--CA 1.483 1.181 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.525 ' SG ' ' N ' ' A' ' 85' ' ' CYS . 31.9 p -80.11 53.76 1.8 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 120.944 -1.098 . . . . 0.0 109.605 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.621 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 39.3 t60 -77.64 105.61 8.91 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -143.62 164.83 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 120.859 -1.151 . . . . 0.0 109.889 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.512 ' OH ' ' NE2' ' A' ' 49' ' ' HIS . 36.4 m-85 -111.56 111.01 21.71 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.921 0.867 . . . . 0.0 110.101 -179.07 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.789 HG13 HD11 ' A' ' 97' ' ' ILE . 15.2 t -85.9 130.62 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.593 ' C ' ' H ' ' A' ' 55' ' ' ALA . 17.8 t-20 -47.11 126.18 8.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.783 -1.198 . . . . 0.0 109.566 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -57.32 13.99 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.737 -0.602 . . . . 0.0 111.291 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.593 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -100.7 -18.99 16.25 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.729 -1.232 . . . . 0.0 109.781 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.559 ' HB2' HD13 ' A' ' 97' ' ' ILE . 65.7 m-85 -113.85 -10.93 12.92 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.098 -1.001 . . . . 0.0 109.078 -178.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 13.1 p -68.99 -43.18 75.39 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.37 -0.831 . . . . 0.0 109.952 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -81.47 4.64 20.36 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.575 -0.703 . . . . 0.0 109.743 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 21.1 mtpt -113.19 -38.29 4.49 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.643 HG23 HD12 ' A' ' 94' ' ' LEU . 0.5 OUTLIER -82.8 158.57 65.0 Favored Pre-proline 0 N--CA 1.497 1.879 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 179.701 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.556 ' O ' ' NH2' ' A' ' 83' ' ' ARG . 1.1 Cg_endo -51.33 84.93 0.02 OUTLIER 'Trans proline' 0 N--CA 1.501 1.939 0 C-N-CA 122.405 2.07 . . . . 0.0 113.792 -176.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.79 105.17 0.28 Allowed 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -56.86 150.76 15.79 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-O 122.235 1.017 . . . . 0.0 112.667 -178.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.546 ' H ' ' ND2' ' A' ' 64' ' ' ASN . 0.6 OUTLIER -61.61 -172.84 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.032 -179.847 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -71.07 1.9 5.19 Favored 'General case' 0 N--CA 1.503 2.198 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -178.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.2 mtm180 -73.77 -46.74 43.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.386 -1.446 . . . . 0.0 109.087 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.443 ' N ' ' CD ' ' A' ' 67' ' ' GLU . 9.2 mp0 -64.39 -25.14 67.89 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.234 -0.916 . . . . 0.0 109.054 178.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.569 HD12 ' N ' ' A' ' 68' ' ' ILE . 1.4 mp -68.3 -34.74 67.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.032 -1.042 . . . . 0.0 108.839 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.82 -23.8 59.39 Favored Glycine 0 N--CA 1.496 2.672 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.434 ' N ' ' SD ' ' A' ' 70' ' ' MET . 0.9 OUTLIER -88.81 -31.54 18.28 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.911 -1.347 . . . . 0.0 107.571 178.931 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.433 HD22 ' HB3' ' A' ' 82' ' ' SER . 52.8 mt -67.74 -23.04 65.21 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -80.34 0.89 31.04 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -121.91 32.61 5.78 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.605 -0.684 . . . . 0.0 110.254 -178.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.603 HG21 HD13 ' A' ' 78' ' ' LEU . 29.3 m -94.69 167.21 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 O-C-N 121.126 -0.984 . . . . 0.0 110.796 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.4 m -104.24 -4.87 22.47 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.378 -0.826 . . . . 0.0 109.883 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.621 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -107.88 170.85 7.74 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.014 -1.053 . . . . 0.0 110.749 -178.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.504 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -61.54 107.67 0.84 Allowed 'General case' 0 N--CA 1.5 2.037 0 CA-C-O 121.532 0.682 . . . . 0.0 110.034 -179.716 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.603 HD13 HG21 ' A' ' 74' ' ' VAL . 8.6 tp -69.6 159.88 32.57 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 119.606 -1.934 . . . . 0.0 110.303 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.404 ' H ' ' HG ' ' A' ' 78' ' ' LEU . 18.7 mmtp -123.27 154.26 65.36 Favored Pre-proline 0 C--N 1.297 -1.715 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 -178.482 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -58.07 -23.6 61.72 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 121.537 1.491 . . . . 0.0 110.014 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 52' ' ' VAL . 1.5 p30 -117.07 27.72 8.95 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.99 -0.444 . . . . 0.0 109.837 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.433 ' HB3' HD22 ' A' ' 71' ' ' LEU . 5.0 m -58.48 166.68 1.67 Allowed 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.373 -1.455 . . . . 0.0 109.452 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.612 HH12 HG12 ' A' ' 60' ' ' VAL . 0.5 OUTLIER -172.32 153.43 2.98 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.122 -1.031 . . . . 0.0 111.267 179.549 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.802 ' H ' HD12 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -83.34 129.04 34.97 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 177.887 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.525 ' N ' ' SG ' ' A' ' 48' ' ' CYS . 0.5 OUTLIER -75.2 -6.11 47.96 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.718 -1.239 . . . . 0.0 112.584 -176.601 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 27.7 p -89.41 -33.65 16.77 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.281 -1.512 . . . . 0.0 110.722 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -92.33 49.54 1.52 Allowed 'General case' 0 N--CA 1.504 2.226 0 O-C-N 120.979 -1.076 . . . . 0.0 110.467 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 30.6 mt -130.56 154.26 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 36.5 mm -129.19 127.79 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.348 0 O-C-N 121.249 -0.907 . . . . 0.0 109.7 -178.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.907 ' SD ' HG21 ' A' ' 97' ' ' ILE . 8.1 tpt -89.02 161.17 16.73 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.908 -1.12 . . . . 0.0 110.099 -179.311 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.6 p -151.19 149.53 24.98 Favored Pre-proline 0 N--CA 1.491 1.62 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.6 -39.51 82.16 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 121.626 1.55 . . . . 0.0 111.754 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -64.16 -24.93 67.86 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.143 -0.973 . . . . 0.0 108.842 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.643 HD12 HG23 ' A' ' 60' ' ' VAL . 14.1 mt -99.52 23.99 8.74 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.434 -0.792 . . . . 0.0 109.577 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.442 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 18.7 p-10 -65.88 140.87 58.39 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.169 -0.957 . . . . 0.0 109.621 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 106.69 7.73 33.54 Favored Glycine 0 N--CA 1.506 3.338 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 178.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.907 HG21 ' SD ' ' A' ' 90' ' ' MET . 0.3 OUTLIER -61.71 127.65 21.89 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 O-C-N 121.707 -0.878 . . . . 0.0 110.346 -178.265 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.3 t -103.74 115.38 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.244 -0.91 . . . . 0.0 109.728 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.5 t -101.65 134.37 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.926 -1.109 . . . . 0.0 109.851 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.49 123.63 49.18 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 121.884 0.85 . . . . 0.0 108.722 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.3 t -112.97 126.37 28.35 Favored Pre-proline 0 N--CA 1.497 1.919 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.415 ' HG3' ' CD2' ' A' ' 49' ' ' HIS . 58.1 Cg_endo -84.52 178.07 5.27 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.797 2.331 . . . . 0.0 113.031 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.424 ' OD2' ' CD2' ' A' ' 8' ' ' HIS . 1.0 OUTLIER -84.2 -17.99 38.08 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.57 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -107.68 83.15 1.76 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.622 ' CD ' ' H ' ' A' ' 105' ' ' GLN . 0.3 OUTLIER -84.69 -31.66 24.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.911 -1.118 . . . . 0.0 108.887 -179.636 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 106' ' ' TRP . . . . . 0.405 ' OXT' ' O ' ' A' ' 105' ' ' GLN . 57.4 t-105 . . . . . 0 C--N 1.3 -1.568 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.145 178.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.432 ' OG ' ' O ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.412 ' H ' ' HB2' ' A' ' 95' ' ' ASP . 27.2 mmtt -76.19 107.14 8.21 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.403 -0.919 . . . . 0.0 108.718 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.401 HG22 ' CG2' ' A' ' 97' ' ' ILE . 11.7 t -107.09 109.97 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 O-C-N 121.176 -0.952 . . . . 0.0 109.201 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.9 t -98.82 94.19 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.039 -1.038 . . . . 0.0 110.59 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -68.06 114.65 6.76 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 71.5 t -98.75 112.07 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.115 -0.99 . . . . 0.0 108.434 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 63.6 p -72.7 -160.08 0.07 Allowed 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.554 0.692 . . . . 0.0 109.517 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.602 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -88.9 -50.93 5.9 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.183 -0.948 . . . . 0.0 108.625 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.504 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 10.1 p30 -64.94 2.71 0.67 Allowed 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 119.804 -0.759 . . . . 0.0 110.442 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.522 ' O ' ' NH1' ' A' ' 12' ' ' ARG . . . 93.83 -3.09 70.39 Favored Glycine 0 N--CA 1.496 2.693 0 O-C-N 120.731 -1.23 . . . . 0.0 110.08 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.09 128.04 34.22 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.932 -1.334 . . . . 0.0 108.438 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.522 ' NH1' ' O ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -108.63 159.54 16.65 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.51 -0.744 . . . . 0.0 111.197 -178.782 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.2 mtt85 -150.08 115.72 5.54 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 178.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -97.82 126.93 43.44 Favored 'General case' 0 N--CA 1.502 2.158 0 CA-C-O 122.633 1.206 . . . . 0.0 110.607 -178.185 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.585 HD13 ' H ' ' A' ' 16' ' ' ASP . 0.2 OUTLIER -111.9 -175.43 2.69 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 123.132 1.444 . . . . 0.0 111.589 -177.723 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.585 ' H ' HD13 ' A' ' 15' ' ' LEU . 11.1 t70 -137.06 101.57 4.59 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 104.548 -2.39 . . . . 0.0 104.548 176.356 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.48 HG12 ' HB ' ' A' ' 21' ' ' VAL . 11.8 t -109.67 119.03 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.56 176.33 4.18 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.188 -0.945 . . . . 0.0 111.141 -177.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -65.64 137.08 57.09 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.953 0.882 . . . . 0.0 110.691 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.92 -17.07 23.99 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 178.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.48 ' HB ' HG12 ' A' ' 17' ' ' VAL . 60.8 t -77.64 139.8 18.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 O-C-N 120.428 -1.631 . . . . 0.0 108.479 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 25' ' ' GLN . 59.5 p -94.16 143.7 26.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.105 -0.997 . . . . 0.0 109.093 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.529 HD21 ' SD ' ' A' ' 90' ' ' MET . 49.6 mt -45.45 -37.14 4.9 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.08 -1.013 . . . . 0.0 109.766 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.492 ' O ' ' SD ' ' A' ' 24' ' ' MET . 5.6 tpt -65.62 -26.43 67.82 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.388 -0.82 . . . . 0.0 109.355 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' A' ' 22' ' ' SER . 13.8 mm100 -75.31 -63.23 1.32 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.183 -0.948 . . . . 0.0 109.702 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.605 ' O ' ' ND2' ' A' ' 30' ' ' ASN . . . -59.94 -26.49 66.02 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.657 -1.277 . . . . 0.0 110.906 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.44 -20.39 66.14 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.585 -1.322 . . . . 0.0 109.011 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 70.6 t -86.51 -25.69 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.438 -0.789 . . . . 0.0 109.587 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.96 -24.55 60.81 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.362 -0.836 . . . . 0.0 109.042 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.605 ' ND2' ' O ' ' A' ' 26' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.303 -1.435 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 179.261 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.439 ' O ' ' OE1' ' A' ' 105' ' ' GLN . 3.1 m . . . . . 0 N--CA 1.483 1.181 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.592 ' SG ' ' N ' ' A' ' 85' ' ' CYS . 18.3 p -97.7 54.18 1.15 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.867 -1.146 . . . . 0.0 109.744 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.794 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 43.3 t60 -75.89 110.43 10.33 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.114 -0.991 . . . . 0.0 109.113 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -146.52 166.94 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 120.813 -1.179 . . . . 0.0 109.582 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.583 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 37.4 m-85 -115.85 115.38 26.15 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.857 0.837 . . . . 0.0 109.815 -179.139 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.847 HG13 HD11 ' A' ' 97' ' ' ILE . 13.3 t -89.46 129.48 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.561 ' C ' ' H ' ' A' ' 55' ' ' ALA . 19.0 t-20 -46.15 131.01 10.32 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.107 -0.996 . . . . 0.0 109.753 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.412 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 9.7 pt-20 -57.01 8.16 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.395 -0.816 . . . . 0.0 111.025 -179.054 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.561 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -95.96 -23.13 16.99 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.636 -1.29 . . . . 0.0 110.113 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -111.25 -6.71 14.5 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.901 -1.124 . . . . 0.0 108.894 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.431 HG21 ' OD1' ' A' ' 81' ' ' ASN . 25.3 p -70.87 -42.14 70.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.643 -0.661 . . . . 0.0 109.806 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -82.8 0.93 41.57 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.59 -0.694 . . . . 0.0 109.894 -179.008 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 15.7 mttt -109.99 -38.72 5.25 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.603 HG23 HD12 ' A' ' 94' ' ' LEU . 0.5 OUTLIER -84.73 158.19 59.83 Favored Pre-proline 0 N--CA 1.496 1.835 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 179.534 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.558 ' HD2' HG22 ' A' ' 60' ' ' VAL . 1.3 Cg_endo -54.49 110.97 0.59 Allowed 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 121.714 1.609 . . . . 0.0 113.698 -177.24 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.37 112.8 12.06 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.208 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.935 ' H ' ' NH1' ' A' ' 83' ' ' ARG . . . -53.81 144.33 18.68 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-O 122.286 1.041 . . . . 0.0 112.073 -178.305 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.49 ' H ' ' ND2' ' A' ' 64' ' ' ASN . 1.3 p30 -66.37 -167.73 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.678 0.751 . . . . 0.0 110.636 -179.265 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -69.47 -6.67 32.0 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.667 -0.646 . . . . 0.0 112.127 -178.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.508 ' O ' ' SD ' ' A' ' 70' ' ' MET . 69.3 mtm-85 -65.03 -44.61 88.55 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 120.424 -1.422 . . . . 0.0 109.405 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -74.27 -39.53 62.93 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.153 -0.967 . . . . 0.0 109.35 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 39.5 mt -48.02 -25.33 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.335 -0.853 . . . . 0.0 109.574 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -82.29 -40.64 9.93 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.508 ' SD ' ' O ' ' A' ' 66' ' ' ARG . 4.3 mpp? -72.05 -34.59 68.88 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 178.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 71' ' ' LEU . 46.1 mt -63.99 -27.75 69.34 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -79.14 2.79 19.64 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.042 -1.037 . . . . 0.0 108.472 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -120.86 28.14 8.09 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.74 -0.6 . . . . 0.0 110.713 -178.306 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.9 m -95.96 169.53 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 O-C-N 120.844 -1.16 . . . . 0.0 109.975 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.476 ' OG1' ' CD2' ' A' ' 106' ' ' TRP . 3.7 m -106.29 -6.78 18.14 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.435 -0.79 . . . . 0.0 111.957 -178.426 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.794 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -106.16 174.7 5.77 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 120.56 -1.338 . . . . 0.0 110.572 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.583 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -56.1 104.39 0.14 Allowed 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.833 -0.542 . . . . 0.0 111.26 -178.516 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.4 tp -69.98 149.44 47.73 Favored 'General case' 0 C--N 1.295 -1.794 0 O-C-N 120.186 -1.572 . . . . 0.0 109.366 178.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.451 ' NZ ' ' OE2' ' A' ' 77' ' ' GLU . 27.2 mmtm -115.31 156.57 45.51 Favored Pre-proline 0 C--N 1.287 -2.133 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -178.487 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -56.97 -21.51 41.8 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 121.358 1.372 . . . . 0.0 109.629 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.431 ' OD1' HG21 ' A' ' 57' ' ' THR . 5.1 p30 -120.33 28.1 8.22 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.422 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.413 ' HG ' ' HE1' ' A' ' 51' ' ' TYR . 37.2 m -57.6 158.38 6.07 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 120.07 -1.644 . . . . 0.0 108.885 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.935 ' NH1' ' H ' ' A' ' 63' ' ' ALA . 1.6 mtp85 -169.47 159.6 8.65 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 118.763 -1.175 . . . . 0.0 111.042 -178.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.761 HD22 ' N ' ' A' ' 84' ' ' LEU . 2.7 mm? -84.21 123.83 30.53 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 179.027 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.592 ' N ' ' SG ' ' A' ' 48' ' ' CYS . 0.5 OUTLIER -64.11 -16.48 61.91 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.197 -0.94 . . . . 0.0 113.145 -176.556 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 22.2 p -81.65 -43.46 18.51 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 119.708 -1.87 . . . . 0.0 110.955 -178.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.648 ' NE2' ' HB2' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -75.61 29.57 0.1 Allowed 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.972 -1.08 . . . . 0.0 111.169 -179.108 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.658 ' O ' HD12 ' A' ' 89' ' ' ILE . 38.4 mt -116.03 151.42 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.295 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 178.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.658 HD12 ' O ' ' A' ' 88' ' ' ILE . 1.5 mp -131.44 125.52 56.71 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.235 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -178.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.529 ' SD ' HD21 ' A' ' 23' ' ' LEU . 1.9 tpt -87.49 161.8 17.6 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.089 -1.007 . . . . 0.0 109.571 -179.226 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.6 p -152.08 149.32 23.08 Favored Pre-proline 0 N--CA 1.489 1.484 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -54.56 -39.29 89.06 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 121.74 1.626 . . . . 0.0 111.643 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -64.03 -24.21 67.62 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.169 -0.957 . . . . 0.0 109.49 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.603 HD12 HG23 ' A' ' 60' ' ' VAL . 13.9 mt -101.73 18.88 19.3 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.449 -0.782 . . . . 0.0 109.434 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.412 ' HB2' ' H ' ' A' ' 2' ' ' LYS . 20.4 p-10 -61.44 139.53 58.2 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.407 -0.808 . . . . 0.0 109.946 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 105.55 8.21 35.53 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 178.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.847 HD11 HG13 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -65.75 138.39 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.207 -1.172 . . . . 0.0 111.878 -177.764 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.5 t -106.48 117.81 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.665 -0.647 . . . . 0.0 109.328 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.8 t -102.74 136.91 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 120.761 -1.212 . . . . 0.0 108.568 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -108.16 114.75 28.88 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.76 0.791 . . . . 0.0 108.88 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.4 t -102.47 124.77 38.18 Favored Pre-proline 0 N--CA 1.495 1.813 0 O-C-N 121.883 -0.511 . . . . 0.0 109.78 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.436 ' HG3' ' CD2' ' A' ' 49' ' ' HIS . 92.6 Cg_endo -81.71 169.61 14.98 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 122.515 2.143 . . . . 0.0 113.88 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -75.61 -15.47 60.34 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.187 0.517 . . . . 0.0 109.649 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 27.4 mtm180 -122.31 93.38 3.96 Favored 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.439 ' OE1' ' O ' ' A' ' 47' ' ' THR . 35.5 tt0 -82.26 -16.96 47.66 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.651 -0.656 . . . . 0.0 109.826 -178.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' TRP . . . . . 0.476 ' CD2' ' OG1' ' A' ' 75' ' ' THR . 61.3 t-105 . . . . . 0 C--N 1.304 -1.397 0 CA-C-O 117.948 -1.025 . . . . 0.0 110.45 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.405 ' H ' ' HB2' ' A' ' 95' ' ' ASP . 16.8 mmtm -77.27 117.12 18.48 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.568 HG21 ' CG2' ' A' ' 17' ' ' VAL . 72.5 t -115.78 109.61 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.334 -0.854 . . . . 0.0 111.048 -178.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 33.6 t -98.9 93.17 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 CA-C-O 122.209 1.004 . . . . 0.0 111.178 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.411 ' CE1' HG12 ' A' ' 3' ' ' VAL . 96.1 m-85 -67.8 113.71 5.77 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 177.297 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 99.7 t -99.0 116.7 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 120.991 -1.068 . . . . 0.0 108.939 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 79.3 p -75.38 -157.71 0.07 Allowed 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.632 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -92.13 -48.51 6.68 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.217 -0.927 . . . . 0.0 109.105 -179.672 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.487 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 8.5 p30 -65.39 1.75 1.05 Allowed 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.323 -0.861 . . . . 0.0 110.7 -178.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.96 -3.45 67.19 Favored Glycine 0 N--CA 1.495 2.606 0 O-C-N 120.717 -1.239 . . . . 0.0 110.262 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -65.6 129.05 38.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.779 -1.424 . . . . 0.0 108.25 179.313 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 29.8 mtm180 -108.25 145.19 34.67 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.879 -0.513 . . . . 0.0 110.986 -178.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.16 114.85 16.22 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 178.335 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -98.6 122.97 42.49 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.51 -0.744 . . . . 0.0 110.237 -178.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.537 HD22 ' ND2' ' A' ' 30' ' ' ASN . 30.4 mt -120.28 -166.04 1.26 Allowed 'General case' 0 N--CA 1.502 2.13 0 CA-C-O 122.746 1.26 . . . . 0.0 109.729 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -134.41 99.81 4.48 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 104.623 -2.362 . . . . 0.0 104.623 176.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.568 ' CG2' HG21 ' A' ' 3' ' ' VAL . 10.6 t -101.4 117.8 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.276 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.24 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.07 178.03 5.97 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 122.366 1.079 . . . . 0.0 112.116 -177.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -64.65 130.38 43.38 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-O 121.981 0.896 . . . . 0.0 111.117 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.74 -17.05 54.96 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 178.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.432 ' HB ' HG12 ' A' ' 17' ' ' VAL . 64.8 t -78.82 134.54 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 120.503 -1.586 . . . . 0.0 108.805 -179.092 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 25' ' ' GLN . 4.2 p -80.59 139.77 36.11 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.027 -1.046 . . . . 0.0 108.847 179.082 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 31.5 mt -45.06 -33.03 1.94 Allowed 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.013 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 9.7 ttt -77.61 -33.07 53.84 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.426 -0.796 . . . . 0.0 109.217 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.419 ' N ' ' O ' ' A' ' 22' ' ' SER . 39.6 mm-40 -59.34 -56.62 19.73 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.457 -0.897 . . . . 0.0 108.796 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.418 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -58.2 -26.55 62.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.829 -1.169 . . . . 0.0 110.512 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.74 -21.59 55.69 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.93 -1.106 . . . . 0.0 108.802 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 54.7 t -86.58 -23.47 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.49 -0.756 . . . . 0.0 109.819 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.81 -29.79 58.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.281 -0.887 . . . . 0.0 108.728 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.537 ' ND2' HD22 ' A' ' 15' ' ' LEU . 6.6 m120 . . . . . 0 C--N 1.303 -1.448 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 24.8 m . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.498 ' SG ' ' O ' ' A' ' 48' ' ' CYS . 14.1 p -90.77 47.96 1.48 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.862 -1.149 . . . . 0.0 109.533 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.775 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 24.5 t60 -76.21 99.64 4.79 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.663 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -133.62 170.7 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.15 -0.969 . . . . 0.0 110.254 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.567 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 36.9 m-85 -116.46 113.3 22.64 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 122.056 0.932 . . . . 0.0 110.057 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.617 HG13 HD11 ' A' ' 97' ' ' ILE . 5.7 t -86.87 129.15 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.59 ' C ' ' H ' ' A' ' 55' ' ' ALA . 16.2 t-20 -46.62 127.35 9.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.034 -1.042 . . . . 0.0 109.662 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -55.76 10.08 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.611 -0.681 . . . . 0.0 111.487 -178.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.59 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -98.65 -19.95 17.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.807 -1.183 . . . . 0.0 109.829 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.711 ' CD2' HD22 ' A' ' 94' ' ' LEU . 39.1 m-85 -113.85 -6.94 13.22 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.919 -1.113 . . . . 0.0 108.574 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.548 ' CA ' HH12 ' A' ' 83' ' ' ARG . 22.5 p -69.76 -43.7 71.68 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.654 0.74 . . . . 0.0 110.138 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -83.5 14.05 4.03 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.964 -0.694 . . . . 0.0 109.228 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.2 mtpt -124.76 -38.74 2.34 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.574 HG22 ' HD2' ' A' ' 61' ' ' PRO . 0.4 OUTLIER -85.8 164.7 38.51 Favored Pre-proline 0 N--CA 1.5 2.06 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 179.148 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.574 ' HD2' HG22 ' A' ' 60' ' ' VAL . 7.8 Cg_endo -59.56 105.0 0.24 Allowed 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 121.208 1.272 . . . . 0.0 114.001 -176.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.498 ' HA ' ' NH2' ' A' ' 83' ' ' ARG . . . -74.43 104.65 5.24 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 177.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -47.09 140.66 4.86 Favored 'General case' 0 C--N 1.287 -2.149 0 CA-C-O 122.061 0.934 . . . . 0.0 111.437 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.473 ' N ' ' OD1' ' A' ' 64' ' ' ASN . 2.6 p30 -58.62 -169.81 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.404 0.621 . . . . 0.0 110.486 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -65.31 0.35 1.47 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.292 -0.88 . . . . 0.0 111.197 -178.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.506 ' O ' ' SD ' ' A' ' 70' ' ' MET . 0.3 OUTLIER -69.44 -45.01 70.14 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.681 -1.262 . . . . 0.0 108.843 -179.913 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.446 ' O ' ' N ' ' A' ' 69' ' ' GLY . 2.5 tt0 -73.82 -49.11 26.75 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.389 -0.819 . . . . 0.0 110.107 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.509 HD12 ' N ' ' A' ' 68' ' ' ILE . 1.4 mp -45.43 -19.76 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.395 -0.816 . . . . 0.0 109.508 -179.103 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.543 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -81.12 -73.39 1.19 Allowed Glycine 0 N--CA 1.497 2.748 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.506 ' SD ' ' O ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -47.38 -39.18 14.65 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.013 -1.286 . . . . 0.0 108.402 179.576 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.488 ' C ' ' H ' ' A' ' 73' ' ' CYS . 24.0 mt -57.14 -34.02 67.99 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 177.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.543 ' N ' ' O ' ' A' ' 69' ' ' GLY . 6.6 tp10 -73.77 12.28 0.69 Allowed 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.106 -0.996 . . . . 0.0 108.331 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.488 ' H ' ' C ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -133.07 36.14 3.48 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.524 -0.735 . . . . 0.0 110.19 -178.463 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.7 m -97.76 174.5 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.363 0 O-C-N 120.951 -1.093 . . . . 0.0 109.741 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.531 ' OG1' ' CG ' ' A' ' 106' ' ' TRP . 5.5 m -104.4 -9.32 18.54 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.016 -1.053 . . . . 0.0 111.295 -179.008 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.775 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -106.55 170.09 8.14 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.764 -1.21 . . . . 0.0 110.315 -179.445 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.567 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -53.45 105.28 0.12 Allowed 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.841 -0.537 . . . . 0.0 111.126 -179.083 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.0 tp -74.0 140.5 45.52 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 120.084 -1.635 . . . . 0.0 108.857 178.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.8 mmtp -102.07 157.21 34.13 Favored Pre-proline 0 C--N 1.289 -2.065 0 CA-C-N 114.876 -1.056 . . . . 0.0 108.588 -178.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -58.9 -19.3 46.78 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 121.631 1.554 . . . . 0.0 109.095 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.413 ' OD1' ' O ' ' A' ' 81' ' ' ASN . 2.7 p30 -121.99 27.68 7.94 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.076 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.425 ' HG ' ' HE1' ' A' ' 51' ' ' TYR . 44.3 m -58.42 169.18 0.93 Allowed 'General case' 0 C--N 1.307 -1.274 0 O-C-N 120.287 -1.508 . . . . 0.0 108.74 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.548 HH12 ' CA ' ' A' ' 57' ' ' THR . 0.7 OUTLIER -171.9 150.6 2.62 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 118.621 -1.231 . . . . 0.0 110.985 -179.477 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.441 ' C ' ' SG ' ' A' ' 48' ' ' CYS . 82.5 mt -88.83 96.27 10.62 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.45 ' N ' ' SG ' ' A' ' 48' ' ' CYS . 0.1 OUTLIER -34.19 -42.03 0.12 Allowed 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -177.431 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 28.5 p -64.58 -28.48 69.66 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 119.932 -1.73 . . . . 0.0 111.392 -178.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 12.7 tp60 -91.56 35.83 0.95 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.98 -1.075 . . . . 0.0 110.703 -179.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.7 ' O ' HD12 ' A' ' 89' ' ' ILE . 39.7 mm -130.14 161.19 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.308 0 O-C-N 121.282 -0.886 . . . . 0.0 109.192 179.011 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.7 HD12 ' O ' ' A' ' 88' ' ' ILE . 1.4 mp -133.87 128.59 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.32 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.508 ' SD ' HG21 ' A' ' 97' ' ' ILE . 4.9 tpt -90.54 164.21 14.32 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.311 -0.868 . . . . 0.0 109.347 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 38.4 p -148.89 145.63 20.08 Favored Pre-proline 0 C--N 1.3 -1.553 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.85 -37.86 91.57 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 121.278 1.319 . . . . 0.0 111.295 -178.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -59.37 -29.51 67.75 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.111 -0.993 . . . . 0.0 109.147 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.711 HD22 ' CD2' ' A' ' 56' ' ' PHE . 6.2 mt -93.75 35.96 1.12 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.555 -0.716 . . . . 0.0 109.819 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.405 ' HB2' ' H ' ' A' ' 2' ' ' LYS . 16.8 p-10 -65.49 136.29 56.24 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.684 -1.26 . . . . 0.0 110.319 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 111.94 8.52 22.04 Favored Glycine 0 N--CA 1.506 3.362 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 178.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.617 HD11 HG13 ' A' ' 52' ' ' VAL . 0.1 OUTLIER -66.24 124.66 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.583 -0.951 . . . . 0.0 110.378 -178.043 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.503 ' N ' HD12 ' A' ' 97' ' ' ILE . 6.5 t -104.72 116.06 47.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.162 -0.961 . . . . 0.0 109.967 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 t -100.08 135.17 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 120.756 -1.215 . . . . 0.0 109.458 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.68 122.82 48.32 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.494 -0.754 . . . . 0.0 109.169 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 5.3 t -113.32 128.29 25.84 Favored Pre-proline 0 N--CA 1.499 2.014 0 O-C-N 121.643 -0.661 . . . . 0.0 109.802 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.437 ' HG3' ' CD2' ' A' ' 49' ' ' HIS . 95.4 Cg_endo -81.42 174.03 10.98 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 122.417 2.078 . . . . 0.0 113.81 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 103' ' ' ASP . 1.6 p-10 -80.47 -12.63 59.52 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-O 121.683 0.754 . . . . 0.0 108.991 178.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.53 86.86 2.65 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 -177.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.441 ' O ' ' O ' ' A' ' 106' ' ' TRP . 12.8 pt20 -81.69 -32.38 31.75 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' TRP . . . . . 0.533 ' OXT' ' CG ' ' A' ' 106' ' ' TRP . 61.9 t-105 . . . . . 0 C--N 1.301 -1.506 0 CA-C-O 118.354 -0.832 . . . . 0.0 110.063 178.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.433 ' CB ' ' SD ' ' A' ' 90' ' ' MET . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.39 117.64 32.07 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.446 -0.784 . . . . 0.0 109.278 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.438 HG21 ' CG2' ' A' ' 17' ' ' VAL . 27.2 t -115.91 109.75 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.301 -0.874 . . . . 0.0 109.691 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.2 t -99.77 130.07 49.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.162 -0.961 . . . . 0.0 110.188 178.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -103.59 116.63 32.72 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 78.8 t -98.71 115.69 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 30.9 p -75.56 -161.48 0.16 Allowed 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 121.584 0.707 . . . . 0.0 109.641 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.59 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.1 OUTLIER -86.88 -47.62 8.86 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.652 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.491 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 17.3 p30 -71.06 1.97 5.07 Favored 'General case' 0 C--N 1.307 -1.249 0 O-C-N 121.148 -0.97 . . . . 0.0 110.928 -178.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.71 1.85 60.05 Favored Glycine 0 N--CA 1.498 2.773 0 O-C-N 120.852 -1.155 . . . . 0.0 110.868 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -67.87 127.37 32.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.809 -1.406 . . . . 0.0 108.913 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.403 ' HD2' HH11 ' A' ' 12' ' ' ARG . 1.5 mtt180 -105.03 157.07 17.49 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.597 -0.689 . . . . 0.0 110.059 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.52 116.04 5.47 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -99.67 124.24 44.71 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 122.626 1.203 . . . . 0.0 111.341 -178.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.491 HD13 ' H ' ' A' ' 16' ' ' ASP . 0.2 OUTLIER -110.05 -176.51 3.01 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-O 122.99 1.376 . . . . 0.0 110.875 -178.843 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.491 ' H ' HD13 ' A' ' 15' ' ' LEU . 24.8 t0 -134.67 100.38 4.61 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 105.181 -2.155 . . . . 0.0 105.181 176.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.565 HG12 ' HB ' ' A' ' 21' ' ' VAL . 3.4 t -108.71 115.3 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.339 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.81 174.91 3.94 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.312 -0.868 . . . . 0.0 111.609 -177.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.03 137.5 57.75 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.952 0.882 . . . . 0.0 110.91 -178.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.62 -13.93 53.73 Favored Glycine 0 N--CA 1.493 2.435 0 C-N-CA 120.519 -0.848 . . . . 0.0 111.182 178.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.565 ' HB ' HG12 ' A' ' 17' ' ' VAL . 94.8 t -80.82 142.25 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.344 -1.68 . . . . 0.0 109.455 -178.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.427 ' OG ' ' OE1' ' A' ' 25' ' ' GLN . 1.2 p -87.82 142.6 27.69 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.559 -0.856 . . . . 0.0 109.176 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -46.95 -40.85 15.1 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 121.247 -0.908 . . . . 0.0 109.507 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 5.8 tpt -65.36 -35.63 81.55 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.046 -1.034 . . . . 0.0 109.531 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.443 ' NE2' ' N ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -60.74 -61.17 2.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.052 -1.03 . . . . 0.0 109.075 -179.421 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.503 ' HB2' HG13 ' A' ' 17' ' ' VAL . . . -59.55 -27.55 66.32 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.569 -1.332 . . . . 0.0 110.522 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.99 -20.85 66.2 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.741 -1.225 . . . . 0.0 108.57 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 69.8 t -87.03 -27.79 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.613 -0.679 . . . . 0.0 109.654 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.52 -23.56 61.03 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.443 ' CG ' HD21 ' A' ' 15' ' ' LEU . 4.5 m120 . . . . . 0 C--N 1.302 -1.477 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 32.2 p . . . . . 0 N--CA 1.482 1.174 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.497 ' SG ' ' O ' ' A' ' 48' ' ' CYS . 21.9 p -79.68 57.0 2.37 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.928 -1.108 . . . . 0.0 110.217 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.581 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 38.0 t60 -76.59 106.05 8.01 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.119 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -139.25 165.43 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 120.617 -1.302 . . . . 0.0 109.74 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.537 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 40.7 m-85 -111.97 112.23 23.73 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 122.149 0.976 . . . . 0.0 109.792 -179.229 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.426 ' O ' ' OD1' ' A' ' 81' ' ' ASN . 96.8 t -85.58 135.25 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.721 ' ND2' ' HB3' ' A' ' 55' ' ' ALA . 1.7 t30 -49.28 123.22 7.07 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.947 -1.095 . . . . 0.0 108.147 179.454 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -54.16 11.57 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.818 -0.551 . . . . 0.0 112.178 -177.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.721 ' HB3' ' ND2' ' A' ' 53' ' ' ASN . . . -100.71 -15.57 17.66 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.999 -1.063 . . . . 0.0 109.817 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.517 ' CD2' HD22 ' A' ' 94' ' ' LEU . 51.9 m-85 -115.26 -10.43 12.09 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.774 -1.204 . . . . 0.0 109.078 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 12.5 p -71.45 -41.62 69.22 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.876 -1.14 . . . . 0.0 109.912 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -86.91 14.46 7.27 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.438 -0.789 . . . . 0.0 109.898 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.479 ' CD ' ' O ' ' A' ' 55' ' ' ALA . 9.6 mtpt -125.46 -39.73 2.16 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.705 HG22 ' HD2' ' A' ' 61' ' ' PRO . 0.4 OUTLIER -78.34 167.28 36.78 Favored Pre-proline 0 N--CA 1.494 1.759 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 179.052 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.705 ' HD2' HG22 ' A' ' 60' ' ' VAL . 1.4 Cg_endo -55.57 105.38 0.15 Allowed 'Trans proline' 0 N--CA 1.489 1.237 0 CA-C-N 120.206 1.109 . . . . 0.0 113.181 -176.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.39 102.38 2.62 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.495 ' HB1' ' CD ' ' A' ' 67' ' ' GLU . . . -53.71 146.41 13.54 Favored 'General case' 0 C--N 1.29 -1.991 0 O-C-N 121.207 -0.933 . . . . 0.0 111.29 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -61.81 -171.3 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.732 -0.605 . . . . 0.0 110.756 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -69.41 1.49 3.87 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.189 -0.944 . . . . 0.0 112.147 -178.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -64.63 -40.46 95.5 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.525 -1.359 . . . . 0.0 108.736 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.519 ' N ' ' CD ' ' A' ' 67' ' ' GLU . 27.8 mp0 -79.36 -47.24 16.11 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.655 -0.653 . . . . 0.0 110.133 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.4 ' H ' HG13 ' A' ' 68' ' ' ILE . 36.3 mt -44.62 -22.67 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.136 -0.977 . . . . 0.0 110.041 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 67' ' ' GLU . . . -86.03 -28.85 27.3 Favored Glycine 0 N--CA 1.498 2.777 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.46 ' N ' ' O ' ' A' ' 67' ' ' GLU . 30.0 mtt -77.33 -34.18 55.37 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.571 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.47 HD22 ' HB3' ' A' ' 82' ' ' SER . 33.1 mt -65.62 -22.17 66.64 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.61 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -85.34 18.85 2.49 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 178.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -133.85 24.47 3.96 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.732 -0.605 . . . . 0.0 110.295 -178.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 17.0 m -97.48 171.9 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 120.772 -1.205 . . . . 0.0 110.58 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.8 m -105.47 -1.78 24.5 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.383 -0.823 . . . . 0.0 110.28 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.581 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -107.48 170.94 7.67 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 120.965 -1.084 . . . . 0.0 110.589 -178.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.537 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -62.87 111.61 2.21 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.474 -0.766 . . . . 0.0 109.845 -179.281 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.458 HD21 ' HB3' ' A' ' 71' ' ' LEU . 8.4 tp -70.92 160.11 33.44 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 120.031 -1.668 . . . . 0.0 110.312 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.2 mmtm -125.12 152.55 70.85 Favored Pre-proline 0 C--N 1.296 -1.748 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -178.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -56.53 -22.45 43.02 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 121.217 1.278 . . . . 0.0 109.771 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.433 ' OD1' ' O ' ' A' ' 81' ' ' ASN . 1.4 p30 -120.21 28.54 7.99 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.888 -0.508 . . . . 0.0 109.862 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.47 ' HB3' HD22 ' A' ' 71' ' ' LEU . 11.3 m -55.41 172.1 0.16 Allowed 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.416 -1.428 . . . . 0.0 108.532 178.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.726 ' HE ' ' CG1' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -170.78 163.64 7.89 Favored 'General case' 0 N--CA 1.5 2.047 0 C-N-CA 118.661 -1.215 . . . . 0.0 111.273 -178.81 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.756 HD22 ' N ' ' A' ' 84' ' ' LEU . 2.2 mm? -104.26 97.71 7.62 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 178.347 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.426 ' C ' ' O ' ' A' ' 84' ' ' LEU . 0.6 OUTLIER -31.94 -42.18 0.06 Allowed 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -177.414 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 17.6 p -76.52 -14.72 60.01 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.076 -1.64 . . . . 0.0 112.187 -177.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.412 ' OE1' HD23 ' A' ' 84' ' ' LEU . 83.2 mt-30 -94.48 37.86 1.11 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.676 -1.265 . . . . 0.0 110.113 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.726 ' CG1' ' HE ' ' A' ' 83' ' ' ARG . 22.7 mt -131.42 168.44 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.269 -0.895 . . . . 0.0 109.4 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.521 ' N ' ' CG2' ' A' ' 88' ' ' ILE . 36.2 mm -139.01 122.72 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.649 ' SD ' ' N ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -78.65 143.34 36.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.965 -1.084 . . . . 0.0 108.511 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.649 ' N ' ' SD ' ' A' ' 90' ' ' MET . 1.1 p -130.07 149.72 73.99 Favored Pre-proline 0 N--CA 1.495 1.785 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.255 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -62.96 -35.18 67.99 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 121.626 1.551 . . . . 0.0 110.854 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -68.82 -26.06 64.98 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 119.68 -0.808 . . . . 0.0 109.936 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.517 HD22 ' CD2' ' A' ' 56' ' ' PHE . 5.5 mt -104.26 29.67 5.84 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.508 -0.745 . . . . 0.0 110.076 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -63.65 146.42 53.83 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.799 -1.188 . . . . 0.0 109.856 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 105.22 12.27 27.64 Favored Glycine 0 N--CA 1.504 3.227 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 178.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.408 ' O ' HG23 ' A' ' 97' ' ' ILE . 17.5 tt -65.57 129.7 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 121.113 -1.227 . . . . 0.0 111.31 -177.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.6 t -104.82 126.52 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 O-C-N 121.208 -0.932 . . . . 0.0 108.852 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.2 t -111.58 135.01 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.994 -1.066 . . . . 0.0 109.997 -178.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -107.85 121.72 45.32 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.343 -0.848 . . . . 0.0 109.065 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 24.7 t -108.99 123.59 36.54 Favored Pre-proline 0 N--CA 1.498 1.967 0 O-C-N 121.689 -0.632 . . . . 0.0 109.4 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.442 ' O ' ' NE2' ' A' ' 105' ' ' GLN . 69.4 Cg_endo -83.25 178.34 5.87 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.711 2.274 . . . . 0.0 113.427 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -84.71 -18.33 35.56 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -108.44 81.95 1.55 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.556 ' CD ' ' H ' ' A' ' 105' ' ' GLN . 13.2 mp0 -84.03 -31.03 25.64 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 119.156 -1.017 . . . . 0.0 108.489 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 62.9 t-105 . . . . . 0 C--N 1.299 -1.594 0 O-C-N 121.028 -1.045 . . . . 0.0 109.814 178.753 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 13.6 p . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.9 mmtt -77.22 108.74 10.55 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.435 -0.906 . . . . 0.0 108.563 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.512 HG21 HG21 ' A' ' 17' ' ' VAL . 36.5 t -108.68 109.33 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.26 -0.9 . . . . 0.0 110.28 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 23.9 t -102.16 127.09 56.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.502 -0.749 . . . . 0.0 110.341 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.425 ' CE1' HG12 ' A' ' 3' ' ' VAL . 69.6 m-85 -102.15 117.54 35.01 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 176.588 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 81.0 t -97.9 113.94 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 34.0 p -74.54 -163.65 0.22 Allowed 'General case' 0 C--N 1.293 -1.863 0 CA-C-O 121.595 0.712 . . . . 0.0 109.623 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.571 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.3 OUTLIER -81.98 -45.84 14.81 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.778 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 23.4 p-10 -74.31 2.36 9.44 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.3 -0.875 . . . . 0.0 111.571 -178.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.88 -4.31 65.6 Favored Glycine 0 N--CA 1.5 2.915 0 O-C-N 120.441 -1.412 . . . . 0.0 110.928 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.89 126.37 27.11 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.79 -1.418 . . . . 0.0 108.418 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.4 mtt85 -106.21 162.25 13.82 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.262 -0.899 . . . . 0.0 111.32 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 17.3 mtt85 -146.29 107.82 4.27 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 178.222 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -98.62 126.73 44.3 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.344 -0.847 . . . . 0.0 110.523 -178.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.563 HD22 ' ND2' ' A' ' 30' ' ' ASN . 31.6 mt -119.06 -164.7 1.06 Allowed 'General case' 0 N--CA 1.503 2.175 0 CA-C-O 122.786 1.279 . . . . 0.0 110.531 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -137.32 99.07 3.87 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 176.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.544 HG12 ' HB ' ' A' ' 21' ' ' VAL . 11.7 t -102.12 119.24 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 121.346 -0.846 . . . . 0.0 109.131 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.42 174.8 3.77 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.308 -0.87 . . . . 0.0 110.56 -178.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -69.95 141.39 53.05 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 122.053 0.93 . . . . 0.0 110.755 -179.282 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.24 -17.16 49.27 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.544 ' HB ' HG12 ' A' ' 17' ' ' VAL . 58.6 t -83.04 139.88 17.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 120.836 -1.391 . . . . 0.0 109.262 -178.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 79.0 p -92.04 146.09 24.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.112 -0.993 . . . . 0.0 109.024 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.493 HD21 ' SD ' ' A' ' 90' ' ' MET . 84.8 mt -46.38 -40.36 11.87 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.478 -0.764 . . . . 0.0 109.218 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 13.5 tpp -55.57 -43.12 75.64 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.427 -0.796 . . . . 0.0 108.953 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -62.26 -58.05 9.15 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.23 -0.919 . . . . 0.0 109.325 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.449 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -50.95 -33.33 24.07 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.675 -1.266 . . . . 0.0 111.743 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.84 -22.97 62.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.428 -1.42 . . . . 0.0 109.344 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 53.5 t -86.31 -19.85 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.189 -0.944 . . . . 0.0 109.857 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.87 -31.29 51.33 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.236 -0.915 . . . . 0.0 109.352 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.563 ' ND2' HD22 ' A' ' 15' ' ' LEU . 8.1 m120 . . . . . 0 N--CA 1.487 1.387 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 8.1 m . . . . . 0 N--CA 1.482 1.161 0 CA-C-O 120.98 0.419 . . . . 0.0 110.154 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.546 ' SG ' ' N ' ' A' ' 85' ' ' CYS . 16.6 p -92.74 53.91 2.13 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.891 -1.13 . . . . 0.0 110.397 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.717 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 48.7 t60 -75.94 111.68 11.56 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.28 -0.887 . . . . 0.0 108.634 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -147.34 167.75 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 120.884 -1.135 . . . . 0.0 109.534 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.524 ' OH ' ' NE2' ' A' ' 49' ' ' HIS . 38.0 m-85 -115.68 111.24 20.3 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 121.788 0.804 . . . . 0.0 109.754 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 80.7 t -85.95 132.81 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.763 ' ND2' ' HB3' ' A' ' 55' ' ' ALA . 1.0 OUTLIER -47.96 126.6 10.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.103 -0.998 . . . . 0.0 108.545 179.359 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -56.67 14.13 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.369 -0.832 . . . . 0.0 111.648 -178.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.763 ' HB3' ' ND2' ' A' ' 53' ' ' ASN . . . -101.99 -19.91 15.02 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.56 -1.338 . . . . 0.0 109.681 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -111.54 -10.49 14.14 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.704 -1.247 . . . . 0.0 108.951 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 10.4 p -70.84 -37.39 73.15 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.126 -0.984 . . . . 0.0 110.353 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -84.42 0.33 49.91 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.235 -0.916 . . . . 0.0 110.268 -178.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.448 ' CE ' ' O ' ' A' ' 55' ' ' ALA . 9.0 mttt -112.61 -37.36 4.94 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.4 0.619 . . . . 0.0 109.512 -179.337 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.742 HG23 HD12 ' A' ' 94' ' ' LEU . 0.4 OUTLIER -81.56 161.67 60.9 Favored Pre-proline 0 N--CA 1.497 1.918 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 179.859 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.734 ' HD2' HG22 ' A' ' 60' ' ' VAL . 5.0 Cg_endo -55.31 90.52 0.04 OUTLIER 'Trans proline' 0 N--CA 1.5 1.905 0 C-N-CA 122.381 2.054 . . . . 0.0 114.348 -176.563 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.61 104.31 0.64 Allowed 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 177.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.489 ' HB1' ' OE1' ' A' ' 67' ' ' GLU . . . -53.8 149.58 8.51 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.77 0.795 . . . . 0.0 112.561 -178.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -60.74 -172.1 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.308 0.575 . . . . 0.0 110.117 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -70.14 4.74 1.98 Allowed 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.727 -0.608 . . . . 0.0 112.11 -178.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.4 mtt85 -65.72 -40.28 92.02 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.65 -1.281 . . . . 0.0 108.928 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.489 ' OE1' ' HB1' ' A' ' 63' ' ' ALA . 34.1 mp0 -80.05 -37.66 33.48 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.701 -1.249 . . . . 0.0 109.636 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.454 HD12 ' N ' ' A' ' 68' ' ' ILE . 1.3 mp -46.15 -35.6 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.219 -0.926 . . . . 0.0 109.055 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.39 -28.97 60.73 Favored Glycine 0 N--CA 1.495 2.599 0 C-N-CA 119.365 -1.398 . . . . 0.0 109.619 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.429 ' N ' ' O ' ' A' ' 67' ' ' GLU . 26.6 mtt -79.0 -35.41 42.86 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 178.703 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 71' ' ' LEU . 74.2 mt -64.98 -24.74 67.6 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 178.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -80.88 5.48 15.98 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.782 -1.198 . . . . 0.0 108.036 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -122.73 25.97 8.46 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.764 -0.585 . . . . 0.0 110.504 -178.166 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.4 m -96.21 168.97 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.339 0 O-C-N 120.682 -1.261 . . . . 0.0 109.97 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.472 ' OG1' ' CD1' ' A' ' 106' ' ' TRP . 3.1 m -106.57 0.14 24.31 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.429 -0.794 . . . . 0.0 110.824 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.717 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -107.4 169.33 8.64 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.171 -0.956 . . . . 0.0 110.564 -178.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.464 ' O ' ' CG ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -59.76 106.14 0.45 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.569 -0.707 . . . . 0.0 109.478 -179.289 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.9 tp -70.13 152.25 44.53 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 119.933 -1.729 . . . . 0.0 110.303 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 46.3 mmtt -114.73 156.6 44.67 Favored Pre-proline 0 C--N 1.294 -1.828 0 CA-C-N 114.506 -1.225 . . . . 0.0 108.478 -178.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -57.56 -20.36 41.2 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 121.807 1.672 . . . . 0.0 110.4 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -125.22 31.91 5.49 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.734 -0.603 . . . . 0.0 110.775 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 33.4 m -59.44 169.85 1.15 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.653 -1.279 . . . . 0.0 110.473 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.566 ' NH2' ' O ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -171.91 171.52 5.08 Favored 'General case' 0 N--CA 1.503 2.219 0 CA-C-O 122.479 1.133 . . . . 0.0 111.864 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 47.3 mt -100.87 112.25 24.64 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 178.164 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.546 ' N ' ' SG ' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -56.7 -11.86 1.58 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.067 -1.02 . . . . 0.0 112.607 -176.554 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 28.3 p -87.54 -39.9 14.74 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 119.896 -1.752 . . . . 0.0 110.932 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -81.29 42.83 0.69 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.802 -1.186 . . . . 0.0 110.573 -178.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.8 mt -130.67 157.56 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 O-C-N 121.124 -0.985 . . . . 0.0 108.494 179.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 36.9 mm -132.46 128.52 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 O-C-N 121.391 -0.818 . . . . 0.0 109.763 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.493 ' SD ' HD21 ' A' ' 23' ' ' LEU . 3.6 tpt -88.62 161.54 16.84 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.969 -1.082 . . . . 0.0 109.657 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.5 p -155.04 148.83 18.83 Favored Pre-proline 0 C--N 1.3 -1.58 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -55.91 -37.7 95.59 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 121.651 1.567 . . . . 0.0 111.874 -178.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -65.13 -27.32 68.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.213 -0.929 . . . . 0.0 109.305 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.742 HD12 HG23 ' A' ' 60' ' ' VAL . 15.7 mt -96.66 24.73 5.73 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.322 -0.861 . . . . 0.0 109.459 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -64.2 138.06 58.26 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.651 -0.655 . . . . 0.0 110.055 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 108.03 8.87 29.02 Favored Glycine 0 N--CA 1.505 3.251 0 N-CA-C 110.669 -0.973 . . . . 0.0 110.669 178.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 16.0 tt -63.2 132.33 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 120.945 -1.326 . . . . 0.0 111.936 -177.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.0 t -104.91 115.33 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.1 t -103.12 133.32 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.898 -1.126 . . . . 0.0 109.01 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -104.71 114.77 29.19 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 23.5 t -102.4 122.18 47.42 Favored Pre-proline 0 N--CA 1.494 1.74 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.455 ' O ' ' NE2' ' A' ' 105' ' ' GLN . 68.5 Cg_endo -83.35 171.17 11.41 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.274 1.983 . . . . 0.0 113.18 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -79.13 -15.24 58.42 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.429 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 2.3 mmp_? -110.75 82.97 1.68 Allowed 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.527 ' H ' ' CD ' ' A' ' 105' ' ' GLN . 14.7 mp0 -83.09 -32.83 26.55 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 120.96 -1.087 . . . . 0.0 108.514 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' TRP . . . . . 0.472 ' CD1' ' OG1' ' A' ' 75' ' ' THR . 61.6 t-105 . . . . . 0 C--N 1.302 -1.476 0 CA-C-O 117.616 -1.183 . . . . 0.0 110.266 178.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.462 ' CB ' ' SD ' ' A' ' 90' ' ' MET . 1.5 p . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.4 ' H ' ' HB2' ' A' ' 95' ' ' ASP . 25.2 mmtt -92.92 116.36 28.98 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.069 -1.019 . . . . 0.0 109.192 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.579 HG12 ' CE2' ' A' ' 5' ' ' TYR . 57.2 t -114.47 108.61 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 O-C-N 121.351 -0.843 . . . . 0.0 109.573 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.4 t -99.6 129.03 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.267 -0.896 . . . . 0.0 110.849 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.579 ' CE2' HG12 ' A' ' 3' ' ' VAL . 96.5 m-85 -104.86 115.77 30.86 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 177.595 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 81.0 t -98.24 114.8 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 120.901 -1.125 . . . . 0.0 108.146 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 63.2 p -72.15 -159.92 0.06 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.708 -0.62 . . . . 0.0 109.682 -178.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.605 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -88.02 -46.93 8.92 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -179.882 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.519 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 13.4 p30 -70.75 4.63 2.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.344 -0.848 . . . . 0.0 110.755 -178.571 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.85 -4.63 65.94 Favored Glycine 0 N--CA 1.498 2.821 0 O-C-N 120.808 -1.182 . . . . 0.0 110.552 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -65.61 126.9 29.8 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.747 -1.443 . . . . 0.0 108.718 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.534 ' CG ' HH11 ' A' ' 12' ' ' ARG . 2.6 mtt-85 -105.52 160.95 14.77 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.474 -0.766 . . . . 0.0 110.84 -178.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -150.83 116.31 5.43 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.535 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -101.98 130.87 48.62 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.701 -0.624 . . . . 0.0 111.14 -178.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.496 HD22 ' ND2' ' A' ' 30' ' ' ASN . 30.7 mt -119.4 -165.29 1.13 Allowed 'General case' 0 N--CA 1.504 2.237 0 CA-C-O 122.737 1.256 . . . . 0.0 109.882 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -135.19 97.24 3.67 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 104.62 -2.363 . . . . 0.0 104.62 176.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.704 HG13 ' HB2' ' A' ' 26' ' ' ALA . 3.7 t -104.79 118.62 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.518 0 O-C-N 121.044 -1.035 . . . . 0.0 108.244 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.05 173.34 6.63 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 122.091 0.948 . . . . 0.0 111.693 -177.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -64.63 138.51 58.44 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.988 0.899 . . . . 0.0 111.166 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.9 -14.43 52.72 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 178.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.602 ' HB ' HG12 ' A' ' 17' ' ' VAL . 48.6 t -82.63 140.48 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 O-C-N 120.721 -1.458 . . . . 0.0 108.87 -179.131 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.471 ' O ' ' N ' ' A' ' 25' ' ' GLN . 35.6 p -92.88 141.05 28.86 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.238 -0.914 . . . . 0.0 109.078 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 57.9 mt -44.48 -36.24 2.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.27 -0.894 . . . . 0.0 109.753 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.405 ' O ' ' SD ' ' A' ' 24' ' ' MET . 4.9 tpt -61.19 -37.84 84.39 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.471 ' N ' ' O ' ' A' ' 22' ' ' SER . 11.8 mm100 -66.82 -58.48 4.95 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.306 -0.871 . . . . 0.0 108.994 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.704 ' HB2' HG13 ' A' ' 17' ' ' VAL . . . -55.29 -30.07 59.44 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.785 -1.197 . . . . 0.0 110.749 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.92 -24.58 66.13 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.955 -1.091 . . . . 0.0 109.06 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 89.5 t -86.05 -23.88 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.393 -0.817 . . . . 0.0 109.709 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.34 -28.92 59.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.17 -0.956 . . . . 0.0 108.618 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.496 ' ND2' HD22 ' A' ' 15' ' ' LEU . 6.4 m120 . . . . . 0 C--N 1.306 -1.29 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 178.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 7.3 m . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.752 0.31 . . . . 0.0 110.251 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.586 ' SG ' ' N ' ' A' ' 85' ' ' CYS . 17.7 p -82.3 54.42 2.56 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.756 -1.215 . . . . 0.0 110.15 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.716 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 35.8 t60 -77.45 109.67 11.58 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.152 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -143.7 164.94 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 120.679 -1.263 . . . . 0.0 109.664 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.546 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 42.4 m-85 -112.52 112.58 24.22 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-O 121.915 0.865 . . . . 0.0 109.747 -179.325 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.534 HG12 HD22 ' A' ' 53' ' ' ASN . 60.7 t -88.54 132.41 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.669 HD22 ' N ' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -47.73 127.01 11.1 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.076 -1.015 . . . . 0.0 108.646 179.301 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -56.36 14.6 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.252 -0.905 . . . . 0.0 111.297 -178.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.598 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -99.67 -18.0 17.5 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.595 -1.315 . . . . 0.0 109.823 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.617 ' CD2' HD22 ' A' ' 94' ' ' LEU . 30.9 m-85 -116.18 -9.4 11.63 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.977 -1.077 . . . . 0.0 108.38 -179.371 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.415 HG21 ' OD1' ' A' ' 81' ' ' ASN . 31.2 p -68.44 -43.62 76.71 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.272 -0.893 . . . . 0.0 109.82 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -91.03 19.86 5.36 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 120.179 -0.608 . . . . 0.0 109.731 -179.091 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.6 mtpt -129.83 -40.83 1.34 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.696 HG22 ' HD2' ' A' ' 61' ' ' PRO . 0.4 OUTLIER -81.06 168.17 26.92 Favored Pre-proline 0 N--CA 1.491 1.599 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 179.254 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.696 ' HD2' HG22 ' A' ' 60' ' ' VAL . 1.1 Cg_endo -59.43 97.68 0.1 Allowed 'Trans proline' 0 N--CA 1.491 1.369 0 CA-C-N 120.123 1.08 . . . . 0.0 113.593 -176.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.84 99.56 3.81 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 178.035 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.595 ' H ' ' NH1' ' A' ' 83' ' ' ARG . . . -47.03 152.17 0.56 Allowed 'General case' 0 C--N 1.287 -2.121 0 CA-C-O 122.242 1.02 . . . . 0.0 113.129 -178.288 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -61.1 -169.81 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.618 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -67.68 -3.92 10.58 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.771 -0.58 . . . . 0.0 111.976 -178.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? -62.74 -42.49 99.7 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.539 -1.351 . . . . 0.0 108.442 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.536 ' OE1' ' N ' ' A' ' 67' ' ' GLU . 22.5 mp0 -75.55 -48.1 23.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.446 -0.784 . . . . 0.0 109.937 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 35.3 mt -44.21 -21.83 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.519 -0.738 . . . . 0.0 109.655 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -80.0 -79.54 0.85 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 9.9 ptp -47.56 -37.81 13.0 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.925 -1.338 . . . . 0.0 108.932 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.448 ' O ' ' CG2' ' A' ' 74' ' ' VAL . 2.5 tm? -56.93 -31.02 64.51 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' A' ' 69' ' ' GLY . 14.5 tt0 -81.88 14.52 2.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.09 -1.007 . . . . 0.0 109.256 178.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -125.51 36.62 4.52 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.225 -0.922 . . . . 0.0 110.083 -179.055 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.603 ' CG2' HD11 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -98.87 176.09 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 121.058 -1.026 . . . . 0.0 108.522 179.218 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.509 ' OG1' ' CE2' ' A' ' 106' ' ' TRP . 4.9 m -120.05 6.36 10.82 Favored 'General case' 0 N--CA 1.508 2.446 0 O-C-N 121.245 -0.91 . . . . 0.0 111.19 -178.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.716 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -105.78 171.94 7.07 Favored 'General case' 0 N--CA 1.506 2.362 0 O-C-N 120.979 -1.076 . . . . 0.0 109.674 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.546 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -59.0 102.66 0.13 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.23 -0.919 . . . . 0.0 109.641 -179.313 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.603 HD11 ' CG2' ' A' ' 74' ' ' VAL . 2.6 mp -71.81 141.54 49.66 Favored 'General case' 0 C--N 1.293 -1.875 0 O-C-N 120.132 -1.605 . . . . 0.0 110.665 -179.516 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.556 ' H ' ' HG ' ' A' ' 82' ' ' SER . 45.2 mmtt -104.81 158.52 31.84 Favored Pre-proline 0 C--N 1.288 -2.081 0 CA-C-N 113.786 -1.552 . . . . 0.0 107.845 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -53.4 -16.24 7.06 Favored 'Trans proline' 0 C--N 1.302 -1.901 0 C-N-CA 121.248 1.298 . . . . 0.0 109.873 178.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.415 ' OD1' HG21 ' A' ' 57' ' ' THR . 3.9 p30 -130.55 39.47 3.62 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.993 -0.442 . . . . 0.0 111.03 -179.371 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.556 ' HG ' ' H ' ' A' ' 79' ' ' LYS . 22.7 m -68.45 150.34 48.23 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 119.978 -1.701 . . . . 0.0 107.554 178.158 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.595 ' NH1' ' H ' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -165.68 169.47 15.17 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.533 -1.354 . . . . 0.0 110.121 -179.669 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.828 HD22 ' N ' ' A' ' 84' ' ' LEU . 1.1 mm? -85.73 119.78 26.44 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.586 ' N ' ' SG ' ' A' ' 48' ' ' CYS . 0.5 OUTLIER -57.26 -41.84 80.4 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.037 -1.039 . . . . 0.0 111.282 -177.875 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 30.6 p -60.56 -22.92 64.2 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 120.635 -1.29 . . . . 0.0 111.444 -177.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 13.2 tp60 -91.18 33.04 0.98 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.009 -1.057 . . . . 0.0 111.16 -179.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.59 ' C ' HD12 ' A' ' 89' ' ' ILE . 33.8 mt -130.27 144.79 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 O-C-N 120.966 -1.084 . . . . 0.0 108.226 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.59 HD12 ' C ' ' A' ' 88' ' ' ILE . 1.7 mp -122.21 134.96 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.43 0 O-C-N 121.678 -0.639 . . . . 0.0 109.304 -179.187 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.628 ' SD ' ' N ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -81.16 144.5 31.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.234 -0.917 . . . . 0.0 108.851 -179.651 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.628 ' N ' ' SD ' ' A' ' 90' ' ' MET . 0.5 OUTLIER -129.46 152.54 79.77 Favored Pre-proline 0 N--CA 1.497 1.876 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 177.833 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.24 -34.75 26.66 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 121.671 1.58 . . . . 0.0 110.791 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -70.57 -23.29 62.57 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.584 -0.846 . . . . 0.0 109.8 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.617 HD22 ' CD2' ' A' ' 56' ' ' PHE . 6.7 mt -104.48 30.91 5.0 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.427 -0.796 . . . . 0.0 110.4 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.4 ' HB2' ' H ' ' A' ' 2' ' ' LYS . 11.0 p-10 -64.46 144.75 56.96 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.114 -1.616 . . . . 0.0 109.676 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 105.8 11.75 27.74 Favored Glycine 0 N--CA 1.503 3.112 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 178.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.436 HG13 HD21 ' A' ' 53' ' ' ASN . 15.3 tt -63.62 128.89 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.013 -1.286 . . . . 0.0 111.015 -177.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.478 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 6.6 t -103.84 123.7 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.225 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.2 t -111.44 135.06 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.067 -1.021 . . . . 0.0 109.688 -179.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -108.91 122.48 47.29 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-O 121.712 0.768 . . . . 0.0 109.055 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 35.0 t -110.3 123.27 36.34 Favored Pre-proline 0 N--CA 1.497 1.889 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.442 ' HG3' ' CD2' ' A' ' 49' ' ' HIS . 41.6 Cg_endo -85.94 -178.3 2.83 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.865 2.377 . . . . 0.0 113.486 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -87.01 -20.15 27.64 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.437 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 0.8 OUTLIER -103.78 82.45 2.0 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 179.623 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -81.13 -23.3 38.42 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.444 -0.902 . . . . 0.0 109.68 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' TRP . . . . . 0.509 ' CE2' ' OG1' ' A' ' 75' ' ' THR . 11.1 t-105 . . . . . 0 C--N 1.305 -1.359 0 O-C-N 120.847 -1.158 . . . . 0.0 110.164 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 98.0 p . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.402 ' H ' ' HB2' ' A' ' 95' ' ' ASP . 1.1 mptm? -76.11 111.03 11.09 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.328 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.534 HG12 ' CE1' ' A' ' 5' ' ' TYR . 96.5 t -111.9 111.89 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.735 -0.603 . . . . 0.0 110.302 -178.27 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 24.4 t -98.89 98.85 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.222 -0.924 . . . . 0.0 111.764 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.534 ' CE1' HG12 ' A' ' 3' ' ' VAL . 29.0 m-85 -72.94 111.89 8.47 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 176.643 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 79.1 t -98.89 117.92 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 75.0 p -73.73 -155.83 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.492 -0.755 . . . . 0.0 109.513 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.598 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -91.54 -50.27 5.87 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.164 -0.96 . . . . 0.0 108.985 -179.727 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.492 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 22.0 p-10 -66.03 2.07 1.24 Allowed 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.509 -0.745 . . . . 0.0 110.734 -179.155 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.408 ' O ' ' NH1' ' A' ' 12' ' ' ARG . . . 96.74 -4.98 63.92 Favored Glycine 0 N--CA 1.501 3.013 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -62.6 126.52 27.62 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.117 -1.226 . . . . 0.0 108.179 179.287 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.432 ' NH1' ' CG ' ' A' ' 12' ' ' ARG . 0.5 OUTLIER -112.09 161.1 16.87 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 121.875 0.845 . . . . 0.0 111.577 -178.16 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.5 ttm105 -149.65 118.67 6.71 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -99.46 128.02 45.55 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.39 -0.819 . . . . 0.0 110.427 -178.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.446 HD12 ' CE1' ' A' ' 5' ' ' TYR . 21.6 mt -117.79 -165.54 1.1 Allowed 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 122.972 1.368 . . . . 0.0 109.978 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -138.0 101.73 4.5 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 176.293 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.49 ' CG2' HG21 ' A' ' 3' ' ' VAL . 12.2 t -104.69 117.07 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.67 179.9 4.5 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-O 122.046 0.927 . . . . 0.0 112.343 -177.211 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -65.89 134.13 52.37 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.849 0.833 . . . . 0.0 110.548 -179.577 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.94 -18.01 42.55 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 178.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.416 ' HB ' HG12 ' A' ' 17' ' ' VAL . 46.2 t -83.72 139.63 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 120.848 -1.384 . . . . 0.0 109.889 -178.29 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.511 ' O ' ' N ' ' A' ' 25' ' ' GLN . 51.4 p -94.84 141.26 28.84 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 178.73 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.1 mt -45.81 -33.86 3.37 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.362 -0.836 . . . . 0.0 109.611 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 2.3 tpt -68.53 -28.46 67.01 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 121.674 0.75 . . . . 0.0 109.165 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.511 ' N ' ' O ' ' A' ' 22' ' ' SER . 7.0 tp-100 -76.55 -62.72 1.53 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.138 -0.976 . . . . 0.0 109.959 -179.422 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.29 -24.17 53.17 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.689 -1.257 . . . . 0.0 109.995 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.94 -22.21 66.61 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.161 -0.962 . . . . 0.0 109.649 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 99.1 t -86.29 -17.93 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.374 -0.829 . . . . 0.0 109.41 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.97 -30.32 22.85 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.391 -0.818 . . . . 0.0 110.066 -178.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 . . . . . 0 N--CA 1.488 1.44 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.259 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 62.0 p . . . . . 0 N--CA 1.483 1.202 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.486 ' SG ' ' N ' ' A' ' 85' ' ' CYS . 30.1 p -73.46 54.85 0.46 Allowed 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.869 -1.145 . . . . 0.0 109.405 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.481 ' CE1' ' OH ' ' A' ' 51' ' ' TYR . 50.9 t60 -76.74 106.45 8.41 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -143.84 160.8 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 120.696 -1.253 . . . . 0.0 109.231 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.509 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 39.5 m-85 -108.52 111.42 23.27 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 122.241 1.019 . . . . 0.0 109.953 -179.082 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.541 HG13 HD11 ' A' ' 97' ' ' ILE . 10.9 t -85.94 133.29 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.576 ' C ' ' H ' ' A' ' 55' ' ' ALA . 1.0 OUTLIER -48.21 127.7 13.04 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.872 -1.143 . . . . 0.0 108.625 -179.852 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -56.35 9.15 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.467 -0.77 . . . . 0.0 111.471 -178.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.576 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -99.11 -17.38 18.24 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.805 -1.184 . . . . 0.0 109.9 -179.272 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.627 ' CD2' HD22 ' A' ' 94' ' ' LEU . 48.1 m-85 -115.61 -4.74 12.2 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.1 -1.0 . . . . 0.0 108.808 -179.493 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 24.8 p -72.95 -41.94 63.93 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.619 -0.676 . . . . 0.0 109.796 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -89.31 15.44 9.05 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 120.204 -0.599 . . . . 0.0 109.886 -179.025 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.1 mtpt -121.68 -40.86 2.51 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.523 HG22 ' HD2' ' A' ' 61' ' ' PRO . 0.5 OUTLIER -78.86 158.33 75.41 Favored Pre-proline 0 N--CA 1.495 1.82 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.61 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.523 ' HD2' HG22 ' A' ' 60' ' ' VAL . 1.3 Cg_endo -49.47 102.74 0.05 OUTLIER 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 122.222 1.948 . . . . 0.0 113.726 -177.136 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.463 ' HA ' HH22 ' A' ' 83' ' ' ARG . . . -75.66 101.62 5.05 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 177.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.805 ' H ' HH22 ' A' ' 83' ' ' ARG . . . -65.25 169.58 5.55 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-O 122.211 1.005 . . . . 0.0 112.58 -178.492 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.422 ' ND2' ' HE ' ' A' ' 66' ' ' ARG . 4.0 p30 -63.24 177.54 0.62 Allowed 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 122.103 0.954 . . . . 0.0 111.428 -178.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -72.23 5.34 2.89 Favored 'General case' 0 N--CA 1.503 2.214 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.523 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.422 ' HE ' ' ND2' ' A' ' 64' ' ' ASN . 10.2 mtm180 -74.16 -50.52 18.96 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 120.37 -1.456 . . . . 0.0 109.185 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.592 ' OE1' ' NE2' ' A' ' 87' ' ' GLN . 82.3 mt-10 -65.58 -16.71 63.97 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.525 -0.734 . . . . 0.0 109.655 179.114 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.563 HD12 ' N ' ' A' ' 68' ' ' ILE . 1.4 mp -75.54 -34.92 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.383 -0.823 . . . . 0.0 108.918 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.81 -20.51 48.21 Favored Glycine 0 N--CA 1.495 2.597 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 3.5 mmt -83.51 -35.42 24.85 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 178.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.484 ' HG ' HD21 ' A' ' 84' ' ' LEU . 59.8 mt -63.75 -21.98 66.68 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.422 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -83.82 11.7 7.16 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -131.26 28.13 4.74 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.446 -0.784 . . . . 0.0 109.774 -178.619 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.604 HG21 HD13 ' A' ' 78' ' ' LEU . 18.0 m -90.92 162.86 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.326 -0.859 . . . . 0.0 110.697 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.524 ' OG1' ' CD2' ' A' ' 106' ' ' TRP . 6.7 m -100.75 -8.7 22.5 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.321 -0.862 . . . . 0.0 109.983 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -107.55 175.33 5.53 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.807 -1.183 . . . . 0.0 110.723 -178.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.509 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -61.46 108.71 1.0 Allowed 'General case' 0 N--CA 1.503 2.21 0 CA-C-O 121.372 0.606 . . . . 0.0 110.967 -178.843 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.604 HD13 HG21 ' A' ' 74' ' ' VAL . 9.2 tp -72.92 156.67 38.62 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 119.547 -1.97 . . . . 0.0 110.101 179.108 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.6 mmtm -118.03 155.76 50.94 Favored Pre-proline 0 C--N 1.293 -1.856 0 CA-C-N 115.105 -0.952 . . . . 0.0 108.534 -178.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.99 -24.26 79.21 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 121.674 1.582 . . . . 0.0 109.261 178.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 81' ' ' ASN . 1.4 p30 -112.9 21.69 15.21 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.013 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.476 ' HB3' HD22 ' A' ' 71' ' ' LEU . 3.7 m -52.07 158.26 1.13 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 120.306 -1.496 . . . . 0.0 109.067 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.805 HH22 ' H ' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -156.69 148.22 22.48 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.061 -1.055 . . . . 0.0 111.924 -178.28 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.787 HD22 ' N ' ' A' ' 84' ' ' LEU . 2.2 mm? -85.48 121.66 28.51 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 177.131 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.486 ' N ' ' SG ' ' A' ' 48' ' ' CYS . 0.2 OUTLIER -70.64 -5.09 26.9 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.867 -1.146 . . . . 0.0 113.183 -175.708 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 27.9 p -93.93 -37.7 11.56 Favored 'General case' 0 N--CA 1.506 2.354 0 CA-C-N 120.438 1.472 . . . . 0.0 111.004 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.592 ' NE2' ' OE1' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -84.91 24.74 1.02 Allowed 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.214 -0.929 . . . . 0.0 110.39 -179.484 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.447 HD11 ' HB3' ' A' ' 83' ' ' ARG . 47.3 mt -108.09 148.3 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 O-C-N 121.131 -0.981 . . . . 0.0 108.651 179.159 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 33.5 mm -127.68 124.35 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.279 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.518 ' SD ' HG21 ' A' ' 97' ' ' ILE . 2.7 tpt -91.14 160.77 15.39 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.301 -0.874 . . . . 0.0 109.928 -178.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 70.9 p -149.38 147.61 23.86 Favored Pre-proline 0 N--CA 1.49 1.532 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -57.1 -29.58 83.71 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 121.46 1.44 . . . . 0.0 111.616 -179.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -67.83 -29.54 68.72 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.19 -0.944 . . . . 0.0 109.938 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.627 HD22 ' CD2' ' A' ' 56' ' ' PHE . 6.4 mt -98.1 31.04 2.85 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.578 -0.701 . . . . 0.0 109.863 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.402 ' HB2' ' H ' ' A' ' 2' ' ' LYS . 5.5 p-10 -62.63 138.51 58.51 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.169 -0.957 . . . . 0.0 110.17 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 111.8 9.1 21.49 Favored Glycine 0 N--CA 1.505 3.281 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 178.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.584 HD12 ' N ' ' A' ' 98' ' ' VAL . 0.1 OUTLIER -67.07 125.94 25.58 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 O-C-N 121.604 -0.939 . . . . 0.0 110.838 -178.213 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.584 ' N ' HD12 ' A' ' 97' ' ' ILE . 2.6 t -101.97 121.51 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.367 -0.833 . . . . 0.0 109.594 178.555 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.3 t -105.88 134.02 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 120.894 -1.129 . . . . 0.0 108.849 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -108.16 119.83 40.59 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 121.864 0.84 . . . . 0.0 109.015 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 23.7 t -107.27 122.94 39.76 Favored Pre-proline 0 N--CA 1.496 1.846 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.423 ' HG3' ' CD2' ' A' ' 49' ' ' HIS . 69.2 Cg_endo -83.57 177.69 6.15 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.703 2.269 . . . . 0.0 113.594 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -84.38 -15.26 46.96 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.467 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -112.05 80.4 1.32 Allowed 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.465 ' NE2' ' O ' ' A' ' 106' ' ' TRP . 2.2 pp0? -80.55 -20.43 43.46 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.724 -1.235 . . . . 0.0 109.659 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' TRP . . . . . 0.524 ' CD2' ' OG1' ' A' ' 75' ' ' THR . 67.4 t-105 . . . . . 0 C--N 1.302 -1.475 0 CA-C-O 117.83 -1.081 . . . . 0.0 110.24 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.462 ' OG ' ' SD ' ' A' ' 90' ' ' MET . 67.9 p . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.1 mmtt -75.94 115.39 15.6 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.558 HG21 ' CG2' ' A' ' 17' ' ' VAL . 45.1 t -116.3 108.1 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.16 -0.963 . . . . 0.0 111.952 -177.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 28.2 t -103.38 134.89 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 CA-C-O 121.687 0.756 . . . . 0.0 110.247 178.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -108.42 118.8 37.72 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 177.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 64.7 t -98.17 113.53 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 120.846 -1.159 . . . . 0.0 108.516 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.401 ' OG ' ' N ' ' A' ' 8' ' ' HIS . 5.3 p -79.6 -153.63 0.08 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.486 -0.759 . . . . 0.0 110.261 -179.167 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.569 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.4 OUTLIER -91.84 -52.67 4.63 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.8 p30 -62.41 -2.0 0.92 Allowed 'General case' 0 N--CA 1.483 1.189 0 O-C-N 120.865 -1.147 . . . . 0.0 111.364 -178.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.65 0.43 64.54 Favored Glycine 0 N--CA 1.498 2.811 0 O-C-N 120.67 -1.269 . . . . 0.0 110.575 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.408 HG23 HH11 ' A' ' 13' ' ' ARG . 1.0 OUTLIER -77.02 141.55 40.28 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.98 -1.306 . . . . 0.0 109.101 -179.597 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.43 ' CD ' ' N ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -119.43 164.38 15.82 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.387 -0.82 . . . . 0.0 112.486 -178.139 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.408 HH11 HG23 ' A' ' 11' ' ' THR . 0.0 OUTLIER -139.89 111.69 7.39 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.014 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -98.35 122.67 41.81 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.197 -0.939 . . . . 0.0 109.589 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.501 HD22 ' CG ' ' A' ' 30' ' ' ASN . 21.0 mt -117.47 -164.48 1.0 Allowed 'General case' 0 N--CA 1.503 2.205 0 CA-C-O 122.747 1.26 . . . . 0.0 109.968 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -137.74 99.6 3.96 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 104.558 -2.386 . . . . 0.0 104.558 176.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.558 ' CG2' HG21 ' A' ' 3' ' ' VAL . 16.8 t -102.31 121.13 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.321 0 O-C-N 121.238 -0.914 . . . . 0.0 109.022 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.71 -178.67 5.48 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.237 -0.914 . . . . 0.0 111.547 -178.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -67.72 131.2 45.12 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 122.078 0.942 . . . . 0.0 111.584 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.78 -18.84 48.6 Favored Glycine 0 N--CA 1.493 2.433 0 N-CA-C 111.121 -0.791 . . . . 0.0 111.121 178.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.407 ' HB ' HG12 ' A' ' 17' ' ' VAL . 62.3 t -79.65 132.81 31.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 120.689 -1.477 . . . . 0.0 108.478 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.425 ' O ' ' N ' ' A' ' 25' ' ' GLN . 18.0 p -88.2 145.59 25.82 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.962 -1.086 . . . . 0.0 108.666 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 70.4 mt -45.64 -39.8 8.23 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 120.594 -1.316 . . . . 0.0 109.864 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 10.5 ttt -64.51 -27.67 69.13 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.549 -0.719 . . . . 0.0 109.255 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.425 ' N ' ' O ' ' A' ' 22' ' ' SER . 52.3 mt-30 -72.78 -58.62 3.2 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.173 -0.954 . . . . 0.0 109.053 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.406 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -62.82 -27.48 69.35 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.768 -1.207 . . . . 0.0 110.89 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.05 -22.02 64.19 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.653 -1.279 . . . . 0.0 108.793 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 89.6 t -84.66 -21.63 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-O 121.492 0.663 . . . . 0.0 109.41 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.18 -28.0 32.31 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.391 -0.818 . . . . 0.0 109.491 -179.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.501 ' CG ' HD22 ' A' ' 15' ' ' LEU . 7.4 m-80 -104.41 4.09 32.97 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 63.6 68.88 1.48 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.4 mt -124.47 -42.86 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.656 -0.908 . . . . 0.0 109.892 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.777 ' O ' ' N ' ' A' ' 35' ' ' ILE . 2.7 m-85 -89.1 7.52 34.61 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.015 -1.053 . . . . 0.0 110.488 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -38.11 72.96 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.3 0 CA-C-O 121.97 0.89 . . . . 0.0 111.473 -178.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.777 ' N ' ' O ' ' A' ' 33' ' ' TYR . 8.2 tp -156.04 20.21 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.57 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.524 HG12 ' H ' ' A' ' 37' ' ' GLY . 4.2 t 56.76 171.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.07 -1.019 . . . . 0.0 109.278 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.524 ' H ' HG12 ' A' ' 36' ' ' VAL . . . -138.85 135.58 7.46 Favored Glycine 0 N--CA 1.499 2.856 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.507 ' C ' ' H ' ' A' ' 40' ' ' GLY . 1.3 m-20 -73.74 -66.21 0.73 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.327 -1.102 . . . . 0.0 109.266 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.612 ' SG ' ' N ' ' A' ' 42' ' ' SER . 11.6 p -70.91 15.29 0.11 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.957 -1.089 . . . . 0.0 109.099 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.507 ' H ' ' C ' ' A' ' 38' ' ' ASP . . . 54.32 10.78 2.11 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 108.335 -1.906 . . . . 0.0 108.335 -179.228 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.47 ' H ' ' C ' ' A' ' 39' ' ' CYS . . . 93.92 22.77 24.73 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.612 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 51.1 m -99.04 39.94 1.24 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.397 -1.06 . . . . 0.0 109.519 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.501 ' O ' ' SD ' ' A' ' 70' ' ' MET . . . 42.34 77.68 0.06 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.296 -0.877 . . . . 0.0 110.315 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -166.63 15.56 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.986 -1.072 . . . . 0.0 109.649 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.491 ' O ' ' S1 ' ' A' ' 107' ' ' FES . 3.0 p -149.51 168.29 23.9 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.455 -0.778 . . . . 0.0 109.575 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.507 ' HB1' HG12 ' A' ' 74' ' ' VAL . . . -102.34 14.76 31.09 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 13.9 m -62.5 -41.48 98.85 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.489 -0.757 . . . . 0.0 109.983 -179.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.529 ' SG ' ' O ' ' A' ' 48' ' ' CYS . 13.8 p -96.42 46.84 1.07 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.887 -1.133 . . . . 0.0 110.224 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.596 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 38.7 t60 -75.32 109.98 9.28 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.045 -1.034 . . . . 0.0 108.347 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -143.49 164.65 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.152 -0.968 . . . . 0.0 109.36 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.516 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 58.1 m-85 -108.81 110.71 22.14 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-O 121.9 0.857 . . . . 0.0 109.477 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.777 HG13 HD11 ' A' ' 97' ' ' ILE . 14.5 t -87.77 132.89 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.577 ' C ' ' H ' ' A' ' 55' ' ' ALA . 21.6 t-20 -47.58 126.21 9.59 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.959 -1.088 . . . . 0.0 109.556 179.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -58.19 15.26 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.638 -0.664 . . . . 0.0 111.193 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.577 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -103.39 -18.75 14.7 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.697 -1.252 . . . . 0.0 109.577 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.676 ' CD2' HD22 ' A' ' 94' ' ' LEU . 44.1 m-85 -113.0 -12.71 13.19 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.104 -0.998 . . . . 0.0 109.172 -178.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 13.6 p -68.08 -37.38 81.18 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.455 -0.778 . . . . 0.0 109.882 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -88.95 13.24 13.27 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.49 -0.757 . . . . 0.0 109.424 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.3 mtpt -124.46 -39.3 2.33 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.626 HG22 ' HD2' ' A' ' 61' ' ' PRO . 0.5 OUTLIER -81.18 161.74 61.6 Favored Pre-proline 0 N--CA 1.497 1.909 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 179.667 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.626 ' HD2' HG22 ' A' ' 60' ' ' VAL . 6.2 Cg_endo -56.23 92.74 0.05 OUTLIER 'Trans proline' 0 N--CA 1.49 1.31 0 C-N-CA 121.584 1.522 . . . . 0.0 113.401 -177.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.37 102.63 5.2 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 178.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.795 ' H ' HH22 ' A' ' 83' ' ' ARG . . . -50.16 151.82 1.92 Allowed 'General case' 0 C--N 1.288 -2.08 0 CA-C-O 122.742 1.258 . . . . 0.0 112.596 -177.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -59.31 -165.38 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.372 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.438 ' HA ' HD12 ' A' ' 68' ' ' ILE . 8.5 pt-20 -68.76 -5.22 19.31 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.254 -0.904 . . . . 0.0 112.783 -177.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.4 mtt180 -60.91 -38.41 85.66 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.154 -1.591 . . . . 0.0 108.997 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -80.74 -39.04 27.65 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.973 -1.08 . . . . 0.0 110.05 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.438 HD12 ' HA ' ' A' ' 65' ' ' GLU . 84.5 mt -46.65 -28.93 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.33 -0.856 . . . . 0.0 110.105 -179.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -82.84 -30.41 32.18 Favored Glycine 0 N--CA 1.498 2.786 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.501 ' SD ' ' O ' ' A' ' 43' ' ' ALA . 25.3 mtt -76.56 -34.21 58.5 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 178.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.529 ' O ' HD13 ' A' ' 78' ' ' LEU . 6.3 mt -59.05 -24.27 62.72 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -92.26 30.38 1.47 Allowed 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -134.89 19.4 3.49 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.533 -0.729 . . . . 0.0 110.487 -179.247 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.507 HG12 ' HB1' ' A' ' 46' ' ' ALA . 3.4 m -97.74 167.42 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 120.809 -1.182 . . . . 0.0 110.214 -179.175 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.546 ' OG1' ' CD1' ' A' ' 106' ' ' TRP . 6.8 m -101.59 -0.16 35.32 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.385 -0.822 . . . . 0.0 109.789 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.596 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -107.18 169.29 8.65 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.242 -0.911 . . . . 0.0 110.465 -178.106 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.516 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -61.21 110.32 1.37 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.741 -0.6 . . . . 0.0 109.839 -179.343 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.529 HD13 ' O ' ' A' ' 71' ' ' LEU . 4.3 tp -68.6 158.01 34.89 Favored 'General case' 0 C--N 1.294 -1.811 0 O-C-N 120.26 -1.525 . . . . 0.0 108.753 178.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.443 ' N ' ' OG ' ' A' ' 82' ' ' SER . 41.5 mmtt -128.25 153.38 78.83 Favored Pre-proline 0 C--N 1.294 -1.818 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 -178.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -55.32 -28.29 61.97 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 121.54 1.494 . . . . 0.0 109.52 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -112.27 29.74 7.65 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.722 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.443 ' OG ' ' N ' ' A' ' 79' ' ' LYS . 4.3 m -61.89 164.64 6.19 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.673 -1.267 . . . . 0.0 109.159 178.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.795 HH22 ' H ' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -164.93 146.24 7.73 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 118.564 -1.254 . . . . 0.0 112.012 -178.6 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.517 HD22 ' N ' ' A' ' 84' ' ' LEU . 3.2 mm? -92.72 95.35 9.51 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 177.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.547 ' HG ' ' HH ' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -31.77 -46.21 0.11 Allowed 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -177.156 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.467 ' SG ' ' N ' ' A' ' 87' ' ' GLN . 30.3 p -58.22 -45.75 87.13 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 119.856 -1.777 . . . . 0.0 111.956 -177.374 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.467 ' N ' ' SG ' ' A' ' 86' ' ' CYS . 10.4 tp60 -74.79 39.58 0.13 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.481 -1.387 . . . . 0.0 111.494 -178.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.556 ' C ' HD12 ' A' ' 89' ' ' ILE . 31.6 mt -131.35 145.71 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 O-C-N 120.86 -1.15 . . . . 0.0 108.715 178.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.556 HD12 ' C ' ' A' ' 88' ' ' ILE . 1.6 mp -121.6 127.84 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.462 ' SD ' ' OG ' ' A' ' 1' ' ' SER . 0.0 OUTLIER -88.33 162.05 16.79 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -178.881 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.415 ' H ' ' HE2' ' A' ' 90' ' ' MET . 45.5 p -152.1 148.4 21.32 Favored Pre-proline 0 N--CA 1.49 1.551 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.1 -32.98 98.3 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 121.69 1.594 . . . . 0.0 111.298 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -66.63 -32.81 74.38 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.126 -0.984 . . . . 0.0 109.502 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.676 HD22 ' CD2' ' A' ' 56' ' ' PHE . 7.6 mt -90.85 31.39 1.07 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.149 -0.969 . . . . 0.0 109.229 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -60.21 133.31 55.98 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.878 -1.139 . . . . 0.0 110.45 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 110.67 11.33 19.53 Favored Glycine 0 N--CA 1.507 3.416 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 178.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.777 HD11 HG13 ' A' ' 52' ' ' VAL . 0.3 OUTLIER -64.07 124.17 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.19 0 O-C-N 120.997 -1.296 . . . . 0.0 110.297 -177.583 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.5 t -101.69 121.92 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.505 -0.747 . . . . 0.0 109.32 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.1 t -108.5 133.53 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 120.977 -1.077 . . . . 0.0 110.109 -178.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.96 118.32 36.39 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.901 0.858 . . . . 0.0 109.113 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 14.9 t -107.74 124.59 34.45 Favored Pre-proline 0 N--CA 1.497 1.909 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.407 ' HG3' ' CD2' ' A' ' 49' ' ' HIS . 97.1 Cg_endo -82.57 178.45 6.14 Favored 'Trans proline' 0 N--CA 1.5 1.886 0 C-N-CA 122.315 2.01 . . . . 0.0 113.497 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -83.03 -14.03 54.69 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.32 87.32 2.72 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 -178.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -87.56 -32.59 19.28 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.546 ' CD1' ' OG1' ' A' ' 75' ' ' THR . 45.3 t-105 . . . . . 0 C--N 1.302 -1.486 0 CA-C-O 117.735 -1.126 . . . . 0.0 109.564 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' FES . . . . . 0.503 ' S1 ' HD12 ' A' ' 84' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 51.9 p . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.51 109.66 12.9 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.563 -0.855 . . . . 0.0 108.953 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.497 HG21 HG21 ' A' ' 17' ' ' VAL . 22.9 t -107.48 108.55 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 O-C-N 121.237 -0.915 . . . . 0.0 110.489 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.0 t -99.04 98.81 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.089 -1.007 . . . . 0.0 111.405 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.484 ' CZ ' HG11 ' A' ' 3' ' ' VAL . 68.9 m-85 -73.08 115.13 12.03 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.062 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 75.2 t -98.81 111.6 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 61.3 p -72.3 -159.66 0.06 Allowed 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 121.666 0.746 . . . . 0.0 109.867 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.584 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.2 OUTLIER -90.58 -50.87 5.69 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.309 -0.869 . . . . 0.0 108.709 -179.966 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.495 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 15.1 p30 -66.34 5.23 0.58 Allowed 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.752 -179.105 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.11 -1.83 74.4 Favored Glycine 0 N--CA 1.499 2.887 0 O-C-N 120.879 -1.138 . . . . 0.0 110.895 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -65.27 129.67 40.56 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.89 -1.359 . . . . 0.0 108.541 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 2.2 mtt85 -108.76 160.64 15.8 Favored 'General case' 0 N--CA 1.502 2.126 0 CA-C-O 121.68 0.752 . . . . 0.0 110.58 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.15 115.38 5.42 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 179.203 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -98.72 127.12 44.54 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-O 121.829 0.823 . . . . 0.0 110.342 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.417 ' CD1' ' H ' ' A' ' 16' ' ' ASP . 0.3 OUTLIER -113.44 -174.33 2.44 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 123.203 1.478 . . . . 0.0 111.032 -177.797 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.417 ' H ' ' CD1' ' A' ' 15' ' ' LEU . 0.8 OUTLIER -136.14 99.97 4.28 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 104.654 -2.35 . . . . 0.0 104.654 176.48 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.497 HG21 HG21 ' A' ' 3' ' ' VAL . 13.0 t -108.22 116.39 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.81 -179.72 2.33 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.311 -0.868 . . . . 0.0 111.409 -178.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 19' ' ' ASP . 3.8 p-10 -70.0 136.75 50.75 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 122.012 0.91 . . . . 0.0 110.724 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.01 -18.2 41.74 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 178.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.434 ' HB ' HG12 ' A' ' 17' ' ' VAL . 57.5 t -80.1 138.52 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 120.616 -1.52 . . . . 0.0 109.432 -178.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.27 153.97 21.06 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.164 -0.96 . . . . 0.0 109.126 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.419 ' CD2' ' N ' ' A' ' 23' ' ' LEU . 1.8 mm? -56.26 -64.05 0.99 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.612 -0.68 . . . . 0.0 109.178 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.515 ' O ' ' SD ' ' A' ' 24' ' ' MET . 6.6 tpt -49.46 -16.28 0.2 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.009 -1.057 . . . . 0.0 109.123 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.418 ' N ' ' C ' ' A' ' 23' ' ' LEU . 7.7 tm0? -78.35 -68.1 0.67 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.104 -0.998 . . . . 0.0 109.47 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.427 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -55.24 -21.7 15.17 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.929 -1.107 . . . . 0.0 110.418 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.78 -19.35 65.78 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 120.844 -1.16 . . . . 0.0 108.809 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 96.5 t -86.98 -23.87 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.472 -0.767 . . . . 0.0 109.381 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.53 -26.43 45.79 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.529 -0.732 . . . . 0.0 109.054 -179.343 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -106.92 -0.69 23.01 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 64.48 75.47 0.37 Allowed Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 56.4 mt -124.09 -52.07 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 O-C-N 121.629 -0.924 . . . . 0.0 109.563 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.473 ' CZ ' HD12 ' A' ' 35' ' ' ILE . 2.0 t80 -91.24 122.43 33.86 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 177.255 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -106.91 65.59 0.66 Allowed 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 176.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.473 HD12 ' CZ ' ' A' ' 33' ' ' TYR . 14.4 mt -149.48 148.25 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.297 0 O-C-N 120.649 -1.282 . . . . 0.0 110.317 -178.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.3 t -88.49 111.07 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -49.21 108.75 0.47 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.524 ' C ' ' H ' ' A' ' 40' ' ' GLY . 12.6 t0 -50.09 -59.48 3.87 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.137 -1.213 . . . . 0.0 109.258 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.613 ' SG ' ' N ' ' A' ' 42' ' ' SER . 17.1 p -71.31 16.68 0.09 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.251 -0.906 . . . . 0.0 108.997 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.524 ' H ' ' C ' ' A' ' 38' ' ' ASP . . . 59.27 9.09 7.52 Favored Glycine 0 N--CA 1.483 1.783 0 N-CA-C 107.226 -2.35 . . . . 0.0 107.226 -178.344 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.459 ' H ' ' C ' ' A' ' 39' ' ' CYS . . . 90.39 23.65 30.97 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 109.186 -1.566 . . . . 0.0 109.186 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.613 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 60.1 m -99.91 41.65 1.15 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.395 -1.062 . . . . 0.0 110.072 -179.321 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 43.71 76.09 0.09 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.278 -0.889 . . . . 0.0 109.934 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.22 23.54 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.143 -0.973 . . . . 0.0 109.488 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.499 ' O ' ' S1 ' ' A' ' 107' ' ' FES . 3.2 p -160.9 163.48 31.9 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.027 -1.046 . . . . 0.0 110.092 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -96.53 8.88 43.04 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.492 ' OG1' ' SG ' ' A' ' 45' ' ' CYS . 9.7 m -51.91 -51.45 56.8 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.798 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.516 ' SG ' ' O ' ' A' ' 48' ' ' CYS . 17.8 p -87.44 54.66 3.22 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.695 -1.253 . . . . 0.0 110.071 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.796 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 43.6 t60 -76.52 109.97 10.69 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.955 -1.091 . . . . 0.0 109.024 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -146.06 168.17 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 120.796 -1.19 . . . . 0.0 109.697 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.601 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 37.2 m-85 -116.7 114.86 24.62 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-O 122.051 0.929 . . . . 0.0 109.58 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.456 ' O ' ' OD1' ' A' ' 81' ' ' ASN . 78.7 t -91.31 131.64 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.765 ' ND2' ' HB3' ' A' ' 55' ' ' ALA . 1.1 t30 -46.95 127.65 10.31 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -57.38 13.9 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.63 -0.669 . . . . 0.0 111.441 -178.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.765 ' HB3' ' ND2' ' A' ' 53' ' ' ASN . . . -103.45 -19.8 14.28 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.57 -1.331 . . . . 0.0 109.8 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.551 ' CD2' HD22 ' A' ' 94' ' ' LEU . 30.2 m-85 -109.59 -9.78 14.87 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.708 -1.245 . . . . 0.0 108.859 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.0 p -71.18 -37.51 72.17 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.565 -0.71 . . . . 0.0 110.141 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.421 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 9.5 p-10 -87.84 10.51 18.33 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.229 -0.919 . . . . 0.0 109.913 -178.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.536 ' HB2' HD21 ' A' ' 94' ' ' LEU . 9.1 mttm -121.21 -40.04 2.63 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.66 HG22 ' HD2' ' A' ' 61' ' ' PRO . 0.4 OUTLIER -78.73 162.09 66.67 Favored Pre-proline 0 N--CA 1.498 1.953 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 179.813 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.66 ' HD2' HG22 ' A' ' 60' ' ' VAL . 4.4 Cg_endo -53.97 94.19 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 121.877 1.718 . . . . 0.0 113.939 -176.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.0 98.5 3.62 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 177.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.967 ' H ' HH22 ' A' ' 83' ' ' ARG . . . -61.05 169.34 2.04 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-O 122.559 1.171 . . . . 0.0 111.953 -178.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -65.18 -175.02 0.19 Allowed 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 122.204 1.002 . . . . 0.0 111.954 -178.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -70.33 3.31 3.0 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.813 -0.555 . . . . 0.0 111.409 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.2 mtm180 -59.95 -41.76 92.58 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.669 -1.269 . . . . 0.0 110.143 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.478 ' N ' ' CD ' ' A' ' 67' ' ' GLU . 23.7 mp0 -80.29 -37.0 33.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.021 -1.049 . . . . 0.0 110.029 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.446 HD12 ' N ' ' A' ' 68' ' ' ILE . 1.3 mp -46.88 -34.13 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 C-N-CA 119.731 -0.788 . . . . 0.0 109.142 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.3 -28.36 62.08 Favored Glycine 0 N--CA 1.498 2.791 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.421 ' N ' ' O ' ' A' ' 67' ' ' GLU . 25.1 mtt -79.97 -35.6 37.31 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 178.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 74.9 mt -66.81 -24.69 66.2 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -77.48 5.83 8.18 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.732 -1.23 . . . . 0.0 108.032 178.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -124.42 30.17 6.1 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.752 -0.592 . . . . 0.0 110.981 -177.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 28.9 m -96.35 169.54 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.42 0 O-C-N 120.652 -1.28 . . . . 0.0 110.723 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.524 ' OG1' ' CG ' ' A' ' 106' ' ' TRP . 3.1 m -102.41 -9.93 19.86 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.342 -0.849 . . . . 0.0 111.281 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.796 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -104.58 176.13 5.26 Favored 'General case' 0 N--CA 1.507 2.405 0 O-C-N 120.627 -1.296 . . . . 0.0 110.411 -178.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.601 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -59.64 105.33 0.36 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.613 -0.679 . . . . 0.0 110.255 -178.528 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.9 tp -73.96 147.35 43.14 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 119.502 -1.999 . . . . 0.0 110.338 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 27.0 mmtm -109.58 155.52 41.2 Favored Pre-proline 0 C--N 1.291 -1.962 0 CA-C-N 114.756 -1.111 . . . . 0.0 108.83 -178.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.47 -23.02 73.96 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 121.964 1.776 . . . . 0.0 109.331 178.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.456 ' OD1' ' O ' ' A' ' 52' ' ' VAL . 2.1 p30 -115.55 23.22 12.53 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.832 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.1 m -47.21 165.66 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.672 -1.268 . . . . 0.0 109.409 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.967 HH22 ' H ' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -161.58 141.99 10.71 Favored 'General case' 0 N--CA 1.5 2.046 0 C-N-CA 118.259 -1.376 . . . . 0.0 111.96 -177.531 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 95.5 mt -86.32 111.16 20.21 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 177.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.604 ' HA ' HD12 ' A' ' 88' ' ' ILE . 0.1 OUTLIER -56.2 -35.14 66.94 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -176.106 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' CYS . . . . . 0.547 ' SG ' ' N ' ' A' ' 87' ' ' GLN . 31.6 p -63.51 -49.06 75.05 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 119.678 -1.889 . . . . 0.0 112.343 -177.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.683 HE22 ' NH1' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -79.61 33.8 0.26 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.841 -1.162 . . . . 0.0 111.425 -177.709 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.604 HD12 ' HA ' ' A' ' 85' ' ' CYS . 71.5 mt -113.17 160.76 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 177.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.484 ' N ' HG22 ' A' ' 88' ' ' ILE . 35.6 mm -136.5 121.85 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.147 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.4 ' SD ' HD21 ' A' ' 23' ' ' LEU . 3.2 tpt -87.28 160.87 18.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.792 -1.193 . . . . 0.0 108.799 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 39.4 p -151.06 148.67 23.2 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -56.03 -32.37 85.97 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 121.379 1.386 . . . . 0.0 111.634 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.57 ' CD ' ' H ' ' A' ' 93' ' ' GLU . 2.3 pm0 -68.11 -31.52 71.18 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.062 -1.024 . . . . 0.0 110.006 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.551 HD22 ' CD2' ' A' ' 56' ' ' PHE . 7.2 mt -94.43 27.99 2.75 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 120.72 -1.237 . . . . 0.0 108.956 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -61.86 138.03 58.31 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.023 -1.048 . . . . 0.0 110.324 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 107.83 9.77 27.81 Favored Glycine 0 N--CA 1.499 2.866 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 178.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 14.4 tt -64.99 133.25 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 120.925 -1.338 . . . . 0.0 111.365 -177.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.3 t -103.06 114.59 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.5 t -103.72 135.75 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.729 -1.232 . . . . 0.0 108.558 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.1 116.17 31.44 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.809 0.814 . . . . 0.0 109.172 -179.023 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.2 t -103.34 125.01 36.24 Favored Pre-proline 0 N--CA 1.498 1.933 0 O-C-N 121.845 -0.534 . . . . 0.0 109.565 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.424 ' HG3' ' CD2' ' A' ' 49' ' ' HIS . 85.2 Cg_endo -80.6 167.24 19.09 Favored 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 122.193 1.929 . . . . 0.0 113.735 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -73.11 -14.98 61.49 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 21.5 mtm180 -123.82 92.32 3.65 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 2.7 pp0? -82.61 -19.51 38.23 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.628 -0.67 . . . . 0.0 109.716 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.524 ' CG ' ' OG1' ' A' ' 75' ' ' THR . 63.5 t-105 . . . . . 0 C--N 1.304 -1.373 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.537 178.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' FES . . . . . 0.499 ' S1 ' ' O ' ' A' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.408 ' OG ' ' O ' ' A' ' 17' ' ' VAL . 83.9 p . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.402 ' H ' ' HB2' ' A' ' 95' ' ' ASP . 25.4 mmtt -75.38 111.71 10.93 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.31 -0.869 . . . . 0.0 109.157 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.446 ' CG2' ' SD ' ' A' ' 90' ' ' MET . 17.2 t -109.49 109.19 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.343 -0.848 . . . . 0.0 109.499 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.473 HG22 ' OE1' ' A' ' 14' ' ' GLU . 38.5 t -99.57 96.49 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.127 -0.983 . . . . 0.0 111.345 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.432 ' CE2' ' CD1' ' A' ' 32' ' ' ILE . 93.9 m-85 -70.54 111.76 6.3 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.163 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 76.1 t -98.46 117.36 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 80.8 p -76.51 -158.6 0.1 Allowed 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.346 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.602 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -90.33 -49.65 6.41 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.089 -1.007 . . . . 0.0 109.466 -179.646 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.485 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 22.9 p-10 -66.39 2.06 1.39 Allowed 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.264 -0.897 . . . . 0.0 110.355 -178.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.01 -0.54 62.47 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -65.05 127.94 33.7 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.9 -1.353 . . . . 0.0 108.227 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.447 HH11 ' HD2' ' A' ' 12' ' ' ARG . 2.3 mtt85 -108.12 160.67 15.63 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 122.156 0.979 . . . . 0.0 110.796 -178.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -150.99 115.19 5.06 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 178.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.473 ' OE1' HG22 ' A' ' 4' ' ' VAL . 0.2 OUTLIER -99.19 128.46 45.32 Favored 'General case' 0 N--CA 1.508 2.436 0 CA-C-O 122.504 1.145 . . . . 0.0 110.613 -178.144 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.459 ' CD1' ' H ' ' A' ' 16' ' ' ASP . 0.2 OUTLIER -115.13 -173.86 2.39 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 123.072 1.415 . . . . 0.0 110.575 -178.475 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.459 ' H ' ' CD1' ' A' ' 15' ' ' LEU . 32.6 t0 -136.36 104.39 5.6 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 176.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.538 HG22 ' CB ' ' A' ' 26' ' ' ALA . 25.2 t -112.9 122.92 67.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 O-C-N 121.525 -0.734 . . . . 0.0 109.604 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.82 179.78 5.9 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.919 0.866 . . . . 0.0 111.519 -178.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -69.31 138.82 54.11 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 122.025 0.917 . . . . 0.0 110.913 -179.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.83 -17.09 37.94 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 62.0 t -81.9 139.13 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 O-C-N 120.51 -1.583 . . . . 0.0 109.122 -178.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 16.0 p -92.68 149.19 21.48 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.158 -0.964 . . . . 0.0 108.588 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 27.0 mt -50.01 -36.15 27.51 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 121.093 -1.004 . . . . 0.0 110.007 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.493 ' SD ' ' OD2' ' A' ' 34' ' ' ASP . 7.5 tpt -68.11 -24.37 65.02 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.319 -0.863 . . . . 0.0 109.474 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -76.94 -63.22 1.41 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.143 -0.973 . . . . 0.0 109.622 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.538 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -52.95 -28.54 24.06 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.123 -0.986 . . . . 0.0 110.599 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.491 ' HA ' HD12 ' A' ' 32' ' ' ILE . . . -57.14 -20.96 29.17 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.749 -1.22 . . . . 0.0 108.756 179.364 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.5 t -88.57 -23.85 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.485 -0.759 . . . . 0.0 110.585 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.3 -31.11 60.56 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.303 -0.873 . . . . 0.0 109.99 -179.287 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -104.54 0.09 28.35 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 64.4 59.03 8.84 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.872 ' O ' ' N ' ' A' ' 34' ' ' ASP . 25.3 mt -91.47 124.74 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.231 -1.159 . . . . 0.0 108.253 179.272 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -40.41 49.32 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.707 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -177.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.872 ' N ' ' O ' ' A' ' 32' ' ' ILE . 29.8 p-10 -94.17 -8.62 38.89 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.175 -0.953 . . . . 0.0 109.816 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.557 ' CG1' ' H ' ' A' ' 36' ' ' VAL . 9.5 tt -47.12 -177.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.451 -0.781 . . . . 0.0 110.693 -178.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.557 ' H ' ' CG1' ' A' ' 35' ' ' ILE . 42.8 t 60.63 91.48 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -178.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -148.87 151.51 23.67 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.505 ' C ' ' H ' ' A' ' 40' ' ' GLY . 26.4 m-20 -88.21 -68.4 0.76 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.126 -1.22 . . . . 0.0 109.956 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.625 ' SG ' ' N ' ' A' ' 42' ' ' SER . 4.7 p -69.81 15.7 0.08 Allowed 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 119.901 -0.72 . . . . 0.0 109.653 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.505 ' H ' ' C ' ' A' ' 38' ' ' ASP . . . 51.4 11.83 0.82 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.487 ' N ' ' C ' ' A' ' 39' ' ' CYS . . . 96.61 19.76 26.44 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.625 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 4.8 p -93.38 35.12 1.11 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.323 -1.104 . . . . 0.0 109.537 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 45.2 74.56 0.13 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.341 -0.849 . . . . 0.0 110.314 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -166.65 26.44 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.846 -1.159 . . . . 0.0 109.927 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.489 ' O ' ' S1 ' ' A' ' 107' ' ' FES . 3.0 p -161.59 -177.0 5.63 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.099 -1.001 . . . . 0.0 109.717 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -116.27 12.75 15.47 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.361 -0.837 . . . . 0.0 109.524 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.457 HG21 ' H ' ' A' ' 38' ' ' ASP . 75.5 p -59.81 -28.5 67.51 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.226 -0.921 . . . . 0.0 109.483 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 20.8 p -97.28 54.21 1.21 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.214 -0.928 . . . . 0.0 109.586 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.679 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 39.5 t60 -76.2 96.11 3.84 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -133.65 164.58 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 121.151 -0.968 . . . . 0.0 109.748 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.518 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 45.8 m-85 -113.54 113.25 24.85 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 122.073 0.94 . . . . 0.0 110.192 -179.05 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.465 HG12 HD22 ' A' ' 53' ' ' ASN . 47.1 t -87.25 131.13 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.609 ' N ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -48.0 128.19 13.29 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.92 -1.113 . . . . 0.0 108.902 179.834 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -55.85 9.96 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.284 -0.885 . . . . 0.0 111.515 -178.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.597 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -98.19 -18.42 18.46 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.892 -1.13 . . . . 0.0 110.137 -179.316 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.612 ' CD2' HD22 ' A' ' 94' ' ' LEU . 26.1 m-85 -114.66 -7.45 12.73 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 120.707 -1.246 . . . . 0.0 108.855 -179.448 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.3 p -71.61 -41.18 69.22 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.083 -1.01 . . . . 0.0 109.858 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -85.48 10.17 13.74 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.435 -0.791 . . . . 0.0 110.006 -178.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.507 ' HB2' HD21 ' A' ' 94' ' ' LEU . 17.3 mttt -120.11 -38.46 2.93 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.684 HG22 ' HD2' ' A' ' 61' ' ' PRO . 0.4 OUTLIER -82.51 164.14 48.79 Favored Pre-proline 0 N--CA 1.493 1.705 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.684 ' HD2' HG22 ' A' ' 60' ' ' VAL . 5.6 Cg_endo -58.31 99.33 0.1 OUTLIER 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 121.773 1.649 . . . . 0.0 114.714 -176.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.27 102.97 1.48 Allowed 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -56.77 155.33 7.88 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-O 122.304 1.049 . . . . 0.0 112.51 -178.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.444 ' ND2' ' NH1' ' A' ' 66' ' ' ARG . 3.0 p30 -59.3 -178.2 0.06 Allowed 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.721 0.772 . . . . 0.0 111.148 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -70.1 2.19 3.88 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.669 -0.644 . . . . 0.0 112.354 -178.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.444 ' NH1' ' ND2' ' A' ' 64' ' ' ASN . 51.4 mtt85 -67.57 -40.97 84.87 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 120.68 -1.263 . . . . 0.0 109.679 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.484 ' N ' ' CD ' ' A' ' 67' ' ' GLU . 23.0 mp0 -72.26 -41.06 67.17 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.08 -1.013 . . . . 0.0 108.609 178.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.499 HD12 ' N ' ' A' ' 68' ' ' ILE . 1.4 mp -48.31 -30.26 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -70.15 -74.9 0.63 Allowed Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 9.0 ptp -46.38 -33.89 4.21 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.875 -1.368 . . . . 0.0 109.144 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.488 HD22 HD11 ' A' ' 78' ' ' LEU . 12.0 mt -58.04 -28.56 64.6 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.536 ' N ' ' O ' ' A' ' 69' ' ' GLY . 39.6 tt0 -79.71 5.11 14.22 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.368 -0.833 . . . . 0.0 108.771 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -122.99 31.57 5.98 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.555 -0.716 . . . . 0.0 110.122 -178.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.562 HG21 HD13 ' A' ' 78' ' ' LEU . 16.4 m -92.09 166.77 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 120.797 -1.189 . . . . 0.0 110.006 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.47 ' OG1' ' CG ' ' A' ' 106' ' ' TRP . 4.8 m -99.56 -8.08 25.02 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.806 -0.558 . . . . 0.0 110.249 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.679 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -107.36 169.74 8.39 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.113 -0.992 . . . . 0.0 110.354 -178.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.518 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -60.91 108.52 0.87 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.815 -0.553 . . . . 0.0 109.67 -179.553 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.562 HD13 HG21 ' A' ' 74' ' ' VAL . 8.5 tp -72.93 155.78 39.52 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 120.011 -1.681 . . . . 0.0 110.118 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 25.3 mmtm -117.15 153.54 49.78 Favored Pre-proline 0 C--N 1.292 -1.916 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 -178.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.4 -22.16 70.37 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 C-N-CA 121.173 1.249 . . . . 0.0 109.77 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.431 ' OD1' ' O ' ' A' ' 81' ' ' ASN . 1.1 p30 -111.77 19.66 17.8 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.867 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 21.6 m -58.24 162.69 3.39 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.542 -1.349 . . . . 0.0 109.746 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.563 ' NH2' ' O ' ' A' ' 61' ' ' PRO . 0.7 OUTLIER -171.72 146.28 2.09 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 118.32 -1.352 . . . . 0.0 111.169 179.447 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.469 HD23 ' S1 ' ' A' ' 107' ' ' FES . 5.3 mp -76.62 116.01 16.9 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -57.51 -16.96 11.25 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.446 -0.784 . . . . 0.0 112.922 -176.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 30.5 p -85.85 -33.16 21.37 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 119.81 -1.806 . . . . 0.0 111.207 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.406 ' OE1' ' CD ' ' A' ' 67' ' ' GLU . 34.2 tt0 -87.53 32.05 0.73 Allowed 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.261 -1.525 . . . . 0.0 110.403 -179.28 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.407 HG22 ' N ' ' A' ' 89' ' ' ILE . 41.3 mm -117.61 157.93 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 O-C-N 121.022 -1.049 . . . . 0.0 108.423 178.266 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.407 ' N ' HG22 ' A' ' 88' ' ' ILE . 35.2 mm -130.5 122.7 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.446 ' SD ' ' CG2' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -86.54 155.84 20.32 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.137 -0.977 . . . . 0.0 108.622 -178.888 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 57.0 p -147.81 148.02 28.98 Favored Pre-proline 0 N--CA 1.492 1.663 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -58.08 -32.71 96.16 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 121.286 1.324 . . . . 0.0 111.018 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -64.82 -28.54 69.63 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.13 -0.981 . . . . 0.0 109.262 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.612 HD22 ' CD2' ' A' ' 56' ' ' PHE . 6.4 mt -99.37 27.59 5.11 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.401 -0.812 . . . . 0.0 109.492 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.402 ' HB2' ' H ' ' A' ' 2' ' ' LYS . 9.2 p-10 -58.9 138.45 57.36 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.876 -1.14 . . . . 0.0 109.361 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 107.22 9.75 29.01 Favored Glycine 0 N--CA 1.501 3.028 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 178.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.446 HG13 HD21 ' A' ' 53' ' ' ASN . 16.4 tt -65.09 130.05 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.842 -1.387 . . . . 0.0 111.113 -178.063 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.8 t -103.5 115.36 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.446 -0.784 . . . . 0.0 109.077 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.5 t -102.65 134.81 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 120.922 -1.112 . . . . 0.0 109.366 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -108.39 124.05 49.78 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.799 0.809 . . . . 0.0 109.661 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.1 t -111.11 124.12 33.58 Favored Pre-proline 0 N--CA 1.495 1.816 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.415 ' HG3' ' CD2' ' A' ' 49' ' ' HIS . 75.6 Cg_endo -83.06 175.53 8.41 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 122.678 2.252 . . . . 0.0 113.37 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -83.5 -17.34 42.25 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -109.74 80.92 1.36 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.447 ' O ' ' OXT' ' A' ' 106' ' ' TRP . 39.5 tt0 -82.95 -33.27 26.77 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.116 -0.99 . . . . 0.0 109.177 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.548 ' CG ' ' O ' ' A' ' 106' ' ' TRP . 57.3 t-105 . . . . . 0 C--N 1.301 -1.522 0 CA-C-O 118.294 -0.86 . . . . 0.0 109.788 179.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' FES . . . . . 0.489 ' S1 ' ' O ' ' A' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 68.0 p . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.414 ' H ' ' HB2' ' A' ' 95' ' ' ASP . 19.1 mmtm -76.96 113.88 15.14 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.98 -1.075 . . . . 0.0 108.534 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.532 HG21 ' CG2' ' A' ' 17' ' ' VAL . 49.5 t -115.0 109.91 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.442 -0.786 . . . . 0.0 110.076 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.6 t -102.64 134.88 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 CA-C-O 121.749 0.785 . . . . 0.0 110.389 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -106.12 114.5 28.68 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 177.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 67.0 t -97.82 115.21 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 27.7 p -77.92 -160.28 0.19 Allowed 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.426 0.631 . . . . 0.0 109.674 -178.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.58 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.2 OUTLIER -87.13 -47.23 9.06 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.563 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.459 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 17.8 p30 -70.52 -2.53 14.36 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.088 -1.007 . . . . 0.0 110.973 -178.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.12 0.0 57.26 Favored Glycine 0 N--CA 1.499 2.863 0 O-C-N 120.854 -1.154 . . . . 0.0 110.953 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -66.31 131.15 45.45 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.628 -1.513 . . . . 0.0 108.847 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.84 156.03 23.61 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.579 0.704 . . . . 0.0 110.979 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.3 mmm-85 -142.76 112.75 7.03 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 177.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.484 ' CD ' ' H ' ' A' ' 14' ' ' GLU . 2.6 mp0 -98.37 127.33 44.26 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.863 -1.148 . . . . 0.0 109.819 -178.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.497 HD22 ' CG ' ' A' ' 30' ' ' ASN . 19.4 mt -117.88 -165.19 1.07 Allowed 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 122.738 1.256 . . . . 0.0 110.0 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -137.13 99.77 4.09 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 104.942 -2.244 . . . . 0.0 104.942 176.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.532 ' CG2' HG21 ' A' ' 3' ' ' VAL . 12.8 t -102.63 115.36 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.33 177.17 4.05 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 122.359 1.076 . . . . 0.0 111.312 -178.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -65.69 133.34 50.88 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.975 0.893 . . . . 0.0 110.709 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.03 -18.4 53.83 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.431 ' HB ' HG12 ' A' ' 17' ' ' VAL . 61.3 t -85.36 138.64 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.585 -1.538 . . . . 0.0 109.175 -178.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.438 ' O ' ' N ' ' A' ' 25' ' ' GLN . 59.9 p -93.38 146.35 23.8 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.266 -0.896 . . . . 0.0 109.458 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.5 mt -48.11 -34.17 9.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.001 -1.062 . . . . 0.0 109.406 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.49 ' O ' ' SD ' ' A' ' 24' ' ' MET . 4.3 tpt -67.55 -29.07 68.35 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.438 ' N ' ' O ' ' A' ' 22' ' ' SER . 14.5 mm100 -73.74 -59.83 2.53 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.104 -0.997 . . . . 0.0 109.637 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.41 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -60.48 -24.42 65.26 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.878 -1.139 . . . . 0.0 111.22 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.4 -24.58 67.9 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.941 -1.099 . . . . 0.0 108.967 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 88.7 t -80.78 -23.52 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 CA-C-O 121.555 0.693 . . . . 0.0 109.148 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.25 -27.54 35.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.4 -0.812 . . . . 0.0 109.28 -179.14 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.497 ' CG ' HD22 ' A' ' 15' ' ' LEU . 7.0 m-80 -103.21 1.31 32.87 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 178.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 63.68 70.55 1.03 Allowed Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.418 HD12 HD11 ' A' ' 15' ' ' LEU . 71.4 mt -124.4 -43.61 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.674 -0.898 . . . . 0.0 110.516 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.692 ' O ' ' N ' ' A' ' 35' ' ' ILE . 0.2 OUTLIER -80.33 15.36 1.62 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.777 -1.202 . . . . 0.0 109.979 -179.047 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -58.11 54.47 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.516 0.674 . . . . 0.0 110.521 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.692 ' N ' ' O ' ' A' ' 33' ' ' TYR . 40.4 mm -126.91 -86.63 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.573 HG12 ' N ' ' A' ' 37' ' ' GLY . 69.9 t -148.8 164.17 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.923 -1.11 . . . . 0.0 109.609 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.573 ' N ' HG12 ' A' ' 36' ' ' VAL . . . -166.01 109.63 0.37 Allowed Glycine 0 N--CA 1.483 1.808 0 N-CA-C 108.741 -1.743 . . . . 0.0 108.741 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -87.44 -91.93 0.11 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.16 -1.2 . . . . 0.0 109.764 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.431 ' SG ' ' N ' ' A' ' 42' ' ' SER . 0.5 OUTLIER -51.65 -28.77 15.5 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.047 -1.033 . . . . 0.0 108.642 -179.677 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 46.71 65.15 2.31 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 85.96 55.22 2.57 Favored Glycine 0 N--CA 1.497 2.755 0 C-N-CA 119.469 -1.348 . . . . 0.0 109.785 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.431 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 0.6 OUTLIER -155.9 14.12 0.34 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.348 -1.678 . . . . 0.0 110.368 179.583 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.739 ' HB2' ' NE2' ' A' ' 87' ' ' GLN . . . 42.42 70.0 0.33 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.271 -0.893 . . . . 0.0 109.957 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.7 t -162.57 22.21 0.1 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.92 -1.113 . . . . 0.0 109.861 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.528 ' SG ' ' N ' ' A' ' 46' ' ' ALA . 2.1 p -155.76 -156.25 0.63 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.047 -1.033 . . . . 0.0 109.975 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.528 ' N ' ' SG ' ' A' ' 45' ' ' CYS . . . -149.04 21.38 0.98 Allowed 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 42.7 p -71.35 -38.92 71.59 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.021 -1.05 . . . . 0.0 110.206 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.497 ' SG ' ' O ' ' A' ' 48' ' ' CYS . 15.0 p -91.37 48.11 1.45 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.795 -1.191 . . . . 0.0 109.996 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.703 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 53.8 t60 -77.99 113.14 15.62 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.969 -1.082 . . . . 0.0 109.026 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -146.05 165.12 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.107 -0.996 . . . . 0.0 109.214 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.576 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 52.0 m-85 -114.03 111.57 21.86 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 121.667 0.746 . . . . 0.0 109.788 -178.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.584 HG13 HD11 ' A' ' 97' ' ' ILE . 81.9 t -86.12 135.02 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.578 ' C ' ' H ' ' A' ' 55' ' ' ALA . 3.3 t30 -49.7 128.09 17.22 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.91 -1.119 . . . . 0.0 108.973 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -56.09 12.13 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.592 -0.692 . . . . 0.0 111.566 -178.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.578 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -101.06 -19.62 15.72 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.892 -1.13 . . . . 0.0 109.8 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.559 ' CD2' HD22 ' A' ' 94' ' ' LEU . 46.3 m-85 -110.78 -11.59 14.37 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.767 -1.208 . . . . 0.0 109.596 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.549 HG21 ' OD1' ' A' ' 81' ' ' ASN . 9.5 p -70.59 -38.3 74.03 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.81 -1.181 . . . . 0.0 110.012 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -85.85 9.71 15.93 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.184 -0.948 . . . . 0.0 110.092 -178.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.437 ' CE ' ' O ' ' A' ' 55' ' ' ALA . 9.6 mttm -121.11 -37.93 2.88 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.605 HG22 ' HD2' ' A' ' 61' ' ' PRO . 0.5 OUTLIER -81.84 159.0 67.06 Favored Pre-proline 0 N--CA 1.494 1.748 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.796 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.605 ' HD2' HG22 ' A' ' 60' ' ' VAL . 3.1 Cg_exo -48.7 101.96 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.029 1.819 . . . . 0.0 112.247 -178.036 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.9 101.44 4.41 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.544 ' HB1' ' OE1' ' A' ' 67' ' ' GLU . . . -49.63 144.05 6.44 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-O 121.878 0.847 . . . . 0.0 111.504 -178.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -53.56 -175.17 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.658 0.742 . . . . 0.0 110.121 -179.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -69.5 -1.44 8.62 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.697 -0.627 . . . . 0.0 111.136 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.507 ' O ' ' SD ' ' A' ' 70' ' ' MET . 8.8 mtt85 -63.85 -39.92 95.36 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.769 -1.207 . . . . 0.0 109.439 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.544 ' OE1' ' HB1' ' A' ' 63' ' ' ALA . 10.2 mp0 -78.18 -40.68 37.0 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.174 -0.953 . . . . 0.0 109.868 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.484 HD12 ' N ' ' A' ' 68' ' ' ILE . 1.4 mp -46.72 -25.33 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.49 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -76.66 -67.81 1.62 Allowed Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.066 -1.614 . . . . 0.0 109.066 179.259 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.573 ' CE ' ' HB1' ' A' ' 43' ' ' ALA . 4.7 mpp? -49.28 -39.42 30.74 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.054 -1.262 . . . . 0.0 108.599 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.566 ' O ' HD13 ' A' ' 78' ' ' LEU . 6.5 mt -55.2 -21.71 14.86 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.49 ' N ' ' O ' ' A' ' 69' ' ' GLY . 27.0 tt0 -91.08 12.46 19.8 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -124.93 31.04 5.74 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.446 -0.784 . . . . 0.0 110.085 -179.083 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.475 HG13 ' HB1' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -98.61 175.5 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.287 0 O-C-N 121.375 -0.828 . . . . 0.0 109.215 179.717 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.525 ' OG1' ' CD1' ' A' ' 106' ' ' TRP . 4.2 m -109.71 -0.61 18.46 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.342 -0.849 . . . . 0.0 110.026 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.703 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -107.45 167.44 9.93 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.053 -1.029 . . . . 0.0 109.882 -179.092 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.576 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -58.07 106.8 0.4 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.616 -0.677 . . . . 0.0 110.935 -178.767 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.566 HD13 ' O ' ' A' ' 71' ' ' LEU . 7.2 tp -70.29 147.67 49.41 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 120.106 -1.621 . . . . 0.0 109.562 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.1 mmtp -112.78 156.04 43.13 Favored Pre-proline 0 C--N 1.29 -2.003 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -178.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -54.22 -22.14 25.02 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 121.349 1.366 . . . . 0.0 109.862 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.549 ' OD1' HG21 ' A' ' 57' ' ' THR . 0.1 OUTLIER -126.99 37.81 4.21 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.955 -0.465 . . . . 0.0 110.426 -179.887 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.441 ' HG ' ' HE1' ' A' ' 51' ' ' TYR . 37.5 m -60.49 175.46 0.45 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.365 -1.46 . . . . 0.0 108.445 179.096 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.458 ' HE ' HG12 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -166.24 159.86 15.43 Favored 'General case' 0 N--CA 1.504 2.227 0 C-N-CA 118.28 -1.368 . . . . 0.0 111.583 -178.183 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.413 ' C ' ' SG ' ' A' ' 48' ' ' CYS . 50.0 mt -105.75 95.35 5.74 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 178.22 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.489 ' C ' ' H ' ' A' ' 87' ' ' GLN . 0.1 OUTLIER -39.78 -44.34 1.57 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.553 -0.717 . . . . 0.0 112.848 -176.718 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 13.9 p -60.65 5.94 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 119.972 -1.705 . . . . 0.0 110.938 -177.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.739 ' NE2' ' HB2' ' A' ' 43' ' ' ALA . 13.6 mt-30 -136.02 45.39 2.39 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 120.937 -1.102 . . . . 0.0 111.664 -178.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.458 HG12 ' HE ' ' A' ' 83' ' ' ARG . 3.7 mt -131.77 156.18 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 O-C-N 121.074 -1.016 . . . . 0.0 108.602 177.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 38.3 mm -129.7 126.48 62.9 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.427 0 O-C-N 121.31 -0.869 . . . . 0.0 109.524 -178.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.468 ' SD ' HG21 ' A' ' 97' ' ' ILE . 4.1 tpt -91.05 163.51 14.28 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.106 -0.996 . . . . 0.0 110.38 -179.436 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 70.6 p -151.93 147.24 19.59 Favored Pre-proline 0 N--CA 1.488 1.469 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -56.35 -30.08 79.63 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 121.259 1.306 . . . . 0.0 111.568 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -68.96 -31.21 69.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.105 -0.997 . . . . 0.0 110.334 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.559 HD22 ' CD2' ' A' ' 56' ' ' PHE . 5.7 mt -95.58 32.72 1.75 Allowed 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.209 -0.932 . . . . 0.0 109.488 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.414 ' HB2' ' H ' ' A' ' 2' ' ' LYS . 3.7 p30 -62.45 138.6 58.49 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.71 -1.244 . . . . 0.0 110.159 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 109.86 9.75 24.03 Favored Glycine 0 N--CA 1.504 3.187 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 178.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.685 HD13 ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -65.04 129.89 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 120.996 -1.297 . . . . 0.0 111.555 -177.708 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.685 ' N ' HD13 ' A' ' 97' ' ' ILE . 4.9 t -106.99 118.97 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.2 -0.937 . . . . 0.0 109.393 -179.249 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.1 t -101.84 133.27 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.014 -1.054 . . . . 0.0 109.283 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.68 115.51 30.37 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.273 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 18.0 t -103.73 122.89 43.08 Favored Pre-proline 0 N--CA 1.494 1.736 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.41 ' HG3' ' CD2' ' A' ' 49' ' ' HIS . 89.7 Cg_endo -82.16 177.8 6.9 Favored 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 121.975 1.784 . . . . 0.0 113.111 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -85.75 -13.78 47.26 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.471 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -120.7 86.89 2.65 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -178.086 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.502 ' OE1' HG21 ' A' ' 35' ' ' ILE . 6.1 pt20 -85.05 -28.76 25.45 Favored 'General case' 0 C--N 1.308 -1.207 0 O-C-N 121.115 -0.99 . . . . 0.0 109.312 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.525 ' CD1' ' OG1' ' A' ' 75' ' ' THR . 62.5 t-105 . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.611 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.448 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.412 ' H ' ' HB2' ' A' ' 95' ' ' ASP . 0.2 OUTLIER -82.69 110.66 17.95 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.614 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.492 HG21 ' CG2' ' A' ' 17' ' ' VAL . 53.6 t -108.59 108.58 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.268 -0.895 . . . . 0.0 110.058 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 62.9 t -99.11 126.31 52.39 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-O 121.97 0.89 . . . . 0.0 110.278 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.509 ' CE2' HD13 ' A' ' 32' ' ' ILE . 88.0 m-85 -103.45 112.95 26.08 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 177.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 64.7 t -99.63 120.88 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.7 p -82.44 -153.28 0.12 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.238 -0.913 . . . . 0.0 109.319 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.589 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -91.14 -44.35 9.31 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.458 -0.776 . . . . 0.0 109.393 -179.908 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.93 -0.87 3.4 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.217 -0.927 . . . . 0.0 111.317 -178.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.5 0.52 69.78 Favored Glycine 0 N--CA 1.498 2.826 0 O-C-N 120.427 -1.421 . . . . 0.0 110.618 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.1 t -72.46 135.7 45.8 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.938 -1.331 . . . . 0.0 108.31 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.29 163.9 12.64 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 122.204 1.002 . . . . 0.0 111.048 -178.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 -151.02 112.77 4.47 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -100.24 127.77 46.45 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-O 122.561 1.172 . . . . 0.0 111.127 -178.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.431 HD21 ' CB ' ' A' ' 30' ' ' ASN . 0.2 OUTLIER -114.63 -174.97 2.58 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-O 122.811 1.291 . . . . 0.0 110.301 -177.954 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.429 ' H ' HD13 ' A' ' 15' ' ' LEU . 18.2 t70 -134.26 100.62 4.74 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 176.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.492 ' CG2' HG21 ' A' ' 3' ' ' VAL . 7.6 t -111.21 115.79 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.15 177.14 3.4 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.884 0.85 . . . . 0.0 111.495 -177.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -66.02 138.55 57.87 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 122.014 0.911 . . . . 0.0 110.325 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.42 -18.11 35.13 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 178.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.485 ' HB ' HG12 ' A' ' 17' ' ' VAL . 51.9 t -83.79 140.68 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 120.704 -1.468 . . . . 0.0 109.326 -178.645 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 51.5 p -93.58 147.69 22.77 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.231 -0.918 . . . . 0.0 109.131 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.405 ' N ' HD23 ' A' ' 23' ' ' LEU . 7.9 mt -50.23 -31.9 15.16 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.193 -0.942 . . . . 0.0 109.477 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.448 ' SD ' ' C ' ' A' ' 24' ' ' MET . 1.4 tmt? -68.64 -29.58 68.1 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 52.5 mm-40 -72.05 -63.76 1.07 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.063 -1.023 . . . . 0.0 109.355 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.439 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -58.35 -25.6 62.16 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.996 -1.065 . . . . 0.0 110.374 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.588 ' HA ' HD12 ' A' ' 32' ' ' ILE . . . -60.27 -20.47 59.15 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.974 -1.079 . . . . 0.0 108.981 179.151 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 84.1 t -86.54 -22.62 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.637 -0.664 . . . . 0.0 109.636 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.74 -26.74 40.66 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.443 -0.786 . . . . 0.0 109.075 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.431 ' CB ' HD21 ' A' ' 15' ' ' LEU . 4.9 m120 -113.14 -0.09 14.78 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 63.66 79.73 0.15 Allowed Glycine 0 N--CA 1.496 2.657 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.588 HD12 ' HA ' ' A' ' 27' ' ' ALA . 78.6 mt -124.53 -63.44 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 O-C-N 121.689 -0.889 . . . . 0.0 111.01 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.55 ' H ' ' HB1' ' A' ' 27' ' ' ALA . 26.7 m-85 -92.66 -12.58 31.19 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.145 -0.972 . . . . 0.0 109.988 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 33' ' ' TYR . 10.6 p-10 -39.29 -50.07 1.97 Allowed 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.528 -0.733 . . . . 0.0 109.875 -178.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.504 HG23 ' O ' ' A' ' 35' ' ' ILE . 19.9 tt -44.03 125.02 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.678 -0.638 . . . . 0.0 109.34 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.568 HG12 ' N ' ' A' ' 37' ' ' GLY . 94.0 t 55.73 163.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 CA-C-O 121.497 0.665 . . . . 0.0 109.905 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.568 ' N ' HG12 ' A' ' 36' ' ' VAL . . . 170.0 115.8 0.35 Allowed Glycine 0 N--CA 1.488 2.146 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.509 ' C ' ' H ' ' A' ' 40' ' ' GLY . 28.7 t70 -87.73 -83.58 0.2 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.947 -1.325 . . . . 0.0 110.039 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.552 ' SG ' ' N ' ' A' ' 42' ' ' SER . 11.9 p -69.73 15.84 0.07 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.087 -1.008 . . . . 0.0 109.51 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.509 ' H ' ' C ' ' A' ' 38' ' ' ASP . . . 52.42 13.4 1.85 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.46 -1.856 . . . . 0.0 108.46 -179.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.468 ' N ' ' C ' ' A' ' 39' ' ' CYS . . . 88.57 89.88 1.14 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.552 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 41.1 t -159.51 22.4 0.18 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.124 -1.221 . . . . 0.0 108.885 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 58.24 63.45 1.74 Allowed 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.296 -0.878 . . . . 0.0 109.837 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.8 t -160.81 23.12 0.14 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.99 -1.069 . . . . 0.0 110.399 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.483 ' O ' ' S1 ' ' A' ' 107' ' ' FES . 1.5 p -162.16 166.24 25.9 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.027 -1.046 . . . . 0.0 110.047 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.444 ' HB1' HG12 ' A' ' 74' ' ' VAL . . . -97.25 4.36 51.0 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.442 ' OG1' ' SG ' ' A' ' 45' ' ' CYS . 11.1 m -49.7 -54.0 21.32 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 120.911 -1.118 . . . . 0.0 109.539 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.525 ' SG ' ' N ' ' A' ' 85' ' ' CYS . 31.9 p -80.11 53.76 1.8 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 120.944 -1.098 . . . . 0.0 109.605 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.621 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 39.3 t60 -77.64 105.61 8.91 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -143.62 164.83 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 120.859 -1.151 . . . . 0.0 109.889 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.512 ' OH ' ' NE2' ' A' ' 49' ' ' HIS . 36.4 m-85 -111.56 111.01 21.71 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.921 0.867 . . . . 0.0 110.101 -179.07 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.789 HG13 HD11 ' A' ' 97' ' ' ILE . 15.2 t -85.9 130.62 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.593 ' C ' ' H ' ' A' ' 55' ' ' ALA . 17.8 t-20 -47.11 126.18 8.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.783 -1.198 . . . . 0.0 109.566 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -57.32 13.99 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.737 -0.602 . . . . 0.0 111.291 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.593 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -100.7 -18.99 16.25 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.729 -1.232 . . . . 0.0 109.781 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.559 ' HB2' HD13 ' A' ' 97' ' ' ILE . 65.7 m-85 -113.85 -10.93 12.92 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.098 -1.001 . . . . 0.0 109.078 -178.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 13.1 p -68.99 -43.18 75.39 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.37 -0.831 . . . . 0.0 109.952 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -81.47 4.64 20.36 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.575 -0.703 . . . . 0.0 109.743 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 21.1 mtpt -113.19 -38.29 4.49 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.643 HG23 HD12 ' A' ' 94' ' ' LEU . 0.5 OUTLIER -82.8 158.57 65.0 Favored Pre-proline 0 N--CA 1.497 1.879 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 179.701 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.556 ' O ' ' NH2' ' A' ' 83' ' ' ARG . 1.1 Cg_endo -51.33 84.93 0.02 OUTLIER 'Trans proline' 0 N--CA 1.501 1.939 0 C-N-CA 122.405 2.07 . . . . 0.0 113.792 -176.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.79 105.17 0.28 Allowed 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -56.86 150.76 15.79 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-O 122.235 1.017 . . . . 0.0 112.667 -178.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.546 ' H ' ' ND2' ' A' ' 64' ' ' ASN . 0.6 OUTLIER -61.61 -172.84 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.032 -179.847 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -71.07 1.9 5.19 Favored 'General case' 0 N--CA 1.503 2.198 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -178.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.2 mtm180 -73.77 -46.74 43.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.386 -1.446 . . . . 0.0 109.087 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.443 ' N ' ' CD ' ' A' ' 67' ' ' GLU . 9.2 mp0 -64.39 -25.14 67.89 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.234 -0.916 . . . . 0.0 109.054 178.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.569 HD12 ' N ' ' A' ' 68' ' ' ILE . 1.4 mp -68.3 -34.74 67.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.032 -1.042 . . . . 0.0 108.839 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.82 -23.8 59.39 Favored Glycine 0 N--CA 1.496 2.672 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.434 ' N ' ' SD ' ' A' ' 70' ' ' MET . 0.9 OUTLIER -88.81 -31.54 18.28 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.911 -1.347 . . . . 0.0 107.571 178.931 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.433 HD22 ' HB3' ' A' ' 82' ' ' SER . 52.8 mt -67.74 -23.04 65.21 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -80.34 0.89 31.04 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -121.91 32.61 5.78 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.605 -0.684 . . . . 0.0 110.254 -178.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.603 HG21 HD13 ' A' ' 78' ' ' LEU . 29.3 m -94.69 167.21 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 O-C-N 121.126 -0.984 . . . . 0.0 110.796 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.4 m -104.24 -4.87 22.47 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.378 -0.826 . . . . 0.0 109.883 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.621 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -107.88 170.85 7.74 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.014 -1.053 . . . . 0.0 110.749 -178.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.504 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -61.54 107.67 0.84 Allowed 'General case' 0 N--CA 1.5 2.037 0 CA-C-O 121.532 0.682 . . . . 0.0 110.034 -179.716 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.603 HD13 HG21 ' A' ' 74' ' ' VAL . 8.6 tp -69.6 159.88 32.57 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 119.606 -1.934 . . . . 0.0 110.303 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.404 ' H ' ' HG ' ' A' ' 78' ' ' LEU . 18.7 mmtp -123.27 154.26 65.36 Favored Pre-proline 0 C--N 1.297 -1.715 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 -178.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -58.07 -23.6 61.72 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 121.537 1.491 . . . . 0.0 110.014 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 52' ' ' VAL . 1.5 p30 -117.07 27.72 8.95 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.99 -0.444 . . . . 0.0 109.837 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.433 ' HB3' HD22 ' A' ' 71' ' ' LEU . 5.0 m -58.48 166.68 1.67 Allowed 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.373 -1.455 . . . . 0.0 109.452 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.612 HH12 HG12 ' A' ' 60' ' ' VAL . 0.5 OUTLIER -172.32 153.43 2.98 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.122 -1.031 . . . . 0.0 111.267 179.549 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.802 ' H ' HD12 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -83.34 129.04 34.97 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 177.887 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.525 ' N ' ' SG ' ' A' ' 48' ' ' CYS . 0.5 OUTLIER -75.2 -6.11 47.96 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.718 -1.239 . . . . 0.0 112.584 -176.601 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 27.7 p -89.41 -33.65 16.77 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.281 -1.512 . . . . 0.0 110.722 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -92.33 49.54 1.52 Allowed 'General case' 0 N--CA 1.504 2.226 0 O-C-N 120.979 -1.076 . . . . 0.0 110.467 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 30.6 mt -130.56 154.26 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 36.5 mm -129.19 127.79 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.348 0 O-C-N 121.249 -0.907 . . . . 0.0 109.7 -178.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.907 ' SD ' HG21 ' A' ' 97' ' ' ILE . 8.1 tpt -89.02 161.17 16.73 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.908 -1.12 . . . . 0.0 110.099 -179.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.6 p -151.19 149.53 24.98 Favored Pre-proline 0 N--CA 1.491 1.62 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.6 -39.51 82.16 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 121.626 1.55 . . . . 0.0 111.754 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -64.16 -24.93 67.86 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.143 -0.973 . . . . 0.0 108.842 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.643 HD12 HG23 ' A' ' 60' ' ' VAL . 14.1 mt -99.52 23.99 8.74 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.434 -0.792 . . . . 0.0 109.577 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.442 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 18.7 p-10 -65.88 140.87 58.39 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.169 -0.957 . . . . 0.0 109.621 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 106.69 7.73 33.54 Favored Glycine 0 N--CA 1.506 3.338 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 178.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.907 HG21 ' SD ' ' A' ' 90' ' ' MET . 0.3 OUTLIER -61.71 127.65 21.89 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 O-C-N 121.707 -0.878 . . . . 0.0 110.346 -178.265 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.3 t -103.74 115.38 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.244 -0.91 . . . . 0.0 109.728 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.5 t -101.65 134.37 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.926 -1.109 . . . . 0.0 109.851 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.49 123.63 49.18 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 121.884 0.85 . . . . 0.0 108.722 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.3 t -112.97 126.37 28.35 Favored Pre-proline 0 N--CA 1.497 1.919 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.415 ' HG3' ' CD2' ' A' ' 49' ' ' HIS . 58.1 Cg_endo -84.52 178.07 5.27 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.797 2.331 . . . . 0.0 113.031 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.424 ' OD2' ' CD2' ' A' ' 8' ' ' HIS . 1.0 OUTLIER -84.2 -17.99 38.08 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.57 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -107.68 83.15 1.76 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.622 ' CD ' ' H ' ' A' ' 105' ' ' GLN . 0.3 OUTLIER -84.69 -31.66 24.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.911 -1.118 . . . . 0.0 108.887 -179.636 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.405 ' OXT' ' O ' ' A' ' 105' ' ' GLN . 57.4 t-105 . . . . . 0 C--N 1.3 -1.568 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.145 178.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' FES . . . . . 0.483 ' S1 ' ' O ' ' A' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.432 ' OG ' ' O ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.412 ' H ' ' HB2' ' A' ' 95' ' ' ASP . 27.2 mmtt -76.19 107.14 8.21 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.403 -0.919 . . . . 0.0 108.718 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.401 HG22 ' CG2' ' A' ' 97' ' ' ILE . 11.7 t -107.09 109.97 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 O-C-N 121.176 -0.952 . . . . 0.0 109.201 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.9 t -98.82 94.19 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.039 -1.038 . . . . 0.0 110.59 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -68.06 114.65 6.76 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 71.5 t -98.75 112.07 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.115 -0.99 . . . . 0.0 108.434 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 63.6 p -72.7 -160.08 0.07 Allowed 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.554 0.692 . . . . 0.0 109.517 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.602 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -88.9 -50.93 5.9 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.183 -0.948 . . . . 0.0 108.625 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.504 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 10.1 p30 -64.94 2.71 0.67 Allowed 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 119.804 -0.759 . . . . 0.0 110.442 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.522 ' O ' ' NH1' ' A' ' 12' ' ' ARG . . . 93.83 -3.09 70.39 Favored Glycine 0 N--CA 1.496 2.693 0 O-C-N 120.731 -1.23 . . . . 0.0 110.08 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.09 128.04 34.22 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.932 -1.334 . . . . 0.0 108.438 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.522 ' NH1' ' O ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -108.63 159.54 16.65 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.51 -0.744 . . . . 0.0 111.197 -178.782 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.2 mtt85 -150.08 115.72 5.54 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 178.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -97.82 126.93 43.44 Favored 'General case' 0 N--CA 1.502 2.158 0 CA-C-O 122.633 1.206 . . . . 0.0 110.607 -178.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.585 HD13 ' H ' ' A' ' 16' ' ' ASP . 0.2 OUTLIER -111.9 -175.43 2.69 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 123.132 1.444 . . . . 0.0 111.589 -177.723 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.585 ' H ' HD13 ' A' ' 15' ' ' LEU . 11.1 t70 -137.06 101.57 4.59 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 104.548 -2.39 . . . . 0.0 104.548 176.356 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.48 HG12 ' HB ' ' A' ' 21' ' ' VAL . 11.8 t -109.67 119.03 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.56 176.33 4.18 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.188 -0.945 . . . . 0.0 111.141 -177.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -65.64 137.08 57.09 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.953 0.882 . . . . 0.0 110.691 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.92 -17.07 23.99 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 178.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.48 ' HB ' HG12 ' A' ' 17' ' ' VAL . 60.8 t -77.64 139.8 18.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 O-C-N 120.428 -1.631 . . . . 0.0 108.479 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 25' ' ' GLN . 59.5 p -94.16 143.7 26.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.105 -0.997 . . . . 0.0 109.093 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.529 HD21 ' SD ' ' A' ' 90' ' ' MET . 49.6 mt -45.45 -37.14 4.9 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.08 -1.013 . . . . 0.0 109.766 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.54 ' SD ' ' CD2' ' A' ' 33' ' ' TYR . 5.6 tpt -65.62 -26.43 67.82 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.388 -0.82 . . . . 0.0 109.355 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' A' ' 22' ' ' SER . 13.8 mm100 -75.31 -63.23 1.32 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.183 -0.948 . . . . 0.0 109.702 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.449 ' O ' ' OD1' ' A' ' 30' ' ' ASN . . . -59.94 -26.49 66.02 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.657 -1.277 . . . . 0.0 110.906 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.43 ' O ' ' N ' ' A' ' 32' ' ' ILE . . . -64.44 -20.39 66.14 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.585 -1.322 . . . . 0.0 109.011 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 70.6 t -86.51 -25.69 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.438 -0.789 . . . . 0.0 109.587 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.96 -24.55 60.81 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.362 -0.836 . . . . 0.0 109.042 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.518 ' ND2' HD11 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -107.38 -0.1 22.61 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 179.261 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 64.66 69.72 1.26 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 108.916 -1.674 . . . . 0.0 108.916 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.43 ' N ' ' O ' ' A' ' 27' ' ' ALA . 53.4 mt -123.85 -37.99 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.795 -0.826 . . . . 0.0 109.394 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.745 ' O ' ' N ' ' A' ' 35' ' ' ILE . 0.2 OUTLIER -89.3 6.87 38.45 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.885 -1.135 . . . . 0.0 109.886 -179.225 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -38.01 74.27 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.204 0 CA-C-O 122.076 0.941 . . . . 0.0 111.602 -177.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.745 ' N ' ' O ' ' A' ' 33' ' ' TYR . 3.3 tp -150.49 4.61 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.934 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.431 ' O ' ' O ' ' A' ' 35' ' ' ILE . 5.6 t 56.14 104.22 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 120.843 -1.161 . . . . 0.0 109.356 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -70.69 151.42 49.35 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.493 ' C ' ' H ' ' A' ' 40' ' ' GLY . 9.3 m-20 -80.69 -63.25 1.45 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.41 -1.053 . . . . 0.0 109.329 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.619 ' SG ' ' N ' ' A' ' 42' ' ' SER . 13.9 p -72.5 17.53 0.11 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.314 -0.866 . . . . 0.0 109.104 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.493 ' H ' ' C ' ' A' ' 38' ' ' ASP . . . 54.72 13.15 4.07 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 108.01 -2.036 . . . . 0.0 108.01 -178.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.458 ' N ' ' C ' ' A' ' 39' ' ' CYS . . . 89.47 23.14 34.83 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.619 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 34.6 t -94.22 38.07 1.09 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.137 -1.214 . . . . 0.0 109.731 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 44.47 72.54 0.19 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.342 -0.849 . . . . 0.0 110.318 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -166.26 27.7 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.728 -1.232 . . . . 0.0 110.426 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.527 ' O ' ' S1 ' ' A' ' 107' ' ' FES . 2.9 p -162.64 159.69 24.83 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.762 -1.211 . . . . 0.0 109.927 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -95.64 12.21 30.53 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.439 ' O ' ' OE1' ' A' ' 105' ' ' GLN . 3.1 m -57.6 -39.0 75.85 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.29 -0.881 . . . . 0.0 109.648 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.592 ' SG ' ' N ' ' A' ' 85' ' ' CYS . 18.3 p -97.7 54.18 1.15 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.867 -1.146 . . . . 0.0 109.744 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.794 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 43.3 t60 -75.89 110.43 10.33 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.114 -0.991 . . . . 0.0 109.113 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -146.52 166.94 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 120.813 -1.179 . . . . 0.0 109.582 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.583 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 37.4 m-85 -115.85 115.38 26.15 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.857 0.837 . . . . 0.0 109.815 -179.139 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.847 HG13 HD11 ' A' ' 97' ' ' ILE . 13.3 t -89.46 129.48 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.561 ' C ' ' H ' ' A' ' 55' ' ' ALA . 19.0 t-20 -46.15 131.01 10.32 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.107 -0.996 . . . . 0.0 109.753 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.412 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 9.7 pt-20 -57.01 8.16 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.395 -0.816 . . . . 0.0 111.025 -179.054 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.561 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -95.96 -23.13 16.99 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.636 -1.29 . . . . 0.0 110.113 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -111.25 -6.71 14.5 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.901 -1.124 . . . . 0.0 108.894 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.431 HG21 ' OD1' ' A' ' 81' ' ' ASN . 25.3 p -70.87 -42.14 70.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.643 -0.661 . . . . 0.0 109.806 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -82.8 0.93 41.57 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.59 -0.694 . . . . 0.0 109.894 -179.008 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 15.7 mttt -109.99 -38.72 5.25 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.603 HG23 HD12 ' A' ' 94' ' ' LEU . 0.5 OUTLIER -84.73 158.19 59.83 Favored Pre-proline 0 N--CA 1.496 1.835 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 179.534 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.558 ' HD2' HG22 ' A' ' 60' ' ' VAL . 1.3 Cg_endo -54.49 110.97 0.59 Allowed 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 121.714 1.609 . . . . 0.0 113.698 -177.24 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.37 112.8 12.06 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.935 ' H ' ' NH1' ' A' ' 83' ' ' ARG . . . -53.81 144.33 18.68 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-O 122.286 1.041 . . . . 0.0 112.073 -178.305 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.49 ' H ' ' ND2' ' A' ' 64' ' ' ASN . 1.3 p30 -66.37 -167.73 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.678 0.751 . . . . 0.0 110.636 -179.265 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -69.47 -6.67 32.0 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.667 -0.646 . . . . 0.0 112.127 -178.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.508 ' O ' ' SD ' ' A' ' 70' ' ' MET . 69.3 mtm-85 -65.03 -44.61 88.55 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 120.424 -1.422 . . . . 0.0 109.405 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -74.27 -39.53 62.93 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.153 -0.967 . . . . 0.0 109.35 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 39.5 mt -48.02 -25.33 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.335 -0.853 . . . . 0.0 109.574 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -82.29 -40.64 9.93 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.508 ' SD ' ' O ' ' A' ' 66' ' ' ARG . 4.3 mpp? -72.05 -34.59 68.88 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 178.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 71' ' ' LEU . 46.1 mt -63.99 -27.75 69.34 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -79.14 2.79 19.64 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.042 -1.037 . . . . 0.0 108.472 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -120.86 28.14 8.09 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.74 -0.6 . . . . 0.0 110.713 -178.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.9 m -95.96 169.53 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 O-C-N 120.844 -1.16 . . . . 0.0 109.975 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.476 ' OG1' ' CD2' ' A' ' 106' ' ' TRP . 3.7 m -106.29 -6.78 18.14 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.435 -0.79 . . . . 0.0 111.957 -178.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.794 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -106.16 174.7 5.77 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 120.56 -1.338 . . . . 0.0 110.572 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.583 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -56.1 104.39 0.14 Allowed 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.833 -0.542 . . . . 0.0 111.26 -178.516 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.4 tp -69.98 149.44 47.73 Favored 'General case' 0 C--N 1.295 -1.794 0 O-C-N 120.186 -1.572 . . . . 0.0 109.366 178.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.451 ' NZ ' ' OE2' ' A' ' 77' ' ' GLU . 27.2 mmtm -115.31 156.57 45.51 Favored Pre-proline 0 C--N 1.287 -2.133 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -178.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -56.97 -21.51 41.8 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 121.358 1.372 . . . . 0.0 109.629 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.431 ' OD1' HG21 ' A' ' 57' ' ' THR . 5.1 p30 -120.33 28.1 8.22 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.422 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.413 ' HG ' ' HE1' ' A' ' 51' ' ' TYR . 37.2 m -57.6 158.38 6.07 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 120.07 -1.644 . . . . 0.0 108.885 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.935 ' NH1' ' H ' ' A' ' 63' ' ' ALA . 1.6 mtp85 -169.47 159.6 8.65 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 118.763 -1.175 . . . . 0.0 111.042 -178.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.761 HD22 ' N ' ' A' ' 84' ' ' LEU . 2.7 mm? -84.21 123.83 30.53 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 179.027 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.592 ' N ' ' SG ' ' A' ' 48' ' ' CYS . 0.5 OUTLIER -64.11 -16.48 61.91 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.197 -0.94 . . . . 0.0 113.145 -176.556 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 22.2 p -81.65 -43.46 18.51 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 119.708 -1.87 . . . . 0.0 110.955 -178.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.648 ' NE2' ' HB2' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -75.61 29.57 0.1 Allowed 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.972 -1.08 . . . . 0.0 111.169 -179.108 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.658 ' O ' HD12 ' A' ' 89' ' ' ILE . 38.4 mt -116.03 151.42 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.295 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 178.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.658 HD12 ' O ' ' A' ' 88' ' ' ILE . 1.5 mp -131.44 125.52 56.71 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.235 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -178.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.529 ' SD ' HD21 ' A' ' 23' ' ' LEU . 1.9 tpt -87.49 161.8 17.6 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.089 -1.007 . . . . 0.0 109.571 -179.226 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.6 p -152.08 149.32 23.08 Favored Pre-proline 0 N--CA 1.489 1.484 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -54.56 -39.29 89.06 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 121.74 1.626 . . . . 0.0 111.643 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -64.03 -24.21 67.62 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.169 -0.957 . . . . 0.0 109.49 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.603 HD12 HG23 ' A' ' 60' ' ' VAL . 13.9 mt -101.73 18.88 19.3 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.449 -0.782 . . . . 0.0 109.434 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.412 ' HB2' ' H ' ' A' ' 2' ' ' LYS . 20.4 p-10 -61.44 139.53 58.2 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.407 -0.808 . . . . 0.0 109.946 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 105.55 8.21 35.53 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 178.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.847 HD11 HG13 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -65.75 138.39 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.207 -1.172 . . . . 0.0 111.878 -177.764 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.5 t -106.48 117.81 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.665 -0.647 . . . . 0.0 109.328 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.8 t -102.74 136.91 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 120.761 -1.212 . . . . 0.0 108.568 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -108.16 114.75 28.88 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.76 0.791 . . . . 0.0 108.88 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.4 t -102.47 124.77 38.18 Favored Pre-proline 0 N--CA 1.495 1.813 0 O-C-N 121.883 -0.511 . . . . 0.0 109.78 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.436 ' HG3' ' CD2' ' A' ' 49' ' ' HIS . 92.6 Cg_endo -81.71 169.61 14.98 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 122.515 2.143 . . . . 0.0 113.88 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -75.61 -15.47 60.34 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.187 0.517 . . . . 0.0 109.649 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 27.4 mtm180 -122.31 93.38 3.96 Favored 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.439 ' OE1' ' O ' ' A' ' 47' ' ' THR . 35.5 tt0 -82.26 -16.96 47.66 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.651 -0.656 . . . . 0.0 109.826 -178.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.476 ' CD2' ' OG1' ' A' ' 75' ' ' THR . 61.3 t-105 . . . . . 0 C--N 1.304 -1.397 0 CA-C-O 117.948 -1.025 . . . . 0.0 110.45 178.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' FES . . . . . 0.527 ' S1 ' ' O ' ' A' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.405 ' H ' ' HB2' ' A' ' 95' ' ' ASP . 16.8 mmtm -77.27 117.12 18.48 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.568 HG21 ' CG2' ' A' ' 17' ' ' VAL . 72.5 t -115.78 109.61 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.334 -0.854 . . . . 0.0 111.048 -178.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 33.6 t -98.9 93.17 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 CA-C-O 122.209 1.004 . . . . 0.0 111.178 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.411 ' CE1' HG12 ' A' ' 3' ' ' VAL . 96.1 m-85 -67.8 113.71 5.77 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 177.297 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 99.7 t -99.0 116.7 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 120.991 -1.068 . . . . 0.0 108.939 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 79.3 p -75.38 -157.71 0.07 Allowed 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.632 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -92.13 -48.51 6.68 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.217 -0.927 . . . . 0.0 109.105 -179.672 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.487 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 8.5 p30 -65.39 1.75 1.05 Allowed 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.323 -0.861 . . . . 0.0 110.7 -178.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.96 -3.45 67.19 Favored Glycine 0 N--CA 1.495 2.606 0 O-C-N 120.717 -1.239 . . . . 0.0 110.262 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -65.6 129.05 38.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.779 -1.424 . . . . 0.0 108.25 179.313 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 29.8 mtm180 -108.25 145.19 34.67 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.879 -0.513 . . . . 0.0 110.986 -178.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.16 114.85 16.22 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 178.335 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -98.6 122.97 42.49 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.51 -0.744 . . . . 0.0 110.237 -178.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.651 HD11 HD12 ' A' ' 32' ' ' ILE . 30.4 mt -120.28 -166.04 1.26 Allowed 'General case' 0 N--CA 1.502 2.13 0 CA-C-O 122.746 1.26 . . . . 0.0 109.729 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -134.41 99.81 4.48 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 104.623 -2.362 . . . . 0.0 104.623 176.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.568 ' CG2' HG21 ' A' ' 3' ' ' VAL . 10.6 t -101.4 117.8 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.276 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.24 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.07 178.03 5.97 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 122.366 1.079 . . . . 0.0 112.116 -177.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -64.65 130.38 43.38 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-O 121.981 0.896 . . . . 0.0 111.117 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.74 -17.05 54.96 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 178.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.432 ' HB ' HG12 ' A' ' 17' ' ' VAL . 64.8 t -78.82 134.54 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 120.503 -1.586 . . . . 0.0 108.805 -179.092 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 25' ' ' GLN . 4.2 p -80.59 139.77 36.11 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.027 -1.046 . . . . 0.0 108.847 179.082 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 31.5 mt -45.06 -33.03 1.94 Allowed 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.013 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 9.7 ttt -77.61 -33.07 53.84 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.426 -0.796 . . . . 0.0 109.217 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.419 ' N ' ' O ' ' A' ' 22' ' ' SER . 39.6 mm-40 -59.34 -56.62 19.73 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.457 -0.897 . . . . 0.0 108.796 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.418 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -58.2 -26.55 62.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.829 -1.169 . . . . 0.0 110.512 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.633 ' HB1' ' H ' ' A' ' 33' ' ' TYR . . . -58.74 -21.59 55.69 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.93 -1.106 . . . . 0.0 108.802 178.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 54.7 t -86.58 -23.47 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.49 -0.756 . . . . 0.0 109.819 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.81 -29.79 58.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.281 -0.887 . . . . 0.0 108.728 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.537 ' ND2' HD22 ' A' ' 15' ' ' LEU . 6.6 m120 -104.65 -3.97 23.07 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.574 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 64.0 70.6 1.02 Allowed Glycine 0 N--CA 1.495 2.607 0 N-CA-C 109.171 -1.571 . . . . 0.0 109.171 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.651 HD12 HD11 ' A' ' 15' ' ' LEU . 70.8 mt -122.77 -63.71 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.276 -1.132 . . . . 0.0 110.705 -178.341 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.798 ' OH ' HG21 ' A' ' 101' ' ' VAL . 55.7 m-85 -97.67 2.57 49.9 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.15 -0.969 . . . . 0.0 110.716 178.033 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.544 ' O ' ' C ' ' A' ' 35' ' ' ILE . 8.8 p-10 -37.45 -37.63 0.21 Allowed 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.455 -0.778 . . . . 0.0 110.397 -178.107 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.544 ' C ' ' O ' ' A' ' 34' ' ' ASP . 96.2 mt -19.8 130.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.752 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.283 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.442 ' C ' ' O ' ' A' ' 35' ' ' ILE . 13.0 m -35.56 151.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 121.474 -0.766 . . . . 0.0 111.102 -178.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.436 ' HA2' HG21 ' A' ' 47' ' ' THR . . . -139.33 172.98 22.98 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -88.4 -76.53 0.39 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.258 -1.142 . . . . 0.0 110.754 -179.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.541 ' SG ' ' N ' ' A' ' 42' ' ' SER . 6.2 p -70.25 7.89 0.9 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.917 -1.114 . . . . 0.0 110.302 -178.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 53.19 8.18 0.66 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.502 ' H ' ' C ' ' A' ' 39' ' ' CYS . . . 102.78 81.27 1.53 Allowed Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.541 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 12.8 t -160.76 31.0 0.15 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.596 -0.944 . . . . 0.0 109.379 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.481 ' HB2' ' CD ' ' A' ' 87' ' ' GLN . . . 50.36 70.43 0.51 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.982 -1.074 . . . . 0.0 109.157 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -165.23 21.16 0.05 OUTLIER 'General case' 0 C--N 1.299 -1.596 0 O-C-N 120.916 -1.115 . . . . 0.0 110.184 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.402 ' SG ' ' CB ' ' A' ' 47' ' ' THR . 1.4 p -163.93 170.0 17.32 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.891 -1.13 . . . . 0.0 109.924 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -99.22 4.18 46.59 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.434 -0.791 . . . . 0.0 108.957 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.436 HG21 ' HA2' ' A' ' 37' ' ' GLY . 24.8 m -47.39 -54.13 12.05 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.346 -0.846 . . . . 0.0 109.582 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.498 ' SG ' ' O ' ' A' ' 48' ' ' CYS . 14.1 p -90.77 47.96 1.48 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.862 -1.149 . . . . 0.0 109.533 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.775 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 24.5 t60 -76.21 99.64 4.79 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.663 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -133.62 170.7 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.15 -0.969 . . . . 0.0 110.254 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.567 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 36.9 m-85 -116.46 113.3 22.64 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 122.056 0.932 . . . . 0.0 110.057 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.617 HG13 HD11 ' A' ' 97' ' ' ILE . 5.7 t -86.87 129.15 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.59 ' C ' ' H ' ' A' ' 55' ' ' ALA . 16.2 t-20 -46.62 127.35 9.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.034 -1.042 . . . . 0.0 109.662 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -55.76 10.08 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.611 -0.681 . . . . 0.0 111.487 -178.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.59 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -98.65 -19.95 17.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.807 -1.183 . . . . 0.0 109.829 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.711 ' CD2' HD22 ' A' ' 94' ' ' LEU . 39.1 m-85 -113.85 -6.94 13.22 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.919 -1.113 . . . . 0.0 108.574 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.548 ' CA ' HH12 ' A' ' 83' ' ' ARG . 22.5 p -69.76 -43.7 71.68 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.654 0.74 . . . . 0.0 110.138 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -83.5 14.05 4.03 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.964 -0.694 . . . . 0.0 109.228 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.2 mtpt -124.76 -38.74 2.34 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.574 HG22 ' HD2' ' A' ' 61' ' ' PRO . 0.4 OUTLIER -85.8 164.7 38.51 Favored Pre-proline 0 N--CA 1.5 2.06 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 179.148 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.574 ' HD2' HG22 ' A' ' 60' ' ' VAL . 7.8 Cg_endo -59.56 105.0 0.24 Allowed 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 121.208 1.272 . . . . 0.0 114.001 -176.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.498 ' HA ' ' NH2' ' A' ' 83' ' ' ARG . . . -74.43 104.65 5.24 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 177.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -47.09 140.66 4.86 Favored 'General case' 0 C--N 1.287 -2.149 0 CA-C-O 122.061 0.934 . . . . 0.0 111.437 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.473 ' N ' ' OD1' ' A' ' 64' ' ' ASN . 2.6 p30 -58.62 -169.81 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.404 0.621 . . . . 0.0 110.486 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -65.31 0.35 1.47 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.292 -0.88 . . . . 0.0 111.197 -178.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.506 ' O ' ' SD ' ' A' ' 70' ' ' MET . 0.3 OUTLIER -69.44 -45.01 70.14 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.681 -1.262 . . . . 0.0 108.843 -179.913 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.446 ' O ' ' N ' ' A' ' 69' ' ' GLY . 2.5 tt0 -73.82 -49.11 26.75 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.389 -0.819 . . . . 0.0 110.107 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.509 HD12 ' N ' ' A' ' 68' ' ' ILE . 1.4 mp -45.43 -19.76 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.395 -0.816 . . . . 0.0 109.508 -179.103 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.543 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -81.12 -73.39 1.19 Allowed Glycine 0 N--CA 1.497 2.748 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.506 ' SD ' ' O ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -47.38 -39.18 14.65 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.013 -1.286 . . . . 0.0 108.402 179.576 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.488 ' C ' ' H ' ' A' ' 73' ' ' CYS . 24.0 mt -57.14 -34.02 67.99 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 177.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.543 ' N ' ' O ' ' A' ' 69' ' ' GLY . 6.6 tp10 -73.77 12.28 0.69 Allowed 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.106 -0.996 . . . . 0.0 108.331 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.488 ' H ' ' C ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -133.07 36.14 3.48 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.524 -0.735 . . . . 0.0 110.19 -178.463 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.7 m -97.76 174.5 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.363 0 O-C-N 120.951 -1.093 . . . . 0.0 109.741 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.531 ' OG1' ' CG ' ' A' ' 106' ' ' TRP . 5.5 m -104.4 -9.32 18.54 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.016 -1.053 . . . . 0.0 111.295 -179.008 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.775 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -106.55 170.09 8.14 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.764 -1.21 . . . . 0.0 110.315 -179.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.567 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -53.45 105.28 0.12 Allowed 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.841 -0.537 . . . . 0.0 111.126 -179.083 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.0 tp -74.0 140.5 45.52 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 120.084 -1.635 . . . . 0.0 108.857 178.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.8 mmtp -102.07 157.21 34.13 Favored Pre-proline 0 C--N 1.289 -2.065 0 CA-C-N 114.876 -1.056 . . . . 0.0 108.588 -178.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -58.9 -19.3 46.78 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 121.631 1.554 . . . . 0.0 109.095 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.413 ' OD1' ' O ' ' A' ' 81' ' ' ASN . 2.7 p30 -121.99 27.68 7.94 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.076 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.425 ' HG ' ' HE1' ' A' ' 51' ' ' TYR . 44.3 m -58.42 169.18 0.93 Allowed 'General case' 0 C--N 1.307 -1.274 0 O-C-N 120.287 -1.508 . . . . 0.0 108.74 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.548 HH12 ' CA ' ' A' ' 57' ' ' THR . 0.7 OUTLIER -171.9 150.6 2.62 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 118.621 -1.231 . . . . 0.0 110.985 -179.477 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.441 ' C ' ' SG ' ' A' ' 48' ' ' CYS . 82.5 mt -88.83 96.27 10.62 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.45 ' N ' ' SG ' ' A' ' 48' ' ' CYS . 0.1 OUTLIER -34.19 -42.03 0.12 Allowed 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -177.431 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 28.5 p -64.58 -28.48 69.66 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 119.932 -1.73 . . . . 0.0 111.392 -178.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.481 ' CD ' ' HB2' ' A' ' 43' ' ' ALA . 12.7 tp60 -91.56 35.83 0.95 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.98 -1.075 . . . . 0.0 110.703 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.7 ' O ' HD12 ' A' ' 89' ' ' ILE . 39.7 mm -130.14 161.19 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.308 0 O-C-N 121.282 -0.886 . . . . 0.0 109.192 179.011 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.7 HD12 ' O ' ' A' ' 88' ' ' ILE . 1.4 mp -133.87 128.59 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.32 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.508 ' SD ' HG21 ' A' ' 97' ' ' ILE . 4.9 tpt -90.54 164.21 14.32 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.311 -0.868 . . . . 0.0 109.347 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 38.4 p -148.89 145.63 20.08 Favored Pre-proline 0 C--N 1.3 -1.553 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.85 -37.86 91.57 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 121.278 1.319 . . . . 0.0 111.295 -178.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -59.37 -29.51 67.75 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.111 -0.993 . . . . 0.0 109.147 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.711 HD22 ' CD2' ' A' ' 56' ' ' PHE . 6.2 mt -93.75 35.96 1.12 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.555 -0.716 . . . . 0.0 109.819 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.405 ' HB2' ' H ' ' A' ' 2' ' ' LYS . 16.8 p-10 -65.49 136.29 56.24 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.684 -1.26 . . . . 0.0 110.319 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 111.94 8.52 22.04 Favored Glycine 0 N--CA 1.506 3.362 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 178.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.617 HD11 HG13 ' A' ' 52' ' ' VAL . 0.1 OUTLIER -66.24 124.66 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.583 -0.951 . . . . 0.0 110.378 -178.043 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.503 ' N ' HD12 ' A' ' 97' ' ' ILE . 6.5 t -104.72 116.06 47.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.162 -0.961 . . . . 0.0 109.967 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 t -100.08 135.17 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 120.756 -1.215 . . . . 0.0 109.458 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.68 122.82 48.32 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.494 -0.754 . . . . 0.0 109.169 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.798 HG21 ' OH ' ' A' ' 33' ' ' TYR . 5.3 t -113.32 128.29 25.84 Favored Pre-proline 0 N--CA 1.499 2.014 0 O-C-N 121.643 -0.661 . . . . 0.0 109.802 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.437 ' HG3' ' CD2' ' A' ' 49' ' ' HIS . 95.4 Cg_endo -81.42 174.03 10.98 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 122.417 2.078 . . . . 0.0 113.81 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 103' ' ' ASP . 1.6 p-10 -80.47 -12.63 59.52 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-O 121.683 0.754 . . . . 0.0 108.991 178.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.53 86.86 2.65 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 -177.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.441 ' O ' ' O ' ' A' ' 106' ' ' TRP . 12.8 pt20 -81.69 -32.38 31.75 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.533 ' OXT' ' CG ' ' A' ' 106' ' ' TRP . 61.9 t-105 . . . . . 0 C--N 1.301 -1.506 0 CA-C-O 118.354 -0.832 . . . . 0.0 110.063 178.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.433 ' CB ' ' SD ' ' A' ' 90' ' ' MET . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.39 117.64 32.07 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.446 -0.784 . . . . 0.0 109.278 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.438 HG21 ' CG2' ' A' ' 17' ' ' VAL . 27.2 t -115.91 109.75 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.301 -0.874 . . . . 0.0 109.691 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.2 t -99.77 130.07 49.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.162 -0.961 . . . . 0.0 110.188 178.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -103.59 116.63 32.72 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 78.8 t -98.71 115.69 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 30.9 p -75.56 -161.48 0.16 Allowed 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 121.584 0.707 . . . . 0.0 109.641 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.59 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.1 OUTLIER -86.88 -47.62 8.86 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.652 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.491 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 17.3 p30 -71.06 1.97 5.07 Favored 'General case' 0 C--N 1.307 -1.249 0 O-C-N 121.148 -0.97 . . . . 0.0 110.928 -178.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.71 1.85 60.05 Favored Glycine 0 N--CA 1.498 2.773 0 O-C-N 120.852 -1.155 . . . . 0.0 110.868 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -67.87 127.37 32.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.809 -1.406 . . . . 0.0 108.913 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.403 ' HD2' HH11 ' A' ' 12' ' ' ARG . 1.5 mtt180 -105.03 157.07 17.49 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.597 -0.689 . . . . 0.0 110.059 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.52 116.04 5.47 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -99.67 124.24 44.71 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 122.626 1.203 . . . . 0.0 111.341 -178.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.491 HD13 ' H ' ' A' ' 16' ' ' ASP . 0.2 OUTLIER -110.05 -176.51 3.01 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-O 122.99 1.376 . . . . 0.0 110.875 -178.843 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.491 ' H ' HD13 ' A' ' 15' ' ' LEU . 24.8 t0 -134.67 100.38 4.61 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 105.181 -2.155 . . . . 0.0 105.181 176.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.565 HG12 ' HB ' ' A' ' 21' ' ' VAL . 3.4 t -108.71 115.3 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.339 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.81 174.91 3.94 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.312 -0.868 . . . . 0.0 111.609 -177.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.03 137.5 57.75 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.952 0.882 . . . . 0.0 110.91 -178.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.62 -13.93 53.73 Favored Glycine 0 N--CA 1.493 2.435 0 C-N-CA 120.519 -0.848 . . . . 0.0 111.182 178.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.565 ' HB ' HG12 ' A' ' 17' ' ' VAL . 94.8 t -80.82 142.25 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.344 -1.68 . . . . 0.0 109.455 -178.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.427 ' OG ' ' OE1' ' A' ' 25' ' ' GLN . 1.2 p -87.82 142.6 27.69 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.559 -0.856 . . . . 0.0 109.176 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -46.95 -40.85 15.1 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 121.247 -0.908 . . . . 0.0 109.507 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 5.8 tpt -65.36 -35.63 81.55 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.046 -1.034 . . . . 0.0 109.531 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.443 ' NE2' ' N ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -60.74 -61.17 2.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.052 -1.03 . . . . 0.0 109.075 -179.421 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.503 ' HB2' HG13 ' A' ' 17' ' ' VAL . . . -59.55 -27.55 66.32 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.569 -1.332 . . . . 0.0 110.522 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.499 ' HB1' ' H ' ' A' ' 33' ' ' TYR . . . -63.99 -20.85 66.2 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.741 -1.225 . . . . 0.0 108.57 179.283 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 69.8 t -87.03 -27.79 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.613 -0.679 . . . . 0.0 109.654 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.52 -23.56 61.03 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.443 ' CG ' HD21 ' A' ' 15' ' ' LEU . 4.5 m120 -110.74 -5.26 15.02 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 63.75 70.98 0.92 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.441 ' N ' ' O ' ' A' ' 27' ' ' ALA . 47.9 mt -121.35 -57.79 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.503 -0.998 . . . . 0.0 110.434 -178.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.499 ' H ' ' HB1' ' A' ' 27' ' ' ALA . 1.0 OUTLIER -92.99 -10.9 34.65 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.833 -1.167 . . . . 0.0 109.906 178.904 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 33' ' ' TYR . 13.5 p-10 -38.93 -42.86 0.9 Allowed 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.833 -0.542 . . . . 0.0 110.275 -178.506 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.434 ' O ' ' O ' ' A' ' 36' ' ' VAL . 94.9 mt -44.33 120.66 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.672 -0.643 . . . . 0.0 109.413 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.523 HG12 ' N ' ' A' ' 37' ' ' GLY . 65.9 t 56.95 160.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.447 -0.783 . . . . 0.0 110.007 -178.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.523 ' N ' HG12 ' A' ' 36' ' ' VAL . . . 159.62 118.62 0.51 Allowed Glycine 0 N--CA 1.495 2.615 0 N-CA-C 108.906 -1.678 . . . . 0.0 108.906 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.511 ' C ' ' H ' ' A' ' 40' ' ' GLY . 15.0 t70 -87.67 -73.48 0.48 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.999 -1.295 . . . . 0.0 110.203 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.623 ' SG ' ' N ' ' A' ' 42' ' ' SER . 8.5 p -70.15 16.95 0.06 Allowed 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.435 -0.906 . . . . 0.0 109.848 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.511 ' H ' ' C ' ' A' ' 38' ' ' ASP . . . 49.85 15.41 0.93 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 108.817 -1.713 . . . . 0.0 108.817 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.471 ' N ' ' C ' ' A' ' 39' ' ' CYS . . . 92.04 21.73 32.28 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.021 -1.631 . . . . 0.0 109.021 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.623 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 6.4 m -93.9 36.07 1.13 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.638 -0.919 . . . . 0.0 109.848 -179.496 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.435 ' HB1' HE21 ' A' ' 87' ' ' GLN . . . 43.2 72.47 0.18 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.322 -0.861 . . . . 0.0 110.336 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.4 t -163.97 17.42 0.06 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.928 -1.107 . . . . 0.0 110.043 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.486 ' O ' ' S1 ' ' A' ' 107' ' ' FES . 1.8 p -153.7 -167.64 2.74 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.96 -1.088 . . . . 0.0 109.333 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -132.21 10.95 4.56 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 32.2 p -56.03 -41.9 75.67 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.25 -0.906 . . . . 0.0 109.276 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.497 ' SG ' ' O ' ' A' ' 48' ' ' CYS . 21.9 p -79.68 57.0 2.37 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.928 -1.108 . . . . 0.0 110.217 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.581 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 38.0 t60 -76.59 106.05 8.01 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.119 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -139.25 165.43 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 120.617 -1.302 . . . . 0.0 109.74 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.537 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 40.7 m-85 -111.97 112.23 23.73 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 122.149 0.976 . . . . 0.0 109.792 -179.229 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.426 ' O ' ' OD1' ' A' ' 81' ' ' ASN . 96.8 t -85.58 135.25 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.721 ' ND2' ' HB3' ' A' ' 55' ' ' ALA . 1.7 t30 -49.28 123.22 7.07 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.947 -1.095 . . . . 0.0 108.147 179.454 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -54.16 11.57 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.818 -0.551 . . . . 0.0 112.178 -177.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.721 ' HB3' ' ND2' ' A' ' 53' ' ' ASN . . . -100.71 -15.57 17.66 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.999 -1.063 . . . . 0.0 109.817 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.517 ' CD2' HD22 ' A' ' 94' ' ' LEU . 51.9 m-85 -115.26 -10.43 12.09 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.774 -1.204 . . . . 0.0 109.078 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 12.5 p -71.45 -41.62 69.22 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.876 -1.14 . . . . 0.0 109.912 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -86.91 14.46 7.27 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.438 -0.789 . . . . 0.0 109.898 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.479 ' CD ' ' O ' ' A' ' 55' ' ' ALA . 9.6 mtpt -125.46 -39.73 2.16 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.705 HG22 ' HD2' ' A' ' 61' ' ' PRO . 0.4 OUTLIER -78.34 167.28 36.78 Favored Pre-proline 0 N--CA 1.494 1.759 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 179.052 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.705 ' HD2' HG22 ' A' ' 60' ' ' VAL . 1.4 Cg_endo -55.57 105.38 0.15 Allowed 'Trans proline' 0 N--CA 1.489 1.237 0 CA-C-N 120.206 1.109 . . . . 0.0 113.181 -176.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.39 102.38 2.62 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.495 ' HB1' ' CD ' ' A' ' 67' ' ' GLU . . . -53.71 146.41 13.54 Favored 'General case' 0 C--N 1.29 -1.991 0 O-C-N 121.207 -0.933 . . . . 0.0 111.29 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -61.81 -171.3 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.732 -0.605 . . . . 0.0 110.756 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -69.41 1.49 3.87 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.189 -0.944 . . . . 0.0 112.147 -178.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -64.63 -40.46 95.5 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.525 -1.359 . . . . 0.0 108.736 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.519 ' N ' ' CD ' ' A' ' 67' ' ' GLU . 27.8 mp0 -79.36 -47.24 16.11 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.655 -0.653 . . . . 0.0 110.133 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.4 ' H ' HG13 ' A' ' 68' ' ' ILE . 36.3 mt -44.62 -22.67 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.136 -0.977 . . . . 0.0 110.041 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 67' ' ' GLU . . . -86.03 -28.85 27.3 Favored Glycine 0 N--CA 1.498 2.777 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.46 ' N ' ' O ' ' A' ' 67' ' ' GLU . 30.0 mtt -77.33 -34.18 55.37 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.47 HD22 ' HB3' ' A' ' 82' ' ' SER . 33.1 mt -65.62 -22.17 66.64 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -85.34 18.85 2.49 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 178.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -133.85 24.47 3.96 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.732 -0.605 . . . . 0.0 110.295 -178.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 17.0 m -97.48 171.9 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 120.772 -1.205 . . . . 0.0 110.58 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.8 m -105.47 -1.78 24.5 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.383 -0.823 . . . . 0.0 110.28 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.581 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -107.48 170.94 7.67 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 120.965 -1.084 . . . . 0.0 110.589 -178.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.537 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -62.87 111.61 2.21 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.474 -0.766 . . . . 0.0 109.845 -179.281 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.458 HD21 ' HB3' ' A' ' 71' ' ' LEU . 8.4 tp -70.92 160.11 33.44 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 120.031 -1.668 . . . . 0.0 110.312 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.2 mmtm -125.12 152.55 70.85 Favored Pre-proline 0 C--N 1.296 -1.748 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -178.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -56.53 -22.45 43.02 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 121.217 1.278 . . . . 0.0 109.771 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.433 ' OD1' ' O ' ' A' ' 81' ' ' ASN . 1.4 p30 -120.21 28.54 7.99 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.888 -0.508 . . . . 0.0 109.862 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.47 ' HB3' HD22 ' A' ' 71' ' ' LEU . 11.3 m -55.41 172.1 0.16 Allowed 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.416 -1.428 . . . . 0.0 108.532 178.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.726 ' HE ' ' CG1' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -170.78 163.64 7.89 Favored 'General case' 0 N--CA 1.5 2.047 0 C-N-CA 118.661 -1.215 . . . . 0.0 111.273 -178.81 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.756 HD22 ' N ' ' A' ' 84' ' ' LEU . 2.2 mm? -104.26 97.71 7.62 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 178.347 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.426 ' C ' ' O ' ' A' ' 84' ' ' LEU . 0.6 OUTLIER -31.94 -42.18 0.06 Allowed 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -177.414 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 17.6 p -76.52 -14.72 60.01 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.076 -1.64 . . . . 0.0 112.187 -177.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.435 HE21 ' HB1' ' A' ' 43' ' ' ALA . 83.2 mt-30 -94.48 37.86 1.11 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.676 -1.265 . . . . 0.0 110.113 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.726 ' CG1' ' HE ' ' A' ' 83' ' ' ARG . 22.7 mt -131.42 168.44 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.269 -0.895 . . . . 0.0 109.4 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.521 ' N ' ' CG2' ' A' ' 88' ' ' ILE . 36.2 mm -139.01 122.72 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.649 ' SD ' ' N ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -78.65 143.34 36.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.965 -1.084 . . . . 0.0 108.511 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.649 ' N ' ' SD ' ' A' ' 90' ' ' MET . 1.1 p -130.07 149.72 73.99 Favored Pre-proline 0 N--CA 1.495 1.785 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.255 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -62.96 -35.18 67.99 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 121.626 1.551 . . . . 0.0 110.854 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -68.82 -26.06 64.98 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 119.68 -0.808 . . . . 0.0 109.936 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.517 HD22 ' CD2' ' A' ' 56' ' ' PHE . 5.5 mt -104.26 29.67 5.84 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.508 -0.745 . . . . 0.0 110.076 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -63.65 146.42 53.83 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.799 -1.188 . . . . 0.0 109.856 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 105.22 12.27 27.64 Favored Glycine 0 N--CA 1.504 3.227 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 178.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.408 ' O ' HG23 ' A' ' 97' ' ' ILE . 17.5 tt -65.57 129.7 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 121.113 -1.227 . . . . 0.0 111.31 -177.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.6 t -104.82 126.52 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 O-C-N 121.208 -0.932 . . . . 0.0 108.852 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.2 t -111.58 135.01 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.994 -1.066 . . . . 0.0 109.997 -178.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -107.85 121.72 45.32 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.343 -0.848 . . . . 0.0 109.065 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 24.7 t -108.99 123.59 36.54 Favored Pre-proline 0 N--CA 1.498 1.967 0 O-C-N 121.689 -0.632 . . . . 0.0 109.4 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.442 ' O ' ' NE2' ' A' ' 105' ' ' GLN . 69.4 Cg_endo -83.25 178.34 5.87 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.711 2.274 . . . . 0.0 113.427 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -84.71 -18.33 35.56 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -108.44 81.95 1.55 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.556 ' CD ' ' H ' ' A' ' 105' ' ' GLN . 13.2 mp0 -84.03 -31.03 25.64 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 119.156 -1.017 . . . . 0.0 108.489 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 62.9 t-105 . . . . . 0 C--N 1.299 -1.594 0 O-C-N 121.028 -1.045 . . . . 0.0 109.814 178.753 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 107' ' ' FES . . . . . 0.486 ' S1 ' ' O ' ' A' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 13.6 p . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.9 mmtt -77.22 108.74 10.55 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.435 -0.906 . . . . 0.0 108.563 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.512 HG21 HG21 ' A' ' 17' ' ' VAL . 36.5 t -108.68 109.33 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.26 -0.9 . . . . 0.0 110.28 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 23.9 t -102.16 127.09 56.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.502 -0.749 . . . . 0.0 110.341 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.425 ' CE1' HG12 ' A' ' 3' ' ' VAL . 69.6 m-85 -102.15 117.54 35.01 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 176.588 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 81.0 t -97.9 113.94 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 34.0 p -74.54 -163.65 0.22 Allowed 'General case' 0 C--N 1.293 -1.863 0 CA-C-O 121.595 0.712 . . . . 0.0 109.623 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.571 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.3 OUTLIER -81.98 -45.84 14.81 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.778 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 23.4 p-10 -74.31 2.36 9.44 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.3 -0.875 . . . . 0.0 111.571 -178.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.88 -4.31 65.6 Favored Glycine 0 N--CA 1.5 2.915 0 O-C-N 120.441 -1.412 . . . . 0.0 110.928 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.89 126.37 27.11 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.79 -1.418 . . . . 0.0 108.418 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.4 mtt85 -106.21 162.25 13.82 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.262 -0.899 . . . . 0.0 111.32 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 17.3 mtt85 -146.29 107.82 4.27 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 178.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -98.62 126.73 44.3 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.344 -0.847 . . . . 0.0 110.523 -178.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.563 HD22 ' ND2' ' A' ' 30' ' ' ASN . 31.6 mt -119.06 -164.7 1.06 Allowed 'General case' 0 N--CA 1.503 2.175 0 CA-C-O 122.786 1.279 . . . . 0.0 110.531 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -137.32 99.07 3.87 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 176.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.544 HG12 ' HB ' ' A' ' 21' ' ' VAL . 11.7 t -102.12 119.24 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 121.346 -0.846 . . . . 0.0 109.131 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.42 174.8 3.77 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.308 -0.87 . . . . 0.0 110.56 -178.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -69.95 141.39 53.05 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 122.053 0.93 . . . . 0.0 110.755 -179.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.24 -17.16 49.27 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.544 ' HB ' HG12 ' A' ' 17' ' ' VAL . 58.6 t -83.04 139.88 17.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 120.836 -1.391 . . . . 0.0 109.262 -178.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 79.0 p -92.04 146.09 24.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.112 -0.993 . . . . 0.0 109.024 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.493 HD21 ' SD ' ' A' ' 90' ' ' MET . 84.8 mt -46.38 -40.36 11.87 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.478 -0.764 . . . . 0.0 109.218 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 13.5 tpp -55.57 -43.12 75.64 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.427 -0.796 . . . . 0.0 108.953 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -62.26 -58.05 9.15 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.23 -0.919 . . . . 0.0 109.325 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.449 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -50.95 -33.33 24.07 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.675 -1.266 . . . . 0.0 111.743 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.84 -22.97 62.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.428 -1.42 . . . . 0.0 109.344 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 53.5 t -86.31 -19.85 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.189 -0.944 . . . . 0.0 109.857 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.87 -31.29 51.33 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.236 -0.915 . . . . 0.0 109.352 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.563 ' ND2' HD22 ' A' ' 15' ' ' LEU . 8.1 m120 -108.06 -2.22 19.78 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 64.65 73.23 0.59 Allowed Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 74.9 mt -116.72 -47.24 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -90.26 131.94 35.8 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 105.127 -2.175 . . . . 0.0 105.127 175.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.9 p30 -103.58 67.01 0.89 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.618 -1.301 . . . . 0.0 107.621 177.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.423 HG12 ' H ' ' A' ' 37' ' ' GLY . 20.0 tt -170.48 166.58 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 O-C-N 121.104 -0.998 . . . . 0.0 109.613 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.477 ' O ' HG22 ' A' ' 36' ' ' VAL . 11.5 p -101.35 8.32 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.151 -0.968 . . . . 0.0 109.482 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.423 ' H ' HG12 ' A' ' 35' ' ' ILE . . . 71.56 117.46 0.05 OUTLIER Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.512 ' C ' ' H ' ' A' ' 40' ' ' GLY . 30.5 t0 -48.95 -60.5 2.71 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.214 -1.168 . . . . 0.0 109.301 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.609 ' SG ' ' N ' ' A' ' 42' ' ' SER . 15.0 p -72.65 18.75 0.09 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.359 -0.838 . . . . 0.0 108.928 179.379 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.512 ' H ' ' C ' ' A' ' 38' ' ' ASP . . . 56.79 10.7 4.89 Favored Glycine 0 N--CA 1.485 1.904 0 N-CA-C 107.786 -2.126 . . . . 0.0 107.786 -178.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.454 ' N ' ' C ' ' A' ' 39' ' ' CYS . . . 89.82 23.77 32.09 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.609 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 17.7 p -98.55 40.6 1.18 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.406 -1.055 . . . . 0.0 109.826 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 42' ' ' SER . . . 42.98 75.79 0.09 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.342 -0.849 . . . . 0.0 110.172 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -166.54 26.01 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.696 -1.252 . . . . 0.0 109.753 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.502 ' O ' ' S1 ' ' A' ' 107' ' ' FES . 3.7 p -162.18 164.17 27.97 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.328 -0.858 . . . . 0.0 110.116 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -95.67 8.79 42.42 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 8.1 m -54.09 -48.37 70.75 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.124 -0.985 . . . . 0.0 110.154 -179.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.546 ' SG ' ' N ' ' A' ' 85' ' ' CYS . 16.6 p -92.74 53.91 2.13 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.891 -1.13 . . . . 0.0 110.397 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.717 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 48.7 t60 -75.94 111.68 11.56 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.28 -0.887 . . . . 0.0 108.634 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -147.34 167.75 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 120.884 -1.135 . . . . 0.0 109.534 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.524 ' OH ' ' NE2' ' A' ' 49' ' ' HIS . 38.0 m-85 -115.68 111.24 20.3 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 121.788 0.804 . . . . 0.0 109.754 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 80.7 t -85.95 132.81 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.763 ' ND2' ' HB3' ' A' ' 55' ' ' ALA . 1.0 OUTLIER -47.96 126.6 10.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.103 -0.998 . . . . 0.0 108.545 179.359 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -56.67 14.13 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.369 -0.832 . . . . 0.0 111.648 -178.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.763 ' HB3' ' ND2' ' A' ' 53' ' ' ASN . . . -101.99 -19.91 15.02 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.56 -1.338 . . . . 0.0 109.681 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -111.54 -10.49 14.14 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.704 -1.247 . . . . 0.0 108.951 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 10.4 p -70.84 -37.39 73.15 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.126 -0.984 . . . . 0.0 110.353 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -84.42 0.33 49.91 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.235 -0.916 . . . . 0.0 110.268 -178.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.448 ' CE ' ' O ' ' A' ' 55' ' ' ALA . 9.0 mttt -112.61 -37.36 4.94 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.4 0.619 . . . . 0.0 109.512 -179.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.742 HG23 HD12 ' A' ' 94' ' ' LEU . 0.4 OUTLIER -81.56 161.67 60.9 Favored Pre-proline 0 N--CA 1.497 1.918 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 179.859 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.734 ' HD2' HG22 ' A' ' 60' ' ' VAL . 5.0 Cg_endo -55.31 90.52 0.04 OUTLIER 'Trans proline' 0 N--CA 1.5 1.905 0 C-N-CA 122.381 2.054 . . . . 0.0 114.348 -176.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.61 104.31 0.64 Allowed 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 177.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.489 ' HB1' ' OE1' ' A' ' 67' ' ' GLU . . . -53.8 149.58 8.51 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.77 0.795 . . . . 0.0 112.561 -178.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -60.74 -172.1 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.308 0.575 . . . . 0.0 110.117 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -70.14 4.74 1.98 Allowed 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.727 -0.608 . . . . 0.0 112.11 -178.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.4 mtt85 -65.72 -40.28 92.02 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.65 -1.281 . . . . 0.0 108.928 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.489 ' OE1' ' HB1' ' A' ' 63' ' ' ALA . 34.1 mp0 -80.05 -37.66 33.48 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.701 -1.249 . . . . 0.0 109.636 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.454 HD12 ' N ' ' A' ' 68' ' ' ILE . 1.3 mp -46.15 -35.6 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.219 -0.926 . . . . 0.0 109.055 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.39 -28.97 60.73 Favored Glycine 0 N--CA 1.495 2.599 0 C-N-CA 119.365 -1.398 . . . . 0.0 109.619 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.429 ' N ' ' O ' ' A' ' 67' ' ' GLU . 26.6 mtt -79.0 -35.41 42.86 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 178.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 71' ' ' LEU . 74.2 mt -64.98 -24.74 67.6 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 178.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -80.88 5.48 15.98 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.782 -1.198 . . . . 0.0 108.036 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -122.73 25.97 8.46 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.764 -0.585 . . . . 0.0 110.504 -178.166 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.4 m -96.21 168.97 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.339 0 O-C-N 120.682 -1.261 . . . . 0.0 109.97 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.472 ' OG1' ' CD1' ' A' ' 106' ' ' TRP . 3.1 m -106.57 0.14 24.31 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.429 -0.794 . . . . 0.0 110.824 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.717 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -107.4 169.33 8.64 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.171 -0.956 . . . . 0.0 110.564 -178.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.464 ' O ' ' CG ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -59.76 106.14 0.45 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.569 -0.707 . . . . 0.0 109.478 -179.289 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.9 tp -70.13 152.25 44.53 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 119.933 -1.729 . . . . 0.0 110.303 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 46.3 mmtt -114.73 156.6 44.67 Favored Pre-proline 0 C--N 1.294 -1.828 0 CA-C-N 114.506 -1.225 . . . . 0.0 108.478 -178.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -57.56 -20.36 41.2 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 121.807 1.672 . . . . 0.0 110.4 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -125.22 31.91 5.49 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.734 -0.603 . . . . 0.0 110.775 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 33.4 m -59.44 169.85 1.15 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.653 -1.279 . . . . 0.0 110.473 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.566 ' NH2' ' O ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -171.91 171.52 5.08 Favored 'General case' 0 N--CA 1.503 2.219 0 CA-C-O 122.479 1.133 . . . . 0.0 111.864 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.476 HD13 ' S1 ' ' A' ' 107' ' ' FES . 47.3 mt -100.87 112.25 24.64 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 178.164 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.546 ' N ' ' SG ' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -56.7 -11.86 1.58 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.067 -1.02 . . . . 0.0 112.607 -176.554 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 28.3 p -87.54 -39.9 14.74 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 119.896 -1.752 . . . . 0.0 110.932 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -81.29 42.83 0.69 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.802 -1.186 . . . . 0.0 110.573 -178.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.8 mt -130.67 157.56 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 O-C-N 121.124 -0.985 . . . . 0.0 108.494 179.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 36.9 mm -132.46 128.52 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 O-C-N 121.391 -0.818 . . . . 0.0 109.763 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.493 ' SD ' HD21 ' A' ' 23' ' ' LEU . 3.6 tpt -88.62 161.54 16.84 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.969 -1.082 . . . . 0.0 109.657 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.5 p -155.04 148.83 18.83 Favored Pre-proline 0 C--N 1.3 -1.58 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -55.91 -37.7 95.59 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 121.651 1.567 . . . . 0.0 111.874 -178.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -65.13 -27.32 68.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.213 -0.929 . . . . 0.0 109.305 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.742 HD12 HG23 ' A' ' 60' ' ' VAL . 15.7 mt -96.66 24.73 5.73 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.322 -0.861 . . . . 0.0 109.459 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -64.2 138.06 58.26 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.651 -0.655 . . . . 0.0 110.055 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 108.03 8.87 29.02 Favored Glycine 0 N--CA 1.505 3.251 0 N-CA-C 110.669 -0.973 . . . . 0.0 110.669 178.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 16.0 tt -63.2 132.33 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 120.945 -1.326 . . . . 0.0 111.936 -177.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.0 t -104.91 115.33 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.1 t -103.12 133.32 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.898 -1.126 . . . . 0.0 109.01 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -104.71 114.77 29.19 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 23.5 t -102.4 122.18 47.42 Favored Pre-proline 0 N--CA 1.494 1.74 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.455 ' O ' ' NE2' ' A' ' 105' ' ' GLN . 68.5 Cg_endo -83.35 171.17 11.41 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.274 1.983 . . . . 0.0 113.18 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -79.13 -15.24 58.42 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.429 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 2.3 mmp_? -110.75 82.97 1.68 Allowed 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.527 ' H ' ' CD ' ' A' ' 105' ' ' GLN . 14.7 mp0 -83.09 -32.83 26.55 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 120.96 -1.087 . . . . 0.0 108.514 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.472 ' CD1' ' OG1' ' A' ' 75' ' ' THR . 61.6 t-105 . . . . . 0 C--N 1.302 -1.476 0 CA-C-O 117.616 -1.183 . . . . 0.0 110.266 178.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' FES . . . . . 0.502 ' S1 ' ' O ' ' A' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.462 ' CB ' ' SD ' ' A' ' 90' ' ' MET . 1.5 p . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.4 ' H ' ' HB2' ' A' ' 95' ' ' ASP . 25.2 mmtt -92.92 116.36 28.98 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.069 -1.019 . . . . 0.0 109.192 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.579 HG12 ' CE2' ' A' ' 5' ' ' TYR . 57.2 t -114.47 108.61 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 O-C-N 121.351 -0.843 . . . . 0.0 109.573 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.4 t -99.6 129.03 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.267 -0.896 . . . . 0.0 110.849 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.579 ' CE2' HG12 ' A' ' 3' ' ' VAL . 96.5 m-85 -104.86 115.77 30.86 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 177.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 81.0 t -98.24 114.8 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 120.901 -1.125 . . . . 0.0 108.146 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 63.2 p -72.15 -159.92 0.06 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.708 -0.62 . . . . 0.0 109.682 -178.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.605 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -88.02 -46.93 8.92 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -179.882 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.519 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 13.4 p30 -70.75 4.63 2.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.344 -0.848 . . . . 0.0 110.755 -178.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.85 -4.63 65.94 Favored Glycine 0 N--CA 1.498 2.821 0 O-C-N 120.808 -1.182 . . . . 0.0 110.552 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -65.61 126.9 29.8 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.747 -1.443 . . . . 0.0 108.718 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.534 ' CG ' HH11 ' A' ' 12' ' ' ARG . 2.6 mtt-85 -105.52 160.95 14.77 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.474 -0.766 . . . . 0.0 110.84 -178.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -150.83 116.31 5.43 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -101.98 130.87 48.62 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.701 -0.624 . . . . 0.0 111.14 -178.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.496 HD22 ' ND2' ' A' ' 30' ' ' ASN . 30.7 mt -119.4 -165.29 1.13 Allowed 'General case' 0 N--CA 1.504 2.237 0 CA-C-O 122.737 1.256 . . . . 0.0 109.882 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -135.19 97.24 3.67 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 104.62 -2.363 . . . . 0.0 104.62 176.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.704 HG13 ' HB2' ' A' ' 26' ' ' ALA . 3.7 t -104.79 118.62 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.518 0 O-C-N 121.044 -1.035 . . . . 0.0 108.244 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.05 173.34 6.63 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 122.091 0.948 . . . . 0.0 111.693 -177.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -64.63 138.51 58.44 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.988 0.899 . . . . 0.0 111.166 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.9 -14.43 52.72 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 178.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.602 ' HB ' HG12 ' A' ' 17' ' ' VAL . 48.6 t -82.63 140.48 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 O-C-N 120.721 -1.458 . . . . 0.0 108.87 -179.131 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.471 ' O ' ' N ' ' A' ' 25' ' ' GLN . 35.6 p -92.88 141.05 28.86 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.238 -0.914 . . . . 0.0 109.078 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 57.9 mt -44.48 -36.24 2.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.27 -0.894 . . . . 0.0 109.753 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.405 ' O ' ' SD ' ' A' ' 24' ' ' MET . 4.9 tpt -61.19 -37.84 84.39 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.471 ' N ' ' O ' ' A' ' 22' ' ' SER . 11.8 mm100 -66.82 -58.48 4.95 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.306 -0.871 . . . . 0.0 108.994 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.704 ' HB2' HG13 ' A' ' 17' ' ' VAL . . . -55.29 -30.07 59.44 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.785 -1.197 . . . . 0.0 110.749 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.759 ' HB1' ' H ' ' A' ' 33' ' ' TYR . . . -60.92 -24.58 66.13 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.955 -1.091 . . . . 0.0 109.06 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 89.5 t -86.05 -23.88 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.393 -0.817 . . . . 0.0 109.709 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.34 -28.92 59.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.17 -0.956 . . . . 0.0 108.618 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.496 ' ND2' HD22 ' A' ' 15' ' ' LEU . 6.4 m120 -108.07 -4.59 17.62 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 178.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 64.1 72.0 0.76 Allowed Glycine 0 N--CA 1.499 2.897 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.2 mt -124.51 -60.3 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.406 -1.056 . . . . 0.0 111.635 -178.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.759 ' H ' ' HB1' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -93.64 -15.19 25.6 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.307 -0.871 . . . . 0.0 109.2 179.267 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.437 ' C ' ' O ' ' A' ' 33' ' ' TYR . 6.8 p-10 -38.67 -43.81 0.93 Allowed 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -178.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.508 HG23 ' O ' ' A' ' 35' ' ' ILE . 19.2 tt -41.76 122.8 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.506 HG12 ' N ' ' A' ' 37' ' ' GLY . 93.4 t 57.46 159.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.309 -0.87 . . . . 0.0 109.577 -178.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.506 ' N ' HG12 ' A' ' 36' ' ' VAL . . . 177.04 111.93 0.3 Allowed Glycine 0 N--CA 1.486 2.007 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.496 ' C ' ' H ' ' A' ' 40' ' ' GLY . 1.0 OUTLIER -88.42 -85.42 0.19 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.004 -1.292 . . . . 0.0 109.99 -178.895 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.533 ' SG ' ' N ' ' A' ' 42' ' ' SER . 11.8 p -65.76 10.36 0.1 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.843 -1.161 . . . . 0.0 110.118 -179.288 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.496 ' H ' ' C ' ' A' ' 38' ' ' ASP . . . 54.61 7.59 1.0 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 -179.496 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.494 ' H ' ' C ' ' A' ' 39' ' ' CYS . . . 100.83 84.2 1.79 Allowed Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.533 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 5.1 m -160.3 28.55 0.17 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.274 -1.133 . . . . 0.0 108.922 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.402 ' HB2' ' OE1' ' A' ' 87' ' ' GLN . . . 50.0 66.35 1.16 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.051 -1.03 . . . . 0.0 109.224 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.1 m -159.15 17.16 0.18 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.168 -0.957 . . . . 0.0 109.965 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.442 ' SG ' ' OG1' ' A' ' 47' ' ' THR . 1.5 p -156.49 160.94 40.0 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.2 -0.937 . . . . 0.0 109.899 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.576 ' HB1' HG13 ' A' ' 74' ' ' VAL . . . -95.28 16.74 15.9 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.442 ' OG1' ' SG ' ' A' ' 45' ' ' CYS . 7.3 m -65.43 -54.42 28.82 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.922 -1.111 . . . . 0.0 110.251 -179.035 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.586 ' SG ' ' N ' ' A' ' 85' ' ' CYS . 17.7 p -82.3 54.42 2.56 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.756 -1.215 . . . . 0.0 110.15 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.716 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 35.8 t60 -77.45 109.67 11.58 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.152 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -143.7 164.94 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 120.679 -1.263 . . . . 0.0 109.664 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.546 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 42.4 m-85 -112.52 112.58 24.22 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-O 121.915 0.865 . . . . 0.0 109.747 -179.325 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.534 HG12 HD22 ' A' ' 53' ' ' ASN . 60.7 t -88.54 132.41 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.669 HD22 ' N ' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -47.73 127.01 11.1 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.076 -1.015 . . . . 0.0 108.646 179.301 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -56.36 14.6 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.252 -0.905 . . . . 0.0 111.297 -178.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.598 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -99.67 -18.0 17.5 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.595 -1.315 . . . . 0.0 109.823 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.617 ' CD2' HD22 ' A' ' 94' ' ' LEU . 30.9 m-85 -116.18 -9.4 11.63 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.977 -1.077 . . . . 0.0 108.38 -179.371 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.415 HG21 ' OD1' ' A' ' 81' ' ' ASN . 31.2 p -68.44 -43.62 76.71 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.272 -0.893 . . . . 0.0 109.82 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -91.03 19.86 5.36 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 120.179 -0.608 . . . . 0.0 109.731 -179.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.6 mtpt -129.83 -40.83 1.34 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.696 HG22 ' HD2' ' A' ' 61' ' ' PRO . 0.4 OUTLIER -81.06 168.17 26.92 Favored Pre-proline 0 N--CA 1.491 1.599 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 179.254 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.696 ' HD2' HG22 ' A' ' 60' ' ' VAL . 1.1 Cg_endo -59.43 97.68 0.1 Allowed 'Trans proline' 0 N--CA 1.491 1.369 0 CA-C-N 120.123 1.08 . . . . 0.0 113.593 -176.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.84 99.56 3.81 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 178.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.595 ' H ' ' NH1' ' A' ' 83' ' ' ARG . . . -47.03 152.17 0.56 Allowed 'General case' 0 C--N 1.287 -2.121 0 CA-C-O 122.242 1.02 . . . . 0.0 113.129 -178.288 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -61.1 -169.81 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.618 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -67.68 -3.92 10.58 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.771 -0.58 . . . . 0.0 111.976 -178.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? -62.74 -42.49 99.7 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.539 -1.351 . . . . 0.0 108.442 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.536 ' OE1' ' N ' ' A' ' 67' ' ' GLU . 22.5 mp0 -75.55 -48.1 23.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.446 -0.784 . . . . 0.0 109.937 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 35.3 mt -44.21 -21.83 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.519 -0.738 . . . . 0.0 109.655 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -80.0 -79.54 0.85 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 9.9 ptp -47.56 -37.81 13.0 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.925 -1.338 . . . . 0.0 108.932 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.448 ' O ' ' CG2' ' A' ' 74' ' ' VAL . 2.5 tm? -56.93 -31.02 64.51 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' A' ' 69' ' ' GLY . 14.5 tt0 -81.88 14.52 2.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.09 -1.007 . . . . 0.0 109.256 178.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -125.51 36.62 4.52 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.225 -0.922 . . . . 0.0 110.083 -179.055 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.603 ' CG2' HD11 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -98.87 176.09 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 121.058 -1.026 . . . . 0.0 108.522 179.218 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.509 ' OG1' ' CE2' ' A' ' 106' ' ' TRP . 4.9 m -120.05 6.36 10.82 Favored 'General case' 0 N--CA 1.508 2.446 0 O-C-N 121.245 -0.91 . . . . 0.0 111.19 -178.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.716 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -105.78 171.94 7.07 Favored 'General case' 0 N--CA 1.506 2.362 0 O-C-N 120.979 -1.076 . . . . 0.0 109.674 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.546 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -59.0 102.66 0.13 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.23 -0.919 . . . . 0.0 109.641 -179.313 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.603 HD11 ' CG2' ' A' ' 74' ' ' VAL . 2.6 mp -71.81 141.54 49.66 Favored 'General case' 0 C--N 1.293 -1.875 0 O-C-N 120.132 -1.605 . . . . 0.0 110.665 -179.516 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.556 ' H ' ' HG ' ' A' ' 82' ' ' SER . 45.2 mmtt -104.81 158.52 31.84 Favored Pre-proline 0 C--N 1.288 -2.081 0 CA-C-N 113.786 -1.552 . . . . 0.0 107.845 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -53.4 -16.24 7.06 Favored 'Trans proline' 0 C--N 1.302 -1.901 0 C-N-CA 121.248 1.298 . . . . 0.0 109.873 178.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.415 ' OD1' HG21 ' A' ' 57' ' ' THR . 3.9 p30 -130.55 39.47 3.62 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.993 -0.442 . . . . 0.0 111.03 -179.371 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.556 ' HG ' ' H ' ' A' ' 79' ' ' LYS . 22.7 m -68.45 150.34 48.23 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 119.978 -1.701 . . . . 0.0 107.554 178.158 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.595 ' NH1' ' H ' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -165.68 169.47 15.17 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.533 -1.354 . . . . 0.0 110.121 -179.669 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.828 HD22 ' N ' ' A' ' 84' ' ' LEU . 1.1 mm? -85.73 119.78 26.44 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.586 ' N ' ' SG ' ' A' ' 48' ' ' CYS . 0.5 OUTLIER -57.26 -41.84 80.4 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.037 -1.039 . . . . 0.0 111.282 -177.875 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 30.6 p -60.56 -22.92 64.2 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 120.635 -1.29 . . . . 0.0 111.444 -177.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.402 ' OE1' ' HB2' ' A' ' 43' ' ' ALA . 13.2 tp60 -91.18 33.04 0.98 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.009 -1.057 . . . . 0.0 111.16 -179.183 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.59 ' C ' HD12 ' A' ' 89' ' ' ILE . 33.8 mt -130.27 144.79 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 O-C-N 120.966 -1.084 . . . . 0.0 108.226 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.59 HD12 ' C ' ' A' ' 88' ' ' ILE . 1.7 mp -122.21 134.96 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.43 0 O-C-N 121.678 -0.639 . . . . 0.0 109.304 -179.187 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.628 ' SD ' ' N ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -81.16 144.5 31.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.234 -0.917 . . . . 0.0 108.851 -179.651 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.628 ' N ' ' SD ' ' A' ' 90' ' ' MET . 0.5 OUTLIER -129.46 152.54 79.77 Favored Pre-proline 0 N--CA 1.497 1.876 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 177.833 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.24 -34.75 26.66 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 121.671 1.58 . . . . 0.0 110.791 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -70.57 -23.29 62.57 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.584 -0.846 . . . . 0.0 109.8 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.617 HD22 ' CD2' ' A' ' 56' ' ' PHE . 6.7 mt -104.48 30.91 5.0 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.427 -0.796 . . . . 0.0 110.4 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.4 ' HB2' ' H ' ' A' ' 2' ' ' LYS . 11.0 p-10 -64.46 144.75 56.96 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.114 -1.616 . . . . 0.0 109.676 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 105.8 11.75 27.74 Favored Glycine 0 N--CA 1.503 3.112 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 178.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.436 HG13 HD21 ' A' ' 53' ' ' ASN . 15.3 tt -63.62 128.89 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.013 -1.286 . . . . 0.0 111.015 -177.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.478 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 6.6 t -103.84 123.7 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.225 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.2 t -111.44 135.06 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.067 -1.021 . . . . 0.0 109.688 -179.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -108.91 122.48 47.29 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-O 121.712 0.768 . . . . 0.0 109.055 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 35.0 t -110.3 123.27 36.34 Favored Pre-proline 0 N--CA 1.497 1.889 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.442 ' HG3' ' CD2' ' A' ' 49' ' ' HIS . 41.6 Cg_endo -85.94 -178.3 2.83 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.865 2.377 . . . . 0.0 113.486 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -87.01 -20.15 27.64 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.437 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 0.8 OUTLIER -103.78 82.45 2.0 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 179.623 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -81.13 -23.3 38.42 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.444 -0.902 . . . . 0.0 109.68 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.509 ' CE2' ' OG1' ' A' ' 75' ' ' THR . 11.1 t-105 . . . . . 0 C--N 1.305 -1.359 0 O-C-N 120.847 -1.158 . . . . 0.0 110.164 179.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 98.0 p . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.402 ' H ' ' HB2' ' A' ' 95' ' ' ASP . 1.1 mptm? -76.11 111.03 11.09 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.328 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.534 HG12 ' CE1' ' A' ' 5' ' ' TYR . 96.5 t -111.9 111.89 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.735 -0.603 . . . . 0.0 110.302 -178.27 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 24.4 t -98.89 98.85 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.222 -0.924 . . . . 0.0 111.764 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.534 ' CE1' HG12 ' A' ' 3' ' ' VAL . 29.0 m-85 -72.94 111.89 8.47 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 176.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 79.1 t -98.89 117.92 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 75.0 p -73.73 -155.83 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.492 -0.755 . . . . 0.0 109.513 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.598 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -91.54 -50.27 5.87 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.164 -0.96 . . . . 0.0 108.985 -179.727 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.492 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 22.0 p-10 -66.03 2.07 1.24 Allowed 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.509 -0.745 . . . . 0.0 110.734 -179.155 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.408 ' O ' ' NH1' ' A' ' 12' ' ' ARG . . . 96.74 -4.98 63.92 Favored Glycine 0 N--CA 1.501 3.013 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -62.6 126.52 27.62 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.117 -1.226 . . . . 0.0 108.179 179.287 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.432 ' NH1' ' CG ' ' A' ' 12' ' ' ARG . 0.5 OUTLIER -112.09 161.1 16.87 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 121.875 0.845 . . . . 0.0 111.577 -178.16 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.5 ttm105 -149.65 118.67 6.71 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -99.46 128.02 45.55 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.39 -0.819 . . . . 0.0 110.427 -178.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.547 HD11 ' CD1' ' A' ' 32' ' ' ILE . 21.6 mt -117.79 -165.54 1.1 Allowed 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 122.972 1.368 . . . . 0.0 109.978 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -138.0 101.73 4.5 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 176.293 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.49 ' CG2' HG21 ' A' ' 3' ' ' VAL . 12.2 t -104.69 117.07 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.67 179.9 4.5 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-O 122.046 0.927 . . . . 0.0 112.343 -177.211 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -65.89 134.13 52.37 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.849 0.833 . . . . 0.0 110.548 -179.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.94 -18.01 42.55 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 178.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.416 ' HB ' HG12 ' A' ' 17' ' ' VAL . 46.2 t -83.72 139.63 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 120.848 -1.384 . . . . 0.0 109.889 -178.29 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.511 ' O ' ' N ' ' A' ' 25' ' ' GLN . 51.4 p -94.84 141.26 28.84 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 178.73 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.1 mt -45.81 -33.86 3.37 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.362 -0.836 . . . . 0.0 109.611 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.512 ' SD ' ' OD1' ' A' ' 34' ' ' ASP . 2.3 tpt -68.53 -28.46 67.01 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 121.674 0.75 . . . . 0.0 109.165 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.511 ' N ' ' O ' ' A' ' 22' ' ' SER . 7.0 tp-100 -76.55 -62.72 1.53 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.138 -0.976 . . . . 0.0 109.959 -179.422 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.29 -24.17 53.17 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.689 -1.257 . . . . 0.0 109.995 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.94 -22.21 66.61 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.161 -0.962 . . . . 0.0 109.649 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 99.1 t -86.29 -17.93 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.374 -0.829 . . . . 0.0 109.41 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.97 -30.32 22.85 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.391 -0.818 . . . . 0.0 110.066 -178.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 -94.18 10.64 33.07 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 63.63 70.08 1.15 Allowed Glycine 0 N--CA 1.499 2.864 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 178.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.79 ' O ' ' N ' ' A' ' 34' ' ' ASP . 10.7 mt -124.95 121.64 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.454 -1.027 . . . . 0.0 109.76 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.541 ' O ' ' CD2' ' A' ' 33' ' ' TYR . 76.3 t80 -48.1 49.28 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.423 0 CA-C-O 120.891 0.377 . . . . 0.0 112.002 -177.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.79 ' N ' ' O ' ' A' ' 32' ' ' ILE . 4.2 p30 -96.27 -21.72 17.67 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.195 -0.941 . . . . 0.0 109.821 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.628 ' CG1' ' H ' ' A' ' 36' ' ' VAL . 3.4 tt -54.02 -167.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.422 -0.799 . . . . 0.0 109.996 -178.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.628 ' H ' ' CG1' ' A' ' 35' ' ' ILE . 13.4 t 58.84 99.88 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.285 -0.884 . . . . 0.0 108.729 -178.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -154.22 169.72 32.68 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.503 ' C ' ' H ' ' A' ' 40' ' ' GLY . 23.8 m-20 -87.97 -67.96 0.79 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.111 -1.229 . . . . 0.0 110.079 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.622 ' SG ' ' N ' ' A' ' 42' ' ' SER . 10.2 p -71.05 18.45 0.06 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.045 -1.034 . . . . 0.0 109.563 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.503 ' H ' ' C ' ' A' ' 38' ' ' ASP . . . 50.34 15.26 1.1 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.609 -1.796 . . . . 0.0 108.609 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.475 ' N ' ' C ' ' A' ' 39' ' ' CYS . . . 91.13 21.26 36.12 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 -179.508 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.622 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 57.9 m -93.77 35.98 1.12 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.437 -1.037 . . . . 0.0 109.991 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.429 ' C ' ' HG ' ' A' ' 44' ' ' SER . . . 44.72 70.58 0.33 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.379 -0.825 . . . . 0.0 110.252 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.429 ' HG ' ' C ' ' A' ' 43' ' ' ALA . 0.7 OUTLIER -163.47 26.6 0.08 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.897 -1.127 . . . . 0.0 110.133 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.455 ' SG ' ' N ' ' A' ' 46' ' ' ALA . 3.4 p -158.9 -159.44 0.78 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.886 -1.134 . . . . 0.0 109.95 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.455 ' N ' ' SG ' ' A' ' 45' ' ' CYS . . . -134.71 3.39 3.25 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.488 HG21 ' H ' ' A' ' 38' ' ' ASP . 62.0 p -49.86 -51.06 43.1 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.434 -0.792 . . . . 0.0 109.458 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.486 ' SG ' ' N ' ' A' ' 85' ' ' CYS . 30.1 p -73.46 54.85 0.46 Allowed 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.869 -1.145 . . . . 0.0 109.405 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.481 ' CE1' ' OH ' ' A' ' 51' ' ' TYR . 50.9 t60 -76.74 106.45 8.41 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -143.84 160.8 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 120.696 -1.253 . . . . 0.0 109.231 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.509 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 39.5 m-85 -108.52 111.42 23.27 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 122.241 1.019 . . . . 0.0 109.953 -179.082 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.541 HG13 HD11 ' A' ' 97' ' ' ILE . 10.9 t -85.94 133.29 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.576 ' C ' ' H ' ' A' ' 55' ' ' ALA . 1.0 OUTLIER -48.21 127.7 13.04 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.872 -1.143 . . . . 0.0 108.625 -179.852 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -56.35 9.15 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.467 -0.77 . . . . 0.0 111.471 -178.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.576 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -99.11 -17.38 18.24 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.805 -1.184 . . . . 0.0 109.9 -179.272 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.627 ' CD2' HD22 ' A' ' 94' ' ' LEU . 48.1 m-85 -115.61 -4.74 12.2 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.1 -1.0 . . . . 0.0 108.808 -179.493 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 24.8 p -72.95 -41.94 63.93 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.619 -0.676 . . . . 0.0 109.796 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -89.31 15.44 9.05 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 120.204 -0.599 . . . . 0.0 109.886 -179.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.1 mtpt -121.68 -40.86 2.51 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.523 HG22 ' HD2' ' A' ' 61' ' ' PRO . 0.5 OUTLIER -78.86 158.33 75.41 Favored Pre-proline 0 N--CA 1.495 1.82 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.61 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.523 ' HD2' HG22 ' A' ' 60' ' ' VAL . 1.3 Cg_endo -49.47 102.74 0.05 OUTLIER 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 122.222 1.948 . . . . 0.0 113.726 -177.136 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.463 ' HA ' HH22 ' A' ' 83' ' ' ARG . . . -75.66 101.62 5.05 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 177.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.805 ' H ' HH22 ' A' ' 83' ' ' ARG . . . -65.25 169.58 5.55 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-O 122.211 1.005 . . . . 0.0 112.58 -178.492 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.422 ' ND2' ' HE ' ' A' ' 66' ' ' ARG . 4.0 p30 -63.24 177.54 0.62 Allowed 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 122.103 0.954 . . . . 0.0 111.428 -178.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -72.23 5.34 2.89 Favored 'General case' 0 N--CA 1.503 2.214 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.523 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.422 ' HE ' ' ND2' ' A' ' 64' ' ' ASN . 10.2 mtm180 -74.16 -50.52 18.96 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 120.37 -1.456 . . . . 0.0 109.185 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.592 ' OE1' ' NE2' ' A' ' 87' ' ' GLN . 82.3 mt-10 -65.58 -16.71 63.97 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.525 -0.734 . . . . 0.0 109.655 179.114 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.563 HD12 ' N ' ' A' ' 68' ' ' ILE . 1.4 mp -75.54 -34.92 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.383 -0.823 . . . . 0.0 108.918 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.81 -20.51 48.21 Favored Glycine 0 N--CA 1.495 2.597 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 3.5 mmt -83.51 -35.42 24.85 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 178.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.484 ' HG ' HD21 ' A' ' 84' ' ' LEU . 59.8 mt -63.75 -21.98 66.68 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.422 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -83.82 11.7 7.16 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -131.26 28.13 4.74 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.446 -0.784 . . . . 0.0 109.774 -178.619 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.604 HG21 HD13 ' A' ' 78' ' ' LEU . 18.0 m -90.92 162.86 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.326 -0.859 . . . . 0.0 110.697 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.524 ' OG1' ' CD2' ' A' ' 106' ' ' TRP . 6.7 m -100.75 -8.7 22.5 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.321 -0.862 . . . . 0.0 109.983 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -107.55 175.33 5.53 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.807 -1.183 . . . . 0.0 110.723 -178.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.509 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -61.46 108.71 1.0 Allowed 'General case' 0 N--CA 1.503 2.21 0 CA-C-O 121.372 0.606 . . . . 0.0 110.967 -178.843 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.604 HD13 HG21 ' A' ' 74' ' ' VAL . 9.2 tp -72.92 156.67 38.62 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 119.547 -1.97 . . . . 0.0 110.101 179.108 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.6 mmtm -118.03 155.76 50.94 Favored Pre-proline 0 C--N 1.293 -1.856 0 CA-C-N 115.105 -0.952 . . . . 0.0 108.534 -178.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.99 -24.26 79.21 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 121.674 1.582 . . . . 0.0 109.261 178.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 81' ' ' ASN . 1.4 p30 -112.9 21.69 15.21 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.013 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.476 ' HB3' HD22 ' A' ' 71' ' ' LEU . 3.7 m -52.07 158.26 1.13 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 120.306 -1.496 . . . . 0.0 109.067 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.805 HH22 ' H ' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -156.69 148.22 22.48 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.061 -1.055 . . . . 0.0 111.924 -178.28 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.787 HD22 ' N ' ' A' ' 84' ' ' LEU . 2.2 mm? -85.48 121.66 28.51 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 177.131 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.486 ' N ' ' SG ' ' A' ' 48' ' ' CYS . 0.2 OUTLIER -70.64 -5.09 26.9 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.867 -1.146 . . . . 0.0 113.183 -175.708 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 27.9 p -93.93 -37.7 11.56 Favored 'General case' 0 N--CA 1.506 2.354 0 CA-C-N 120.438 1.472 . . . . 0.0 111.004 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.592 ' NE2' ' OE1' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -84.91 24.74 1.02 Allowed 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.214 -0.929 . . . . 0.0 110.39 -179.484 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.447 HD11 ' HB3' ' A' ' 83' ' ' ARG . 47.3 mt -108.09 148.3 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 O-C-N 121.131 -0.981 . . . . 0.0 108.651 179.159 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 33.5 mm -127.68 124.35 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.279 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.518 ' SD ' HG21 ' A' ' 97' ' ' ILE . 2.7 tpt -91.14 160.77 15.39 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.301 -0.874 . . . . 0.0 109.928 -178.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 70.9 p -149.38 147.61 23.86 Favored Pre-proline 0 N--CA 1.49 1.532 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -57.1 -29.58 83.71 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 121.46 1.44 . . . . 0.0 111.616 -179.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -67.83 -29.54 68.72 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.19 -0.944 . . . . 0.0 109.938 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.627 HD22 ' CD2' ' A' ' 56' ' ' PHE . 6.4 mt -98.1 31.04 2.85 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.578 -0.701 . . . . 0.0 109.863 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.402 ' HB2' ' H ' ' A' ' 2' ' ' LYS . 5.5 p-10 -62.63 138.51 58.51 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.169 -0.957 . . . . 0.0 110.17 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 111.8 9.1 21.49 Favored Glycine 0 N--CA 1.505 3.281 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 178.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.584 HD12 ' N ' ' A' ' 98' ' ' VAL . 0.1 OUTLIER -67.07 125.94 25.58 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 O-C-N 121.604 -0.939 . . . . 0.0 110.838 -178.213 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.584 ' N ' HD12 ' A' ' 97' ' ' ILE . 2.6 t -101.97 121.51 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.367 -0.833 . . . . 0.0 109.594 178.555 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.3 t -105.88 134.02 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 120.894 -1.129 . . . . 0.0 108.849 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -108.16 119.83 40.59 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 121.864 0.84 . . . . 0.0 109.015 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 23.7 t -107.27 122.94 39.76 Favored Pre-proline 0 N--CA 1.496 1.846 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.423 ' HG3' ' CD2' ' A' ' 49' ' ' HIS . 69.2 Cg_endo -83.57 177.69 6.15 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.703 2.269 . . . . 0.0 113.594 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -84.38 -15.26 46.96 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -112.05 80.4 1.32 Allowed 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.465 ' NE2' ' O ' ' A' ' 106' ' ' TRP . 2.2 pp0? -80.55 -20.43 43.46 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.724 -1.235 . . . . 0.0 109.659 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.524 ' CD2' ' OG1' ' A' ' 75' ' ' THR . 67.4 t-105 . . . . . 0 C--N 1.302 -1.475 0 CA-C-O 117.83 -1.081 . . . . 0.0 110.24 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.462 ' OG ' ' SD ' ' A' ' 90' ' ' MET . 67.9 p . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.1 mmtt -75.94 115.39 15.6 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.558 HG21 ' CG2' ' A' ' 17' ' ' VAL . 45.1 t -116.3 108.1 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.16 -0.963 . . . . 0.0 111.952 -177.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 28.2 t -103.38 134.89 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 CA-C-O 121.687 0.756 . . . . 0.0 110.247 178.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -108.42 118.8 37.72 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 177.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 64.7 t -98.17 113.53 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 120.846 -1.159 . . . . 0.0 108.516 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.401 ' OG ' ' N ' ' A' ' 8' ' ' HIS . 5.3 p -79.6 -153.63 0.08 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.486 -0.759 . . . . 0.0 110.261 -179.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.569 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.4 OUTLIER -91.84 -52.67 4.63 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.8 p30 -62.41 -2.0 0.92 Allowed 'General case' 0 N--CA 1.483 1.189 0 O-C-N 120.865 -1.147 . . . . 0.0 111.364 -178.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.65 0.43 64.54 Favored Glycine 0 N--CA 1.498 2.811 0 O-C-N 120.67 -1.269 . . . . 0.0 110.575 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.408 HG23 HH11 ' A' ' 13' ' ' ARG . 1.0 OUTLIER -77.02 141.55 40.28 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.98 -1.306 . . . . 0.0 109.101 -179.597 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.43 ' CD ' ' N ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -119.43 164.38 15.82 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.387 -0.82 . . . . 0.0 112.486 -178.139 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.408 HH11 HG23 ' A' ' 11' ' ' THR . 0.0 OUTLIER -139.89 111.69 7.39 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.014 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -98.35 122.67 41.81 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.197 -0.939 . . . . 0.0 109.589 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.501 HD22 ' CG ' ' A' ' 30' ' ' ASN . 21.0 mt -117.47 -164.48 1.0 Allowed 'General case' 0 N--CA 1.503 2.205 0 CA-C-O 122.747 1.26 . . . . 0.0 109.968 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -137.74 99.6 3.96 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 104.558 -2.386 . . . . 0.0 104.558 176.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.558 ' CG2' HG21 ' A' ' 3' ' ' VAL . 16.8 t -102.31 121.13 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.321 0 O-C-N 121.238 -0.914 . . . . 0.0 109.022 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.71 -178.67 5.48 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.237 -0.914 . . . . 0.0 111.547 -178.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -67.72 131.2 45.12 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 122.078 0.942 . . . . 0.0 111.584 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.78 -18.84 48.6 Favored Glycine 0 N--CA 1.493 2.433 0 N-CA-C 111.121 -0.791 . . . . 0.0 111.121 178.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.407 ' HB ' HG12 ' A' ' 17' ' ' VAL . 62.3 t -79.65 132.81 31.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 120.689 -1.477 . . . . 0.0 108.478 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.425 ' O ' ' N ' ' A' ' 25' ' ' GLN . 18.0 p -88.2 145.59 25.82 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.962 -1.086 . . . . 0.0 108.666 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 70.4 mt -45.64 -39.8 8.23 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 120.594 -1.316 . . . . 0.0 109.864 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 10.5 ttt -64.51 -27.67 69.13 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.549 -0.719 . . . . 0.0 109.255 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.425 ' N ' ' O ' ' A' ' 22' ' ' SER . 52.3 mt-30 -72.78 -58.62 3.2 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.173 -0.954 . . . . 0.0 109.053 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.406 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -62.82 -27.48 69.35 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.768 -1.207 . . . . 0.0 110.89 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.05 -22.02 64.19 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.653 -1.279 . . . . 0.0 108.793 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 89.6 t -84.66 -21.63 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-O 121.492 0.663 . . . . 0.0 109.41 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.18 -28.0 32.31 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.391 -0.818 . . . . 0.0 109.491 -179.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.501 ' CG ' HD22 ' A' ' 15' ' ' LEU . 7.4 m-80 . . . . . 0 N--CA 1.485 1.306 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 13.9 m . . . . . 0 N--CA 1.484 1.265 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.529 ' SG ' ' O ' ' A' ' 48' ' ' CYS . 13.8 p -96.42 46.84 1.07 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.887 -1.133 . . . . 0.0 110.224 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.596 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 38.7 t60 -75.32 109.98 9.28 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.045 -1.034 . . . . 0.0 108.347 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -143.49 164.65 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.152 -0.968 . . . . 0.0 109.36 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.516 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 58.1 m-85 -108.81 110.71 22.14 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-O 121.9 0.857 . . . . 0.0 109.477 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.777 HG13 HD11 ' A' ' 97' ' ' ILE . 14.5 t -87.77 132.89 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.577 ' C ' ' H ' ' A' ' 55' ' ' ALA . 21.6 t-20 -47.58 126.21 9.59 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.959 -1.088 . . . . 0.0 109.556 179.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -58.19 15.26 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.638 -0.664 . . . . 0.0 111.193 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.577 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -103.39 -18.75 14.7 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.697 -1.252 . . . . 0.0 109.577 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.676 ' CD2' HD22 ' A' ' 94' ' ' LEU . 44.1 m-85 -113.0 -12.71 13.19 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.104 -0.998 . . . . 0.0 109.172 -178.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 13.6 p -68.08 -37.38 81.18 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.455 -0.778 . . . . 0.0 109.882 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -88.95 13.24 13.27 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.49 -0.757 . . . . 0.0 109.424 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.3 mtpt -124.46 -39.3 2.33 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.626 HG22 ' HD2' ' A' ' 61' ' ' PRO . 0.5 OUTLIER -81.18 161.74 61.6 Favored Pre-proline 0 N--CA 1.497 1.909 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 179.667 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.626 ' HD2' HG22 ' A' ' 60' ' ' VAL . 6.2 Cg_endo -56.23 92.74 0.05 OUTLIER 'Trans proline' 0 N--CA 1.49 1.31 0 C-N-CA 121.584 1.522 . . . . 0.0 113.401 -177.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.37 102.63 5.2 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 178.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.795 ' H ' HH22 ' A' ' 83' ' ' ARG . . . -50.16 151.82 1.92 Allowed 'General case' 0 C--N 1.288 -2.08 0 CA-C-O 122.742 1.258 . . . . 0.0 112.596 -177.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -59.31 -165.38 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.372 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.438 ' HA ' HD12 ' A' ' 68' ' ' ILE . 8.5 pt-20 -68.76 -5.22 19.31 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.254 -0.904 . . . . 0.0 112.783 -177.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.4 mtt180 -60.91 -38.41 85.66 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.154 -1.591 . . . . 0.0 108.997 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -80.74 -39.04 27.65 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.973 -1.08 . . . . 0.0 110.05 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.438 HD12 ' HA ' ' A' ' 65' ' ' GLU . 84.5 mt -46.65 -28.93 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.33 -0.856 . . . . 0.0 110.105 -179.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -82.84 -30.41 32.18 Favored Glycine 0 N--CA 1.498 2.786 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 25.3 mtt -76.56 -34.21 58.5 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 178.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.529 ' O ' HD13 ' A' ' 78' ' ' LEU . 6.3 mt -59.05 -24.27 62.72 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -92.26 30.38 1.47 Allowed 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -134.89 19.4 3.49 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.533 -0.729 . . . . 0.0 110.487 -179.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.4 m -97.74 167.42 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 120.809 -1.182 . . . . 0.0 110.214 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.546 ' OG1' ' CD1' ' A' ' 106' ' ' TRP . 6.8 m -101.59 -0.16 35.32 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.385 -0.822 . . . . 0.0 109.789 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.596 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -107.18 169.29 8.65 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.242 -0.911 . . . . 0.0 110.465 -178.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.516 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -61.21 110.32 1.37 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.741 -0.6 . . . . 0.0 109.839 -179.343 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.529 HD13 ' O ' ' A' ' 71' ' ' LEU . 4.3 tp -68.6 158.01 34.89 Favored 'General case' 0 C--N 1.294 -1.811 0 O-C-N 120.26 -1.525 . . . . 0.0 108.753 178.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.443 ' N ' ' OG ' ' A' ' 82' ' ' SER . 41.5 mmtt -128.25 153.38 78.83 Favored Pre-proline 0 C--N 1.294 -1.818 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 -178.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -55.32 -28.29 61.97 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 121.54 1.494 . . . . 0.0 109.52 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -112.27 29.74 7.65 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.722 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.443 ' OG ' ' N ' ' A' ' 79' ' ' LYS . 4.3 m -61.89 164.64 6.19 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.673 -1.267 . . . . 0.0 109.159 178.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.795 HH22 ' H ' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -164.93 146.24 7.73 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 118.564 -1.254 . . . . 0.0 112.012 -178.6 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.517 HD22 ' N ' ' A' ' 84' ' ' LEU . 3.2 mm? -92.72 95.35 9.51 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 177.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -31.77 -46.21 0.11 Allowed 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -177.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.467 ' SG ' ' N ' ' A' ' 87' ' ' GLN . 30.3 p -58.22 -45.75 87.13 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 119.856 -1.777 . . . . 0.0 111.956 -177.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.467 ' N ' ' SG ' ' A' ' 86' ' ' CYS . 10.4 tp60 -74.79 39.58 0.13 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.481 -1.387 . . . . 0.0 111.494 -178.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.556 ' C ' HD12 ' A' ' 89' ' ' ILE . 31.6 mt -131.35 145.71 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 O-C-N 120.86 -1.15 . . . . 0.0 108.715 178.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.556 HD12 ' C ' ' A' ' 88' ' ' ILE . 1.6 mp -121.6 127.84 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.462 ' SD ' ' OG ' ' A' ' 1' ' ' SER . 0.0 OUTLIER -88.33 162.05 16.79 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -178.881 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.415 ' H ' ' HE2' ' A' ' 90' ' ' MET . 45.5 p -152.1 148.4 21.32 Favored Pre-proline 0 N--CA 1.49 1.551 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.1 -32.98 98.3 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 121.69 1.594 . . . . 0.0 111.298 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -66.63 -32.81 74.38 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.126 -0.984 . . . . 0.0 109.502 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.676 HD22 ' CD2' ' A' ' 56' ' ' PHE . 7.6 mt -90.85 31.39 1.07 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.149 -0.969 . . . . 0.0 109.229 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -60.21 133.31 55.98 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.878 -1.139 . . . . 0.0 110.45 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 110.67 11.33 19.53 Favored Glycine 0 N--CA 1.507 3.416 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 178.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.777 HD11 HG13 ' A' ' 52' ' ' VAL . 0.3 OUTLIER -64.07 124.17 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.19 0 O-C-N 120.997 -1.296 . . . . 0.0 110.297 -177.583 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.5 t -101.69 121.92 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.505 -0.747 . . . . 0.0 109.32 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.1 t -108.5 133.53 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 120.977 -1.077 . . . . 0.0 110.109 -178.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.96 118.32 36.39 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.901 0.858 . . . . 0.0 109.113 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 14.9 t -107.74 124.59 34.45 Favored Pre-proline 0 N--CA 1.497 1.909 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.407 ' HG3' ' CD2' ' A' ' 49' ' ' HIS . 97.1 Cg_endo -82.57 178.45 6.14 Favored 'Trans proline' 0 N--CA 1.5 1.886 0 C-N-CA 122.315 2.01 . . . . 0.0 113.497 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -83.03 -14.03 54.69 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.32 87.32 2.72 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 -178.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -87.56 -32.59 19.28 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . 0.546 ' CD1' ' OG1' ' A' ' 75' ' ' THR . 45.3 t-105 . . . . . 0 C--N 1.302 -1.486 0 CA-C-O 117.735 -1.126 . . . . 0.0 109.564 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 51.9 p . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.51 109.66 12.9 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.563 -0.855 . . . . 0.0 108.953 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.497 HG21 HG21 ' A' ' 17' ' ' VAL . 22.9 t -107.48 108.55 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 O-C-N 121.237 -0.915 . . . . 0.0 110.489 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.0 t -99.04 98.81 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.089 -1.007 . . . . 0.0 111.405 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.484 ' CZ ' HG11 ' A' ' 3' ' ' VAL . 68.9 m-85 -73.08 115.13 12.03 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 75.2 t -98.81 111.6 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 61.3 p -72.3 -159.66 0.06 Allowed 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 121.666 0.746 . . . . 0.0 109.867 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.584 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.2 OUTLIER -90.58 -50.87 5.69 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.309 -0.869 . . . . 0.0 108.709 -179.966 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.495 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 15.1 p30 -66.34 5.23 0.58 Allowed 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.752 -179.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.11 -1.83 74.4 Favored Glycine 0 N--CA 1.499 2.887 0 O-C-N 120.879 -1.138 . . . . 0.0 110.895 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -65.27 129.67 40.56 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.89 -1.359 . . . . 0.0 108.541 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 2.2 mtt85 -108.76 160.64 15.8 Favored 'General case' 0 N--CA 1.502 2.126 0 CA-C-O 121.68 0.752 . . . . 0.0 110.58 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.15 115.38 5.42 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 179.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -98.72 127.12 44.54 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-O 121.829 0.823 . . . . 0.0 110.342 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.491 HD11 ' ND2' ' A' ' 30' ' ' ASN . 0.3 OUTLIER -113.44 -174.33 2.44 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 123.203 1.478 . . . . 0.0 111.032 -177.797 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.417 ' H ' ' CD1' ' A' ' 15' ' ' LEU . 0.8 OUTLIER -136.14 99.97 4.28 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 104.654 -2.35 . . . . 0.0 104.654 176.48 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.497 HG21 HG21 ' A' ' 3' ' ' VAL . 13.0 t -108.22 116.39 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.81 -179.72 2.33 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.311 -0.868 . . . . 0.0 111.409 -178.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 19' ' ' ASP . 3.8 p-10 -70.0 136.75 50.75 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 122.012 0.91 . . . . 0.0 110.724 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.01 -18.2 41.74 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 178.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.434 ' HB ' HG12 ' A' ' 17' ' ' VAL . 57.5 t -80.1 138.52 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 120.616 -1.52 . . . . 0.0 109.432 -178.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.27 153.97 21.06 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.164 -0.96 . . . . 0.0 109.126 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.419 ' CD2' ' N ' ' A' ' 23' ' ' LEU . 1.8 mm? -56.26 -64.05 0.99 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.612 -0.68 . . . . 0.0 109.178 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.515 ' O ' ' SD ' ' A' ' 24' ' ' MET . 6.6 tpt -49.46 -16.28 0.2 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.009 -1.057 . . . . 0.0 109.123 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.418 ' N ' ' C ' ' A' ' 23' ' ' LEU . 7.7 tm0? -78.35 -68.1 0.67 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.104 -0.998 . . . . 0.0 109.47 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.427 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -55.24 -21.7 15.17 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.929 -1.107 . . . . 0.0 110.418 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.78 -19.35 65.78 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 120.844 -1.16 . . . . 0.0 108.809 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 96.5 t -86.98 -23.87 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.472 -0.767 . . . . 0.0 109.381 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.53 -26.43 45.79 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.529 -0.732 . . . . 0.0 109.054 -179.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.491 ' ND2' HD11 ' A' ' 15' ' ' LEU . 1.8 m-80 . . . . . 0 C--N 1.304 -1.408 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 9.7 m . . . . . 0 N--CA 1.487 1.395 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.516 ' SG ' ' O ' ' A' ' 48' ' ' CYS . 17.8 p -87.44 54.66 3.22 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.695 -1.253 . . . . 0.0 110.071 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.796 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 43.6 t60 -76.52 109.97 10.69 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.955 -1.091 . . . . 0.0 109.024 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -146.06 168.17 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 120.796 -1.19 . . . . 0.0 109.697 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.601 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 37.2 m-85 -116.7 114.86 24.62 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-O 122.051 0.929 . . . . 0.0 109.58 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.456 ' O ' ' OD1' ' A' ' 81' ' ' ASN . 78.7 t -91.31 131.64 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.765 ' ND2' ' HB3' ' A' ' 55' ' ' ALA . 1.1 t30 -46.95 127.65 10.31 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -57.38 13.9 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.63 -0.669 . . . . 0.0 111.441 -178.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.765 ' HB3' ' ND2' ' A' ' 53' ' ' ASN . . . -103.45 -19.8 14.28 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.57 -1.331 . . . . 0.0 109.8 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.551 ' CD2' HD22 ' A' ' 94' ' ' LEU . 30.2 m-85 -109.59 -9.78 14.87 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.708 -1.245 . . . . 0.0 108.859 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.0 p -71.18 -37.51 72.17 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.565 -0.71 . . . . 0.0 110.141 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.421 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 9.5 p-10 -87.84 10.51 18.33 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.229 -0.919 . . . . 0.0 109.913 -178.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.536 ' HB2' HD21 ' A' ' 94' ' ' LEU . 9.1 mttm -121.21 -40.04 2.63 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.66 HG22 ' HD2' ' A' ' 61' ' ' PRO . 0.4 OUTLIER -78.73 162.09 66.67 Favored Pre-proline 0 N--CA 1.498 1.953 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 179.813 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.66 ' HD2' HG22 ' A' ' 60' ' ' VAL . 4.4 Cg_endo -53.97 94.19 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 121.877 1.718 . . . . 0.0 113.939 -176.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.0 98.5 3.62 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 177.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.967 ' H ' HH22 ' A' ' 83' ' ' ARG . . . -61.05 169.34 2.04 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-O 122.559 1.171 . . . . 0.0 111.953 -178.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -65.18 -175.02 0.19 Allowed 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 122.204 1.002 . . . . 0.0 111.954 -178.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -70.33 3.31 3.0 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.813 -0.555 . . . . 0.0 111.409 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.2 mtm180 -59.95 -41.76 92.58 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.669 -1.269 . . . . 0.0 110.143 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.478 ' N ' ' CD ' ' A' ' 67' ' ' GLU . 23.7 mp0 -80.29 -37.0 33.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.021 -1.049 . . . . 0.0 110.029 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.446 HD12 ' N ' ' A' ' 68' ' ' ILE . 1.3 mp -46.88 -34.13 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 C-N-CA 119.731 -0.788 . . . . 0.0 109.142 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.3 -28.36 62.08 Favored Glycine 0 N--CA 1.498 2.791 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.421 ' N ' ' O ' ' A' ' 67' ' ' GLU . 25.1 mtt -79.97 -35.6 37.31 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 178.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 74.9 mt -66.81 -24.69 66.2 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -77.48 5.83 8.18 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.732 -1.23 . . . . 0.0 108.032 178.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -124.42 30.17 6.1 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.752 -0.592 . . . . 0.0 110.981 -177.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 28.9 m -96.35 169.54 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.42 0 O-C-N 120.652 -1.28 . . . . 0.0 110.723 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.524 ' OG1' ' CG ' ' A' ' 106' ' ' TRP . 3.1 m -102.41 -9.93 19.86 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.342 -0.849 . . . . 0.0 111.281 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.796 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -104.58 176.13 5.26 Favored 'General case' 0 N--CA 1.507 2.405 0 O-C-N 120.627 -1.296 . . . . 0.0 110.411 -178.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.601 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -59.64 105.33 0.36 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.613 -0.679 . . . . 0.0 110.255 -178.528 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.9 tp -73.96 147.35 43.14 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 119.502 -1.999 . . . . 0.0 110.338 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 27.0 mmtm -109.58 155.52 41.2 Favored Pre-proline 0 C--N 1.291 -1.962 0 CA-C-N 114.756 -1.111 . . . . 0.0 108.83 -178.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.47 -23.02 73.96 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 121.964 1.776 . . . . 0.0 109.331 178.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.456 ' OD1' ' O ' ' A' ' 52' ' ' VAL . 2.1 p30 -115.55 23.22 12.53 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.832 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.1 m -47.21 165.66 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.672 -1.268 . . . . 0.0 109.409 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.967 HH22 ' H ' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -161.58 141.99 10.71 Favored 'General case' 0 N--CA 1.5 2.046 0 C-N-CA 118.259 -1.376 . . . . 0.0 111.96 -177.531 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 95.5 mt -86.32 111.16 20.21 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 177.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.604 ' HA ' HD12 ' A' ' 88' ' ' ILE . 0.1 OUTLIER -56.2 -35.14 66.94 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -176.106 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . 0.547 ' SG ' ' N ' ' A' ' 87' ' ' GLN . 31.6 p -63.51 -49.06 75.05 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 119.678 -1.889 . . . . 0.0 112.343 -177.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.683 HE22 ' NH1' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -79.61 33.8 0.26 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.841 -1.162 . . . . 0.0 111.425 -177.709 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.604 HD12 ' HA ' ' A' ' 85' ' ' CYS . 71.5 mt -113.17 160.76 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 177.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.484 ' N ' HG22 ' A' ' 88' ' ' ILE . 35.6 mm -136.5 121.85 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.4 ' SD ' HD21 ' A' ' 23' ' ' LEU . 3.2 tpt -87.28 160.87 18.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.792 -1.193 . . . . 0.0 108.799 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 39.4 p -151.06 148.67 23.2 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -56.03 -32.37 85.97 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 121.379 1.386 . . . . 0.0 111.634 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.57 ' CD ' ' H ' ' A' ' 93' ' ' GLU . 2.3 pm0 -68.11 -31.52 71.18 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.062 -1.024 . . . . 0.0 110.006 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.551 HD22 ' CD2' ' A' ' 56' ' ' PHE . 7.2 mt -94.43 27.99 2.75 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 120.72 -1.237 . . . . 0.0 108.956 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -61.86 138.03 58.31 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.023 -1.048 . . . . 0.0 110.324 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 107.83 9.77 27.81 Favored Glycine 0 N--CA 1.499 2.866 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 178.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 14.4 tt -64.99 133.25 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 120.925 -1.338 . . . . 0.0 111.365 -177.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.3 t -103.06 114.59 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.5 t -103.72 135.75 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.729 -1.232 . . . . 0.0 108.558 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.1 116.17 31.44 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.809 0.814 . . . . 0.0 109.172 -179.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.2 t -103.34 125.01 36.24 Favored Pre-proline 0 N--CA 1.498 1.933 0 O-C-N 121.845 -0.534 . . . . 0.0 109.565 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.424 ' HG3' ' CD2' ' A' ' 49' ' ' HIS . 85.2 Cg_endo -80.6 167.24 19.09 Favored 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 122.193 1.929 . . . . 0.0 113.735 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -73.11 -14.98 61.49 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 21.5 mtm180 -123.82 92.32 3.65 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 2.7 pp0? -82.61 -19.51 38.23 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.628 -0.67 . . . . 0.0 109.716 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . 0.524 ' CG ' ' OG1' ' A' ' 75' ' ' THR . 63.5 t-105 . . . . . 0 C--N 1.304 -1.373 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.537 178.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.408 ' OG ' ' O ' ' A' ' 17' ' ' VAL . 83.9 p . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.402 ' H ' ' HB2' ' A' ' 95' ' ' ASP . 25.4 mmtt -75.38 111.71 10.93 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.31 -0.869 . . . . 0.0 109.157 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.446 ' CG2' ' SD ' ' A' ' 90' ' ' MET . 17.2 t -109.49 109.19 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.343 -0.848 . . . . 0.0 109.499 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.473 HG22 ' OE1' ' A' ' 14' ' ' GLU . 38.5 t -99.57 96.49 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.127 -0.983 . . . . 0.0 111.345 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -70.54 111.76 6.3 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 76.1 t -98.46 117.36 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 80.8 p -76.51 -158.6 0.1 Allowed 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.346 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.602 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -90.33 -49.65 6.41 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.089 -1.007 . . . . 0.0 109.466 -179.646 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.485 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 22.9 p-10 -66.39 2.06 1.39 Allowed 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.264 -0.897 . . . . 0.0 110.355 -178.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.01 -0.54 62.47 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -65.05 127.94 33.7 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.9 -1.353 . . . . 0.0 108.227 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.447 HH11 ' HD2' ' A' ' 12' ' ' ARG . 2.3 mtt85 -108.12 160.67 15.63 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 122.156 0.979 . . . . 0.0 110.796 -178.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -150.99 115.19 5.06 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 178.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.473 ' OE1' HG22 ' A' ' 4' ' ' VAL . 0.2 OUTLIER -99.19 128.46 45.32 Favored 'General case' 0 N--CA 1.508 2.436 0 CA-C-O 122.504 1.145 . . . . 0.0 110.613 -178.144 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.529 HD11 ' ND2' ' A' ' 30' ' ' ASN . 0.2 OUTLIER -115.13 -173.86 2.39 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 123.072 1.415 . . . . 0.0 110.575 -178.475 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.459 ' H ' ' CD1' ' A' ' 15' ' ' LEU . 32.6 t0 -136.36 104.39 5.6 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 176.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.538 HG22 ' CB ' ' A' ' 26' ' ' ALA . 25.2 t -112.9 122.92 67.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 O-C-N 121.525 -0.734 . . . . 0.0 109.604 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.82 179.78 5.9 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.919 0.866 . . . . 0.0 111.519 -178.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -69.31 138.82 54.11 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 122.025 0.917 . . . . 0.0 110.913 -179.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.83 -17.09 37.94 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 62.0 t -81.9 139.13 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 O-C-N 120.51 -1.583 . . . . 0.0 109.122 -178.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 16.0 p -92.68 149.19 21.48 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.158 -0.964 . . . . 0.0 108.588 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 27.0 mt -50.01 -36.15 27.51 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 121.093 -1.004 . . . . 0.0 110.007 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 7.5 tpt -68.11 -24.37 65.02 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.319 -0.863 . . . . 0.0 109.474 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -76.94 -63.22 1.41 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.143 -0.973 . . . . 0.0 109.622 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.538 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -52.95 -28.54 24.06 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.123 -0.986 . . . . 0.0 110.599 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.14 -20.96 29.17 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.749 -1.22 . . . . 0.0 108.756 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.5 t -88.57 -23.85 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.485 -0.759 . . . . 0.0 110.585 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.485 ' OG ' ' ND2' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -75.3 -31.11 60.56 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.303 -0.873 . . . . 0.0 109.99 -179.287 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.529 ' ND2' HD11 ' A' ' 15' ' ' LEU . 1.7 m-80 . . . . . 0 C--N 1.304 -1.37 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 75.5 p . . . . . 0 N--CA 1.482 1.127 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 20.8 p -97.28 54.21 1.21 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.214 -0.928 . . . . 0.0 109.586 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.679 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 39.5 t60 -76.2 96.11 3.84 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -133.65 164.58 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 121.151 -0.968 . . . . 0.0 109.748 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.518 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 45.8 m-85 -113.54 113.25 24.85 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 122.073 0.94 . . . . 0.0 110.192 -179.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.465 HG12 HD22 ' A' ' 53' ' ' ASN . 47.1 t -87.25 131.13 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.609 ' N ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -48.0 128.19 13.29 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.92 -1.113 . . . . 0.0 108.902 179.834 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -55.85 9.96 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.284 -0.885 . . . . 0.0 111.515 -178.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.597 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -98.19 -18.42 18.46 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.892 -1.13 . . . . 0.0 110.137 -179.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.612 ' CD2' HD22 ' A' ' 94' ' ' LEU . 26.1 m-85 -114.66 -7.45 12.73 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 120.707 -1.246 . . . . 0.0 108.855 -179.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.3 p -71.61 -41.18 69.22 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.083 -1.01 . . . . 0.0 109.858 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -85.48 10.17 13.74 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.435 -0.791 . . . . 0.0 110.006 -178.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.507 ' HB2' HD21 ' A' ' 94' ' ' LEU . 17.3 mttt -120.11 -38.46 2.93 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.684 HG22 ' HD2' ' A' ' 61' ' ' PRO . 0.4 OUTLIER -82.51 164.14 48.79 Favored Pre-proline 0 N--CA 1.493 1.705 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.684 ' HD2' HG22 ' A' ' 60' ' ' VAL . 5.6 Cg_endo -58.31 99.33 0.1 OUTLIER 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 121.773 1.649 . . . . 0.0 114.714 -176.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.27 102.97 1.48 Allowed 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -56.77 155.33 7.88 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-O 122.304 1.049 . . . . 0.0 112.51 -178.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.444 ' ND2' ' NH1' ' A' ' 66' ' ' ARG . 3.0 p30 -59.3 -178.2 0.06 Allowed 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.721 0.772 . . . . 0.0 111.148 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -70.1 2.19 3.88 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.669 -0.644 . . . . 0.0 112.354 -178.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.444 ' NH1' ' ND2' ' A' ' 64' ' ' ASN . 51.4 mtt85 -67.57 -40.97 84.87 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 120.68 -1.263 . . . . 0.0 109.679 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.484 ' N ' ' CD ' ' A' ' 67' ' ' GLU . 23.0 mp0 -72.26 -41.06 67.17 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.08 -1.013 . . . . 0.0 108.609 178.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.499 HD12 ' N ' ' A' ' 68' ' ' ILE . 1.4 mp -48.31 -30.26 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -70.15 -74.9 0.63 Allowed Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 9.0 ptp -46.38 -33.89 4.21 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.875 -1.368 . . . . 0.0 109.144 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.488 HD22 HD11 ' A' ' 78' ' ' LEU . 12.0 mt -58.04 -28.56 64.6 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.536 ' N ' ' O ' ' A' ' 69' ' ' GLY . 39.6 tt0 -79.71 5.11 14.22 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.368 -0.833 . . . . 0.0 108.771 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -122.99 31.57 5.98 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.555 -0.716 . . . . 0.0 110.122 -178.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.562 HG21 HD13 ' A' ' 78' ' ' LEU . 16.4 m -92.09 166.77 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 120.797 -1.189 . . . . 0.0 110.006 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.47 ' OG1' ' CG ' ' A' ' 106' ' ' TRP . 4.8 m -99.56 -8.08 25.02 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.806 -0.558 . . . . 0.0 110.249 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.679 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -107.36 169.74 8.39 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.113 -0.992 . . . . 0.0 110.354 -178.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.518 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -60.91 108.52 0.87 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.815 -0.553 . . . . 0.0 109.67 -179.553 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.562 HD13 HG21 ' A' ' 74' ' ' VAL . 8.5 tp -72.93 155.78 39.52 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 120.011 -1.681 . . . . 0.0 110.118 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 25.3 mmtm -117.15 153.54 49.78 Favored Pre-proline 0 C--N 1.292 -1.916 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 -178.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.4 -22.16 70.37 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 C-N-CA 121.173 1.249 . . . . 0.0 109.77 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.431 ' OD1' ' O ' ' A' ' 81' ' ' ASN . 1.1 p30 -111.77 19.66 17.8 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.867 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 21.6 m -58.24 162.69 3.39 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.542 -1.349 . . . . 0.0 109.746 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.563 ' NH2' ' O ' ' A' ' 61' ' ' PRO . 0.7 OUTLIER -171.72 146.28 2.09 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 118.32 -1.352 . . . . 0.0 111.169 179.447 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.444 ' CD1' ' N ' ' A' ' 84' ' ' LEU . 5.3 mp -76.62 116.01 16.9 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -57.51 -16.96 11.25 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.446 -0.784 . . . . 0.0 112.922 -176.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 30.5 p -85.85 -33.16 21.37 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 119.81 -1.806 . . . . 0.0 111.207 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.406 ' OE1' ' CD ' ' A' ' 67' ' ' GLU . 34.2 tt0 -87.53 32.05 0.73 Allowed 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.261 -1.525 . . . . 0.0 110.403 -179.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.407 HG22 ' N ' ' A' ' 89' ' ' ILE . 41.3 mm -117.61 157.93 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 O-C-N 121.022 -1.049 . . . . 0.0 108.423 178.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.407 ' N ' HG22 ' A' ' 88' ' ' ILE . 35.2 mm -130.5 122.7 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.446 ' SD ' ' CG2' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -86.54 155.84 20.32 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.137 -0.977 . . . . 0.0 108.622 -178.888 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 57.0 p -147.81 148.02 28.98 Favored Pre-proline 0 N--CA 1.492 1.663 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -58.08 -32.71 96.16 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 121.286 1.324 . . . . 0.0 111.018 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -64.82 -28.54 69.63 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.13 -0.981 . . . . 0.0 109.262 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.612 HD22 ' CD2' ' A' ' 56' ' ' PHE . 6.4 mt -99.37 27.59 5.11 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.401 -0.812 . . . . 0.0 109.492 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.402 ' HB2' ' H ' ' A' ' 2' ' ' LYS . 9.2 p-10 -58.9 138.45 57.36 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.876 -1.14 . . . . 0.0 109.361 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 107.22 9.75 29.01 Favored Glycine 0 N--CA 1.501 3.028 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 178.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.446 HG13 HD21 ' A' ' 53' ' ' ASN . 16.4 tt -65.09 130.05 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.842 -1.387 . . . . 0.0 111.113 -178.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.8 t -103.5 115.36 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.446 -0.784 . . . . 0.0 109.077 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.5 t -102.65 134.81 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 120.922 -1.112 . . . . 0.0 109.366 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -108.39 124.05 49.78 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.799 0.809 . . . . 0.0 109.661 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.1 t -111.11 124.12 33.58 Favored Pre-proline 0 N--CA 1.495 1.816 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.415 ' HG3' ' CD2' ' A' ' 49' ' ' HIS . 75.6 Cg_endo -83.06 175.53 8.41 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 122.678 2.252 . . . . 0.0 113.37 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -83.5 -17.34 42.25 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -109.74 80.92 1.36 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.447 ' O ' ' OXT' ' A' ' 106' ' ' TRP . 39.5 tt0 -82.95 -33.27 26.77 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.116 -0.99 . . . . 0.0 109.177 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . 0.548 ' CG ' ' O ' ' A' ' 106' ' ' TRP . 57.3 t-105 . . . . . 0 C--N 1.301 -1.522 0 CA-C-O 118.294 -0.86 . . . . 0.0 109.788 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 68.0 p . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.414 ' H ' ' HB2' ' A' ' 95' ' ' ASP . 19.1 mmtm -76.96 113.88 15.14 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.98 -1.075 . . . . 0.0 108.534 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.532 HG21 ' CG2' ' A' ' 17' ' ' VAL . 49.5 t -115.0 109.91 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.442 -0.786 . . . . 0.0 110.076 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.6 t -102.64 134.88 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 CA-C-O 121.749 0.785 . . . . 0.0 110.389 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -106.12 114.5 28.68 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 177.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 67.0 t -97.82 115.21 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 27.7 p -77.92 -160.28 0.19 Allowed 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.426 0.631 . . . . 0.0 109.674 -178.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.58 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.2 OUTLIER -87.13 -47.23 9.06 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.563 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.459 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 17.8 p30 -70.52 -2.53 14.36 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.088 -1.007 . . . . 0.0 110.973 -178.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.12 0.0 57.26 Favored Glycine 0 N--CA 1.499 2.863 0 O-C-N 120.854 -1.154 . . . . 0.0 110.953 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -66.31 131.15 45.45 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.628 -1.513 . . . . 0.0 108.847 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.84 156.03 23.61 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.579 0.704 . . . . 0.0 110.979 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.3 mmm-85 -142.76 112.75 7.03 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 177.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.484 ' CD ' ' H ' ' A' ' 14' ' ' GLU . 2.6 mp0 -98.37 127.33 44.26 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.863 -1.148 . . . . 0.0 109.819 -178.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.497 HD22 ' CG ' ' A' ' 30' ' ' ASN . 19.4 mt -117.88 -165.19 1.07 Allowed 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 122.738 1.256 . . . . 0.0 110.0 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -137.13 99.77 4.09 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 104.942 -2.244 . . . . 0.0 104.942 176.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.532 ' CG2' HG21 ' A' ' 3' ' ' VAL . 12.8 t -102.63 115.36 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.33 177.17 4.05 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 122.359 1.076 . . . . 0.0 111.312 -178.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -65.69 133.34 50.88 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.975 0.893 . . . . 0.0 110.709 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.03 -18.4 53.83 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.431 ' HB ' HG12 ' A' ' 17' ' ' VAL . 61.3 t -85.36 138.64 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.585 -1.538 . . . . 0.0 109.175 -178.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.438 ' O ' ' N ' ' A' ' 25' ' ' GLN . 59.9 p -93.38 146.35 23.8 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.266 -0.896 . . . . 0.0 109.458 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.5 mt -48.11 -34.17 9.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.001 -1.062 . . . . 0.0 109.406 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.49 ' O ' ' SD ' ' A' ' 24' ' ' MET . 4.3 tpt -67.55 -29.07 68.35 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.438 ' N ' ' O ' ' A' ' 22' ' ' SER . 14.5 mm100 -73.74 -59.83 2.53 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.104 -0.997 . . . . 0.0 109.637 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.41 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -60.48 -24.42 65.26 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.878 -1.139 . . . . 0.0 111.22 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.4 -24.58 67.9 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.941 -1.099 . . . . 0.0 108.967 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 88.7 t -80.78 -23.52 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 CA-C-O 121.555 0.693 . . . . 0.0 109.148 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.25 -27.54 35.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.4 -0.812 . . . . 0.0 109.28 -179.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.497 ' CG ' HD22 ' A' ' 15' ' ' LEU . 7.0 m-80 . . . . . 0 C--N 1.303 -1.449 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 178.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 42.7 p . . . . . 0 N--CA 1.482 1.14 0 CA-C-O 121.159 0.504 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.497 ' SG ' ' O ' ' A' ' 48' ' ' CYS . 15.0 p -91.37 48.11 1.45 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.795 -1.191 . . . . 0.0 109.996 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.703 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 53.8 t60 -77.99 113.14 15.62 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.969 -1.082 . . . . 0.0 109.026 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -146.05 165.12 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.107 -0.996 . . . . 0.0 109.214 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.576 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 52.0 m-85 -114.03 111.57 21.86 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 121.667 0.746 . . . . 0.0 109.788 -178.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.584 HG13 HD11 ' A' ' 97' ' ' ILE . 81.9 t -86.12 135.02 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.578 ' C ' ' H ' ' A' ' 55' ' ' ALA . 3.3 t30 -49.7 128.09 17.22 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.91 -1.119 . . . . 0.0 108.973 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -56.09 12.13 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.592 -0.692 . . . . 0.0 111.566 -178.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.578 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -101.06 -19.62 15.72 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.892 -1.13 . . . . 0.0 109.8 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.559 ' CD2' HD22 ' A' ' 94' ' ' LEU . 46.3 m-85 -110.78 -11.59 14.37 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.767 -1.208 . . . . 0.0 109.596 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.549 HG21 ' OD1' ' A' ' 81' ' ' ASN . 9.5 p -70.59 -38.3 74.03 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.81 -1.181 . . . . 0.0 110.012 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -85.85 9.71 15.93 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.184 -0.948 . . . . 0.0 110.092 -178.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.437 ' CE ' ' O ' ' A' ' 55' ' ' ALA . 9.6 mttm -121.11 -37.93 2.88 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.605 HG22 ' HD2' ' A' ' 61' ' ' PRO . 0.5 OUTLIER -81.84 159.0 67.06 Favored Pre-proline 0 N--CA 1.494 1.748 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.796 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.605 ' HD2' HG22 ' A' ' 60' ' ' VAL . 3.1 Cg_exo -48.7 101.96 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.029 1.819 . . . . 0.0 112.247 -178.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.9 101.44 4.41 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.544 ' HB1' ' OE1' ' A' ' 67' ' ' GLU . . . -49.63 144.05 6.44 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-O 121.878 0.847 . . . . 0.0 111.504 -178.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -53.56 -175.17 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.658 0.742 . . . . 0.0 110.121 -179.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -69.5 -1.44 8.62 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.697 -0.627 . . . . 0.0 111.136 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.507 ' O ' ' SD ' ' A' ' 70' ' ' MET . 8.8 mtt85 -63.85 -39.92 95.36 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.769 -1.207 . . . . 0.0 109.439 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.544 ' OE1' ' HB1' ' A' ' 63' ' ' ALA . 10.2 mp0 -78.18 -40.68 37.0 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.174 -0.953 . . . . 0.0 109.868 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.484 HD12 ' N ' ' A' ' 68' ' ' ILE . 1.4 mp -46.72 -25.33 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.49 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -76.66 -67.81 1.62 Allowed Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.066 -1.614 . . . . 0.0 109.066 179.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.507 ' SD ' ' O ' ' A' ' 66' ' ' ARG . 4.7 mpp? -49.28 -39.42 30.74 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.054 -1.262 . . . . 0.0 108.599 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.566 ' O ' HD13 ' A' ' 78' ' ' LEU . 6.5 mt -55.2 -21.71 14.86 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.49 ' N ' ' O ' ' A' ' 69' ' ' GLY . 27.0 tt0 -91.08 12.46 19.8 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -124.93 31.04 5.74 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.446 -0.784 . . . . 0.0 110.085 -179.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -98.61 175.5 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.287 0 O-C-N 121.375 -0.828 . . . . 0.0 109.215 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.525 ' OG1' ' CD1' ' A' ' 106' ' ' TRP . 4.2 m -109.71 -0.61 18.46 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.342 -0.849 . . . . 0.0 110.026 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.703 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -107.45 167.44 9.93 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.053 -1.029 . . . . 0.0 109.882 -179.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.576 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -58.07 106.8 0.4 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.616 -0.677 . . . . 0.0 110.935 -178.767 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.566 HD13 ' O ' ' A' ' 71' ' ' LEU . 7.2 tp -70.29 147.67 49.41 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 120.106 -1.621 . . . . 0.0 109.562 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.1 mmtp -112.78 156.04 43.13 Favored Pre-proline 0 C--N 1.29 -2.003 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -178.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -54.22 -22.14 25.02 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 121.349 1.366 . . . . 0.0 109.862 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.549 ' OD1' HG21 ' A' ' 57' ' ' THR . 0.1 OUTLIER -126.99 37.81 4.21 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.955 -0.465 . . . . 0.0 110.426 -179.887 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.441 ' HG ' ' HE1' ' A' ' 51' ' ' TYR . 37.5 m -60.49 175.46 0.45 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.365 -1.46 . . . . 0.0 108.445 179.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.458 ' HE ' HG12 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -166.24 159.86 15.43 Favored 'General case' 0 N--CA 1.504 2.227 0 C-N-CA 118.28 -1.368 . . . . 0.0 111.583 -178.183 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.413 ' C ' ' SG ' ' A' ' 48' ' ' CYS . 50.0 mt -105.75 95.35 5.74 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 178.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.489 ' C ' ' H ' ' A' ' 87' ' ' GLN . 0.1 OUTLIER -39.78 -44.34 1.57 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.553 -0.717 . . . . 0.0 112.848 -176.718 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 13.9 p -60.65 5.94 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 119.972 -1.705 . . . . 0.0 110.938 -177.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.489 ' H ' ' C ' ' A' ' 85' ' ' CYS . 13.6 mt-30 -136.02 45.39 2.39 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 120.937 -1.102 . . . . 0.0 111.664 -178.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.458 HG12 ' HE ' ' A' ' 83' ' ' ARG . 3.7 mt -131.77 156.18 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 O-C-N 121.074 -1.016 . . . . 0.0 108.602 177.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 38.3 mm -129.7 126.48 62.9 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.427 0 O-C-N 121.31 -0.869 . . . . 0.0 109.524 -178.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.468 ' SD ' HG21 ' A' ' 97' ' ' ILE . 4.1 tpt -91.05 163.51 14.28 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.106 -0.996 . . . . 0.0 110.38 -179.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 70.6 p -151.93 147.24 19.59 Favored Pre-proline 0 N--CA 1.488 1.469 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -56.35 -30.08 79.63 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 121.259 1.306 . . . . 0.0 111.568 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -68.96 -31.21 69.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.105 -0.997 . . . . 0.0 110.334 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.559 HD22 ' CD2' ' A' ' 56' ' ' PHE . 5.7 mt -95.58 32.72 1.75 Allowed 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.209 -0.932 . . . . 0.0 109.488 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.414 ' HB2' ' H ' ' A' ' 2' ' ' LYS . 3.7 p30 -62.45 138.6 58.49 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.71 -1.244 . . . . 0.0 110.159 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 109.86 9.75 24.03 Favored Glycine 0 N--CA 1.504 3.187 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 178.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.685 HD13 ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -65.04 129.89 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 120.996 -1.297 . . . . 0.0 111.555 -177.708 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.685 ' N ' HD13 ' A' ' 97' ' ' ILE . 4.9 t -106.99 118.97 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.2 -0.937 . . . . 0.0 109.393 -179.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.1 t -101.84 133.27 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.014 -1.054 . . . . 0.0 109.283 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.68 115.51 30.37 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 18.0 t -103.73 122.89 43.08 Favored Pre-proline 0 N--CA 1.494 1.736 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.41 ' HG3' ' CD2' ' A' ' 49' ' ' HIS . 89.7 Cg_endo -82.16 177.8 6.9 Favored 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 121.975 1.784 . . . . 0.0 113.111 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -85.75 -13.78 47.26 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.471 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -120.7 86.89 2.65 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -178.086 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -85.05 -28.76 25.45 Favored 'General case' 0 C--N 1.308 -1.207 0 O-C-N 121.115 -0.99 . . . . 0.0 109.312 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . 0.525 ' CD1' ' OG1' ' A' ' 75' ' ' THR . 62.5 t-105 . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.611 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.448 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.412 ' H ' ' HB2' ' A' ' 95' ' ' ASP . 0.2 OUTLIER -82.69 110.66 17.95 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.614 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.492 HG21 ' CG2' ' A' ' 17' ' ' VAL . 53.6 t -108.59 108.58 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.268 -0.895 . . . . 0.0 110.058 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 62.9 t -99.11 126.31 52.39 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-O 121.97 0.89 . . . . 0.0 110.278 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -103.45 112.95 26.08 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 177.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 64.7 t -99.63 120.88 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.7 p -82.44 -153.28 0.12 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.238 -0.913 . . . . 0.0 109.319 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.589 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -91.14 -44.35 9.31 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.458 -0.776 . . . . 0.0 109.393 -179.908 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.93 -0.87 3.4 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.217 -0.927 . . . . 0.0 111.317 -178.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.5 0.52 69.78 Favored Glycine 0 N--CA 1.498 2.826 0 O-C-N 120.427 -1.421 . . . . 0.0 110.618 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.1 t -72.46 135.7 45.8 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.938 -1.331 . . . . 0.0 108.31 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.29 163.9 12.64 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 122.204 1.002 . . . . 0.0 111.048 -178.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 -151.02 112.77 4.47 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -100.24 127.77 46.45 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-O 122.561 1.172 . . . . 0.0 111.127 -178.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.515 HD11 ' ND2' ' A' ' 30' ' ' ASN . 0.2 OUTLIER -114.63 -174.97 2.58 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-O 122.811 1.291 . . . . 0.0 110.301 -177.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.429 ' H ' HD13 ' A' ' 15' ' ' LEU . 18.2 t70 -134.26 100.62 4.74 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 176.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.492 ' CG2' HG21 ' A' ' 3' ' ' VAL . 7.6 t -111.21 115.79 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.15 177.14 3.4 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.884 0.85 . . . . 0.0 111.495 -177.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -66.02 138.55 57.87 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 122.014 0.911 . . . . 0.0 110.325 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.42 -18.11 35.13 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 178.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.485 ' HB ' HG12 ' A' ' 17' ' ' VAL . 51.9 t -83.79 140.68 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 120.704 -1.468 . . . . 0.0 109.326 -178.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 51.5 p -93.58 147.69 22.77 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.231 -0.918 . . . . 0.0 109.131 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.405 ' N ' HD23 ' A' ' 23' ' ' LEU . 7.9 mt -50.23 -31.9 15.16 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.193 -0.942 . . . . 0.0 109.477 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.448 ' SD ' ' C ' ' A' ' 24' ' ' MET . 1.4 tmt? -68.64 -29.58 68.1 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 52.5 mm-40 -72.05 -63.76 1.07 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.063 -1.023 . . . . 0.0 109.355 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.439 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -58.35 -25.6 62.16 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.996 -1.065 . . . . 0.0 110.374 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.27 -20.47 59.15 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.974 -1.079 . . . . 0.0 108.981 179.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 84.1 t -86.54 -22.62 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.637 -0.664 . . . . 0.0 109.636 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.484 ' OG ' ' ND2' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -79.74 -26.74 40.66 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.443 -0.786 . . . . 0.0 109.075 -179.525 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.515 ' ND2' HD11 ' A' ' 15' ' ' LEU . 2.4 m-80 . . . . . 0 N--CA 1.484 1.249 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 11.1 m . . . . . 0 N--CA 1.483 1.181 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.525 ' SG ' ' N ' ' A' ' 85' ' ' CYS . 31.9 p -80.11 53.76 1.8 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 120.944 -1.098 . . . . 0.0 109.605 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.621 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 39.3 t60 -77.64 105.61 8.91 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -143.62 164.83 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 120.859 -1.151 . . . . 0.0 109.889 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.512 ' OH ' ' NE2' ' A' ' 49' ' ' HIS . 36.4 m-85 -111.56 111.01 21.71 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.921 0.867 . . . . 0.0 110.101 -179.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.789 HG13 HD11 ' A' ' 97' ' ' ILE . 15.2 t -85.9 130.62 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.593 ' C ' ' H ' ' A' ' 55' ' ' ALA . 17.8 t-20 -47.11 126.18 8.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.783 -1.198 . . . . 0.0 109.566 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -57.32 13.99 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.737 -0.602 . . . . 0.0 111.291 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.593 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -100.7 -18.99 16.25 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.729 -1.232 . . . . 0.0 109.781 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.559 ' HB2' HD13 ' A' ' 97' ' ' ILE . 65.7 m-85 -113.85 -10.93 12.92 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.098 -1.001 . . . . 0.0 109.078 -178.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 13.1 p -68.99 -43.18 75.39 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.37 -0.831 . . . . 0.0 109.952 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -81.47 4.64 20.36 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.575 -0.703 . . . . 0.0 109.743 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 21.1 mtpt -113.19 -38.29 4.49 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.643 HG23 HD12 ' A' ' 94' ' ' LEU . 0.5 OUTLIER -82.8 158.57 65.0 Favored Pre-proline 0 N--CA 1.497 1.879 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 179.701 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.556 ' O ' ' NH2' ' A' ' 83' ' ' ARG . 1.1 Cg_endo -51.33 84.93 0.02 OUTLIER 'Trans proline' 0 N--CA 1.501 1.939 0 C-N-CA 122.405 2.07 . . . . 0.0 113.792 -176.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.79 105.17 0.28 Allowed 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -56.86 150.76 15.79 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-O 122.235 1.017 . . . . 0.0 112.667 -178.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.546 ' H ' ' ND2' ' A' ' 64' ' ' ASN . 0.6 OUTLIER -61.61 -172.84 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.032 -179.847 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -71.07 1.9 5.19 Favored 'General case' 0 N--CA 1.503 2.198 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -178.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.2 mtm180 -73.77 -46.74 43.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.386 -1.446 . . . . 0.0 109.087 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.443 ' N ' ' CD ' ' A' ' 67' ' ' GLU . 9.2 mp0 -64.39 -25.14 67.89 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.234 -0.916 . . . . 0.0 109.054 178.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.569 HD12 ' N ' ' A' ' 68' ' ' ILE . 1.4 mp -68.3 -34.74 67.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.032 -1.042 . . . . 0.0 108.839 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.82 -23.8 59.39 Favored Glycine 0 N--CA 1.496 2.672 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.434 ' N ' ' SD ' ' A' ' 70' ' ' MET . 0.9 OUTLIER -88.81 -31.54 18.28 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.911 -1.347 . . . . 0.0 107.571 178.931 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.433 HD22 ' HB3' ' A' ' 82' ' ' SER . 52.8 mt -67.74 -23.04 65.21 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -80.34 0.89 31.04 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -121.91 32.61 5.78 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.605 -0.684 . . . . 0.0 110.254 -178.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.603 HG21 HD13 ' A' ' 78' ' ' LEU . 29.3 m -94.69 167.21 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 O-C-N 121.126 -0.984 . . . . 0.0 110.796 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.4 m -104.24 -4.87 22.47 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.378 -0.826 . . . . 0.0 109.883 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.621 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -107.88 170.85 7.74 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.014 -1.053 . . . . 0.0 110.749 -178.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.504 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -61.54 107.67 0.84 Allowed 'General case' 0 N--CA 1.5 2.037 0 CA-C-O 121.532 0.682 . . . . 0.0 110.034 -179.716 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.603 HD13 HG21 ' A' ' 74' ' ' VAL . 8.6 tp -69.6 159.88 32.57 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 119.606 -1.934 . . . . 0.0 110.303 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.404 ' H ' ' HG ' ' A' ' 78' ' ' LEU . 18.7 mmtp -123.27 154.26 65.36 Favored Pre-proline 0 C--N 1.297 -1.715 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 -178.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -58.07 -23.6 61.72 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 121.537 1.491 . . . . 0.0 110.014 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 52' ' ' VAL . 1.5 p30 -117.07 27.72 8.95 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.99 -0.444 . . . . 0.0 109.837 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.433 ' HB3' HD22 ' A' ' 71' ' ' LEU . 5.0 m -58.48 166.68 1.67 Allowed 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.373 -1.455 . . . . 0.0 109.452 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.612 HH12 HG12 ' A' ' 60' ' ' VAL . 0.5 OUTLIER -172.32 153.43 2.98 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.122 -1.031 . . . . 0.0 111.267 179.549 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.802 ' H ' HD12 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -83.34 129.04 34.97 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 177.887 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.525 ' N ' ' SG ' ' A' ' 48' ' ' CYS . 0.5 OUTLIER -75.2 -6.11 47.96 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.718 -1.239 . . . . 0.0 112.584 -176.601 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 27.7 p -89.41 -33.65 16.77 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.281 -1.512 . . . . 0.0 110.722 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -92.33 49.54 1.52 Allowed 'General case' 0 N--CA 1.504 2.226 0 O-C-N 120.979 -1.076 . . . . 0.0 110.467 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 30.6 mt -130.56 154.26 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 36.5 mm -129.19 127.79 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.348 0 O-C-N 121.249 -0.907 . . . . 0.0 109.7 -178.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.907 ' SD ' HG21 ' A' ' 97' ' ' ILE . 8.1 tpt -89.02 161.17 16.73 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.908 -1.12 . . . . 0.0 110.099 -179.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.6 p -151.19 149.53 24.98 Favored Pre-proline 0 N--CA 1.491 1.62 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.6 -39.51 82.16 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 121.626 1.55 . . . . 0.0 111.754 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -64.16 -24.93 67.86 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.143 -0.973 . . . . 0.0 108.842 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.643 HD12 HG23 ' A' ' 60' ' ' VAL . 14.1 mt -99.52 23.99 8.74 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.434 -0.792 . . . . 0.0 109.577 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.442 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 18.7 p-10 -65.88 140.87 58.39 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.169 -0.957 . . . . 0.0 109.621 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 106.69 7.73 33.54 Favored Glycine 0 N--CA 1.506 3.338 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 178.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.907 HG21 ' SD ' ' A' ' 90' ' ' MET . 0.3 OUTLIER -61.71 127.65 21.89 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 O-C-N 121.707 -0.878 . . . . 0.0 110.346 -178.265 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.3 t -103.74 115.38 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.244 -0.91 . . . . 0.0 109.728 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.5 t -101.65 134.37 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.926 -1.109 . . . . 0.0 109.851 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.49 123.63 49.18 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 121.884 0.85 . . . . 0.0 108.722 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.3 t -112.97 126.37 28.35 Favored Pre-proline 0 N--CA 1.497 1.919 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.415 ' HG3' ' CD2' ' A' ' 49' ' ' HIS . 58.1 Cg_endo -84.52 178.07 5.27 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.797 2.331 . . . . 0.0 113.031 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.424 ' OD2' ' CD2' ' A' ' 8' ' ' HIS . 1.0 OUTLIER -84.2 -17.99 38.08 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.57 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -107.68 83.15 1.76 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.642 ' H ' ' NE2' ' A' ' 105' ' ' GLN . 1.3 pm0 -84.69 -31.66 24.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.911 -1.118 . . . . 0.0 108.887 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . 0.405 ' OXT' ' O ' ' A' ' 105' ' ' GLN . 57.4 t-105 . . . . . 0 C--N 1.3 -1.568 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.145 178.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.432 ' OG ' ' O ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.412 ' H ' ' HB2' ' A' ' 95' ' ' ASP . 27.2 mmtt -76.19 107.14 8.21 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.403 -0.919 . . . . 0.0 108.718 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.401 HG22 ' CG2' ' A' ' 97' ' ' ILE . 11.7 t -107.09 109.97 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 O-C-N 121.176 -0.952 . . . . 0.0 109.201 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.9 t -98.82 94.19 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.039 -1.038 . . . . 0.0 110.59 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -68.06 114.65 6.76 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 71.5 t -98.75 112.07 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.115 -0.99 . . . . 0.0 108.434 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 63.6 p -72.7 -160.08 0.07 Allowed 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.554 0.692 . . . . 0.0 109.517 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.602 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -88.9 -50.93 5.9 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.183 -0.948 . . . . 0.0 108.625 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.504 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 10.1 p30 -64.94 2.71 0.67 Allowed 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 119.804 -0.759 . . . . 0.0 110.442 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.522 ' O ' ' NH1' ' A' ' 12' ' ' ARG . . . 93.83 -3.09 70.39 Favored Glycine 0 N--CA 1.496 2.693 0 O-C-N 120.731 -1.23 . . . . 0.0 110.08 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.09 128.04 34.22 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.932 -1.334 . . . . 0.0 108.438 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.522 ' NH1' ' O ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -108.63 159.54 16.65 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.51 -0.744 . . . . 0.0 111.197 -178.782 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.2 mtt85 -150.08 115.72 5.54 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 178.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -97.82 126.93 43.44 Favored 'General case' 0 N--CA 1.502 2.158 0 CA-C-O 122.633 1.206 . . . . 0.0 110.607 -178.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.585 HD13 ' H ' ' A' ' 16' ' ' ASP . 0.2 OUTLIER -111.9 -175.43 2.69 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 123.132 1.444 . . . . 0.0 111.589 -177.723 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.585 ' H ' HD13 ' A' ' 15' ' ' LEU . 11.1 t70 -137.06 101.57 4.59 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 104.548 -2.39 . . . . 0.0 104.548 176.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.48 HG12 ' HB ' ' A' ' 21' ' ' VAL . 11.8 t -109.67 119.03 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.56 176.33 4.18 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.188 -0.945 . . . . 0.0 111.141 -177.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -65.64 137.08 57.09 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.953 0.882 . . . . 0.0 110.691 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.92 -17.07 23.99 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 178.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.48 ' HB ' HG12 ' A' ' 17' ' ' VAL . 60.8 t -77.64 139.8 18.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 O-C-N 120.428 -1.631 . . . . 0.0 108.479 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 25' ' ' GLN . 59.5 p -94.16 143.7 26.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.105 -0.997 . . . . 0.0 109.093 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.529 HD21 ' SD ' ' A' ' 90' ' ' MET . 49.6 mt -45.45 -37.14 4.9 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.08 -1.013 . . . . 0.0 109.766 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.492 ' O ' ' SD ' ' A' ' 24' ' ' MET . 5.6 tpt -65.62 -26.43 67.82 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.388 -0.82 . . . . 0.0 109.355 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' A' ' 22' ' ' SER . 13.8 mm100 -75.31 -63.23 1.32 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.183 -0.948 . . . . 0.0 109.702 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.449 ' O ' ' OD1' ' A' ' 30' ' ' ASN . . . -59.94 -26.49 66.02 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.657 -1.277 . . . . 0.0 110.906 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.44 -20.39 66.14 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.585 -1.322 . . . . 0.0 109.011 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 70.6 t -86.51 -25.69 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.438 -0.789 . . . . 0.0 109.587 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.96 -24.55 60.81 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.362 -0.836 . . . . 0.0 109.042 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.518 ' ND2' HD11 ' A' ' 15' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.303 -1.435 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 179.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.439 ' O ' ' OE1' ' A' ' 105' ' ' GLN . 3.1 m . . . . . 0 N--CA 1.483 1.181 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.592 ' SG ' ' N ' ' A' ' 85' ' ' CYS . 18.3 p -97.7 54.18 1.15 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.867 -1.146 . . . . 0.0 109.744 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.794 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 43.3 t60 -75.89 110.43 10.33 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.114 -0.991 . . . . 0.0 109.113 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -146.52 166.94 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 120.813 -1.179 . . . . 0.0 109.582 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.583 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 37.4 m-85 -115.85 115.38 26.15 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.857 0.837 . . . . 0.0 109.815 -179.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.847 HG13 HD11 ' A' ' 97' ' ' ILE . 13.3 t -89.46 129.48 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.561 ' C ' ' H ' ' A' ' 55' ' ' ALA . 19.0 t-20 -46.15 131.01 10.32 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.107 -0.996 . . . . 0.0 109.753 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.412 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 9.7 pt-20 -57.01 8.16 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.395 -0.816 . . . . 0.0 111.025 -179.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.561 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -95.96 -23.13 16.99 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.636 -1.29 . . . . 0.0 110.113 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -111.25 -6.71 14.5 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.901 -1.124 . . . . 0.0 108.894 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.431 HG21 ' OD1' ' A' ' 81' ' ' ASN . 25.3 p -70.87 -42.14 70.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.643 -0.661 . . . . 0.0 109.806 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -82.8 0.93 41.57 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.59 -0.694 . . . . 0.0 109.894 -179.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 15.7 mttt -109.99 -38.72 5.25 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.603 HG23 HD12 ' A' ' 94' ' ' LEU . 0.5 OUTLIER -84.73 158.19 59.83 Favored Pre-proline 0 N--CA 1.496 1.835 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 179.534 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.558 ' HD2' HG22 ' A' ' 60' ' ' VAL . 1.3 Cg_endo -54.49 110.97 0.59 Allowed 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 121.714 1.609 . . . . 0.0 113.698 -177.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.37 112.8 12.06 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.935 ' H ' ' NH1' ' A' ' 83' ' ' ARG . . . -53.81 144.33 18.68 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-O 122.286 1.041 . . . . 0.0 112.073 -178.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.49 ' H ' ' ND2' ' A' ' 64' ' ' ASN . 1.3 p30 -66.37 -167.73 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.678 0.751 . . . . 0.0 110.636 -179.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -69.47 -6.67 32.0 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.667 -0.646 . . . . 0.0 112.127 -178.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.508 ' O ' ' SD ' ' A' ' 70' ' ' MET . 69.3 mtm-85 -65.03 -44.61 88.55 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 120.424 -1.422 . . . . 0.0 109.405 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -74.27 -39.53 62.93 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.153 -0.967 . . . . 0.0 109.35 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 39.5 mt -48.02 -25.33 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.335 -0.853 . . . . 0.0 109.574 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -82.29 -40.64 9.93 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.508 ' SD ' ' O ' ' A' ' 66' ' ' ARG . 4.3 mpp? -72.05 -34.59 68.88 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 178.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 71' ' ' LEU . 46.1 mt -63.99 -27.75 69.34 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -79.14 2.79 19.64 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.042 -1.037 . . . . 0.0 108.472 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -120.86 28.14 8.09 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.74 -0.6 . . . . 0.0 110.713 -178.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.9 m -95.96 169.53 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 O-C-N 120.844 -1.16 . . . . 0.0 109.975 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.476 ' OG1' ' CD2' ' A' ' 106' ' ' TRP . 3.7 m -106.29 -6.78 18.14 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.435 -0.79 . . . . 0.0 111.957 -178.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.794 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -106.16 174.7 5.77 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 120.56 -1.338 . . . . 0.0 110.572 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.583 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -56.1 104.39 0.14 Allowed 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.833 -0.542 . . . . 0.0 111.26 -178.516 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.4 tp -69.98 149.44 47.73 Favored 'General case' 0 C--N 1.295 -1.794 0 O-C-N 120.186 -1.572 . . . . 0.0 109.366 178.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.451 ' NZ ' ' OE2' ' A' ' 77' ' ' GLU . 27.2 mmtm -115.31 156.57 45.51 Favored Pre-proline 0 C--N 1.287 -2.133 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -178.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -56.97 -21.51 41.8 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 121.358 1.372 . . . . 0.0 109.629 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.431 ' OD1' HG21 ' A' ' 57' ' ' THR . 5.1 p30 -120.33 28.1 8.22 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.422 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.413 ' HG ' ' HE1' ' A' ' 51' ' ' TYR . 37.2 m -57.6 158.38 6.07 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 120.07 -1.644 . . . . 0.0 108.885 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.935 ' NH1' ' H ' ' A' ' 63' ' ' ALA . 1.6 mtp85 -169.47 159.6 8.65 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 118.763 -1.175 . . . . 0.0 111.042 -178.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.761 HD22 ' N ' ' A' ' 84' ' ' LEU . 2.7 mm? -84.21 123.83 30.53 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 179.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.592 ' N ' ' SG ' ' A' ' 48' ' ' CYS . 0.5 OUTLIER -64.11 -16.48 61.91 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.197 -0.94 . . . . 0.0 113.145 -176.556 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 22.2 p -81.65 -43.46 18.51 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 119.708 -1.87 . . . . 0.0 110.955 -178.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.695 HE22 ' CZ ' ' A' ' 83' ' ' ARG . 5.2 pp0? -75.61 29.57 0.1 Allowed 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.972 -1.08 . . . . 0.0 111.169 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.658 ' O ' HD12 ' A' ' 89' ' ' ILE . 38.4 mt -116.03 151.42 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.295 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 178.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.658 HD12 ' O ' ' A' ' 88' ' ' ILE . 1.5 mp -131.44 125.52 56.71 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.235 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -178.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.529 ' SD ' HD21 ' A' ' 23' ' ' LEU . 1.9 tpt -87.49 161.8 17.6 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.089 -1.007 . . . . 0.0 109.571 -179.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.6 p -152.08 149.32 23.08 Favored Pre-proline 0 N--CA 1.489 1.484 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -54.56 -39.29 89.06 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 121.74 1.626 . . . . 0.0 111.643 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -64.03 -24.21 67.62 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.169 -0.957 . . . . 0.0 109.49 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.603 HD12 HG23 ' A' ' 60' ' ' VAL . 13.9 mt -101.73 18.88 19.3 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.449 -0.782 . . . . 0.0 109.434 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.412 ' HB2' ' H ' ' A' ' 2' ' ' LYS . 20.4 p-10 -61.44 139.53 58.2 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.407 -0.808 . . . . 0.0 109.946 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 105.55 8.21 35.53 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 178.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.847 HD11 HG13 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -65.75 138.39 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.207 -1.172 . . . . 0.0 111.878 -177.764 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.5 t -106.48 117.81 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.665 -0.647 . . . . 0.0 109.328 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.8 t -102.74 136.91 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 120.761 -1.212 . . . . 0.0 108.568 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -108.16 114.75 28.88 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.76 0.791 . . . . 0.0 108.88 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.4 t -102.47 124.77 38.18 Favored Pre-proline 0 N--CA 1.495 1.813 0 O-C-N 121.883 -0.511 . . . . 0.0 109.78 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.436 ' HG3' ' CD2' ' A' ' 49' ' ' HIS . 92.6 Cg_endo -81.71 169.61 14.98 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 122.515 2.143 . . . . 0.0 113.88 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -75.61 -15.47 60.34 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.187 0.517 . . . . 0.0 109.649 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 27.4 mtm180 -122.31 93.38 3.96 Favored 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.439 ' OE1' ' O ' ' A' ' 47' ' ' THR . 35.5 tt0 -82.26 -16.96 47.66 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.651 -0.656 . . . . 0.0 109.826 -178.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . 0.476 ' CD2' ' OG1' ' A' ' 75' ' ' THR . 61.3 t-105 . . . . . 0 C--N 1.304 -1.397 0 CA-C-O 117.948 -1.025 . . . . 0.0 110.45 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.405 ' H ' ' HB2' ' A' ' 95' ' ' ASP . 16.8 mmtm -77.27 117.12 18.48 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.568 HG21 ' CG2' ' A' ' 17' ' ' VAL . 72.5 t -115.78 109.61 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.334 -0.854 . . . . 0.0 111.048 -178.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 33.6 t -98.9 93.17 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 CA-C-O 122.209 1.004 . . . . 0.0 111.178 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.411 ' CE1' HG12 ' A' ' 3' ' ' VAL . 96.1 m-85 -67.8 113.71 5.77 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 177.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 99.7 t -99.0 116.7 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 120.991 -1.068 . . . . 0.0 108.939 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 79.3 p -75.38 -157.71 0.07 Allowed 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.632 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -92.13 -48.51 6.68 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.217 -0.927 . . . . 0.0 109.105 -179.672 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.487 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 8.5 p30 -65.39 1.75 1.05 Allowed 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.323 -0.861 . . . . 0.0 110.7 -178.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.96 -3.45 67.19 Favored Glycine 0 N--CA 1.495 2.606 0 O-C-N 120.717 -1.239 . . . . 0.0 110.262 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -65.6 129.05 38.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.779 -1.424 . . . . 0.0 108.25 179.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 29.8 mtm180 -108.25 145.19 34.67 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.879 -0.513 . . . . 0.0 110.986 -178.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.16 114.85 16.22 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 178.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -98.6 122.97 42.49 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.51 -0.744 . . . . 0.0 110.237 -178.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.402 HD12 ' CE1' ' A' ' 5' ' ' TYR . 30.4 mt -120.28 -166.04 1.26 Allowed 'General case' 0 N--CA 1.502 2.13 0 CA-C-O 122.746 1.26 . . . . 0.0 109.729 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -134.41 99.81 4.48 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 104.623 -2.362 . . . . 0.0 104.623 176.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.568 ' CG2' HG21 ' A' ' 3' ' ' VAL . 10.6 t -101.4 117.8 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.276 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.07 178.03 5.97 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 122.366 1.079 . . . . 0.0 112.116 -177.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -64.65 130.38 43.38 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-O 121.981 0.896 . . . . 0.0 111.117 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.74 -17.05 54.96 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 178.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.432 ' HB ' HG12 ' A' ' 17' ' ' VAL . 64.8 t -78.82 134.54 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 120.503 -1.586 . . . . 0.0 108.805 -179.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 25' ' ' GLN . 4.2 p -80.59 139.77 36.11 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.027 -1.046 . . . . 0.0 108.847 179.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 31.5 mt -45.06 -33.03 1.94 Allowed 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.013 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 9.7 ttt -77.61 -33.07 53.84 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.426 -0.796 . . . . 0.0 109.217 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.419 ' N ' ' O ' ' A' ' 22' ' ' SER . 39.6 mm-40 -59.34 -56.62 19.73 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.457 -0.897 . . . . 0.0 108.796 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.418 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -58.2 -26.55 62.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.829 -1.169 . . . . 0.0 110.512 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.74 -21.59 55.69 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.93 -1.106 . . . . 0.0 108.802 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 54.7 t -86.58 -23.47 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.49 -0.756 . . . . 0.0 109.819 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.81 -29.79 58.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.281 -0.887 . . . . 0.0 108.728 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 . . . . . 0 C--N 1.303 -1.448 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.574 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 24.8 m . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.498 ' SG ' ' O ' ' A' ' 48' ' ' CYS . 14.1 p -90.77 47.96 1.48 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.862 -1.149 . . . . 0.0 109.533 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.775 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 24.5 t60 -76.21 99.64 4.79 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -133.62 170.7 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.15 -0.969 . . . . 0.0 110.254 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.567 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 36.9 m-85 -116.46 113.3 22.64 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 122.056 0.932 . . . . 0.0 110.057 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.617 HG13 HD11 ' A' ' 97' ' ' ILE . 5.7 t -86.87 129.15 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.59 ' C ' ' H ' ' A' ' 55' ' ' ALA . 16.2 t-20 -46.62 127.35 9.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.034 -1.042 . . . . 0.0 109.662 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -55.76 10.08 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.611 -0.681 . . . . 0.0 111.487 -178.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.59 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -98.65 -19.95 17.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.807 -1.183 . . . . 0.0 109.829 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.711 ' CD2' HD22 ' A' ' 94' ' ' LEU . 39.1 m-85 -113.85 -6.94 13.22 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.919 -1.113 . . . . 0.0 108.574 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.548 ' CA ' HH12 ' A' ' 83' ' ' ARG . 22.5 p -69.76 -43.7 71.68 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.654 0.74 . . . . 0.0 110.138 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -83.5 14.05 4.03 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.964 -0.694 . . . . 0.0 109.228 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.2 mtpt -124.76 -38.74 2.34 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.574 HG22 ' HD2' ' A' ' 61' ' ' PRO . 0.4 OUTLIER -85.8 164.7 38.51 Favored Pre-proline 0 N--CA 1.5 2.06 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 179.148 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.574 ' HD2' HG22 ' A' ' 60' ' ' VAL . 7.8 Cg_endo -59.56 105.0 0.24 Allowed 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 121.208 1.272 . . . . 0.0 114.001 -176.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.498 ' HA ' ' NH2' ' A' ' 83' ' ' ARG . . . -74.43 104.65 5.24 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 177.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -47.09 140.66 4.86 Favored 'General case' 0 C--N 1.287 -2.149 0 CA-C-O 122.061 0.934 . . . . 0.0 111.437 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.473 ' N ' ' OD1' ' A' ' 64' ' ' ASN . 2.6 p30 -58.62 -169.81 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.404 0.621 . . . . 0.0 110.486 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -65.31 0.35 1.47 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.292 -0.88 . . . . 0.0 111.197 -178.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.506 ' O ' ' SD ' ' A' ' 70' ' ' MET . 0.3 OUTLIER -69.44 -45.01 70.14 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.681 -1.262 . . . . 0.0 108.843 -179.913 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.446 ' O ' ' N ' ' A' ' 69' ' ' GLY . 2.5 tt0 -73.82 -49.11 26.75 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.389 -0.819 . . . . 0.0 110.107 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.509 HD12 ' N ' ' A' ' 68' ' ' ILE . 1.4 mp -45.43 -19.76 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.395 -0.816 . . . . 0.0 109.508 -179.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.543 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -81.12 -73.39 1.19 Allowed Glycine 0 N--CA 1.497 2.748 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.506 ' SD ' ' O ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -47.38 -39.18 14.65 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.013 -1.286 . . . . 0.0 108.402 179.576 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.488 ' C ' ' H ' ' A' ' 73' ' ' CYS . 24.0 mt -57.14 -34.02 67.99 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 177.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.543 ' N ' ' O ' ' A' ' 69' ' ' GLY . 6.6 tp10 -73.77 12.28 0.69 Allowed 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.106 -0.996 . . . . 0.0 108.331 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.488 ' H ' ' C ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -133.07 36.14 3.48 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.524 -0.735 . . . . 0.0 110.19 -178.463 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.7 m -97.76 174.5 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.363 0 O-C-N 120.951 -1.093 . . . . 0.0 109.741 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.531 ' OG1' ' CG ' ' A' ' 106' ' ' TRP . 5.5 m -104.4 -9.32 18.54 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.016 -1.053 . . . . 0.0 111.295 -179.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.775 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -106.55 170.09 8.14 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.764 -1.21 . . . . 0.0 110.315 -179.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.567 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -53.45 105.28 0.12 Allowed 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.841 -0.537 . . . . 0.0 111.126 -179.083 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.0 tp -74.0 140.5 45.52 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 120.084 -1.635 . . . . 0.0 108.857 178.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.8 mmtp -102.07 157.21 34.13 Favored Pre-proline 0 C--N 1.289 -2.065 0 CA-C-N 114.876 -1.056 . . . . 0.0 108.588 -178.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -58.9 -19.3 46.78 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 121.631 1.554 . . . . 0.0 109.095 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.413 ' OD1' ' O ' ' A' ' 81' ' ' ASN . 2.7 p30 -121.99 27.68 7.94 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.076 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.425 ' HG ' ' HE1' ' A' ' 51' ' ' TYR . 44.3 m -58.42 169.18 0.93 Allowed 'General case' 0 C--N 1.307 -1.274 0 O-C-N 120.287 -1.508 . . . . 0.0 108.74 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.548 HH12 ' CA ' ' A' ' 57' ' ' THR . 0.7 OUTLIER -171.9 150.6 2.62 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 118.621 -1.231 . . . . 0.0 110.985 -179.477 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.441 ' C ' ' SG ' ' A' ' 48' ' ' CYS . 82.5 mt -88.83 96.27 10.62 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.45 ' N ' ' SG ' ' A' ' 48' ' ' CYS . 0.1 OUTLIER -34.19 -42.03 0.12 Allowed 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -177.431 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 28.5 p -64.58 -28.48 69.66 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 119.932 -1.73 . . . . 0.0 111.392 -178.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 12.7 tp60 -91.56 35.83 0.95 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.98 -1.075 . . . . 0.0 110.703 -179.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.7 ' O ' HD12 ' A' ' 89' ' ' ILE . 39.7 mm -130.14 161.19 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.308 0 O-C-N 121.282 -0.886 . . . . 0.0 109.192 179.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.7 HD12 ' O ' ' A' ' 88' ' ' ILE . 1.4 mp -133.87 128.59 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.32 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.508 ' SD ' HG21 ' A' ' 97' ' ' ILE . 4.9 tpt -90.54 164.21 14.32 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.311 -0.868 . . . . 0.0 109.347 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 38.4 p -148.89 145.63 20.08 Favored Pre-proline 0 C--N 1.3 -1.553 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.85 -37.86 91.57 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 121.278 1.319 . . . . 0.0 111.295 -178.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -59.37 -29.51 67.75 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.111 -0.993 . . . . 0.0 109.147 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.711 HD22 ' CD2' ' A' ' 56' ' ' PHE . 6.2 mt -93.75 35.96 1.12 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.555 -0.716 . . . . 0.0 109.819 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.405 ' HB2' ' H ' ' A' ' 2' ' ' LYS . 16.8 p-10 -65.49 136.29 56.24 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.684 -1.26 . . . . 0.0 110.319 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 111.94 8.52 22.04 Favored Glycine 0 N--CA 1.506 3.362 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 178.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.617 HD11 HG13 ' A' ' 52' ' ' VAL . 0.1 OUTLIER -66.24 124.66 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.583 -0.951 . . . . 0.0 110.378 -178.043 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.503 ' N ' HD12 ' A' ' 97' ' ' ILE . 6.5 t -104.72 116.06 47.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.162 -0.961 . . . . 0.0 109.967 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 t -100.08 135.17 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 120.756 -1.215 . . . . 0.0 109.458 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.68 122.82 48.32 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.494 -0.754 . . . . 0.0 109.169 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 5.3 t -113.32 128.29 25.84 Favored Pre-proline 0 N--CA 1.499 2.014 0 O-C-N 121.643 -0.661 . . . . 0.0 109.802 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.437 ' HG3' ' CD2' ' A' ' 49' ' ' HIS . 95.4 Cg_endo -81.42 174.03 10.98 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 122.417 2.078 . . . . 0.0 113.81 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 103' ' ' ASP . 1.6 p-10 -80.47 -12.63 59.52 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-O 121.683 0.754 . . . . 0.0 108.991 178.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.53 86.86 2.65 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 -177.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.441 ' O ' ' O ' ' A' ' 106' ' ' TRP . 12.8 pt20 -81.69 -32.38 31.75 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . 0.533 ' OXT' ' CG ' ' A' ' 106' ' ' TRP . 61.9 t-105 . . . . . 0 C--N 1.301 -1.506 0 CA-C-O 118.354 -0.832 . . . . 0.0 110.063 178.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.433 ' CB ' ' SD ' ' A' ' 90' ' ' MET . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.39 117.64 32.07 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.446 -0.784 . . . . 0.0 109.278 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.438 HG21 ' CG2' ' A' ' 17' ' ' VAL . 27.2 t -115.91 109.75 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.301 -0.874 . . . . 0.0 109.691 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.2 t -99.77 130.07 49.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.162 -0.961 . . . . 0.0 110.188 178.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -103.59 116.63 32.72 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 78.8 t -98.71 115.69 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 30.9 p -75.56 -161.48 0.16 Allowed 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 121.584 0.707 . . . . 0.0 109.641 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.59 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.1 OUTLIER -86.88 -47.62 8.86 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.652 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.491 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 17.3 p30 -71.06 1.97 5.07 Favored 'General case' 0 C--N 1.307 -1.249 0 O-C-N 121.148 -0.97 . . . . 0.0 110.928 -178.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.71 1.85 60.05 Favored Glycine 0 N--CA 1.498 2.773 0 O-C-N 120.852 -1.155 . . . . 0.0 110.868 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -67.87 127.37 32.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.809 -1.406 . . . . 0.0 108.913 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.403 ' HD2' HH11 ' A' ' 12' ' ' ARG . 1.5 mtt180 -105.03 157.07 17.49 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.597 -0.689 . . . . 0.0 110.059 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.52 116.04 5.47 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -99.67 124.24 44.71 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 122.626 1.203 . . . . 0.0 111.341 -178.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.499 HD11 ' ND2' ' A' ' 30' ' ' ASN . 0.2 OUTLIER -110.05 -176.51 3.01 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-O 122.99 1.376 . . . . 0.0 110.875 -178.843 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.491 ' H ' HD13 ' A' ' 15' ' ' LEU . 24.8 t0 -134.67 100.38 4.61 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 105.181 -2.155 . . . . 0.0 105.181 176.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.565 HG12 ' HB ' ' A' ' 21' ' ' VAL . 3.4 t -108.71 115.3 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.339 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.81 174.91 3.94 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.312 -0.868 . . . . 0.0 111.609 -177.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.03 137.5 57.75 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.952 0.882 . . . . 0.0 110.91 -178.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.62 -13.93 53.73 Favored Glycine 0 N--CA 1.493 2.435 0 C-N-CA 120.519 -0.848 . . . . 0.0 111.182 178.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.565 ' HB ' HG12 ' A' ' 17' ' ' VAL . 94.8 t -80.82 142.25 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.344 -1.68 . . . . 0.0 109.455 -178.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.427 ' OG ' ' OE1' ' A' ' 25' ' ' GLN . 1.2 p -87.82 142.6 27.69 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.559 -0.856 . . . . 0.0 109.176 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -46.95 -40.85 15.1 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 121.247 -0.908 . . . . 0.0 109.507 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 5.8 tpt -65.36 -35.63 81.55 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.046 -1.034 . . . . 0.0 109.531 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.443 ' NE2' ' N ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -60.74 -61.17 2.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.052 -1.03 . . . . 0.0 109.075 -179.421 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.503 ' HB2' HG13 ' A' ' 17' ' ' VAL . . . -59.55 -27.55 66.32 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.569 -1.332 . . . . 0.0 110.522 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.99 -20.85 66.2 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.741 -1.225 . . . . 0.0 108.57 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 69.8 t -87.03 -27.79 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.613 -0.679 . . . . 0.0 109.654 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.52 -23.56 61.03 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.499 ' ND2' HD11 ' A' ' 15' ' ' LEU . 2.3 m-80 . . . . . 0 C--N 1.302 -1.477 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 32.2 p . . . . . 0 N--CA 1.482 1.174 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.497 ' SG ' ' O ' ' A' ' 48' ' ' CYS . 21.9 p -79.68 57.0 2.37 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.928 -1.108 . . . . 0.0 110.217 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.581 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 38.0 t60 -76.59 106.05 8.01 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -139.25 165.43 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 120.617 -1.302 . . . . 0.0 109.74 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.537 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 40.7 m-85 -111.97 112.23 23.73 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 122.149 0.976 . . . . 0.0 109.792 -179.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.426 ' O ' ' OD1' ' A' ' 81' ' ' ASN . 96.8 t -85.58 135.25 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.721 ' ND2' ' HB3' ' A' ' 55' ' ' ALA . 1.7 t30 -49.28 123.22 7.07 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.947 -1.095 . . . . 0.0 108.147 179.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -54.16 11.57 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.818 -0.551 . . . . 0.0 112.178 -177.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.721 ' HB3' ' ND2' ' A' ' 53' ' ' ASN . . . -100.71 -15.57 17.66 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.999 -1.063 . . . . 0.0 109.817 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.517 ' CD2' HD22 ' A' ' 94' ' ' LEU . 51.9 m-85 -115.26 -10.43 12.09 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.774 -1.204 . . . . 0.0 109.078 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 12.5 p -71.45 -41.62 69.22 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.876 -1.14 . . . . 0.0 109.912 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -86.91 14.46 7.27 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.438 -0.789 . . . . 0.0 109.898 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.479 ' CD ' ' O ' ' A' ' 55' ' ' ALA . 9.6 mtpt -125.46 -39.73 2.16 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.705 HG22 ' HD2' ' A' ' 61' ' ' PRO . 0.4 OUTLIER -78.34 167.28 36.78 Favored Pre-proline 0 N--CA 1.494 1.759 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 179.052 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.705 ' HD2' HG22 ' A' ' 60' ' ' VAL . 1.4 Cg_endo -55.57 105.38 0.15 Allowed 'Trans proline' 0 N--CA 1.489 1.237 0 CA-C-N 120.206 1.109 . . . . 0.0 113.181 -176.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.39 102.38 2.62 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.495 ' HB1' ' CD ' ' A' ' 67' ' ' GLU . . . -53.71 146.41 13.54 Favored 'General case' 0 C--N 1.29 -1.991 0 O-C-N 121.207 -0.933 . . . . 0.0 111.29 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -61.81 -171.3 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.732 -0.605 . . . . 0.0 110.756 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -69.41 1.49 3.87 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.189 -0.944 . . . . 0.0 112.147 -178.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -64.63 -40.46 95.5 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.525 -1.359 . . . . 0.0 108.736 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.519 ' N ' ' CD ' ' A' ' 67' ' ' GLU . 27.8 mp0 -79.36 -47.24 16.11 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.655 -0.653 . . . . 0.0 110.133 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.4 ' H ' HG13 ' A' ' 68' ' ' ILE . 36.3 mt -44.62 -22.67 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.136 -0.977 . . . . 0.0 110.041 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 67' ' ' GLU . . . -86.03 -28.85 27.3 Favored Glycine 0 N--CA 1.498 2.777 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.46 ' N ' ' O ' ' A' ' 67' ' ' GLU . 30.0 mtt -77.33 -34.18 55.37 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.47 HD22 ' HB3' ' A' ' 82' ' ' SER . 33.1 mt -65.62 -22.17 66.64 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -85.34 18.85 2.49 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 178.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -133.85 24.47 3.96 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.732 -0.605 . . . . 0.0 110.295 -178.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 17.0 m -97.48 171.9 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 120.772 -1.205 . . . . 0.0 110.58 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.8 m -105.47 -1.78 24.5 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.383 -0.823 . . . . 0.0 110.28 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.581 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -107.48 170.94 7.67 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 120.965 -1.084 . . . . 0.0 110.589 -178.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.537 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -62.87 111.61 2.21 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.474 -0.766 . . . . 0.0 109.845 -179.281 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.458 HD21 ' HB3' ' A' ' 71' ' ' LEU . 8.4 tp -70.92 160.11 33.44 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 120.031 -1.668 . . . . 0.0 110.312 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.2 mmtm -125.12 152.55 70.85 Favored Pre-proline 0 C--N 1.296 -1.748 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -178.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -56.53 -22.45 43.02 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 121.217 1.278 . . . . 0.0 109.771 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.433 ' OD1' ' O ' ' A' ' 81' ' ' ASN . 1.4 p30 -120.21 28.54 7.99 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.888 -0.508 . . . . 0.0 109.862 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.47 ' HB3' HD22 ' A' ' 71' ' ' LEU . 11.3 m -55.41 172.1 0.16 Allowed 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.416 -1.428 . . . . 0.0 108.532 178.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.726 ' HE ' ' CG1' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -170.78 163.64 7.89 Favored 'General case' 0 N--CA 1.5 2.047 0 C-N-CA 118.661 -1.215 . . . . 0.0 111.273 -178.81 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.756 HD22 ' N ' ' A' ' 84' ' ' LEU . 2.2 mm? -104.26 97.71 7.62 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 178.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.426 ' C ' ' O ' ' A' ' 84' ' ' LEU . 0.6 OUTLIER -31.94 -42.18 0.06 Allowed 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -177.414 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 17.6 p -76.52 -14.72 60.01 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.076 -1.64 . . . . 0.0 112.187 -177.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.564 ' NE2' HD23 ' A' ' 84' ' ' LEU . 25.3 mt-30 -94.48 37.86 1.11 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.676 -1.265 . . . . 0.0 110.113 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.726 ' CG1' ' HE ' ' A' ' 83' ' ' ARG . 22.7 mt -131.42 168.44 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.269 -0.895 . . . . 0.0 109.4 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.521 ' N ' ' CG2' ' A' ' 88' ' ' ILE . 36.2 mm -139.01 122.72 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.649 ' SD ' ' N ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -78.65 143.34 36.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.965 -1.084 . . . . 0.0 108.511 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.649 ' N ' ' SD ' ' A' ' 90' ' ' MET . 1.1 p -130.07 149.72 73.99 Favored Pre-proline 0 N--CA 1.495 1.785 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -62.96 -35.18 67.99 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 121.626 1.551 . . . . 0.0 110.854 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -68.82 -26.06 64.98 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 119.68 -0.808 . . . . 0.0 109.936 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.517 HD22 ' CD2' ' A' ' 56' ' ' PHE . 5.5 mt -104.26 29.67 5.84 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.508 -0.745 . . . . 0.0 110.076 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -63.65 146.42 53.83 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.799 -1.188 . . . . 0.0 109.856 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 105.22 12.27 27.64 Favored Glycine 0 N--CA 1.504 3.227 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 178.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.408 ' O ' HG23 ' A' ' 97' ' ' ILE . 17.5 tt -65.57 129.7 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 121.113 -1.227 . . . . 0.0 111.31 -177.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.6 t -104.82 126.52 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 O-C-N 121.208 -0.932 . . . . 0.0 108.852 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.2 t -111.58 135.01 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.994 -1.066 . . . . 0.0 109.997 -178.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -107.85 121.72 45.32 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.343 -0.848 . . . . 0.0 109.065 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 24.7 t -108.99 123.59 36.54 Favored Pre-proline 0 N--CA 1.498 1.967 0 O-C-N 121.689 -0.632 . . . . 0.0 109.4 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.442 ' O ' ' NE2' ' A' ' 105' ' ' GLN . 69.4 Cg_endo -83.25 178.34 5.87 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.711 2.274 . . . . 0.0 113.427 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -84.71 -18.33 35.56 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -108.44 81.95 1.55 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.556 ' CD ' ' H ' ' A' ' 105' ' ' GLN . 13.2 mp0 -84.03 -31.03 25.64 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 119.156 -1.017 . . . . 0.0 108.489 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 62.9 t-105 . . . . . 0 C--N 1.299 -1.594 0 O-C-N 121.028 -1.045 . . . . 0.0 109.814 178.753 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 13.6 p . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.9 mmtt -77.22 108.74 10.55 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.435 -0.906 . . . . 0.0 108.563 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.512 HG21 HG21 ' A' ' 17' ' ' VAL . 36.5 t -108.68 109.33 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.26 -0.9 . . . . 0.0 110.28 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 23.9 t -102.16 127.09 56.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.502 -0.749 . . . . 0.0 110.341 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.425 ' CE1' HG12 ' A' ' 3' ' ' VAL . 69.6 m-85 -102.15 117.54 35.01 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 176.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 81.0 t -97.9 113.94 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 34.0 p -74.54 -163.65 0.22 Allowed 'General case' 0 C--N 1.293 -1.863 0 CA-C-O 121.595 0.712 . . . . 0.0 109.623 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.571 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.3 OUTLIER -81.98 -45.84 14.81 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.778 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 23.4 p-10 -74.31 2.36 9.44 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.3 -0.875 . . . . 0.0 111.571 -178.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.88 -4.31 65.6 Favored Glycine 0 N--CA 1.5 2.915 0 O-C-N 120.441 -1.412 . . . . 0.0 110.928 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.89 126.37 27.11 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.79 -1.418 . . . . 0.0 108.418 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.4 mtt85 -106.21 162.25 13.82 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.262 -0.899 . . . . 0.0 111.32 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 17.3 mtt85 -146.29 107.82 4.27 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 178.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -98.62 126.73 44.3 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.344 -0.847 . . . . 0.0 110.523 -178.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.531 HD22 ' CG ' ' A' ' 30' ' ' ASN . 31.6 mt -119.06 -164.7 1.06 Allowed 'General case' 0 N--CA 1.503 2.175 0 CA-C-O 122.786 1.279 . . . . 0.0 110.531 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -137.32 99.07 3.87 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 176.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.544 HG12 ' HB ' ' A' ' 21' ' ' VAL . 11.7 t -102.12 119.24 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 121.346 -0.846 . . . . 0.0 109.131 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.42 174.8 3.77 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.308 -0.87 . . . . 0.0 110.56 -178.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -69.95 141.39 53.05 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 122.053 0.93 . . . . 0.0 110.755 -179.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.24 -17.16 49.27 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.544 ' HB ' HG12 ' A' ' 17' ' ' VAL . 58.6 t -83.04 139.88 17.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 120.836 -1.391 . . . . 0.0 109.262 -178.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 79.0 p -92.04 146.09 24.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.112 -0.993 . . . . 0.0 109.024 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.493 HD21 ' SD ' ' A' ' 90' ' ' MET . 84.8 mt -46.38 -40.36 11.87 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.478 -0.764 . . . . 0.0 109.218 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 13.5 tpp -55.57 -43.12 75.64 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.427 -0.796 . . . . 0.0 108.953 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -62.26 -58.05 9.15 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.23 -0.919 . . . . 0.0 109.325 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.449 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -50.95 -33.33 24.07 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.675 -1.266 . . . . 0.0 111.743 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.84 -22.97 62.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.428 -1.42 . . . . 0.0 109.344 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 53.5 t -86.31 -19.85 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.189 -0.944 . . . . 0.0 109.857 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.87 -31.29 51.33 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.236 -0.915 . . . . 0.0 109.352 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.531 ' CG ' HD22 ' A' ' 15' ' ' LEU . 5.7 m-80 . . . . . 0 N--CA 1.487 1.387 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 8.1 m . . . . . 0 N--CA 1.482 1.161 0 CA-C-O 120.98 0.419 . . . . 0.0 110.154 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.546 ' SG ' ' N ' ' A' ' 85' ' ' CYS . 16.6 p -92.74 53.91 2.13 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.891 -1.13 . . . . 0.0 110.397 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.717 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 48.7 t60 -75.94 111.68 11.56 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.28 -0.887 . . . . 0.0 108.634 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -147.34 167.75 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 120.884 -1.135 . . . . 0.0 109.534 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.524 ' OH ' ' NE2' ' A' ' 49' ' ' HIS . 38.0 m-85 -115.68 111.24 20.3 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 121.788 0.804 . . . . 0.0 109.754 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 80.7 t -85.95 132.81 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.763 ' ND2' ' HB3' ' A' ' 55' ' ' ALA . 1.0 OUTLIER -47.96 126.6 10.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.103 -0.998 . . . . 0.0 108.545 179.359 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -56.67 14.13 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.369 -0.832 . . . . 0.0 111.648 -178.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.763 ' HB3' ' ND2' ' A' ' 53' ' ' ASN . . . -101.99 -19.91 15.02 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.56 -1.338 . . . . 0.0 109.681 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -111.54 -10.49 14.14 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.704 -1.247 . . . . 0.0 108.951 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 10.4 p -70.84 -37.39 73.15 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.126 -0.984 . . . . 0.0 110.353 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -84.42 0.33 49.91 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.235 -0.916 . . . . 0.0 110.268 -178.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.448 ' CE ' ' O ' ' A' ' 55' ' ' ALA . 9.0 mttt -112.61 -37.36 4.94 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.4 0.619 . . . . 0.0 109.512 -179.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.742 HG23 HD12 ' A' ' 94' ' ' LEU . 0.4 OUTLIER -81.56 161.67 60.9 Favored Pre-proline 0 N--CA 1.497 1.918 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 179.859 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.734 ' HD2' HG22 ' A' ' 60' ' ' VAL . 5.0 Cg_endo -55.31 90.52 0.04 OUTLIER 'Trans proline' 0 N--CA 1.5 1.905 0 C-N-CA 122.381 2.054 . . . . 0.0 114.348 -176.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.61 104.31 0.64 Allowed 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 177.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.489 ' HB1' ' OE1' ' A' ' 67' ' ' GLU . . . -53.8 149.58 8.51 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.77 0.795 . . . . 0.0 112.561 -178.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.453 ' N ' ' ND2' ' A' ' 64' ' ' ASN . 0.1 OUTLIER -60.74 -172.1 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.308 0.575 . . . . 0.0 110.117 179.678 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -70.14 4.74 1.98 Allowed 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.727 -0.608 . . . . 0.0 112.11 -178.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.4 mtt85 -65.72 -40.28 92.02 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.65 -1.281 . . . . 0.0 108.928 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.489 ' OE1' ' HB1' ' A' ' 63' ' ' ALA . 34.1 mp0 -80.05 -37.66 33.48 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.701 -1.249 . . . . 0.0 109.636 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.454 HD12 ' N ' ' A' ' 68' ' ' ILE . 1.3 mp -46.15 -35.6 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.219 -0.926 . . . . 0.0 109.055 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.39 -28.97 60.73 Favored Glycine 0 N--CA 1.495 2.599 0 C-N-CA 119.365 -1.398 . . . . 0.0 109.619 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.429 ' N ' ' O ' ' A' ' 67' ' ' GLU . 26.6 mtt -79.0 -35.41 42.86 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 178.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 71' ' ' LEU . 74.2 mt -64.98 -24.74 67.6 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 178.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -80.88 5.48 15.98 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.782 -1.198 . . . . 0.0 108.036 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -122.73 25.97 8.46 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.764 -0.585 . . . . 0.0 110.504 -178.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.4 m -96.21 168.97 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.339 0 O-C-N 120.682 -1.261 . . . . 0.0 109.97 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.472 ' OG1' ' CD1' ' A' ' 106' ' ' TRP . 3.1 m -106.57 0.14 24.31 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.429 -0.794 . . . . 0.0 110.824 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.717 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -107.4 169.33 8.64 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.171 -0.956 . . . . 0.0 110.564 -178.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.464 ' O ' ' CG ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -59.76 106.14 0.45 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.569 -0.707 . . . . 0.0 109.478 -179.289 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.9 tp -70.13 152.25 44.53 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 119.933 -1.729 . . . . 0.0 110.303 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 46.3 mmtt -114.73 156.6 44.67 Favored Pre-proline 0 C--N 1.294 -1.828 0 CA-C-N 114.506 -1.225 . . . . 0.0 108.478 -178.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -57.56 -20.36 41.2 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 121.807 1.672 . . . . 0.0 110.4 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -125.22 31.91 5.49 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.734 -0.603 . . . . 0.0 110.775 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 33.4 m -59.44 169.85 1.15 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.653 -1.279 . . . . 0.0 110.473 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.566 ' NH2' ' O ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -171.91 171.52 5.08 Favored 'General case' 0 N--CA 1.503 2.219 0 CA-C-O 122.479 1.133 . . . . 0.0 111.864 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 47.3 mt -100.87 112.25 24.64 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 178.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.546 ' N ' ' SG ' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -56.7 -11.86 1.58 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.067 -1.02 . . . . 0.0 112.607 -176.554 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 28.3 p -87.54 -39.9 14.74 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 119.896 -1.752 . . . . 0.0 110.932 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -81.29 42.83 0.69 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.802 -1.186 . . . . 0.0 110.573 -178.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.8 mt -130.67 157.56 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 O-C-N 121.124 -0.985 . . . . 0.0 108.494 179.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 36.9 mm -132.46 128.52 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 O-C-N 121.391 -0.818 . . . . 0.0 109.763 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.493 ' SD ' HD21 ' A' ' 23' ' ' LEU . 3.6 tpt -88.62 161.54 16.84 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.969 -1.082 . . . . 0.0 109.657 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.5 p -155.04 148.83 18.83 Favored Pre-proline 0 C--N 1.3 -1.58 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -55.91 -37.7 95.59 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 121.651 1.567 . . . . 0.0 111.874 -178.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -65.13 -27.32 68.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.213 -0.929 . . . . 0.0 109.305 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.742 HD12 HG23 ' A' ' 60' ' ' VAL . 15.7 mt -96.66 24.73 5.73 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.322 -0.861 . . . . 0.0 109.459 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -64.2 138.06 58.26 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.651 -0.655 . . . . 0.0 110.055 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 108.03 8.87 29.02 Favored Glycine 0 N--CA 1.505 3.251 0 N-CA-C 110.669 -0.973 . . . . 0.0 110.669 178.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 16.0 tt -63.2 132.33 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 120.945 -1.326 . . . . 0.0 111.936 -177.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.0 t -104.91 115.33 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.1 t -103.12 133.32 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.898 -1.126 . . . . 0.0 109.01 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -104.71 114.77 29.19 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 23.5 t -102.4 122.18 47.42 Favored Pre-proline 0 N--CA 1.494 1.74 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.455 ' O ' ' NE2' ' A' ' 105' ' ' GLN . 68.5 Cg_endo -83.35 171.17 11.41 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.274 1.983 . . . . 0.0 113.18 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -79.13 -15.24 58.42 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.429 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 2.3 mmp_? -110.75 82.97 1.68 Allowed 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.527 ' H ' ' CD ' ' A' ' 105' ' ' GLN . 14.7 mp0 -83.09 -32.83 26.55 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 120.96 -1.087 . . . . 0.0 108.514 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . 0.472 ' CD1' ' OG1' ' A' ' 75' ' ' THR . 61.6 t-105 . . . . . 0 C--N 1.302 -1.476 0 CA-C-O 117.616 -1.183 . . . . 0.0 110.266 178.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.462 ' CB ' ' SD ' ' A' ' 90' ' ' MET . 1.5 p . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.4 ' H ' ' HB2' ' A' ' 95' ' ' ASP . 25.2 mmtt -92.92 116.36 28.98 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.069 -1.019 . . . . 0.0 109.192 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.579 HG12 ' CE2' ' A' ' 5' ' ' TYR . 57.2 t -114.47 108.61 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 O-C-N 121.351 -0.843 . . . . 0.0 109.573 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.4 t -99.6 129.03 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.267 -0.896 . . . . 0.0 110.849 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.579 ' CE2' HG12 ' A' ' 3' ' ' VAL . 96.5 m-85 -104.86 115.77 30.86 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 177.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 81.0 t -98.24 114.8 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 120.901 -1.125 . . . . 0.0 108.146 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 63.2 p -72.15 -159.92 0.06 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.708 -0.62 . . . . 0.0 109.682 -178.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.605 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -88.02 -46.93 8.92 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -179.882 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.519 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 13.4 p30 -70.75 4.63 2.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.344 -0.848 . . . . 0.0 110.755 -178.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.85 -4.63 65.94 Favored Glycine 0 N--CA 1.498 2.821 0 O-C-N 120.808 -1.182 . . . . 0.0 110.552 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -65.61 126.9 29.8 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.747 -1.443 . . . . 0.0 108.718 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.534 ' CG ' HH11 ' A' ' 12' ' ' ARG . 2.6 mtt-85 -105.52 160.95 14.77 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.474 -0.766 . . . . 0.0 110.84 -178.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -150.83 116.31 5.43 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -101.98 130.87 48.62 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.701 -0.624 . . . . 0.0 111.14 -178.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 30.7 mt -119.4 -165.29 1.13 Allowed 'General case' 0 N--CA 1.504 2.237 0 CA-C-O 122.737 1.256 . . . . 0.0 109.882 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -135.19 97.24 3.67 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 104.62 -2.363 . . . . 0.0 104.62 176.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.704 HG13 ' HB2' ' A' ' 26' ' ' ALA . 3.7 t -104.79 118.62 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.518 0 O-C-N 121.044 -1.035 . . . . 0.0 108.244 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.05 173.34 6.63 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 122.091 0.948 . . . . 0.0 111.693 -177.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -64.63 138.51 58.44 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.988 0.899 . . . . 0.0 111.166 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.9 -14.43 52.72 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 178.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.602 ' HB ' HG12 ' A' ' 17' ' ' VAL . 48.6 t -82.63 140.48 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 O-C-N 120.721 -1.458 . . . . 0.0 108.87 -179.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.471 ' O ' ' N ' ' A' ' 25' ' ' GLN . 35.6 p -92.88 141.05 28.86 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.238 -0.914 . . . . 0.0 109.078 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 57.9 mt -44.48 -36.24 2.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.27 -0.894 . . . . 0.0 109.753 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.405 ' O ' ' SD ' ' A' ' 24' ' ' MET . 4.9 tpt -61.19 -37.84 84.39 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.471 ' N ' ' O ' ' A' ' 22' ' ' SER . 11.8 mm100 -66.82 -58.48 4.95 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.306 -0.871 . . . . 0.0 108.994 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.704 ' HB2' HG13 ' A' ' 17' ' ' VAL . . . -55.29 -30.07 59.44 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.785 -1.197 . . . . 0.0 110.749 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.92 -24.58 66.13 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.955 -1.091 . . . . 0.0 109.06 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 89.5 t -86.05 -23.88 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.393 -0.817 . . . . 0.0 109.709 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.34 -28.92 59.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.17 -0.956 . . . . 0.0 108.618 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 . . . . . 0 C--N 1.306 -1.29 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 178.748 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 7.3 m . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.752 0.31 . . . . 0.0 110.251 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.586 ' SG ' ' N ' ' A' ' 85' ' ' CYS . 17.7 p -82.3 54.42 2.56 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.756 -1.215 . . . . 0.0 110.15 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.716 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 35.8 t60 -77.45 109.67 11.58 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -143.7 164.94 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 120.679 -1.263 . . . . 0.0 109.664 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.546 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 42.4 m-85 -112.52 112.58 24.22 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-O 121.915 0.865 . . . . 0.0 109.747 -179.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.534 HG12 HD22 ' A' ' 53' ' ' ASN . 60.7 t -88.54 132.41 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.669 HD22 ' N ' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -47.73 127.01 11.1 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.076 -1.015 . . . . 0.0 108.646 179.301 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -56.36 14.6 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.252 -0.905 . . . . 0.0 111.297 -178.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.598 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -99.67 -18.0 17.5 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.595 -1.315 . . . . 0.0 109.823 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.617 ' CD2' HD22 ' A' ' 94' ' ' LEU . 30.9 m-85 -116.18 -9.4 11.63 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.977 -1.077 . . . . 0.0 108.38 -179.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.415 HG21 ' OD1' ' A' ' 81' ' ' ASN . 31.2 p -68.44 -43.62 76.71 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.272 -0.893 . . . . 0.0 109.82 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -91.03 19.86 5.36 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 120.179 -0.608 . . . . 0.0 109.731 -179.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.6 mtpt -129.83 -40.83 1.34 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.696 HG22 ' HD2' ' A' ' 61' ' ' PRO . 0.4 OUTLIER -81.06 168.17 26.92 Favored Pre-proline 0 N--CA 1.491 1.599 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 179.254 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.696 ' HD2' HG22 ' A' ' 60' ' ' VAL . 1.1 Cg_endo -59.43 97.68 0.1 Allowed 'Trans proline' 0 N--CA 1.491 1.369 0 CA-C-N 120.123 1.08 . . . . 0.0 113.593 -176.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.84 99.56 3.81 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 178.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.595 ' H ' ' NH1' ' A' ' 83' ' ' ARG . . . -47.03 152.17 0.56 Allowed 'General case' 0 C--N 1.287 -2.121 0 CA-C-O 122.242 1.02 . . . . 0.0 113.129 -178.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -61.1 -169.81 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.618 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -67.68 -3.92 10.58 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.771 -0.58 . . . . 0.0 111.976 -178.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? -62.74 -42.49 99.7 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.539 -1.351 . . . . 0.0 108.442 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.536 ' OE1' ' N ' ' A' ' 67' ' ' GLU . 22.5 mp0 -75.55 -48.1 23.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.446 -0.784 . . . . 0.0 109.937 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 35.3 mt -44.21 -21.83 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.519 -0.738 . . . . 0.0 109.655 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -80.0 -79.54 0.85 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 9.9 ptp -47.56 -37.81 13.0 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.925 -1.338 . . . . 0.0 108.932 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.448 ' O ' ' CG2' ' A' ' 74' ' ' VAL . 2.5 tm? -56.93 -31.02 64.51 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' A' ' 69' ' ' GLY . 14.5 tt0 -81.88 14.52 2.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.09 -1.007 . . . . 0.0 109.256 178.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -125.51 36.62 4.52 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.225 -0.922 . . . . 0.0 110.083 -179.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.603 ' CG2' HD11 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -98.87 176.09 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 121.058 -1.026 . . . . 0.0 108.522 179.218 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.509 ' OG1' ' CE2' ' A' ' 106' ' ' TRP . 4.9 m -120.05 6.36 10.82 Favored 'General case' 0 N--CA 1.508 2.446 0 O-C-N 121.245 -0.91 . . . . 0.0 111.19 -178.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.716 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -105.78 171.94 7.07 Favored 'General case' 0 N--CA 1.506 2.362 0 O-C-N 120.979 -1.076 . . . . 0.0 109.674 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.546 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -59.0 102.66 0.13 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.23 -0.919 . . . . 0.0 109.641 -179.313 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.603 HD11 ' CG2' ' A' ' 74' ' ' VAL . 2.6 mp -71.81 141.54 49.66 Favored 'General case' 0 C--N 1.293 -1.875 0 O-C-N 120.132 -1.605 . . . . 0.0 110.665 -179.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.556 ' H ' ' HG ' ' A' ' 82' ' ' SER . 45.2 mmtt -104.81 158.52 31.84 Favored Pre-proline 0 C--N 1.288 -2.081 0 CA-C-N 113.786 -1.552 . . . . 0.0 107.845 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -53.4 -16.24 7.06 Favored 'Trans proline' 0 C--N 1.302 -1.901 0 C-N-CA 121.248 1.298 . . . . 0.0 109.873 178.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.415 ' OD1' HG21 ' A' ' 57' ' ' THR . 3.9 p30 -130.55 39.47 3.62 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.993 -0.442 . . . . 0.0 111.03 -179.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.556 ' HG ' ' H ' ' A' ' 79' ' ' LYS . 22.7 m -68.45 150.34 48.23 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 119.978 -1.701 . . . . 0.0 107.554 178.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.595 ' NH1' ' H ' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -165.68 169.47 15.17 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.533 -1.354 . . . . 0.0 110.121 -179.669 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.828 HD22 ' N ' ' A' ' 84' ' ' LEU . 1.1 mm? -85.73 119.78 26.44 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.586 ' N ' ' SG ' ' A' ' 48' ' ' CYS . 0.5 OUTLIER -57.26 -41.84 80.4 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.037 -1.039 . . . . 0.0 111.282 -177.875 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 30.6 p -60.56 -22.92 64.2 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 120.635 -1.29 . . . . 0.0 111.444 -177.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -91.18 33.04 0.98 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.009 -1.057 . . . . 0.0 111.16 -179.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.59 ' C ' HD12 ' A' ' 89' ' ' ILE . 33.8 mt -130.27 144.79 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 O-C-N 120.966 -1.084 . . . . 0.0 108.226 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.59 HD12 ' C ' ' A' ' 88' ' ' ILE . 1.7 mp -122.21 134.96 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.43 0 O-C-N 121.678 -0.639 . . . . 0.0 109.304 -179.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.628 ' SD ' ' N ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -81.16 144.5 31.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.234 -0.917 . . . . 0.0 108.851 -179.651 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.628 ' N ' ' SD ' ' A' ' 90' ' ' MET . 0.5 OUTLIER -129.46 152.54 79.77 Favored Pre-proline 0 N--CA 1.497 1.876 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 177.833 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.24 -34.75 26.66 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 121.671 1.58 . . . . 0.0 110.791 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -70.57 -23.29 62.57 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.584 -0.846 . . . . 0.0 109.8 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.617 HD22 ' CD2' ' A' ' 56' ' ' PHE . 6.7 mt -104.48 30.91 5.0 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.427 -0.796 . . . . 0.0 110.4 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.4 ' HB2' ' H ' ' A' ' 2' ' ' LYS . 11.0 p-10 -64.46 144.75 56.96 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.114 -1.616 . . . . 0.0 109.676 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 105.8 11.75 27.74 Favored Glycine 0 N--CA 1.503 3.112 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 178.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.436 HG13 HD21 ' A' ' 53' ' ' ASN . 15.3 tt -63.62 128.89 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.013 -1.286 . . . . 0.0 111.015 -177.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.478 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 6.6 t -103.84 123.7 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.225 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.2 t -111.44 135.06 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.067 -1.021 . . . . 0.0 109.688 -179.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -108.91 122.48 47.29 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-O 121.712 0.768 . . . . 0.0 109.055 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 35.0 t -110.3 123.27 36.34 Favored Pre-proline 0 N--CA 1.497 1.889 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.442 ' HG3' ' CD2' ' A' ' 49' ' ' HIS . 41.6 Cg_endo -85.94 -178.3 2.83 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.865 2.377 . . . . 0.0 113.486 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -87.01 -20.15 27.64 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.437 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 0.8 OUTLIER -103.78 82.45 2.0 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 179.623 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -81.13 -23.3 38.42 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.444 -0.902 . . . . 0.0 109.68 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . 0.509 ' CE2' ' OG1' ' A' ' 75' ' ' THR . 11.1 t-105 . . . . . 0 C--N 1.305 -1.359 0 O-C-N 120.847 -1.158 . . . . 0.0 110.164 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 98.0 p . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.402 ' H ' ' HB2' ' A' ' 95' ' ' ASP . 1.1 mptm? -76.11 111.03 11.09 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.534 HG12 ' CE1' ' A' ' 5' ' ' TYR . 96.5 t -111.9 111.89 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.735 -0.603 . . . . 0.0 110.302 -178.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 24.4 t -98.89 98.85 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.222 -0.924 . . . . 0.0 111.764 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.534 ' CE1' HG12 ' A' ' 3' ' ' VAL . 29.0 m-85 -72.94 111.89 8.47 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 176.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 79.1 t -98.89 117.92 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 75.0 p -73.73 -155.83 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.492 -0.755 . . . . 0.0 109.513 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.598 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -91.54 -50.27 5.87 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.164 -0.96 . . . . 0.0 108.985 -179.727 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.492 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 22.0 p-10 -66.03 2.07 1.24 Allowed 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.509 -0.745 . . . . 0.0 110.734 -179.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.408 ' O ' ' NH1' ' A' ' 12' ' ' ARG . . . 96.74 -4.98 63.92 Favored Glycine 0 N--CA 1.501 3.013 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -62.6 126.52 27.62 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.117 -1.226 . . . . 0.0 108.179 179.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.432 ' NH1' ' CG ' ' A' ' 12' ' ' ARG . 0.5 OUTLIER -112.09 161.1 16.87 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 121.875 0.845 . . . . 0.0 111.577 -178.16 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.5 ttm105 -149.65 118.67 6.71 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -99.46 128.02 45.55 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.39 -0.819 . . . . 0.0 110.427 -178.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.446 HD12 ' CE1' ' A' ' 5' ' ' TYR . 21.6 mt -117.79 -165.54 1.1 Allowed 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 122.972 1.368 . . . . 0.0 109.978 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -138.0 101.73 4.5 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 176.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.49 ' CG2' HG21 ' A' ' 3' ' ' VAL . 12.2 t -104.69 117.07 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.67 179.9 4.5 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-O 122.046 0.927 . . . . 0.0 112.343 -177.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -65.89 134.13 52.37 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.849 0.833 . . . . 0.0 110.548 -179.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.94 -18.01 42.55 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 178.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.416 ' HB ' HG12 ' A' ' 17' ' ' VAL . 46.2 t -83.72 139.63 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 120.848 -1.384 . . . . 0.0 109.889 -178.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.511 ' O ' ' N ' ' A' ' 25' ' ' GLN . 51.4 p -94.84 141.26 28.84 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 178.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.1 mt -45.81 -33.86 3.37 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.362 -0.836 . . . . 0.0 109.611 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 2.3 tpt -68.53 -28.46 67.01 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 121.674 0.75 . . . . 0.0 109.165 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.511 ' N ' ' O ' ' A' ' 22' ' ' SER . 7.0 tp-100 -76.55 -62.72 1.53 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.138 -0.976 . . . . 0.0 109.959 -179.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.29 -24.17 53.17 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.689 -1.257 . . . . 0.0 109.995 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.94 -22.21 66.61 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.161 -0.962 . . . . 0.0 109.649 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 99.1 t -86.29 -17.93 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.374 -0.829 . . . . 0.0 109.41 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.97 -30.32 22.85 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.391 -0.818 . . . . 0.0 110.066 -178.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 . . . . . 0 N--CA 1.488 1.44 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.259 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 62.0 p . . . . . 0 N--CA 1.483 1.202 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.486 ' SG ' ' N ' ' A' ' 85' ' ' CYS . 30.1 p -73.46 54.85 0.46 Allowed 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.869 -1.145 . . . . 0.0 109.405 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.481 ' CE1' ' OH ' ' A' ' 51' ' ' TYR . 50.9 t60 -76.74 106.45 8.41 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -143.84 160.8 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 120.696 -1.253 . . . . 0.0 109.231 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.509 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 39.5 m-85 -108.52 111.42 23.27 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 122.241 1.019 . . . . 0.0 109.953 -179.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.541 HG13 HD11 ' A' ' 97' ' ' ILE . 10.9 t -85.94 133.29 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.576 ' C ' ' H ' ' A' ' 55' ' ' ALA . 1.0 OUTLIER -48.21 127.7 13.04 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.872 -1.143 . . . . 0.0 108.625 -179.852 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -56.35 9.15 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.467 -0.77 . . . . 0.0 111.471 -178.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.576 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -99.11 -17.38 18.24 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.805 -1.184 . . . . 0.0 109.9 -179.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.627 ' CD2' HD22 ' A' ' 94' ' ' LEU . 48.1 m-85 -115.61 -4.74 12.2 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.1 -1.0 . . . . 0.0 108.808 -179.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 24.8 p -72.95 -41.94 63.93 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.619 -0.676 . . . . 0.0 109.796 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -89.31 15.44 9.05 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 120.204 -0.599 . . . . 0.0 109.886 -179.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.1 mtpt -121.68 -40.86 2.51 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.523 HG22 ' HD2' ' A' ' 61' ' ' PRO . 0.5 OUTLIER -78.86 158.33 75.41 Favored Pre-proline 0 N--CA 1.495 1.82 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.61 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.523 ' HD2' HG22 ' A' ' 60' ' ' VAL . 1.3 Cg_endo -49.47 102.74 0.05 OUTLIER 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 122.222 1.948 . . . . 0.0 113.726 -177.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.463 ' HA ' HH22 ' A' ' 83' ' ' ARG . . . -75.66 101.62 5.05 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 177.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.805 ' H ' HH22 ' A' ' 83' ' ' ARG . . . -65.25 169.58 5.55 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-O 122.211 1.005 . . . . 0.0 112.58 -178.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.422 ' ND2' ' HE ' ' A' ' 66' ' ' ARG . 4.0 p30 -63.24 177.54 0.62 Allowed 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 122.103 0.954 . . . . 0.0 111.428 -178.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -72.23 5.34 2.89 Favored 'General case' 0 N--CA 1.503 2.214 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.523 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.422 ' HE ' ' ND2' ' A' ' 64' ' ' ASN . 10.2 mtm180 -74.16 -50.52 18.96 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 120.37 -1.456 . . . . 0.0 109.185 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.442 ' OE1' ' OE1' ' A' ' 87' ' ' GLN . 82.3 mt-10 -65.58 -16.71 63.97 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.525 -0.734 . . . . 0.0 109.655 179.114 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.563 HD12 ' N ' ' A' ' 68' ' ' ILE . 1.4 mp -75.54 -34.92 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.383 -0.823 . . . . 0.0 108.918 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.81 -20.51 48.21 Favored Glycine 0 N--CA 1.495 2.597 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 3.5 mmt -83.51 -35.42 24.85 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 178.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.484 ' HG ' HD21 ' A' ' 84' ' ' LEU . 59.8 mt -63.75 -21.98 66.68 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -83.82 11.7 7.16 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -131.26 28.13 4.74 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.446 -0.784 . . . . 0.0 109.774 -178.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.604 HG21 HD13 ' A' ' 78' ' ' LEU . 18.0 m -90.92 162.86 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.326 -0.859 . . . . 0.0 110.697 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.524 ' OG1' ' CD2' ' A' ' 106' ' ' TRP . 6.7 m -100.75 -8.7 22.5 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.321 -0.862 . . . . 0.0 109.983 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -107.55 175.33 5.53 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.807 -1.183 . . . . 0.0 110.723 -178.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.509 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -61.46 108.71 1.0 Allowed 'General case' 0 N--CA 1.503 2.21 0 CA-C-O 121.372 0.606 . . . . 0.0 110.967 -178.843 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.604 HD13 HG21 ' A' ' 74' ' ' VAL . 9.2 tp -72.92 156.67 38.62 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 119.547 -1.97 . . . . 0.0 110.101 179.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.6 mmtm -118.03 155.76 50.94 Favored Pre-proline 0 C--N 1.293 -1.856 0 CA-C-N 115.105 -0.952 . . . . 0.0 108.534 -178.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.99 -24.26 79.21 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 121.674 1.582 . . . . 0.0 109.261 178.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 81' ' ' ASN . 1.4 p30 -112.9 21.69 15.21 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.013 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.476 ' HB3' HD22 ' A' ' 71' ' ' LEU . 3.7 m -52.07 158.26 1.13 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 120.306 -1.496 . . . . 0.0 109.067 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.805 HH22 ' H ' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -156.69 148.22 22.48 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.061 -1.055 . . . . 0.0 111.924 -178.28 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.787 HD22 ' N ' ' A' ' 84' ' ' LEU . 2.2 mm? -85.48 121.66 28.51 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 177.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.486 ' N ' ' SG ' ' A' ' 48' ' ' CYS . 0.2 OUTLIER -70.64 -5.09 26.9 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.867 -1.146 . . . . 0.0 113.183 -175.708 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 27.9 p -93.93 -37.7 11.56 Favored 'General case' 0 N--CA 1.506 2.354 0 CA-C-N 120.438 1.472 . . . . 0.0 111.004 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.669 HE22 ' NH1' ' A' ' 83' ' ' ARG . 5.0 pp0? -84.91 24.74 1.02 Allowed 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.214 -0.929 . . . . 0.0 110.39 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.447 HD11 ' HB3' ' A' ' 83' ' ' ARG . 47.3 mt -108.09 148.3 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 O-C-N 121.131 -0.981 . . . . 0.0 108.651 179.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 33.5 mm -127.68 124.35 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.518 ' SD ' HG21 ' A' ' 97' ' ' ILE . 2.7 tpt -91.14 160.77 15.39 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.301 -0.874 . . . . 0.0 109.928 -178.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 70.9 p -149.38 147.61 23.86 Favored Pre-proline 0 N--CA 1.49 1.532 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -57.1 -29.58 83.71 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 121.46 1.44 . . . . 0.0 111.616 -179.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -67.83 -29.54 68.72 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.19 -0.944 . . . . 0.0 109.938 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.627 HD22 ' CD2' ' A' ' 56' ' ' PHE . 6.4 mt -98.1 31.04 2.85 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.578 -0.701 . . . . 0.0 109.863 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.402 ' HB2' ' H ' ' A' ' 2' ' ' LYS . 5.5 p-10 -62.63 138.51 58.51 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.169 -0.957 . . . . 0.0 110.17 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 111.8 9.1 21.49 Favored Glycine 0 N--CA 1.505 3.281 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 178.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.584 HD12 ' N ' ' A' ' 98' ' ' VAL . 0.1 OUTLIER -67.07 125.94 25.58 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 O-C-N 121.604 -0.939 . . . . 0.0 110.838 -178.213 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.584 ' N ' HD12 ' A' ' 97' ' ' ILE . 2.6 t -101.97 121.51 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.367 -0.833 . . . . 0.0 109.594 178.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.3 t -105.88 134.02 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 120.894 -1.129 . . . . 0.0 108.849 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -108.16 119.83 40.59 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 121.864 0.84 . . . . 0.0 109.015 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 23.7 t -107.27 122.94 39.76 Favored Pre-proline 0 N--CA 1.496 1.846 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.423 ' HG3' ' CD2' ' A' ' 49' ' ' HIS . 69.2 Cg_endo -83.57 177.69 6.15 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.703 2.269 . . . . 0.0 113.594 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -84.38 -15.26 46.96 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -112.05 80.4 1.32 Allowed 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.465 ' NE2' ' O ' ' A' ' 106' ' ' TRP . 2.2 pp0? -80.55 -20.43 43.46 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.724 -1.235 . . . . 0.0 109.659 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . 0.524 ' CD2' ' OG1' ' A' ' 75' ' ' THR . 67.4 t-105 . . . . . 0 C--N 1.302 -1.475 0 CA-C-O 117.83 -1.081 . . . . 0.0 110.24 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.462 ' OG ' ' SD ' ' A' ' 90' ' ' MET . 67.9 p . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.1 mmtt -75.94 115.39 15.6 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.558 HG21 ' CG2' ' A' ' 17' ' ' VAL . 45.1 t -116.3 108.1 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.16 -0.963 . . . . 0.0 111.952 -177.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 28.2 t -103.38 134.89 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 CA-C-O 121.687 0.756 . . . . 0.0 110.247 178.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -108.42 118.8 37.72 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 177.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 64.7 t -98.17 113.53 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 120.846 -1.159 . . . . 0.0 108.516 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.401 ' OG ' ' N ' ' A' ' 8' ' ' HIS . 5.3 p -79.6 -153.63 0.08 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.486 -0.759 . . . . 0.0 110.261 -179.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.569 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.4 OUTLIER -91.84 -52.67 4.63 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.8 p30 -62.41 -2.0 0.92 Allowed 'General case' 0 N--CA 1.483 1.189 0 O-C-N 120.865 -1.147 . . . . 0.0 111.364 -178.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.65 0.43 64.54 Favored Glycine 0 N--CA 1.498 2.811 0 O-C-N 120.67 -1.269 . . . . 0.0 110.575 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.408 HG23 HH11 ' A' ' 13' ' ' ARG . 1.0 OUTLIER -77.02 141.55 40.28 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.98 -1.306 . . . . 0.0 109.101 -179.597 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.43 ' CD ' ' N ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -119.43 164.38 15.82 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.387 -0.82 . . . . 0.0 112.486 -178.139 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.408 HH11 HG23 ' A' ' 11' ' ' THR . 0.0 OUTLIER -139.89 111.69 7.39 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.014 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -98.35 122.67 41.81 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.197 -0.939 . . . . 0.0 109.589 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.501 HD22 ' CG ' ' A' ' 30' ' ' ASN . 21.0 mt -117.47 -164.48 1.0 Allowed 'General case' 0 N--CA 1.503 2.205 0 CA-C-O 122.747 1.26 . . . . 0.0 109.968 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -137.74 99.6 3.96 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 104.558 -2.386 . . . . 0.0 104.558 176.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.558 ' CG2' HG21 ' A' ' 3' ' ' VAL . 16.8 t -102.31 121.13 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.321 0 O-C-N 121.238 -0.914 . . . . 0.0 109.022 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -77.71 -178.67 5.48 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.237 -0.914 . . . . 0.0 111.547 -178.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -67.72 131.2 45.12 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 122.078 0.942 . . . . 0.0 111.584 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.78 -18.84 48.6 Favored Glycine 0 N--CA 1.493 2.433 0 N-CA-C 111.121 -0.791 . . . . 0.0 111.121 178.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.407 ' HB ' HG12 ' A' ' 17' ' ' VAL . 62.3 t -79.65 132.81 31.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 120.689 -1.477 . . . . 0.0 108.478 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.425 ' O ' ' N ' ' A' ' 25' ' ' GLN . 18.0 p -88.2 145.59 25.82 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.962 -1.086 . . . . 0.0 108.666 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 70.4 mt -45.64 -39.8 8.23 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 120.594 -1.316 . . . . 0.0 109.864 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 10.5 ttt -64.51 -27.67 69.13 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.549 -0.719 . . . . 0.0 109.255 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.425 ' N ' ' O ' ' A' ' 22' ' ' SER . 52.3 mt-30 -72.78 -58.62 3.2 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.173 -0.954 . . . . 0.0 109.053 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.406 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -62.82 -27.48 69.35 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.768 -1.207 . . . . 0.0 110.89 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.05 -22.02 64.19 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.653 -1.279 . . . . 0.0 108.793 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 89.6 t -84.66 -21.63 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-O 121.492 0.663 . . . . 0.0 109.41 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.18 -28.0 32.31 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.391 -0.818 . . . . 0.0 109.491 -179.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.501 ' CG ' HD22 ' A' ' 15' ' ' LEU . 7.4 m-80 -104.41 4.09 32.97 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 63.6 68.88 1.48 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 11.4 mt -124.47 -42.86 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.656 -0.908 . . . . 0.0 109.892 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.777 ' O ' ' N ' ' A' ' 35' ' ' ILE . 2.7 m-85 -89.1 7.52 34.61 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.015 -1.053 . . . . 0.0 110.488 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -38.11 72.96 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.3 0 CA-C-O 121.97 0.89 . . . . 0.0 111.473 -178.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.777 ' N ' ' O ' ' A' ' 33' ' ' TYR . 8.2 tp -156.04 20.21 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.57 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.524 HG12 ' H ' ' A' ' 37' ' ' GLY . 4.2 t 56.76 171.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.07 -1.019 . . . . 0.0 109.278 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.524 ' H ' HG12 ' A' ' 36' ' ' VAL . . . -138.85 135.58 7.46 Favored Glycine 0 N--CA 1.499 2.856 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.507 ' C ' ' H ' ' A' ' 40' ' ' GLY . 1.3 m-20 -73.74 -66.21 0.73 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.327 -1.102 . . . . 0.0 109.266 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.612 ' SG ' ' N ' ' A' ' 42' ' ' SER . 11.6 p -70.91 15.29 0.11 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.957 -1.089 . . . . 0.0 109.099 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.507 ' H ' ' C ' ' A' ' 38' ' ' ASP . . . 54.32 10.78 2.11 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 108.335 -1.906 . . . . 0.0 108.335 -179.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.47 ' H ' ' C ' ' A' ' 39' ' ' CYS . . . 93.92 22.77 24.73 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.612 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 51.1 m -99.04 39.94 1.24 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.397 -1.06 . . . . 0.0 109.519 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.501 ' O ' ' SD ' ' A' ' 70' ' ' MET . . . 42.34 77.68 0.06 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.296 -0.877 . . . . 0.0 110.315 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -166.63 15.56 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.986 -1.072 . . . . 0.0 109.649 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.491 ' O ' ' S1 ' ' A' ' 107' ' ' FES . 3.0 p -149.51 168.29 23.9 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.455 -0.778 . . . . 0.0 109.575 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.507 ' HB1' HG12 ' A' ' 74' ' ' VAL . . . -102.34 14.76 31.09 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 13.9 m -62.5 -41.48 98.85 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.489 -0.757 . . . . 0.0 109.983 -179.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.529 ' SG ' ' O ' ' A' ' 48' ' ' CYS . 13.8 p -96.42 46.84 1.07 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.887 -1.133 . . . . 0.0 110.224 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.596 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 38.7 t60 -75.32 109.98 9.28 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.045 -1.034 . . . . 0.0 108.347 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -143.49 164.65 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.152 -0.968 . . . . 0.0 109.36 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.516 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 58.1 m-85 -108.81 110.71 22.14 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-O 121.9 0.857 . . . . 0.0 109.477 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.777 HG13 HD11 ' A' ' 97' ' ' ILE . 14.5 t -87.77 132.89 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.577 ' C ' ' H ' ' A' ' 55' ' ' ALA . 21.6 t-20 -47.58 126.21 9.59 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.959 -1.088 . . . . 0.0 109.556 179.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -58.19 15.26 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.638 -0.664 . . . . 0.0 111.193 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.577 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -103.39 -18.75 14.7 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.697 -1.252 . . . . 0.0 109.577 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.676 ' CD2' HD22 ' A' ' 94' ' ' LEU . 44.1 m-85 -113.0 -12.71 13.19 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.104 -0.998 . . . . 0.0 109.172 -178.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 13.6 p -68.08 -37.38 81.18 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.455 -0.778 . . . . 0.0 109.882 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -88.95 13.24 13.27 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.49 -0.757 . . . . 0.0 109.424 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.3 mtpt -124.46 -39.3 2.33 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.626 HG22 ' HD2' ' A' ' 61' ' ' PRO . 0.5 OUTLIER -81.18 161.74 61.6 Favored Pre-proline 0 N--CA 1.497 1.909 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 179.667 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.626 ' HD2' HG22 ' A' ' 60' ' ' VAL . 6.2 Cg_endo -56.23 92.74 0.05 OUTLIER 'Trans proline' 0 N--CA 1.49 1.31 0 C-N-CA 121.584 1.522 . . . . 0.0 113.401 -177.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.37 102.63 5.2 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 178.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.795 ' H ' HH22 ' A' ' 83' ' ' ARG . . . -50.16 151.82 1.92 Allowed 'General case' 0 C--N 1.288 -2.08 0 CA-C-O 122.742 1.258 . . . . 0.0 112.596 -177.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -59.31 -165.38 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.372 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.438 ' HA ' HD12 ' A' ' 68' ' ' ILE . 8.5 pt-20 -68.76 -5.22 19.31 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.254 -0.904 . . . . 0.0 112.783 -177.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.4 mtt180 -60.91 -38.41 85.66 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.154 -1.591 . . . . 0.0 108.997 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -80.74 -39.04 27.65 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.973 -1.08 . . . . 0.0 110.05 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.438 HD12 ' HA ' ' A' ' 65' ' ' GLU . 84.5 mt -46.65 -28.93 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.33 -0.856 . . . . 0.0 110.105 -179.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -82.84 -30.41 32.18 Favored Glycine 0 N--CA 1.498 2.786 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.501 ' SD ' ' O ' ' A' ' 43' ' ' ALA . 25.3 mtt -76.56 -34.21 58.5 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 178.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.529 ' O ' HD13 ' A' ' 78' ' ' LEU . 6.3 mt -59.05 -24.27 62.72 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -92.26 30.38 1.47 Allowed 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -134.89 19.4 3.49 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.533 -0.729 . . . . 0.0 110.487 -179.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.507 HG12 ' HB1' ' A' ' 46' ' ' ALA . 3.4 m -97.74 167.42 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 120.809 -1.182 . . . . 0.0 110.214 -179.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.546 ' OG1' ' CD1' ' A' ' 106' ' ' TRP . 6.8 m -101.59 -0.16 35.32 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.385 -0.822 . . . . 0.0 109.789 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.596 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -107.18 169.29 8.65 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.242 -0.911 . . . . 0.0 110.465 -178.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.516 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -61.21 110.32 1.37 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.741 -0.6 . . . . 0.0 109.839 -179.343 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.529 HD13 ' O ' ' A' ' 71' ' ' LEU . 4.3 tp -68.6 158.01 34.89 Favored 'General case' 0 C--N 1.294 -1.811 0 O-C-N 120.26 -1.525 . . . . 0.0 108.753 178.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.443 ' N ' ' OG ' ' A' ' 82' ' ' SER . 41.5 mmtt -128.25 153.38 78.83 Favored Pre-proline 0 C--N 1.294 -1.818 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 -178.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -55.32 -28.29 61.97 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 121.54 1.494 . . . . 0.0 109.52 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -112.27 29.74 7.65 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.722 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.443 ' OG ' ' N ' ' A' ' 79' ' ' LYS . 4.3 m -61.89 164.64 6.19 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.673 -1.267 . . . . 0.0 109.159 178.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.795 HH22 ' H ' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -164.93 146.24 7.73 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 118.564 -1.254 . . . . 0.0 112.012 -178.6 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.517 HD22 ' N ' ' A' ' 84' ' ' LEU . 3.2 mm? -92.72 95.35 9.51 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 177.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.547 ' HG ' ' HH ' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -31.77 -46.21 0.11 Allowed 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -177.156 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.467 ' SG ' ' N ' ' A' ' 87' ' ' GLN . 30.3 p -58.22 -45.75 87.13 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 119.856 -1.777 . . . . 0.0 111.956 -177.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.467 ' N ' ' SG ' ' A' ' 86' ' ' CYS . 10.4 tp60 -74.79 39.58 0.13 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.481 -1.387 . . . . 0.0 111.494 -178.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.556 ' C ' HD12 ' A' ' 89' ' ' ILE . 31.6 mt -131.35 145.71 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 O-C-N 120.86 -1.15 . . . . 0.0 108.715 178.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.556 HD12 ' C ' ' A' ' 88' ' ' ILE . 1.6 mp -121.6 127.84 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.462 ' SD ' ' OG ' ' A' ' 1' ' ' SER . 0.0 OUTLIER -88.33 162.05 16.79 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -178.881 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.415 ' H ' ' HE2' ' A' ' 90' ' ' MET . 45.5 p -152.1 148.4 21.32 Favored Pre-proline 0 N--CA 1.49 1.551 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.1 -32.98 98.3 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 121.69 1.594 . . . . 0.0 111.298 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -66.63 -32.81 74.38 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.126 -0.984 . . . . 0.0 109.502 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.676 HD22 ' CD2' ' A' ' 56' ' ' PHE . 7.6 mt -90.85 31.39 1.07 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.149 -0.969 . . . . 0.0 109.229 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -60.21 133.31 55.98 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.878 -1.139 . . . . 0.0 110.45 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 110.67 11.33 19.53 Favored Glycine 0 N--CA 1.507 3.416 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 178.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.777 HD11 HG13 ' A' ' 52' ' ' VAL . 0.3 OUTLIER -64.07 124.17 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.19 0 O-C-N 120.997 -1.296 . . . . 0.0 110.297 -177.583 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.5 t -101.69 121.92 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.505 -0.747 . . . . 0.0 109.32 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.1 t -108.5 133.53 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 120.977 -1.077 . . . . 0.0 110.109 -178.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.96 118.32 36.39 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.901 0.858 . . . . 0.0 109.113 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 14.9 t -107.74 124.59 34.45 Favored Pre-proline 0 N--CA 1.497 1.909 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.407 ' HG3' ' CD2' ' A' ' 49' ' ' HIS . 97.1 Cg_endo -82.57 178.45 6.14 Favored 'Trans proline' 0 N--CA 1.5 1.886 0 C-N-CA 122.315 2.01 . . . . 0.0 113.497 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -83.03 -14.03 54.69 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.32 87.32 2.72 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 -178.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -87.56 -32.59 19.28 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.546 ' CD1' ' OG1' ' A' ' 75' ' ' THR . 45.3 t-105 . . . . . 0 C--N 1.302 -1.486 0 CA-C-O 117.735 -1.126 . . . . 0.0 109.564 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' FES . . . . . 0.503 ' S1 ' HD12 ' A' ' 84' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 51.9 p . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.51 109.66 12.9 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.563 -0.855 . . . . 0.0 108.953 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.497 HG21 HG21 ' A' ' 17' ' ' VAL . 22.9 t -107.48 108.55 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 O-C-N 121.237 -0.915 . . . . 0.0 110.489 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.0 t -99.04 98.81 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.089 -1.007 . . . . 0.0 111.405 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.484 ' CZ ' HG11 ' A' ' 3' ' ' VAL . 68.9 m-85 -73.08 115.13 12.03 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 75.2 t -98.81 111.6 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 61.3 p -72.3 -159.66 0.06 Allowed 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 121.666 0.746 . . . . 0.0 109.867 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.584 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.2 OUTLIER -90.58 -50.87 5.69 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.309 -0.869 . . . . 0.0 108.709 -179.966 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.495 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 15.1 p30 -66.34 5.23 0.58 Allowed 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.752 -179.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.11 -1.83 74.4 Favored Glycine 0 N--CA 1.499 2.887 0 O-C-N 120.879 -1.138 . . . . 0.0 110.895 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -65.27 129.67 40.56 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.89 -1.359 . . . . 0.0 108.541 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 2.2 mtt85 -108.76 160.64 15.8 Favored 'General case' 0 N--CA 1.502 2.126 0 CA-C-O 121.68 0.752 . . . . 0.0 110.58 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.15 115.38 5.42 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 179.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -98.72 127.12 44.54 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-O 121.829 0.823 . . . . 0.0 110.342 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.491 HD11 ' ND2' ' A' ' 30' ' ' ASN . 0.3 OUTLIER -113.44 -174.33 2.44 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 123.203 1.478 . . . . 0.0 111.032 -177.797 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.417 ' H ' ' CD1' ' A' ' 15' ' ' LEU . 0.8 OUTLIER -136.14 99.97 4.28 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 104.654 -2.35 . . . . 0.0 104.654 176.48 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.497 HG21 HG21 ' A' ' 3' ' ' VAL . 13.0 t -108.22 116.39 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.81 -179.72 2.33 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.311 -0.868 . . . . 0.0 111.409 -178.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 19' ' ' ASP . 3.8 p-10 -70.0 136.75 50.75 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 122.012 0.91 . . . . 0.0 110.724 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.01 -18.2 41.74 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 178.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.434 ' HB ' HG12 ' A' ' 17' ' ' VAL . 57.5 t -80.1 138.52 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 120.616 -1.52 . . . . 0.0 109.432 -178.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.27 153.97 21.06 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.164 -0.96 . . . . 0.0 109.126 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.419 ' CD2' ' N ' ' A' ' 23' ' ' LEU . 1.8 mm? -56.26 -64.05 0.99 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.612 -0.68 . . . . 0.0 109.178 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.515 ' O ' ' SD ' ' A' ' 24' ' ' MET . 6.6 tpt -49.46 -16.28 0.2 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.009 -1.057 . . . . 0.0 109.123 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.418 ' N ' ' C ' ' A' ' 23' ' ' LEU . 7.7 tm0? -78.35 -68.1 0.67 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.104 -0.998 . . . . 0.0 109.47 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.427 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -55.24 -21.7 15.17 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.929 -1.107 . . . . 0.0 110.418 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.78 -19.35 65.78 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 120.844 -1.16 . . . . 0.0 108.809 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 96.5 t -86.98 -23.87 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.472 -0.767 . . . . 0.0 109.381 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.53 -26.43 45.79 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.529 -0.732 . . . . 0.0 109.054 -179.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.491 ' ND2' HD11 ' A' ' 15' ' ' LEU . 1.8 m-80 -106.92 -0.69 23.01 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 64.48 75.47 0.37 Allowed Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 56.4 mt -124.09 -52.07 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 O-C-N 121.629 -0.924 . . . . 0.0 109.563 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.473 ' CZ ' HD12 ' A' ' 35' ' ' ILE . 2.0 t80 -91.24 122.43 33.86 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 177.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -106.91 65.59 0.66 Allowed 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 176.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.473 HD12 ' CZ ' ' A' ' 33' ' ' TYR . 14.4 mt -149.48 148.25 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.297 0 O-C-N 120.649 -1.282 . . . . 0.0 110.317 -178.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.3 t -88.49 111.07 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -49.21 108.75 0.47 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.524 ' C ' ' H ' ' A' ' 40' ' ' GLY . 12.6 t0 -50.09 -59.48 3.87 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.137 -1.213 . . . . 0.0 109.258 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.613 ' SG ' ' N ' ' A' ' 42' ' ' SER . 17.1 p -71.31 16.68 0.09 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.251 -0.906 . . . . 0.0 108.997 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.524 ' H ' ' C ' ' A' ' 38' ' ' ASP . . . 59.27 9.09 7.52 Favored Glycine 0 N--CA 1.483 1.783 0 N-CA-C 107.226 -2.35 . . . . 0.0 107.226 -178.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.459 ' H ' ' C ' ' A' ' 39' ' ' CYS . . . 90.39 23.65 30.97 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 109.186 -1.566 . . . . 0.0 109.186 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.613 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 60.1 m -99.91 41.65 1.15 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.395 -1.062 . . . . 0.0 110.072 -179.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 43.71 76.09 0.09 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.278 -0.889 . . . . 0.0 109.934 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.22 23.54 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.143 -0.973 . . . . 0.0 109.488 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.499 ' O ' ' S1 ' ' A' ' 107' ' ' FES . 3.2 p -160.9 163.48 31.9 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.027 -1.046 . . . . 0.0 110.092 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -96.53 8.88 43.04 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.492 ' OG1' ' SG ' ' A' ' 45' ' ' CYS . 9.7 m -51.91 -51.45 56.8 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.798 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.516 ' SG ' ' O ' ' A' ' 48' ' ' CYS . 17.8 p -87.44 54.66 3.22 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.695 -1.253 . . . . 0.0 110.071 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.796 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 43.6 t60 -76.52 109.97 10.69 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.955 -1.091 . . . . 0.0 109.024 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -146.06 168.17 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 120.796 -1.19 . . . . 0.0 109.697 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.601 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 37.2 m-85 -116.7 114.86 24.62 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-O 122.051 0.929 . . . . 0.0 109.58 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.456 ' O ' ' OD1' ' A' ' 81' ' ' ASN . 78.7 t -91.31 131.64 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.765 ' ND2' ' HB3' ' A' ' 55' ' ' ALA . 1.1 t30 -46.95 127.65 10.31 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -57.38 13.9 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.63 -0.669 . . . . 0.0 111.441 -178.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.765 ' HB3' ' ND2' ' A' ' 53' ' ' ASN . . . -103.45 -19.8 14.28 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.57 -1.331 . . . . 0.0 109.8 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.551 ' CD2' HD22 ' A' ' 94' ' ' LEU . 30.2 m-85 -109.59 -9.78 14.87 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.708 -1.245 . . . . 0.0 108.859 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.0 p -71.18 -37.51 72.17 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.565 -0.71 . . . . 0.0 110.141 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.421 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 9.5 p-10 -87.84 10.51 18.33 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.229 -0.919 . . . . 0.0 109.913 -178.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.536 ' HB2' HD21 ' A' ' 94' ' ' LEU . 9.1 mttm -121.21 -40.04 2.63 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.66 HG22 ' HD2' ' A' ' 61' ' ' PRO . 0.4 OUTLIER -78.73 162.09 66.67 Favored Pre-proline 0 N--CA 1.498 1.953 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 179.813 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.66 ' HD2' HG22 ' A' ' 60' ' ' VAL . 4.4 Cg_endo -53.97 94.19 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 121.877 1.718 . . . . 0.0 113.939 -176.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.0 98.5 3.62 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 177.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.967 ' H ' HH22 ' A' ' 83' ' ' ARG . . . -61.05 169.34 2.04 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-O 122.559 1.171 . . . . 0.0 111.953 -178.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -65.18 -175.02 0.19 Allowed 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 122.204 1.002 . . . . 0.0 111.954 -178.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -70.33 3.31 3.0 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.813 -0.555 . . . . 0.0 111.409 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.2 mtm180 -59.95 -41.76 92.58 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.669 -1.269 . . . . 0.0 110.143 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.478 ' N ' ' CD ' ' A' ' 67' ' ' GLU . 23.7 mp0 -80.29 -37.0 33.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.021 -1.049 . . . . 0.0 110.029 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.446 HD12 ' N ' ' A' ' 68' ' ' ILE . 1.3 mp -46.88 -34.13 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 C-N-CA 119.731 -0.788 . . . . 0.0 109.142 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.3 -28.36 62.08 Favored Glycine 0 N--CA 1.498 2.791 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.421 ' N ' ' O ' ' A' ' 67' ' ' GLU . 25.1 mtt -79.97 -35.6 37.31 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 178.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 74.9 mt -66.81 -24.69 66.2 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -77.48 5.83 8.18 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.732 -1.23 . . . . 0.0 108.032 178.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -124.42 30.17 6.1 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.752 -0.592 . . . . 0.0 110.981 -177.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 28.9 m -96.35 169.54 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.42 0 O-C-N 120.652 -1.28 . . . . 0.0 110.723 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.524 ' OG1' ' CG ' ' A' ' 106' ' ' TRP . 3.1 m -102.41 -9.93 19.86 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.342 -0.849 . . . . 0.0 111.281 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.796 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -104.58 176.13 5.26 Favored 'General case' 0 N--CA 1.507 2.405 0 O-C-N 120.627 -1.296 . . . . 0.0 110.411 -178.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.601 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -59.64 105.33 0.36 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.613 -0.679 . . . . 0.0 110.255 -178.528 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.9 tp -73.96 147.35 43.14 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 119.502 -1.999 . . . . 0.0 110.338 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 27.0 mmtm -109.58 155.52 41.2 Favored Pre-proline 0 C--N 1.291 -1.962 0 CA-C-N 114.756 -1.111 . . . . 0.0 108.83 -178.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.47 -23.02 73.96 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 121.964 1.776 . . . . 0.0 109.331 178.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.456 ' OD1' ' O ' ' A' ' 52' ' ' VAL . 2.1 p30 -115.55 23.22 12.53 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.832 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.1 m -47.21 165.66 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.672 -1.268 . . . . 0.0 109.409 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.967 HH22 ' H ' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -161.58 141.99 10.71 Favored 'General case' 0 N--CA 1.5 2.046 0 C-N-CA 118.259 -1.376 . . . . 0.0 111.96 -177.531 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 95.5 mt -86.32 111.16 20.21 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 177.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.604 ' HA ' HD12 ' A' ' 88' ' ' ILE . 0.1 OUTLIER -56.2 -35.14 66.94 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -176.106 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . 0.547 ' SG ' ' N ' ' A' ' 87' ' ' GLN . 31.6 p -63.51 -49.06 75.05 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 119.678 -1.889 . . . . 0.0 112.343 -177.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.683 HE22 ' NH1' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -79.61 33.8 0.26 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.841 -1.162 . . . . 0.0 111.425 -177.709 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.604 HD12 ' HA ' ' A' ' 85' ' ' CYS . 71.5 mt -113.17 160.76 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 177.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.484 ' N ' HG22 ' A' ' 88' ' ' ILE . 35.6 mm -136.5 121.85 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.4 ' SD ' HD21 ' A' ' 23' ' ' LEU . 3.2 tpt -87.28 160.87 18.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.792 -1.193 . . . . 0.0 108.799 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 39.4 p -151.06 148.67 23.2 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -56.03 -32.37 85.97 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 121.379 1.386 . . . . 0.0 111.634 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.57 ' CD ' ' H ' ' A' ' 93' ' ' GLU . 2.3 pm0 -68.11 -31.52 71.18 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.062 -1.024 . . . . 0.0 110.006 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.551 HD22 ' CD2' ' A' ' 56' ' ' PHE . 7.2 mt -94.43 27.99 2.75 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 120.72 -1.237 . . . . 0.0 108.956 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -61.86 138.03 58.31 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.023 -1.048 . . . . 0.0 110.324 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 107.83 9.77 27.81 Favored Glycine 0 N--CA 1.499 2.866 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 178.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 14.4 tt -64.99 133.25 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 120.925 -1.338 . . . . 0.0 111.365 -177.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.3 t -103.06 114.59 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.5 t -103.72 135.75 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.729 -1.232 . . . . 0.0 108.558 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.1 116.17 31.44 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.809 0.814 . . . . 0.0 109.172 -179.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.2 t -103.34 125.01 36.24 Favored Pre-proline 0 N--CA 1.498 1.933 0 O-C-N 121.845 -0.534 . . . . 0.0 109.565 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.424 ' HG3' ' CD2' ' A' ' 49' ' ' HIS . 85.2 Cg_endo -80.6 167.24 19.09 Favored 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 122.193 1.929 . . . . 0.0 113.735 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -73.11 -14.98 61.49 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 21.5 mtm180 -123.82 92.32 3.65 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 2.7 pp0? -82.61 -19.51 38.23 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.628 -0.67 . . . . 0.0 109.716 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.524 ' CG ' ' OG1' ' A' ' 75' ' ' THR . 63.5 t-105 . . . . . 0 C--N 1.304 -1.373 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.537 178.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' FES . . . . . 0.499 ' S1 ' ' O ' ' A' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.408 ' OG ' ' O ' ' A' ' 17' ' ' VAL . 83.9 p . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.402 ' H ' ' HB2' ' A' ' 95' ' ' ASP . 25.4 mmtt -75.38 111.71 10.93 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.31 -0.869 . . . . 0.0 109.157 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.446 ' CG2' ' SD ' ' A' ' 90' ' ' MET . 17.2 t -109.49 109.19 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.343 -0.848 . . . . 0.0 109.499 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.473 HG22 ' OE1' ' A' ' 14' ' ' GLU . 38.5 t -99.57 96.49 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.127 -0.983 . . . . 0.0 111.345 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.432 ' CE2' ' CD1' ' A' ' 32' ' ' ILE . 93.9 m-85 -70.54 111.76 6.3 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 76.1 t -98.46 117.36 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 80.8 p -76.51 -158.6 0.1 Allowed 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.346 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.602 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -90.33 -49.65 6.41 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.089 -1.007 . . . . 0.0 109.466 -179.646 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.485 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 22.9 p-10 -66.39 2.06 1.39 Allowed 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.264 -0.897 . . . . 0.0 110.355 -178.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.01 -0.54 62.47 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -65.05 127.94 33.7 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.9 -1.353 . . . . 0.0 108.227 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.447 HH11 ' HD2' ' A' ' 12' ' ' ARG . 2.3 mtt85 -108.12 160.67 15.63 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 122.156 0.979 . . . . 0.0 110.796 -178.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -150.99 115.19 5.06 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 178.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.473 ' OE1' HG22 ' A' ' 4' ' ' VAL . 0.2 OUTLIER -99.19 128.46 45.32 Favored 'General case' 0 N--CA 1.508 2.436 0 CA-C-O 122.504 1.145 . . . . 0.0 110.613 -178.144 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.529 HD11 ' ND2' ' A' ' 30' ' ' ASN . 0.2 OUTLIER -115.13 -173.86 2.39 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 123.072 1.415 . . . . 0.0 110.575 -178.475 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.459 ' H ' ' CD1' ' A' ' 15' ' ' LEU . 32.6 t0 -136.36 104.39 5.6 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 176.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.538 HG22 ' CB ' ' A' ' 26' ' ' ALA . 25.2 t -112.9 122.92 67.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 O-C-N 121.525 -0.734 . . . . 0.0 109.604 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.82 179.78 5.9 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.919 0.866 . . . . 0.0 111.519 -178.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -69.31 138.82 54.11 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 122.025 0.917 . . . . 0.0 110.913 -179.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.83 -17.09 37.94 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 62.0 t -81.9 139.13 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 O-C-N 120.51 -1.583 . . . . 0.0 109.122 -178.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 16.0 p -92.68 149.19 21.48 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.158 -0.964 . . . . 0.0 108.588 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 27.0 mt -50.01 -36.15 27.51 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 121.093 -1.004 . . . . 0.0 110.007 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.493 ' SD ' ' OD2' ' A' ' 34' ' ' ASP . 7.5 tpt -68.11 -24.37 65.02 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.319 -0.863 . . . . 0.0 109.474 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -76.94 -63.22 1.41 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.143 -0.973 . . . . 0.0 109.622 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.538 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -52.95 -28.54 24.06 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.123 -0.986 . . . . 0.0 110.599 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.491 ' HA ' HD12 ' A' ' 32' ' ' ILE . . . -57.14 -20.96 29.17 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.749 -1.22 . . . . 0.0 108.756 179.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.5 t -88.57 -23.85 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.485 -0.759 . . . . 0.0 110.585 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.485 ' OG ' ' ND2' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -75.3 -31.11 60.56 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.303 -0.873 . . . . 0.0 109.99 -179.287 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.529 ' ND2' HD11 ' A' ' 15' ' ' LEU . 1.7 m-80 -104.54 0.09 28.35 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 64.4 59.03 8.84 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.872 ' O ' ' N ' ' A' ' 34' ' ' ASP . 25.3 mt -91.47 124.74 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.231 -1.159 . . . . 0.0 108.253 179.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -40.41 49.32 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.707 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -177.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.872 ' N ' ' O ' ' A' ' 32' ' ' ILE . 29.8 p-10 -94.17 -8.62 38.89 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.175 -0.953 . . . . 0.0 109.816 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.557 ' CG1' ' H ' ' A' ' 36' ' ' VAL . 9.5 tt -47.12 -177.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.451 -0.781 . . . . 0.0 110.693 -178.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.557 ' H ' ' CG1' ' A' ' 35' ' ' ILE . 42.8 t 60.63 91.48 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -178.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -148.87 151.51 23.67 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.505 ' C ' ' H ' ' A' ' 40' ' ' GLY . 26.4 m-20 -88.21 -68.4 0.76 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.126 -1.22 . . . . 0.0 109.956 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.625 ' SG ' ' N ' ' A' ' 42' ' ' SER . 4.7 p -69.81 15.7 0.08 Allowed 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 119.901 -0.72 . . . . 0.0 109.653 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.505 ' H ' ' C ' ' A' ' 38' ' ' ASP . . . 51.4 11.83 0.82 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.487 ' N ' ' C ' ' A' ' 39' ' ' CYS . . . 96.61 19.76 26.44 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.625 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 4.8 p -93.38 35.12 1.11 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.323 -1.104 . . . . 0.0 109.537 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 45.2 74.56 0.13 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.341 -0.849 . . . . 0.0 110.314 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -166.65 26.44 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.846 -1.159 . . . . 0.0 109.927 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.489 ' O ' ' S1 ' ' A' ' 107' ' ' FES . 3.0 p -161.59 -177.0 5.63 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.099 -1.001 . . . . 0.0 109.717 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -116.27 12.75 15.47 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.361 -0.837 . . . . 0.0 109.524 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.457 HG21 ' H ' ' A' ' 38' ' ' ASP . 75.5 p -59.81 -28.5 67.51 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.226 -0.921 . . . . 0.0 109.483 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 20.8 p -97.28 54.21 1.21 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.214 -0.928 . . . . 0.0 109.586 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.679 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 39.5 t60 -76.2 96.11 3.84 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -133.65 164.58 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 121.151 -0.968 . . . . 0.0 109.748 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.518 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 45.8 m-85 -113.54 113.25 24.85 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 122.073 0.94 . . . . 0.0 110.192 -179.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.465 HG12 HD22 ' A' ' 53' ' ' ASN . 47.1 t -87.25 131.13 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.609 ' N ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -48.0 128.19 13.29 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.92 -1.113 . . . . 0.0 108.902 179.834 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -55.85 9.96 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.284 -0.885 . . . . 0.0 111.515 -178.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.597 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -98.19 -18.42 18.46 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.892 -1.13 . . . . 0.0 110.137 -179.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.612 ' CD2' HD22 ' A' ' 94' ' ' LEU . 26.1 m-85 -114.66 -7.45 12.73 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 120.707 -1.246 . . . . 0.0 108.855 -179.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.3 p -71.61 -41.18 69.22 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.083 -1.01 . . . . 0.0 109.858 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -85.48 10.17 13.74 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.435 -0.791 . . . . 0.0 110.006 -178.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.507 ' HB2' HD21 ' A' ' 94' ' ' LEU . 17.3 mttt -120.11 -38.46 2.93 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.684 HG22 ' HD2' ' A' ' 61' ' ' PRO . 0.4 OUTLIER -82.51 164.14 48.79 Favored Pre-proline 0 N--CA 1.493 1.705 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.684 ' HD2' HG22 ' A' ' 60' ' ' VAL . 5.6 Cg_endo -58.31 99.33 0.1 OUTLIER 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 121.773 1.649 . . . . 0.0 114.714 -176.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.27 102.97 1.48 Allowed 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -56.77 155.33 7.88 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-O 122.304 1.049 . . . . 0.0 112.51 -178.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.444 ' ND2' ' NH1' ' A' ' 66' ' ' ARG . 3.0 p30 -59.3 -178.2 0.06 Allowed 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.721 0.772 . . . . 0.0 111.148 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -70.1 2.19 3.88 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.669 -0.644 . . . . 0.0 112.354 -178.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.444 ' NH1' ' ND2' ' A' ' 64' ' ' ASN . 51.4 mtt85 -67.57 -40.97 84.87 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 120.68 -1.263 . . . . 0.0 109.679 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.484 ' N ' ' CD ' ' A' ' 67' ' ' GLU . 23.0 mp0 -72.26 -41.06 67.17 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.08 -1.013 . . . . 0.0 108.609 178.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.499 HD12 ' N ' ' A' ' 68' ' ' ILE . 1.4 mp -48.31 -30.26 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -70.15 -74.9 0.63 Allowed Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 9.0 ptp -46.38 -33.89 4.21 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.875 -1.368 . . . . 0.0 109.144 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.488 HD22 HD11 ' A' ' 78' ' ' LEU . 12.0 mt -58.04 -28.56 64.6 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.536 ' N ' ' O ' ' A' ' 69' ' ' GLY . 39.6 tt0 -79.71 5.11 14.22 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.368 -0.833 . . . . 0.0 108.771 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -122.99 31.57 5.98 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.555 -0.716 . . . . 0.0 110.122 -178.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.562 HG21 HD13 ' A' ' 78' ' ' LEU . 16.4 m -92.09 166.77 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 120.797 -1.189 . . . . 0.0 110.006 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.47 ' OG1' ' CG ' ' A' ' 106' ' ' TRP . 4.8 m -99.56 -8.08 25.02 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.806 -0.558 . . . . 0.0 110.249 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.679 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -107.36 169.74 8.39 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.113 -0.992 . . . . 0.0 110.354 -178.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.518 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -60.91 108.52 0.87 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.815 -0.553 . . . . 0.0 109.67 -179.553 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.562 HD13 HG21 ' A' ' 74' ' ' VAL . 8.5 tp -72.93 155.78 39.52 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 120.011 -1.681 . . . . 0.0 110.118 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 25.3 mmtm -117.15 153.54 49.78 Favored Pre-proline 0 C--N 1.292 -1.916 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 -178.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.4 -22.16 70.37 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 C-N-CA 121.173 1.249 . . . . 0.0 109.77 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.431 ' OD1' ' O ' ' A' ' 81' ' ' ASN . 1.1 p30 -111.77 19.66 17.8 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.867 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 21.6 m -58.24 162.69 3.39 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.542 -1.349 . . . . 0.0 109.746 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.563 ' NH2' ' O ' ' A' ' 61' ' ' PRO . 0.7 OUTLIER -171.72 146.28 2.09 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 118.32 -1.352 . . . . 0.0 111.169 179.447 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.469 HD23 ' S1 ' ' A' ' 107' ' ' FES . 5.3 mp -76.62 116.01 16.9 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -57.51 -16.96 11.25 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.446 -0.784 . . . . 0.0 112.922 -176.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 30.5 p -85.85 -33.16 21.37 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 119.81 -1.806 . . . . 0.0 111.207 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.406 ' OE1' ' CD ' ' A' ' 67' ' ' GLU . 34.2 tt0 -87.53 32.05 0.73 Allowed 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.261 -1.525 . . . . 0.0 110.403 -179.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.407 HG22 ' N ' ' A' ' 89' ' ' ILE . 41.3 mm -117.61 157.93 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 O-C-N 121.022 -1.049 . . . . 0.0 108.423 178.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.407 ' N ' HG22 ' A' ' 88' ' ' ILE . 35.2 mm -130.5 122.7 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.446 ' SD ' ' CG2' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -86.54 155.84 20.32 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.137 -0.977 . . . . 0.0 108.622 -178.888 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 57.0 p -147.81 148.02 28.98 Favored Pre-proline 0 N--CA 1.492 1.663 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -58.08 -32.71 96.16 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 121.286 1.324 . . . . 0.0 111.018 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -64.82 -28.54 69.63 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.13 -0.981 . . . . 0.0 109.262 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.612 HD22 ' CD2' ' A' ' 56' ' ' PHE . 6.4 mt -99.37 27.59 5.11 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.401 -0.812 . . . . 0.0 109.492 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.402 ' HB2' ' H ' ' A' ' 2' ' ' LYS . 9.2 p-10 -58.9 138.45 57.36 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.876 -1.14 . . . . 0.0 109.361 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 107.22 9.75 29.01 Favored Glycine 0 N--CA 1.501 3.028 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 178.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.446 HG13 HD21 ' A' ' 53' ' ' ASN . 16.4 tt -65.09 130.05 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.842 -1.387 . . . . 0.0 111.113 -178.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.8 t -103.5 115.36 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.446 -0.784 . . . . 0.0 109.077 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.5 t -102.65 134.81 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 120.922 -1.112 . . . . 0.0 109.366 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -108.39 124.05 49.78 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.799 0.809 . . . . 0.0 109.661 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.1 t -111.11 124.12 33.58 Favored Pre-proline 0 N--CA 1.495 1.816 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.415 ' HG3' ' CD2' ' A' ' 49' ' ' HIS . 75.6 Cg_endo -83.06 175.53 8.41 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 122.678 2.252 . . . . 0.0 113.37 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -83.5 -17.34 42.25 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -109.74 80.92 1.36 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.447 ' O ' ' OXT' ' A' ' 106' ' ' TRP . 39.5 tt0 -82.95 -33.27 26.77 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.116 -0.99 . . . . 0.0 109.177 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.548 ' CG ' ' O ' ' A' ' 106' ' ' TRP . 57.3 t-105 . . . . . 0 C--N 1.301 -1.522 0 CA-C-O 118.294 -0.86 . . . . 0.0 109.788 179.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' FES . . . . . 0.489 ' S1 ' ' O ' ' A' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 68.0 p . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.414 ' H ' ' HB2' ' A' ' 95' ' ' ASP . 19.1 mmtm -76.96 113.88 15.14 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.98 -1.075 . . . . 0.0 108.534 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.532 HG21 ' CG2' ' A' ' 17' ' ' VAL . 49.5 t -115.0 109.91 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.442 -0.786 . . . . 0.0 110.076 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.6 t -102.64 134.88 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 CA-C-O 121.749 0.785 . . . . 0.0 110.389 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -106.12 114.5 28.68 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 177.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 67.0 t -97.82 115.21 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 27.7 p -77.92 -160.28 0.19 Allowed 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.426 0.631 . . . . 0.0 109.674 -178.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.58 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.2 OUTLIER -87.13 -47.23 9.06 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.563 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.459 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 17.8 p30 -70.52 -2.53 14.36 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.088 -1.007 . . . . 0.0 110.973 -178.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.12 0.0 57.26 Favored Glycine 0 N--CA 1.499 2.863 0 O-C-N 120.854 -1.154 . . . . 0.0 110.953 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -66.31 131.15 45.45 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.628 -1.513 . . . . 0.0 108.847 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.84 156.03 23.61 Favored 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.579 0.704 . . . . 0.0 110.979 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.3 mmm-85 -142.76 112.75 7.03 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 177.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.484 ' CD ' ' H ' ' A' ' 14' ' ' GLU . 2.6 mp0 -98.37 127.33 44.26 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.863 -1.148 . . . . 0.0 109.819 -178.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.497 HD22 ' CG ' ' A' ' 30' ' ' ASN . 19.4 mt -117.88 -165.19 1.07 Allowed 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 122.738 1.256 . . . . 0.0 110.0 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -137.13 99.77 4.09 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 104.942 -2.244 . . . . 0.0 104.942 176.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.532 ' CG2' HG21 ' A' ' 3' ' ' VAL . 12.8 t -102.63 115.36 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.33 177.17 4.05 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 122.359 1.076 . . . . 0.0 111.312 -178.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -65.69 133.34 50.88 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.975 0.893 . . . . 0.0 110.709 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.03 -18.4 53.83 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.431 ' HB ' HG12 ' A' ' 17' ' ' VAL . 61.3 t -85.36 138.64 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.585 -1.538 . . . . 0.0 109.175 -178.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.438 ' O ' ' N ' ' A' ' 25' ' ' GLN . 59.9 p -93.38 146.35 23.8 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.266 -0.896 . . . . 0.0 109.458 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.5 mt -48.11 -34.17 9.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.001 -1.062 . . . . 0.0 109.406 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.49 ' O ' ' SD ' ' A' ' 24' ' ' MET . 4.3 tpt -67.55 -29.07 68.35 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.438 ' N ' ' O ' ' A' ' 22' ' ' SER . 14.5 mm100 -73.74 -59.83 2.53 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.104 -0.997 . . . . 0.0 109.637 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.41 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -60.48 -24.42 65.26 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.878 -1.139 . . . . 0.0 111.22 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.4 -24.58 67.9 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.941 -1.099 . . . . 0.0 108.967 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 88.7 t -80.78 -23.52 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 CA-C-O 121.555 0.693 . . . . 0.0 109.148 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.25 -27.54 35.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.4 -0.812 . . . . 0.0 109.28 -179.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.497 ' CG ' HD22 ' A' ' 15' ' ' LEU . 7.0 m-80 -103.21 1.31 32.87 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 178.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 63.68 70.55 1.03 Allowed Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.418 HD12 HD11 ' A' ' 15' ' ' LEU . 71.4 mt -124.4 -43.61 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.674 -0.898 . . . . 0.0 110.516 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.692 ' O ' ' N ' ' A' ' 35' ' ' ILE . 0.2 OUTLIER -80.33 15.36 1.62 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.777 -1.202 . . . . 0.0 109.979 -179.047 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -58.11 54.47 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.516 0.674 . . . . 0.0 110.521 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.692 ' N ' ' O ' ' A' ' 33' ' ' TYR . 40.4 mm -126.91 -86.63 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.573 HG12 ' N ' ' A' ' 37' ' ' GLY . 69.9 t -148.8 164.17 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.923 -1.11 . . . . 0.0 109.609 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.573 ' N ' HG12 ' A' ' 36' ' ' VAL . . . -166.01 109.63 0.37 Allowed Glycine 0 N--CA 1.483 1.808 0 N-CA-C 108.741 -1.743 . . . . 0.0 108.741 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -87.44 -91.93 0.11 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.16 -1.2 . . . . 0.0 109.764 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.431 ' SG ' ' N ' ' A' ' 42' ' ' SER . 0.5 OUTLIER -51.65 -28.77 15.5 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.047 -1.033 . . . . 0.0 108.642 -179.677 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 46.71 65.15 2.31 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 85.96 55.22 2.57 Favored Glycine 0 N--CA 1.497 2.755 0 C-N-CA 119.469 -1.348 . . . . 0.0 109.785 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.431 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 0.6 OUTLIER -155.9 14.12 0.34 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.348 -1.678 . . . . 0.0 110.368 179.583 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.739 ' HB2' ' NE2' ' A' ' 87' ' ' GLN . . . 42.42 70.0 0.33 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.271 -0.893 . . . . 0.0 109.957 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.7 t -162.57 22.21 0.1 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.92 -1.113 . . . . 0.0 109.861 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.528 ' SG ' ' N ' ' A' ' 46' ' ' ALA . 2.1 p -155.76 -156.25 0.63 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.047 -1.033 . . . . 0.0 109.975 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.528 ' N ' ' SG ' ' A' ' 45' ' ' CYS . . . -149.04 21.38 0.98 Allowed 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 42.7 p -71.35 -38.92 71.59 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.021 -1.05 . . . . 0.0 110.206 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.497 ' SG ' ' O ' ' A' ' 48' ' ' CYS . 15.0 p -91.37 48.11 1.45 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.795 -1.191 . . . . 0.0 109.996 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.703 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 53.8 t60 -77.99 113.14 15.62 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.969 -1.082 . . . . 0.0 109.026 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -146.05 165.12 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.107 -0.996 . . . . 0.0 109.214 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.576 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 52.0 m-85 -114.03 111.57 21.86 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 121.667 0.746 . . . . 0.0 109.788 -178.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.584 HG13 HD11 ' A' ' 97' ' ' ILE . 81.9 t -86.12 135.02 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.578 ' C ' ' H ' ' A' ' 55' ' ' ALA . 3.3 t30 -49.7 128.09 17.22 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.91 -1.119 . . . . 0.0 108.973 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -56.09 12.13 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.592 -0.692 . . . . 0.0 111.566 -178.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.578 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -101.06 -19.62 15.72 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.892 -1.13 . . . . 0.0 109.8 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.559 ' CD2' HD22 ' A' ' 94' ' ' LEU . 46.3 m-85 -110.78 -11.59 14.37 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.767 -1.208 . . . . 0.0 109.596 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.549 HG21 ' OD1' ' A' ' 81' ' ' ASN . 9.5 p -70.59 -38.3 74.03 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.81 -1.181 . . . . 0.0 110.012 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -85.85 9.71 15.93 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.184 -0.948 . . . . 0.0 110.092 -178.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.437 ' CE ' ' O ' ' A' ' 55' ' ' ALA . 9.6 mttm -121.11 -37.93 2.88 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.605 HG22 ' HD2' ' A' ' 61' ' ' PRO . 0.5 OUTLIER -81.84 159.0 67.06 Favored Pre-proline 0 N--CA 1.494 1.748 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.796 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.605 ' HD2' HG22 ' A' ' 60' ' ' VAL . 3.1 Cg_exo -48.7 101.96 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.029 1.819 . . . . 0.0 112.247 -178.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.9 101.44 4.41 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.544 ' HB1' ' OE1' ' A' ' 67' ' ' GLU . . . -49.63 144.05 6.44 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-O 121.878 0.847 . . . . 0.0 111.504 -178.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -53.56 -175.17 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.658 0.742 . . . . 0.0 110.121 -179.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -69.5 -1.44 8.62 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.697 -0.627 . . . . 0.0 111.136 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.507 ' O ' ' SD ' ' A' ' 70' ' ' MET . 8.8 mtt85 -63.85 -39.92 95.36 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.769 -1.207 . . . . 0.0 109.439 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.544 ' OE1' ' HB1' ' A' ' 63' ' ' ALA . 10.2 mp0 -78.18 -40.68 37.0 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.174 -0.953 . . . . 0.0 109.868 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.484 HD12 ' N ' ' A' ' 68' ' ' ILE . 1.4 mp -46.72 -25.33 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.49 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -76.66 -67.81 1.62 Allowed Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.066 -1.614 . . . . 0.0 109.066 179.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.573 ' CE ' ' HB1' ' A' ' 43' ' ' ALA . 4.7 mpp? -49.28 -39.42 30.74 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.054 -1.262 . . . . 0.0 108.599 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.566 ' O ' HD13 ' A' ' 78' ' ' LEU . 6.5 mt -55.2 -21.71 14.86 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.49 ' N ' ' O ' ' A' ' 69' ' ' GLY . 27.0 tt0 -91.08 12.46 19.8 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -124.93 31.04 5.74 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.446 -0.784 . . . . 0.0 110.085 -179.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.475 HG13 ' HB1' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -98.61 175.5 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.287 0 O-C-N 121.375 -0.828 . . . . 0.0 109.215 179.717 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.525 ' OG1' ' CD1' ' A' ' 106' ' ' TRP . 4.2 m -109.71 -0.61 18.46 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.342 -0.849 . . . . 0.0 110.026 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.703 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -107.45 167.44 9.93 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.053 -1.029 . . . . 0.0 109.882 -179.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.576 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -58.07 106.8 0.4 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.616 -0.677 . . . . 0.0 110.935 -178.767 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.566 HD13 ' O ' ' A' ' 71' ' ' LEU . 7.2 tp -70.29 147.67 49.41 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 120.106 -1.621 . . . . 0.0 109.562 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.1 mmtp -112.78 156.04 43.13 Favored Pre-proline 0 C--N 1.29 -2.003 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -178.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -54.22 -22.14 25.02 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 121.349 1.366 . . . . 0.0 109.862 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.549 ' OD1' HG21 ' A' ' 57' ' ' THR . 0.1 OUTLIER -126.99 37.81 4.21 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.955 -0.465 . . . . 0.0 110.426 -179.887 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.441 ' HG ' ' HE1' ' A' ' 51' ' ' TYR . 37.5 m -60.49 175.46 0.45 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.365 -1.46 . . . . 0.0 108.445 179.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.458 ' HE ' HG12 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -166.24 159.86 15.43 Favored 'General case' 0 N--CA 1.504 2.227 0 C-N-CA 118.28 -1.368 . . . . 0.0 111.583 -178.183 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.413 ' C ' ' SG ' ' A' ' 48' ' ' CYS . 50.0 mt -105.75 95.35 5.74 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 178.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.489 ' C ' ' H ' ' A' ' 87' ' ' GLN . 0.1 OUTLIER -39.78 -44.34 1.57 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.553 -0.717 . . . . 0.0 112.848 -176.718 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 13.9 p -60.65 5.94 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 119.972 -1.705 . . . . 0.0 110.938 -177.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.739 ' NE2' ' HB2' ' A' ' 43' ' ' ALA . 13.6 mt-30 -136.02 45.39 2.39 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 120.937 -1.102 . . . . 0.0 111.664 -178.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.458 HG12 ' HE ' ' A' ' 83' ' ' ARG . 3.7 mt -131.77 156.18 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 O-C-N 121.074 -1.016 . . . . 0.0 108.602 177.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 38.3 mm -129.7 126.48 62.9 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.427 0 O-C-N 121.31 -0.869 . . . . 0.0 109.524 -178.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.468 ' SD ' HG21 ' A' ' 97' ' ' ILE . 4.1 tpt -91.05 163.51 14.28 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.106 -0.996 . . . . 0.0 110.38 -179.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 70.6 p -151.93 147.24 19.59 Favored Pre-proline 0 N--CA 1.488 1.469 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -56.35 -30.08 79.63 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 121.259 1.306 . . . . 0.0 111.568 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -68.96 -31.21 69.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.105 -0.997 . . . . 0.0 110.334 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.559 HD22 ' CD2' ' A' ' 56' ' ' PHE . 5.7 mt -95.58 32.72 1.75 Allowed 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.209 -0.932 . . . . 0.0 109.488 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.414 ' HB2' ' H ' ' A' ' 2' ' ' LYS . 3.7 p30 -62.45 138.6 58.49 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.71 -1.244 . . . . 0.0 110.159 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 109.86 9.75 24.03 Favored Glycine 0 N--CA 1.504 3.187 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 178.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.685 HD13 ' N ' ' A' ' 98' ' ' VAL . 0.0 OUTLIER -65.04 129.89 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 120.996 -1.297 . . . . 0.0 111.555 -177.708 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.685 ' N ' HD13 ' A' ' 97' ' ' ILE . 4.9 t -106.99 118.97 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.2 -0.937 . . . . 0.0 109.393 -179.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.1 t -101.84 133.27 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.014 -1.054 . . . . 0.0 109.283 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.68 115.51 30.37 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 18.0 t -103.73 122.89 43.08 Favored Pre-proline 0 N--CA 1.494 1.736 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.41 ' HG3' ' CD2' ' A' ' 49' ' ' HIS . 89.7 Cg_endo -82.16 177.8 6.9 Favored 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 121.975 1.784 . . . . 0.0 113.111 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -85.75 -13.78 47.26 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.471 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -120.7 86.89 2.65 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -178.086 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.502 ' OE1' HG21 ' A' ' 35' ' ' ILE . 6.1 pt20 -85.05 -28.76 25.45 Favored 'General case' 0 C--N 1.308 -1.207 0 O-C-N 121.115 -0.99 . . . . 0.0 109.312 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.525 ' CD1' ' OG1' ' A' ' 75' ' ' THR . 62.5 t-105 . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.611 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.448 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.412 ' H ' ' HB2' ' A' ' 95' ' ' ASP . 0.2 OUTLIER -82.69 110.66 17.95 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.614 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.492 HG21 ' CG2' ' A' ' 17' ' ' VAL . 53.6 t -108.59 108.58 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.268 -0.895 . . . . 0.0 110.058 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 62.9 t -99.11 126.31 52.39 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-O 121.97 0.89 . . . . 0.0 110.278 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.509 ' CE2' HD13 ' A' ' 32' ' ' ILE . 88.0 m-85 -103.45 112.95 26.08 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 177.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 64.7 t -99.63 120.88 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.7 p -82.44 -153.28 0.12 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.238 -0.913 . . . . 0.0 109.319 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.589 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -91.14 -44.35 9.31 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.458 -0.776 . . . . 0.0 109.393 -179.908 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.93 -0.87 3.4 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.217 -0.927 . . . . 0.0 111.317 -178.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.5 0.52 69.78 Favored Glycine 0 N--CA 1.498 2.826 0 O-C-N 120.427 -1.421 . . . . 0.0 110.618 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.1 t -72.46 135.7 45.8 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.938 -1.331 . . . . 0.0 108.31 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.29 163.9 12.64 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 122.204 1.002 . . . . 0.0 111.048 -178.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 -151.02 112.77 4.47 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -100.24 127.77 46.45 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-O 122.561 1.172 . . . . 0.0 111.127 -178.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.515 HD11 ' ND2' ' A' ' 30' ' ' ASN . 0.2 OUTLIER -114.63 -174.97 2.58 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-O 122.811 1.291 . . . . 0.0 110.301 -177.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.429 ' H ' HD13 ' A' ' 15' ' ' LEU . 18.2 t70 -134.26 100.62 4.74 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 176.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.492 ' CG2' HG21 ' A' ' 3' ' ' VAL . 7.6 t -111.21 115.79 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.15 177.14 3.4 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.884 0.85 . . . . 0.0 111.495 -177.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -66.02 138.55 57.87 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 122.014 0.911 . . . . 0.0 110.325 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.42 -18.11 35.13 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 178.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.485 ' HB ' HG12 ' A' ' 17' ' ' VAL . 51.9 t -83.79 140.68 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 120.704 -1.468 . . . . 0.0 109.326 -178.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 51.5 p -93.58 147.69 22.77 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.231 -0.918 . . . . 0.0 109.131 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.405 ' N ' HD23 ' A' ' 23' ' ' LEU . 7.9 mt -50.23 -31.9 15.16 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.193 -0.942 . . . . 0.0 109.477 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.448 ' SD ' ' C ' ' A' ' 24' ' ' MET . 1.4 tmt? -68.64 -29.58 68.1 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 52.5 mm-40 -72.05 -63.76 1.07 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.063 -1.023 . . . . 0.0 109.355 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.439 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -58.35 -25.6 62.16 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.996 -1.065 . . . . 0.0 110.374 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.588 ' HA ' HD12 ' A' ' 32' ' ' ILE . . . -60.27 -20.47 59.15 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.974 -1.079 . . . . 0.0 108.981 179.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 84.1 t -86.54 -22.62 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.637 -0.664 . . . . 0.0 109.636 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.484 ' OG ' ' ND2' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -79.74 -26.74 40.66 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.443 -0.786 . . . . 0.0 109.075 -179.525 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.515 ' ND2' HD11 ' A' ' 15' ' ' LEU . 2.4 m-80 -113.14 -0.09 14.78 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 63.66 79.73 0.15 Allowed Glycine 0 N--CA 1.496 2.657 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.588 HD12 ' HA ' ' A' ' 27' ' ' ALA . 78.6 mt -124.53 -63.44 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 O-C-N 121.689 -0.889 . . . . 0.0 111.01 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.55 ' H ' ' HB1' ' A' ' 27' ' ' ALA . 26.7 m-85 -92.66 -12.58 31.19 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.145 -0.972 . . . . 0.0 109.988 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 33' ' ' TYR . 10.6 p-10 -39.29 -50.07 1.97 Allowed 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.528 -0.733 . . . . 0.0 109.875 -178.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.504 HG23 ' O ' ' A' ' 35' ' ' ILE . 19.9 tt -44.03 125.02 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.678 -0.638 . . . . 0.0 109.34 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.568 HG12 ' N ' ' A' ' 37' ' ' GLY . 94.0 t 55.73 163.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 CA-C-O 121.497 0.665 . . . . 0.0 109.905 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.568 ' N ' HG12 ' A' ' 36' ' ' VAL . . . 170.0 115.8 0.35 Allowed Glycine 0 N--CA 1.488 2.146 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.509 ' C ' ' H ' ' A' ' 40' ' ' GLY . 28.7 t70 -87.73 -83.58 0.2 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.947 -1.325 . . . . 0.0 110.039 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.552 ' SG ' ' N ' ' A' ' 42' ' ' SER . 11.9 p -69.73 15.84 0.07 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.087 -1.008 . . . . 0.0 109.51 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.509 ' H ' ' C ' ' A' ' 38' ' ' ASP . . . 52.42 13.4 1.85 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.46 -1.856 . . . . 0.0 108.46 -179.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.468 ' N ' ' C ' ' A' ' 39' ' ' CYS . . . 88.57 89.88 1.14 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.552 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 41.1 t -159.51 22.4 0.18 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.124 -1.221 . . . . 0.0 108.885 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.521 ' CB ' HE21 ' A' ' 87' ' ' GLN . . . 58.24 63.45 1.74 Allowed 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.296 -0.878 . . . . 0.0 109.837 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.8 t -160.81 23.12 0.14 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.99 -1.069 . . . . 0.0 110.399 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.483 ' O ' ' S1 ' ' A' ' 107' ' ' FES . 1.5 p -162.16 166.24 25.9 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.027 -1.046 . . . . 0.0 110.047 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.444 ' HB1' HG12 ' A' ' 74' ' ' VAL . . . -97.25 4.36 51.0 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.442 ' OG1' ' SG ' ' A' ' 45' ' ' CYS . 11.1 m -49.7 -54.0 21.32 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 120.911 -1.118 . . . . 0.0 109.539 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.525 ' SG ' ' N ' ' A' ' 85' ' ' CYS . 31.9 p -80.11 53.76 1.8 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 120.944 -1.098 . . . . 0.0 109.605 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.621 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 39.3 t60 -77.64 105.61 8.91 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -143.62 164.83 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 120.859 -1.151 . . . . 0.0 109.889 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.512 ' OH ' ' NE2' ' A' ' 49' ' ' HIS . 36.4 m-85 -111.56 111.01 21.71 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.921 0.867 . . . . 0.0 110.101 -179.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.789 HG13 HD11 ' A' ' 97' ' ' ILE . 15.2 t -85.9 130.62 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.593 ' C ' ' H ' ' A' ' 55' ' ' ALA . 17.8 t-20 -47.11 126.18 8.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.783 -1.198 . . . . 0.0 109.566 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -57.32 13.99 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.737 -0.602 . . . . 0.0 111.291 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.593 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -100.7 -18.99 16.25 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.729 -1.232 . . . . 0.0 109.781 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.559 ' HB2' HD13 ' A' ' 97' ' ' ILE . 65.7 m-85 -113.85 -10.93 12.92 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.098 -1.001 . . . . 0.0 109.078 -178.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 13.1 p -68.99 -43.18 75.39 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.37 -0.831 . . . . 0.0 109.952 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -81.47 4.64 20.36 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.575 -0.703 . . . . 0.0 109.743 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 21.1 mtpt -113.19 -38.29 4.49 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.643 HG23 HD12 ' A' ' 94' ' ' LEU . 0.5 OUTLIER -82.8 158.57 65.0 Favored Pre-proline 0 N--CA 1.497 1.879 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 179.701 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.556 ' O ' ' NH2' ' A' ' 83' ' ' ARG . 1.1 Cg_endo -51.33 84.93 0.02 OUTLIER 'Trans proline' 0 N--CA 1.501 1.939 0 C-N-CA 122.405 2.07 . . . . 0.0 113.792 -176.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.79 105.17 0.28 Allowed 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -56.86 150.76 15.79 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-O 122.235 1.017 . . . . 0.0 112.667 -178.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.546 ' H ' ' ND2' ' A' ' 64' ' ' ASN . 0.6 OUTLIER -61.61 -172.84 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.032 -179.847 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -71.07 1.9 5.19 Favored 'General case' 0 N--CA 1.503 2.198 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -178.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.2 mtm180 -73.77 -46.74 43.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.386 -1.446 . . . . 0.0 109.087 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.443 ' N ' ' CD ' ' A' ' 67' ' ' GLU . 9.2 mp0 -64.39 -25.14 67.89 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.234 -0.916 . . . . 0.0 109.054 178.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.569 HD12 ' N ' ' A' ' 68' ' ' ILE . 1.4 mp -68.3 -34.74 67.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.032 -1.042 . . . . 0.0 108.839 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.82 -23.8 59.39 Favored Glycine 0 N--CA 1.496 2.672 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.434 ' N ' ' SD ' ' A' ' 70' ' ' MET . 0.9 OUTLIER -88.81 -31.54 18.28 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.911 -1.347 . . . . 0.0 107.571 178.931 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.433 HD22 ' HB3' ' A' ' 82' ' ' SER . 52.8 mt -67.74 -23.04 65.21 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -80.34 0.89 31.04 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -121.91 32.61 5.78 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.605 -0.684 . . . . 0.0 110.254 -178.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.603 HG21 HD13 ' A' ' 78' ' ' LEU . 29.3 m -94.69 167.21 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 O-C-N 121.126 -0.984 . . . . 0.0 110.796 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.4 m -104.24 -4.87 22.47 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.378 -0.826 . . . . 0.0 109.883 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.621 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -107.88 170.85 7.74 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.014 -1.053 . . . . 0.0 110.749 -178.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.504 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -61.54 107.67 0.84 Allowed 'General case' 0 N--CA 1.5 2.037 0 CA-C-O 121.532 0.682 . . . . 0.0 110.034 -179.716 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.603 HD13 HG21 ' A' ' 74' ' ' VAL . 8.6 tp -69.6 159.88 32.57 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 119.606 -1.934 . . . . 0.0 110.303 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.404 ' H ' ' HG ' ' A' ' 78' ' ' LEU . 18.7 mmtp -123.27 154.26 65.36 Favored Pre-proline 0 C--N 1.297 -1.715 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 -178.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -58.07 -23.6 61.72 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 121.537 1.491 . . . . 0.0 110.014 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 52' ' ' VAL . 1.5 p30 -117.07 27.72 8.95 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.99 -0.444 . . . . 0.0 109.837 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.433 ' HB3' HD22 ' A' ' 71' ' ' LEU . 5.0 m -58.48 166.68 1.67 Allowed 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.373 -1.455 . . . . 0.0 109.452 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.612 HH12 HG12 ' A' ' 60' ' ' VAL . 0.5 OUTLIER -172.32 153.43 2.98 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.122 -1.031 . . . . 0.0 111.267 179.549 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.802 ' H ' HD12 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -83.34 129.04 34.97 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 177.887 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.525 ' N ' ' SG ' ' A' ' 48' ' ' CYS . 0.5 OUTLIER -75.2 -6.11 47.96 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.718 -1.239 . . . . 0.0 112.584 -176.601 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 27.7 p -89.41 -33.65 16.77 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.281 -1.512 . . . . 0.0 110.722 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.521 HE21 ' CB ' ' A' ' 43' ' ' ALA . 12.1 tt0 -92.33 49.54 1.52 Allowed 'General case' 0 N--CA 1.504 2.226 0 O-C-N 120.979 -1.076 . . . . 0.0 110.467 -179.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 30.6 mt -130.56 154.26 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 36.5 mm -129.19 127.79 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.348 0 O-C-N 121.249 -0.907 . . . . 0.0 109.7 -178.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.907 ' SD ' HG21 ' A' ' 97' ' ' ILE . 8.1 tpt -89.02 161.17 16.73 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.908 -1.12 . . . . 0.0 110.099 -179.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.6 p -151.19 149.53 24.98 Favored Pre-proline 0 N--CA 1.491 1.62 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.6 -39.51 82.16 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 121.626 1.55 . . . . 0.0 111.754 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -64.16 -24.93 67.86 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.143 -0.973 . . . . 0.0 108.842 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.643 HD12 HG23 ' A' ' 60' ' ' VAL . 14.1 mt -99.52 23.99 8.74 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.434 -0.792 . . . . 0.0 109.577 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.442 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 18.7 p-10 -65.88 140.87 58.39 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.169 -0.957 . . . . 0.0 109.621 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 106.69 7.73 33.54 Favored Glycine 0 N--CA 1.506 3.338 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 178.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.907 HG21 ' SD ' ' A' ' 90' ' ' MET . 0.3 OUTLIER -61.71 127.65 21.89 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 O-C-N 121.707 -0.878 . . . . 0.0 110.346 -178.265 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.3 t -103.74 115.38 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.244 -0.91 . . . . 0.0 109.728 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.5 t -101.65 134.37 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.926 -1.109 . . . . 0.0 109.851 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.49 123.63 49.18 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 121.884 0.85 . . . . 0.0 108.722 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.3 t -112.97 126.37 28.35 Favored Pre-proline 0 N--CA 1.497 1.919 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.415 ' HG3' ' CD2' ' A' ' 49' ' ' HIS . 58.1 Cg_endo -84.52 178.07 5.27 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.797 2.331 . . . . 0.0 113.031 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.424 ' OD2' ' CD2' ' A' ' 8' ' ' HIS . 1.0 OUTLIER -84.2 -17.99 38.08 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.57 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -107.68 83.15 1.76 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.642 ' H ' ' NE2' ' A' ' 105' ' ' GLN . 1.3 pm0 -84.69 -31.66 24.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.911 -1.118 . . . . 0.0 108.887 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.405 ' OXT' ' O ' ' A' ' 105' ' ' GLN . 57.4 t-105 . . . . . 0 C--N 1.3 -1.568 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.145 178.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' FES . . . . . 0.483 ' S1 ' ' O ' ' A' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.432 ' OG ' ' O ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.412 ' H ' ' HB2' ' A' ' 95' ' ' ASP . 27.2 mmtt -76.19 107.14 8.21 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.403 -0.919 . . . . 0.0 108.718 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.401 HG22 ' CG2' ' A' ' 97' ' ' ILE . 11.7 t -107.09 109.97 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 O-C-N 121.176 -0.952 . . . . 0.0 109.201 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.9 t -98.82 94.19 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.039 -1.038 . . . . 0.0 110.59 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -68.06 114.65 6.76 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 71.5 t -98.75 112.07 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.115 -0.99 . . . . 0.0 108.434 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 63.6 p -72.7 -160.08 0.07 Allowed 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.554 0.692 . . . . 0.0 109.517 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.602 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -88.9 -50.93 5.9 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.183 -0.948 . . . . 0.0 108.625 179.936 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.504 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 10.1 p30 -64.94 2.71 0.67 Allowed 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 119.804 -0.759 . . . . 0.0 110.442 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.522 ' O ' ' NH1' ' A' ' 12' ' ' ARG . . . 93.83 -3.09 70.39 Favored Glycine 0 N--CA 1.496 2.693 0 O-C-N 120.731 -1.23 . . . . 0.0 110.08 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.09 128.04 34.22 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.932 -1.334 . . . . 0.0 108.438 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.522 ' NH1' ' O ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -108.63 159.54 16.65 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.51 -0.744 . . . . 0.0 111.197 -178.782 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.2 mtt85 -150.08 115.72 5.54 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 178.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -97.82 126.93 43.44 Favored 'General case' 0 N--CA 1.502 2.158 0 CA-C-O 122.633 1.206 . . . . 0.0 110.607 -178.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.585 HD13 ' H ' ' A' ' 16' ' ' ASP . 0.2 OUTLIER -111.9 -175.43 2.69 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 123.132 1.444 . . . . 0.0 111.589 -177.723 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.585 ' H ' HD13 ' A' ' 15' ' ' LEU . 11.1 t70 -137.06 101.57 4.59 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 104.548 -2.39 . . . . 0.0 104.548 176.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.48 HG12 ' HB ' ' A' ' 21' ' ' VAL . 11.8 t -109.67 119.03 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.56 176.33 4.18 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.188 -0.945 . . . . 0.0 111.141 -177.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -65.64 137.08 57.09 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.953 0.882 . . . . 0.0 110.691 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.92 -17.07 23.99 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 178.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.48 ' HB ' HG12 ' A' ' 17' ' ' VAL . 60.8 t -77.64 139.8 18.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 O-C-N 120.428 -1.631 . . . . 0.0 108.479 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 25' ' ' GLN . 59.5 p -94.16 143.7 26.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.105 -0.997 . . . . 0.0 109.093 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.529 HD21 ' SD ' ' A' ' 90' ' ' MET . 49.6 mt -45.45 -37.14 4.9 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.08 -1.013 . . . . 0.0 109.766 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.54 ' SD ' ' CD2' ' A' ' 33' ' ' TYR . 5.6 tpt -65.62 -26.43 67.82 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.388 -0.82 . . . . 0.0 109.355 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' A' ' 22' ' ' SER . 13.8 mm100 -75.31 -63.23 1.32 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.183 -0.948 . . . . 0.0 109.702 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.449 ' O ' ' OD1' ' A' ' 30' ' ' ASN . . . -59.94 -26.49 66.02 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.657 -1.277 . . . . 0.0 110.906 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.43 ' O ' ' N ' ' A' ' 32' ' ' ILE . . . -64.44 -20.39 66.14 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.585 -1.322 . . . . 0.0 109.011 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 70.6 t -86.51 -25.69 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.438 -0.789 . . . . 0.0 109.587 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.96 -24.55 60.81 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.362 -0.836 . . . . 0.0 109.042 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.518 ' ND2' HD11 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -107.38 -0.1 22.61 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 179.261 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 64.66 69.72 1.26 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 108.916 -1.674 . . . . 0.0 108.916 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.43 ' N ' ' O ' ' A' ' 27' ' ' ALA . 53.4 mt -123.85 -37.99 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.795 -0.826 . . . . 0.0 109.394 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.745 ' O ' ' N ' ' A' ' 35' ' ' ILE . 0.2 OUTLIER -89.3 6.87 38.45 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.885 -1.135 . . . . 0.0 109.886 -179.225 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -38.01 74.27 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.204 0 CA-C-O 122.076 0.941 . . . . 0.0 111.602 -177.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.745 ' N ' ' O ' ' A' ' 33' ' ' TYR . 3.3 tp -150.49 4.61 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.934 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.431 ' O ' ' O ' ' A' ' 35' ' ' ILE . 5.6 t 56.14 104.22 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 120.843 -1.161 . . . . 0.0 109.356 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -70.69 151.42 49.35 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.493 ' C ' ' H ' ' A' ' 40' ' ' GLY . 9.3 m-20 -80.69 -63.25 1.45 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.41 -1.053 . . . . 0.0 109.329 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.619 ' SG ' ' N ' ' A' ' 42' ' ' SER . 13.9 p -72.5 17.53 0.11 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.314 -0.866 . . . . 0.0 109.104 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.493 ' H ' ' C ' ' A' ' 38' ' ' ASP . . . 54.72 13.15 4.07 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 108.01 -2.036 . . . . 0.0 108.01 -178.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.458 ' N ' ' C ' ' A' ' 39' ' ' CYS . . . 89.47 23.14 34.83 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.619 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 34.6 t -94.22 38.07 1.09 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.137 -1.214 . . . . 0.0 109.731 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 44.47 72.54 0.19 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.342 -0.849 . . . . 0.0 110.318 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -166.26 27.7 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.728 -1.232 . . . . 0.0 110.426 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.527 ' O ' ' S1 ' ' A' ' 107' ' ' FES . 2.9 p -162.64 159.69 24.83 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.762 -1.211 . . . . 0.0 109.927 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -95.64 12.21 30.53 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.439 ' O ' ' OE1' ' A' ' 105' ' ' GLN . 3.1 m -57.6 -39.0 75.85 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.29 -0.881 . . . . 0.0 109.648 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.592 ' SG ' ' N ' ' A' ' 85' ' ' CYS . 18.3 p -97.7 54.18 1.15 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.867 -1.146 . . . . 0.0 109.744 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.794 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 43.3 t60 -75.89 110.43 10.33 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.114 -0.991 . . . . 0.0 109.113 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -146.52 166.94 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 120.813 -1.179 . . . . 0.0 109.582 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.583 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 37.4 m-85 -115.85 115.38 26.15 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.857 0.837 . . . . 0.0 109.815 -179.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.847 HG13 HD11 ' A' ' 97' ' ' ILE . 13.3 t -89.46 129.48 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.561 ' C ' ' H ' ' A' ' 55' ' ' ALA . 19.0 t-20 -46.15 131.01 10.32 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.107 -0.996 . . . . 0.0 109.753 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.412 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 9.7 pt-20 -57.01 8.16 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.395 -0.816 . . . . 0.0 111.025 -179.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.561 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -95.96 -23.13 16.99 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.636 -1.29 . . . . 0.0 110.113 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -111.25 -6.71 14.5 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.901 -1.124 . . . . 0.0 108.894 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.431 HG21 ' OD1' ' A' ' 81' ' ' ASN . 25.3 p -70.87 -42.14 70.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.643 -0.661 . . . . 0.0 109.806 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -82.8 0.93 41.57 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.59 -0.694 . . . . 0.0 109.894 -179.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 15.7 mttt -109.99 -38.72 5.25 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.603 HG23 HD12 ' A' ' 94' ' ' LEU . 0.5 OUTLIER -84.73 158.19 59.83 Favored Pre-proline 0 N--CA 1.496 1.835 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 179.534 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.558 ' HD2' HG22 ' A' ' 60' ' ' VAL . 1.3 Cg_endo -54.49 110.97 0.59 Allowed 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 121.714 1.609 . . . . 0.0 113.698 -177.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.37 112.8 12.06 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.935 ' H ' ' NH1' ' A' ' 83' ' ' ARG . . . -53.81 144.33 18.68 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-O 122.286 1.041 . . . . 0.0 112.073 -178.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.49 ' H ' ' ND2' ' A' ' 64' ' ' ASN . 1.3 p30 -66.37 -167.73 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.678 0.751 . . . . 0.0 110.636 -179.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -69.47 -6.67 32.0 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.667 -0.646 . . . . 0.0 112.127 -178.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.508 ' O ' ' SD ' ' A' ' 70' ' ' MET . 69.3 mtm-85 -65.03 -44.61 88.55 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 120.424 -1.422 . . . . 0.0 109.405 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -74.27 -39.53 62.93 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.153 -0.967 . . . . 0.0 109.35 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 39.5 mt -48.02 -25.33 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.335 -0.853 . . . . 0.0 109.574 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -82.29 -40.64 9.93 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.508 ' SD ' ' O ' ' A' ' 66' ' ' ARG . 4.3 mpp? -72.05 -34.59 68.88 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 178.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 71' ' ' LEU . 46.1 mt -63.99 -27.75 69.34 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -79.14 2.79 19.64 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.042 -1.037 . . . . 0.0 108.472 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -120.86 28.14 8.09 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.74 -0.6 . . . . 0.0 110.713 -178.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.9 m -95.96 169.53 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 O-C-N 120.844 -1.16 . . . . 0.0 109.975 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.476 ' OG1' ' CD2' ' A' ' 106' ' ' TRP . 3.7 m -106.29 -6.78 18.14 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.435 -0.79 . . . . 0.0 111.957 -178.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.794 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -106.16 174.7 5.77 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 120.56 -1.338 . . . . 0.0 110.572 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.583 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -56.1 104.39 0.14 Allowed 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.833 -0.542 . . . . 0.0 111.26 -178.516 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.4 tp -69.98 149.44 47.73 Favored 'General case' 0 C--N 1.295 -1.794 0 O-C-N 120.186 -1.572 . . . . 0.0 109.366 178.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.451 ' NZ ' ' OE2' ' A' ' 77' ' ' GLU . 27.2 mmtm -115.31 156.57 45.51 Favored Pre-proline 0 C--N 1.287 -2.133 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -178.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -56.97 -21.51 41.8 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 121.358 1.372 . . . . 0.0 109.629 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.431 ' OD1' HG21 ' A' ' 57' ' ' THR . 5.1 p30 -120.33 28.1 8.22 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.422 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.413 ' HG ' ' HE1' ' A' ' 51' ' ' TYR . 37.2 m -57.6 158.38 6.07 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 120.07 -1.644 . . . . 0.0 108.885 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.935 ' NH1' ' H ' ' A' ' 63' ' ' ALA . 1.6 mtp85 -169.47 159.6 8.65 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 118.763 -1.175 . . . . 0.0 111.042 -178.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.761 HD22 ' N ' ' A' ' 84' ' ' LEU . 2.7 mm? -84.21 123.83 30.53 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 179.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.592 ' N ' ' SG ' ' A' ' 48' ' ' CYS . 0.5 OUTLIER -64.11 -16.48 61.91 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.197 -0.94 . . . . 0.0 113.145 -176.556 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 22.2 p -81.65 -43.46 18.51 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 119.708 -1.87 . . . . 0.0 110.955 -178.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.695 HE22 ' CZ ' ' A' ' 83' ' ' ARG . 5.2 pp0? -75.61 29.57 0.1 Allowed 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.972 -1.08 . . . . 0.0 111.169 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.658 ' O ' HD12 ' A' ' 89' ' ' ILE . 38.4 mt -116.03 151.42 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.295 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 178.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.658 HD12 ' O ' ' A' ' 88' ' ' ILE . 1.5 mp -131.44 125.52 56.71 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.235 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -178.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.529 ' SD ' HD21 ' A' ' 23' ' ' LEU . 1.9 tpt -87.49 161.8 17.6 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.089 -1.007 . . . . 0.0 109.571 -179.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.6 p -152.08 149.32 23.08 Favored Pre-proline 0 N--CA 1.489 1.484 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -54.56 -39.29 89.06 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 121.74 1.626 . . . . 0.0 111.643 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -64.03 -24.21 67.62 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.169 -0.957 . . . . 0.0 109.49 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.603 HD12 HG23 ' A' ' 60' ' ' VAL . 13.9 mt -101.73 18.88 19.3 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.449 -0.782 . . . . 0.0 109.434 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.412 ' HB2' ' H ' ' A' ' 2' ' ' LYS . 20.4 p-10 -61.44 139.53 58.2 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.407 -0.808 . . . . 0.0 109.946 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 105.55 8.21 35.53 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 178.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.847 HD11 HG13 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -65.75 138.39 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.207 -1.172 . . . . 0.0 111.878 -177.764 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.5 t -106.48 117.81 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.665 -0.647 . . . . 0.0 109.328 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.8 t -102.74 136.91 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 120.761 -1.212 . . . . 0.0 108.568 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -108.16 114.75 28.88 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.76 0.791 . . . . 0.0 108.88 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.4 t -102.47 124.77 38.18 Favored Pre-proline 0 N--CA 1.495 1.813 0 O-C-N 121.883 -0.511 . . . . 0.0 109.78 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.436 ' HG3' ' CD2' ' A' ' 49' ' ' HIS . 92.6 Cg_endo -81.71 169.61 14.98 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 122.515 2.143 . . . . 0.0 113.88 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -75.61 -15.47 60.34 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.187 0.517 . . . . 0.0 109.649 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 27.4 mtm180 -122.31 93.38 3.96 Favored 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.439 ' OE1' ' O ' ' A' ' 47' ' ' THR . 35.5 tt0 -82.26 -16.96 47.66 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.651 -0.656 . . . . 0.0 109.826 -178.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.476 ' CD2' ' OG1' ' A' ' 75' ' ' THR . 61.3 t-105 . . . . . 0 C--N 1.304 -1.397 0 CA-C-O 117.948 -1.025 . . . . 0.0 110.45 178.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' FES . . . . . 0.527 ' S1 ' ' O ' ' A' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.405 ' H ' ' HB2' ' A' ' 95' ' ' ASP . 16.8 mmtm -77.27 117.12 18.48 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.568 HG21 ' CG2' ' A' ' 17' ' ' VAL . 72.5 t -115.78 109.61 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.334 -0.854 . . . . 0.0 111.048 -178.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 33.6 t -98.9 93.17 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 CA-C-O 122.209 1.004 . . . . 0.0 111.178 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.411 ' CE1' HG12 ' A' ' 3' ' ' VAL . 96.1 m-85 -67.8 113.71 5.77 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 177.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 99.7 t -99.0 116.7 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 120.991 -1.068 . . . . 0.0 108.939 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 79.3 p -75.38 -157.71 0.07 Allowed 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.632 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -92.13 -48.51 6.68 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.217 -0.927 . . . . 0.0 109.105 -179.672 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.487 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 8.5 p30 -65.39 1.75 1.05 Allowed 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.323 -0.861 . . . . 0.0 110.7 -178.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.96 -3.45 67.19 Favored Glycine 0 N--CA 1.495 2.606 0 O-C-N 120.717 -1.239 . . . . 0.0 110.262 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -65.6 129.05 38.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.779 -1.424 . . . . 0.0 108.25 179.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 29.8 mtm180 -108.25 145.19 34.67 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.879 -0.513 . . . . 0.0 110.986 -178.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.16 114.85 16.22 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 178.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -98.6 122.97 42.49 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.51 -0.744 . . . . 0.0 110.237 -178.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.651 HD11 HD12 ' A' ' 32' ' ' ILE . 30.4 mt -120.28 -166.04 1.26 Allowed 'General case' 0 N--CA 1.502 2.13 0 CA-C-O 122.746 1.26 . . . . 0.0 109.729 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -134.41 99.81 4.48 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 104.623 -2.362 . . . . 0.0 104.623 176.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.568 ' CG2' HG21 ' A' ' 3' ' ' VAL . 10.6 t -101.4 117.8 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.276 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -75.07 178.03 5.97 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 122.366 1.079 . . . . 0.0 112.116 -177.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -64.65 130.38 43.38 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-O 121.981 0.896 . . . . 0.0 111.117 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.74 -17.05 54.96 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 178.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.432 ' HB ' HG12 ' A' ' 17' ' ' VAL . 64.8 t -78.82 134.54 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 120.503 -1.586 . . . . 0.0 108.805 -179.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 25' ' ' GLN . 4.2 p -80.59 139.77 36.11 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.027 -1.046 . . . . 0.0 108.847 179.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 31.5 mt -45.06 -33.03 1.94 Allowed 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.013 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 9.7 ttt -77.61 -33.07 53.84 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.426 -0.796 . . . . 0.0 109.217 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.419 ' N ' ' O ' ' A' ' 22' ' ' SER . 39.6 mm-40 -59.34 -56.62 19.73 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.457 -0.897 . . . . 0.0 108.796 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.418 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -58.2 -26.55 62.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.829 -1.169 . . . . 0.0 110.512 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.633 ' HB1' ' H ' ' A' ' 33' ' ' TYR . . . -58.74 -21.59 55.69 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.93 -1.106 . . . . 0.0 108.802 178.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 54.7 t -86.58 -23.47 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.49 -0.756 . . . . 0.0 109.819 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.81 -29.79 58.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.281 -0.887 . . . . 0.0 108.728 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -104.65 -3.97 23.07 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 64.0 70.6 1.02 Allowed Glycine 0 N--CA 1.495 2.607 0 N-CA-C 109.171 -1.571 . . . . 0.0 109.171 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.651 HD12 HD11 ' A' ' 15' ' ' LEU . 70.8 mt -122.77 -63.71 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.276 -1.132 . . . . 0.0 110.705 -178.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.798 ' OH ' HG21 ' A' ' 101' ' ' VAL . 55.7 m-85 -97.67 2.57 49.9 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.15 -0.969 . . . . 0.0 110.716 178.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.544 ' O ' ' C ' ' A' ' 35' ' ' ILE . 8.8 p-10 -37.45 -37.63 0.21 Allowed 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.455 -0.778 . . . . 0.0 110.397 -178.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.544 ' C ' ' O ' ' A' ' 34' ' ' ASP . 96.2 mt -19.8 130.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.752 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.283 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.442 ' C ' ' O ' ' A' ' 35' ' ' ILE . 13.0 m -35.56 151.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 121.474 -0.766 . . . . 0.0 111.102 -178.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.436 ' HA2' HG21 ' A' ' 47' ' ' THR . . . -139.33 172.98 22.98 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -88.4 -76.53 0.39 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.258 -1.142 . . . . 0.0 110.754 -179.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.541 ' SG ' ' N ' ' A' ' 42' ' ' SER . 6.2 p -70.25 7.89 0.9 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.917 -1.114 . . . . 0.0 110.302 -178.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 53.19 8.18 0.66 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.502 ' H ' ' C ' ' A' ' 39' ' ' CYS . . . 102.78 81.27 1.53 Allowed Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.541 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 12.8 t -160.76 31.0 0.15 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.596 -0.944 . . . . 0.0 109.379 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.481 ' HB2' ' CD ' ' A' ' 87' ' ' GLN . . . 50.36 70.43 0.51 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.982 -1.074 . . . . 0.0 109.157 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -165.23 21.16 0.05 OUTLIER 'General case' 0 C--N 1.299 -1.596 0 O-C-N 120.916 -1.115 . . . . 0.0 110.184 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.402 ' SG ' ' CB ' ' A' ' 47' ' ' THR . 1.4 p -163.93 170.0 17.32 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.891 -1.13 . . . . 0.0 109.924 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -99.22 4.18 46.59 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.434 -0.791 . . . . 0.0 108.957 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.436 HG21 ' HA2' ' A' ' 37' ' ' GLY . 24.8 m -47.39 -54.13 12.05 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.346 -0.846 . . . . 0.0 109.582 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.498 ' SG ' ' O ' ' A' ' 48' ' ' CYS . 14.1 p -90.77 47.96 1.48 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.862 -1.149 . . . . 0.0 109.533 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.775 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 24.5 t60 -76.21 99.64 4.79 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -133.62 170.7 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.15 -0.969 . . . . 0.0 110.254 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.567 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 36.9 m-85 -116.46 113.3 22.64 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 122.056 0.932 . . . . 0.0 110.057 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.617 HG13 HD11 ' A' ' 97' ' ' ILE . 5.7 t -86.87 129.15 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.59 ' C ' ' H ' ' A' ' 55' ' ' ALA . 16.2 t-20 -46.62 127.35 9.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.034 -1.042 . . . . 0.0 109.662 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -55.76 10.08 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.611 -0.681 . . . . 0.0 111.487 -178.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.59 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -98.65 -19.95 17.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.807 -1.183 . . . . 0.0 109.829 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.711 ' CD2' HD22 ' A' ' 94' ' ' LEU . 39.1 m-85 -113.85 -6.94 13.22 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.919 -1.113 . . . . 0.0 108.574 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.548 ' CA ' HH12 ' A' ' 83' ' ' ARG . 22.5 p -69.76 -43.7 71.68 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.654 0.74 . . . . 0.0 110.138 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -83.5 14.05 4.03 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.964 -0.694 . . . . 0.0 109.228 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.2 mtpt -124.76 -38.74 2.34 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.574 HG22 ' HD2' ' A' ' 61' ' ' PRO . 0.4 OUTLIER -85.8 164.7 38.51 Favored Pre-proline 0 N--CA 1.5 2.06 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 179.148 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.574 ' HD2' HG22 ' A' ' 60' ' ' VAL . 7.8 Cg_endo -59.56 105.0 0.24 Allowed 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 121.208 1.272 . . . . 0.0 114.001 -176.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.498 ' HA ' ' NH2' ' A' ' 83' ' ' ARG . . . -74.43 104.65 5.24 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 177.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -47.09 140.66 4.86 Favored 'General case' 0 C--N 1.287 -2.149 0 CA-C-O 122.061 0.934 . . . . 0.0 111.437 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.473 ' N ' ' OD1' ' A' ' 64' ' ' ASN . 2.6 p30 -58.62 -169.81 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.404 0.621 . . . . 0.0 110.486 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -65.31 0.35 1.47 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.292 -0.88 . . . . 0.0 111.197 -178.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.506 ' O ' ' SD ' ' A' ' 70' ' ' MET . 0.3 OUTLIER -69.44 -45.01 70.14 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.681 -1.262 . . . . 0.0 108.843 -179.913 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.446 ' O ' ' N ' ' A' ' 69' ' ' GLY . 2.5 tt0 -73.82 -49.11 26.75 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.389 -0.819 . . . . 0.0 110.107 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.509 HD12 ' N ' ' A' ' 68' ' ' ILE . 1.4 mp -45.43 -19.76 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.395 -0.816 . . . . 0.0 109.508 -179.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.543 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -81.12 -73.39 1.19 Allowed Glycine 0 N--CA 1.497 2.748 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.506 ' SD ' ' O ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -47.38 -39.18 14.65 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.013 -1.286 . . . . 0.0 108.402 179.576 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.488 ' C ' ' H ' ' A' ' 73' ' ' CYS . 24.0 mt -57.14 -34.02 67.99 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 177.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.543 ' N ' ' O ' ' A' ' 69' ' ' GLY . 6.6 tp10 -73.77 12.28 0.69 Allowed 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.106 -0.996 . . . . 0.0 108.331 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.488 ' H ' ' C ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -133.07 36.14 3.48 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.524 -0.735 . . . . 0.0 110.19 -178.463 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.7 m -97.76 174.5 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.363 0 O-C-N 120.951 -1.093 . . . . 0.0 109.741 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.531 ' OG1' ' CG ' ' A' ' 106' ' ' TRP . 5.5 m -104.4 -9.32 18.54 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.016 -1.053 . . . . 0.0 111.295 -179.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.775 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -106.55 170.09 8.14 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.764 -1.21 . . . . 0.0 110.315 -179.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.567 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -53.45 105.28 0.12 Allowed 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.841 -0.537 . . . . 0.0 111.126 -179.083 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.0 tp -74.0 140.5 45.52 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 120.084 -1.635 . . . . 0.0 108.857 178.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.8 mmtp -102.07 157.21 34.13 Favored Pre-proline 0 C--N 1.289 -2.065 0 CA-C-N 114.876 -1.056 . . . . 0.0 108.588 -178.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -58.9 -19.3 46.78 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 121.631 1.554 . . . . 0.0 109.095 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.413 ' OD1' ' O ' ' A' ' 81' ' ' ASN . 2.7 p30 -121.99 27.68 7.94 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.076 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.425 ' HG ' ' HE1' ' A' ' 51' ' ' TYR . 44.3 m -58.42 169.18 0.93 Allowed 'General case' 0 C--N 1.307 -1.274 0 O-C-N 120.287 -1.508 . . . . 0.0 108.74 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.548 HH12 ' CA ' ' A' ' 57' ' ' THR . 0.7 OUTLIER -171.9 150.6 2.62 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 118.621 -1.231 . . . . 0.0 110.985 -179.477 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.441 ' C ' ' SG ' ' A' ' 48' ' ' CYS . 82.5 mt -88.83 96.27 10.62 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.45 ' N ' ' SG ' ' A' ' 48' ' ' CYS . 0.1 OUTLIER -34.19 -42.03 0.12 Allowed 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -177.431 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 28.5 p -64.58 -28.48 69.66 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 119.932 -1.73 . . . . 0.0 111.392 -178.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.481 ' CD ' ' HB2' ' A' ' 43' ' ' ALA . 12.7 tp60 -91.56 35.83 0.95 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.98 -1.075 . . . . 0.0 110.703 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.7 ' O ' HD12 ' A' ' 89' ' ' ILE . 39.7 mm -130.14 161.19 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.308 0 O-C-N 121.282 -0.886 . . . . 0.0 109.192 179.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.7 HD12 ' O ' ' A' ' 88' ' ' ILE . 1.4 mp -133.87 128.59 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.32 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.508 ' SD ' HG21 ' A' ' 97' ' ' ILE . 4.9 tpt -90.54 164.21 14.32 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.311 -0.868 . . . . 0.0 109.347 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 38.4 p -148.89 145.63 20.08 Favored Pre-proline 0 C--N 1.3 -1.553 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.85 -37.86 91.57 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 121.278 1.319 . . . . 0.0 111.295 -178.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -59.37 -29.51 67.75 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.111 -0.993 . . . . 0.0 109.147 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.711 HD22 ' CD2' ' A' ' 56' ' ' PHE . 6.2 mt -93.75 35.96 1.12 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.555 -0.716 . . . . 0.0 109.819 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.405 ' HB2' ' H ' ' A' ' 2' ' ' LYS . 16.8 p-10 -65.49 136.29 56.24 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.684 -1.26 . . . . 0.0 110.319 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 111.94 8.52 22.04 Favored Glycine 0 N--CA 1.506 3.362 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 178.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.617 HD11 HG13 ' A' ' 52' ' ' VAL . 0.1 OUTLIER -66.24 124.66 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.583 -0.951 . . . . 0.0 110.378 -178.043 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.503 ' N ' HD12 ' A' ' 97' ' ' ILE . 6.5 t -104.72 116.06 47.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.162 -0.961 . . . . 0.0 109.967 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 t -100.08 135.17 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 120.756 -1.215 . . . . 0.0 109.458 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.68 122.82 48.32 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.494 -0.754 . . . . 0.0 109.169 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.798 HG21 ' OH ' ' A' ' 33' ' ' TYR . 5.3 t -113.32 128.29 25.84 Favored Pre-proline 0 N--CA 1.499 2.014 0 O-C-N 121.643 -0.661 . . . . 0.0 109.802 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.437 ' HG3' ' CD2' ' A' ' 49' ' ' HIS . 95.4 Cg_endo -81.42 174.03 10.98 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 122.417 2.078 . . . . 0.0 113.81 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 103' ' ' ASP . 1.6 p-10 -80.47 -12.63 59.52 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-O 121.683 0.754 . . . . 0.0 108.991 178.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.53 86.86 2.65 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 -177.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.441 ' O ' ' O ' ' A' ' 106' ' ' TRP . 12.8 pt20 -81.69 -32.38 31.75 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.533 ' OXT' ' CG ' ' A' ' 106' ' ' TRP . 61.9 t-105 . . . . . 0 C--N 1.301 -1.506 0 CA-C-O 118.354 -0.832 . . . . 0.0 110.063 178.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.433 ' CB ' ' SD ' ' A' ' 90' ' ' MET . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.39 117.64 32.07 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.446 -0.784 . . . . 0.0 109.278 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.438 HG21 ' CG2' ' A' ' 17' ' ' VAL . 27.2 t -115.91 109.75 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.301 -0.874 . . . . 0.0 109.691 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.2 t -99.77 130.07 49.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.162 -0.961 . . . . 0.0 110.188 178.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -103.59 116.63 32.72 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 78.8 t -98.71 115.69 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 30.9 p -75.56 -161.48 0.16 Allowed 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 121.584 0.707 . . . . 0.0 109.641 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.59 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.1 OUTLIER -86.88 -47.62 8.86 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.652 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.491 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 17.3 p30 -71.06 1.97 5.07 Favored 'General case' 0 C--N 1.307 -1.249 0 O-C-N 121.148 -0.97 . . . . 0.0 110.928 -178.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.71 1.85 60.05 Favored Glycine 0 N--CA 1.498 2.773 0 O-C-N 120.852 -1.155 . . . . 0.0 110.868 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -67.87 127.37 32.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.809 -1.406 . . . . 0.0 108.913 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.403 ' HD2' HH11 ' A' ' 12' ' ' ARG . 1.5 mtt180 -105.03 157.07 17.49 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.597 -0.689 . . . . 0.0 110.059 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.52 116.04 5.47 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -99.67 124.24 44.71 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 122.626 1.203 . . . . 0.0 111.341 -178.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.499 HD11 ' ND2' ' A' ' 30' ' ' ASN . 0.2 OUTLIER -110.05 -176.51 3.01 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-O 122.99 1.376 . . . . 0.0 110.875 -178.843 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.491 ' H ' HD13 ' A' ' 15' ' ' LEU . 24.8 t0 -134.67 100.38 4.61 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 105.181 -2.155 . . . . 0.0 105.181 176.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.565 HG12 ' HB ' ' A' ' 21' ' ' VAL . 3.4 t -108.71 115.3 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.339 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.81 174.91 3.94 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.312 -0.868 . . . . 0.0 111.609 -177.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.03 137.5 57.75 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.952 0.882 . . . . 0.0 110.91 -178.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.62 -13.93 53.73 Favored Glycine 0 N--CA 1.493 2.435 0 C-N-CA 120.519 -0.848 . . . . 0.0 111.182 178.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.565 ' HB ' HG12 ' A' ' 17' ' ' VAL . 94.8 t -80.82 142.25 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.344 -1.68 . . . . 0.0 109.455 -178.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.427 ' OG ' ' OE1' ' A' ' 25' ' ' GLN . 1.2 p -87.82 142.6 27.69 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.559 -0.856 . . . . 0.0 109.176 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -46.95 -40.85 15.1 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 121.247 -0.908 . . . . 0.0 109.507 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 5.8 tpt -65.36 -35.63 81.55 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.046 -1.034 . . . . 0.0 109.531 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.443 ' NE2' ' N ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -60.74 -61.17 2.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.052 -1.03 . . . . 0.0 109.075 -179.421 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.503 ' HB2' HG13 ' A' ' 17' ' ' VAL . . . -59.55 -27.55 66.32 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.569 -1.332 . . . . 0.0 110.522 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.499 ' HB1' ' H ' ' A' ' 33' ' ' TYR . . . -63.99 -20.85 66.2 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.741 -1.225 . . . . 0.0 108.57 179.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 69.8 t -87.03 -27.79 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.613 -0.679 . . . . 0.0 109.654 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.52 -23.56 61.03 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.499 ' ND2' HD11 ' A' ' 15' ' ' LEU . 2.3 m-80 -110.74 -5.26 15.02 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 63.75 70.98 0.92 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.441 ' N ' ' O ' ' A' ' 27' ' ' ALA . 47.9 mt -121.35 -57.79 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.503 -0.998 . . . . 0.0 110.434 -178.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.499 ' H ' ' HB1' ' A' ' 27' ' ' ALA . 1.0 OUTLIER -92.99 -10.9 34.65 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.833 -1.167 . . . . 0.0 109.906 178.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 33' ' ' TYR . 13.5 p-10 -38.93 -42.86 0.9 Allowed 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.833 -0.542 . . . . 0.0 110.275 -178.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.434 ' O ' ' O ' ' A' ' 36' ' ' VAL . 94.9 mt -44.33 120.66 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.672 -0.643 . . . . 0.0 109.413 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.523 HG12 ' N ' ' A' ' 37' ' ' GLY . 65.9 t 56.95 160.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.447 -0.783 . . . . 0.0 110.007 -178.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.523 ' N ' HG12 ' A' ' 36' ' ' VAL . . . 159.62 118.62 0.51 Allowed Glycine 0 N--CA 1.495 2.615 0 N-CA-C 108.906 -1.678 . . . . 0.0 108.906 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.511 ' C ' ' H ' ' A' ' 40' ' ' GLY . 15.0 t70 -87.67 -73.48 0.48 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.999 -1.295 . . . . 0.0 110.203 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.623 ' SG ' ' N ' ' A' ' 42' ' ' SER . 8.5 p -70.15 16.95 0.06 Allowed 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.435 -0.906 . . . . 0.0 109.848 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.511 ' H ' ' C ' ' A' ' 38' ' ' ASP . . . 49.85 15.41 0.93 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 108.817 -1.713 . . . . 0.0 108.817 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.471 ' N ' ' C ' ' A' ' 39' ' ' CYS . . . 92.04 21.73 32.28 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.021 -1.631 . . . . 0.0 109.021 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.623 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 6.4 m -93.9 36.07 1.13 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.638 -0.919 . . . . 0.0 109.848 -179.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 43.2 72.47 0.18 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.322 -0.861 . . . . 0.0 110.336 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.4 t -163.97 17.42 0.06 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.928 -1.107 . . . . 0.0 110.043 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.486 ' O ' ' S1 ' ' A' ' 107' ' ' FES . 1.8 p -153.7 -167.64 2.74 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.96 -1.088 . . . . 0.0 109.333 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -132.21 10.95 4.56 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 32.2 p -56.03 -41.9 75.67 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.25 -0.906 . . . . 0.0 109.276 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.497 ' SG ' ' O ' ' A' ' 48' ' ' CYS . 21.9 p -79.68 57.0 2.37 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.928 -1.108 . . . . 0.0 110.217 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.581 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 38.0 t60 -76.59 106.05 8.01 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -139.25 165.43 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 120.617 -1.302 . . . . 0.0 109.74 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.537 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 40.7 m-85 -111.97 112.23 23.73 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 122.149 0.976 . . . . 0.0 109.792 -179.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.426 ' O ' ' OD1' ' A' ' 81' ' ' ASN . 96.8 t -85.58 135.25 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.721 ' ND2' ' HB3' ' A' ' 55' ' ' ALA . 1.7 t30 -49.28 123.22 7.07 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.947 -1.095 . . . . 0.0 108.147 179.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -54.16 11.57 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.818 -0.551 . . . . 0.0 112.178 -177.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.721 ' HB3' ' ND2' ' A' ' 53' ' ' ASN . . . -100.71 -15.57 17.66 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.999 -1.063 . . . . 0.0 109.817 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.517 ' CD2' HD22 ' A' ' 94' ' ' LEU . 51.9 m-85 -115.26 -10.43 12.09 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.774 -1.204 . . . . 0.0 109.078 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 12.5 p -71.45 -41.62 69.22 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.876 -1.14 . . . . 0.0 109.912 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -86.91 14.46 7.27 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.438 -0.789 . . . . 0.0 109.898 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.479 ' CD ' ' O ' ' A' ' 55' ' ' ALA . 9.6 mtpt -125.46 -39.73 2.16 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.705 HG22 ' HD2' ' A' ' 61' ' ' PRO . 0.4 OUTLIER -78.34 167.28 36.78 Favored Pre-proline 0 N--CA 1.494 1.759 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 179.052 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.705 ' HD2' HG22 ' A' ' 60' ' ' VAL . 1.4 Cg_endo -55.57 105.38 0.15 Allowed 'Trans proline' 0 N--CA 1.489 1.237 0 CA-C-N 120.206 1.109 . . . . 0.0 113.181 -176.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.39 102.38 2.62 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.495 ' HB1' ' CD ' ' A' ' 67' ' ' GLU . . . -53.71 146.41 13.54 Favored 'General case' 0 C--N 1.29 -1.991 0 O-C-N 121.207 -0.933 . . . . 0.0 111.29 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -61.81 -171.3 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.732 -0.605 . . . . 0.0 110.756 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -69.41 1.49 3.87 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.189 -0.944 . . . . 0.0 112.147 -178.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -64.63 -40.46 95.5 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.525 -1.359 . . . . 0.0 108.736 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.519 ' N ' ' CD ' ' A' ' 67' ' ' GLU . 27.8 mp0 -79.36 -47.24 16.11 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.655 -0.653 . . . . 0.0 110.133 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.4 ' H ' HG13 ' A' ' 68' ' ' ILE . 36.3 mt -44.62 -22.67 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.136 -0.977 . . . . 0.0 110.041 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 67' ' ' GLU . . . -86.03 -28.85 27.3 Favored Glycine 0 N--CA 1.498 2.777 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.46 ' N ' ' O ' ' A' ' 67' ' ' GLU . 30.0 mtt -77.33 -34.18 55.37 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.47 HD22 ' HB3' ' A' ' 82' ' ' SER . 33.1 mt -65.62 -22.17 66.64 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -85.34 18.85 2.49 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 178.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -133.85 24.47 3.96 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.732 -0.605 . . . . 0.0 110.295 -178.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 17.0 m -97.48 171.9 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 120.772 -1.205 . . . . 0.0 110.58 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.8 m -105.47 -1.78 24.5 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.383 -0.823 . . . . 0.0 110.28 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.581 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -107.48 170.94 7.67 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 120.965 -1.084 . . . . 0.0 110.589 -178.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.537 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -62.87 111.61 2.21 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.474 -0.766 . . . . 0.0 109.845 -179.281 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.458 HD21 ' HB3' ' A' ' 71' ' ' LEU . 8.4 tp -70.92 160.11 33.44 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 120.031 -1.668 . . . . 0.0 110.312 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.2 mmtm -125.12 152.55 70.85 Favored Pre-proline 0 C--N 1.296 -1.748 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -178.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -56.53 -22.45 43.02 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 121.217 1.278 . . . . 0.0 109.771 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.433 ' OD1' ' O ' ' A' ' 81' ' ' ASN . 1.4 p30 -120.21 28.54 7.99 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.888 -0.508 . . . . 0.0 109.862 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.47 ' HB3' HD22 ' A' ' 71' ' ' LEU . 11.3 m -55.41 172.1 0.16 Allowed 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.416 -1.428 . . . . 0.0 108.532 178.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.726 ' HE ' ' CG1' ' A' ' 88' ' ' ILE . 0.0 OUTLIER -170.78 163.64 7.89 Favored 'General case' 0 N--CA 1.5 2.047 0 C-N-CA 118.661 -1.215 . . . . 0.0 111.273 -178.81 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.756 HD22 ' N ' ' A' ' 84' ' ' LEU . 2.2 mm? -104.26 97.71 7.62 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 178.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.426 ' C ' ' O ' ' A' ' 84' ' ' LEU . 0.6 OUTLIER -31.94 -42.18 0.06 Allowed 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -177.414 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 17.6 p -76.52 -14.72 60.01 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.076 -1.64 . . . . 0.0 112.187 -177.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.564 ' NE2' HD23 ' A' ' 84' ' ' LEU . 25.3 mt-30 -94.48 37.86 1.11 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.676 -1.265 . . . . 0.0 110.113 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.726 ' CG1' ' HE ' ' A' ' 83' ' ' ARG . 22.7 mt -131.42 168.44 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.269 -0.895 . . . . 0.0 109.4 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.521 ' N ' ' CG2' ' A' ' 88' ' ' ILE . 36.2 mm -139.01 122.72 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.649 ' SD ' ' N ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -78.65 143.34 36.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.965 -1.084 . . . . 0.0 108.511 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.649 ' N ' ' SD ' ' A' ' 90' ' ' MET . 1.1 p -130.07 149.72 73.99 Favored Pre-proline 0 N--CA 1.495 1.785 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -62.96 -35.18 67.99 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 121.626 1.551 . . . . 0.0 110.854 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -68.82 -26.06 64.98 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 119.68 -0.808 . . . . 0.0 109.936 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.517 HD22 ' CD2' ' A' ' 56' ' ' PHE . 5.5 mt -104.26 29.67 5.84 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.508 -0.745 . . . . 0.0 110.076 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -63.65 146.42 53.83 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.799 -1.188 . . . . 0.0 109.856 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 105.22 12.27 27.64 Favored Glycine 0 N--CA 1.504 3.227 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 178.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.408 ' O ' HG23 ' A' ' 97' ' ' ILE . 17.5 tt -65.57 129.7 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 121.113 -1.227 . . . . 0.0 111.31 -177.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 4.6 t -104.82 126.52 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 O-C-N 121.208 -0.932 . . . . 0.0 108.852 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.2 t -111.58 135.01 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.994 -1.066 . . . . 0.0 109.997 -178.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -107.85 121.72 45.32 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.343 -0.848 . . . . 0.0 109.065 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 24.7 t -108.99 123.59 36.54 Favored Pre-proline 0 N--CA 1.498 1.967 0 O-C-N 121.689 -0.632 . . . . 0.0 109.4 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.442 ' O ' ' NE2' ' A' ' 105' ' ' GLN . 69.4 Cg_endo -83.25 178.34 5.87 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.711 2.274 . . . . 0.0 113.427 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -84.71 -18.33 35.56 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -108.44 81.95 1.55 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.556 ' CD ' ' H ' ' A' ' 105' ' ' GLN . 13.2 mp0 -84.03 -31.03 25.64 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 119.156 -1.017 . . . . 0.0 108.489 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 62.9 t-105 . . . . . 0 C--N 1.299 -1.594 0 O-C-N 121.028 -1.045 . . . . 0.0 109.814 178.753 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' FES . . . . . 0.486 ' S1 ' ' O ' ' A' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 13.6 p . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.9 mmtt -77.22 108.74 10.55 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.435 -0.906 . . . . 0.0 108.563 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.512 HG21 HG21 ' A' ' 17' ' ' VAL . 36.5 t -108.68 109.33 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.26 -0.9 . . . . 0.0 110.28 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 23.9 t -102.16 127.09 56.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.502 -0.749 . . . . 0.0 110.341 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.425 ' CE1' HG12 ' A' ' 3' ' ' VAL . 69.6 m-85 -102.15 117.54 35.01 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 176.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 81.0 t -97.9 113.94 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 34.0 p -74.54 -163.65 0.22 Allowed 'General case' 0 C--N 1.293 -1.863 0 CA-C-O 121.595 0.712 . . . . 0.0 109.623 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.571 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.3 OUTLIER -81.98 -45.84 14.81 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.778 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 23.4 p-10 -74.31 2.36 9.44 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.3 -0.875 . . . . 0.0 111.571 -178.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.88 -4.31 65.6 Favored Glycine 0 N--CA 1.5 2.915 0 O-C-N 120.441 -1.412 . . . . 0.0 110.928 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.89 126.37 27.11 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.79 -1.418 . . . . 0.0 108.418 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.4 mtt85 -106.21 162.25 13.82 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.262 -0.899 . . . . 0.0 111.32 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 17.3 mtt85 -146.29 107.82 4.27 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 178.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -98.62 126.73 44.3 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.344 -0.847 . . . . 0.0 110.523 -178.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.531 HD22 ' CG ' ' A' ' 30' ' ' ASN . 31.6 mt -119.06 -164.7 1.06 Allowed 'General case' 0 N--CA 1.503 2.175 0 CA-C-O 122.786 1.279 . . . . 0.0 110.531 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -137.32 99.07 3.87 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 176.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.544 HG12 ' HB ' ' A' ' 21' ' ' VAL . 11.7 t -102.12 119.24 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 121.346 -0.846 . . . . 0.0 109.131 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.42 174.8 3.77 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.308 -0.87 . . . . 0.0 110.56 -178.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -69.95 141.39 53.05 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 122.053 0.93 . . . . 0.0 110.755 -179.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.24 -17.16 49.27 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.544 ' HB ' HG12 ' A' ' 17' ' ' VAL . 58.6 t -83.04 139.88 17.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 120.836 -1.391 . . . . 0.0 109.262 -178.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 79.0 p -92.04 146.09 24.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.112 -0.993 . . . . 0.0 109.024 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.493 HD21 ' SD ' ' A' ' 90' ' ' MET . 84.8 mt -46.38 -40.36 11.87 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.478 -0.764 . . . . 0.0 109.218 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 13.5 tpp -55.57 -43.12 75.64 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.427 -0.796 . . . . 0.0 108.953 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -62.26 -58.05 9.15 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.23 -0.919 . . . . 0.0 109.325 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.449 ' CB ' HG22 ' A' ' 17' ' ' VAL . . . -50.95 -33.33 24.07 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.675 -1.266 . . . . 0.0 111.743 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.84 -22.97 62.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.428 -1.42 . . . . 0.0 109.344 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 53.5 t -86.31 -19.85 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.189 -0.944 . . . . 0.0 109.857 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.87 -31.29 51.33 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.236 -0.915 . . . . 0.0 109.352 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.531 ' CG ' HD22 ' A' ' 15' ' ' LEU . 5.7 m-80 -108.06 -2.22 19.78 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 64.65 73.23 0.59 Allowed Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 74.9 mt -116.72 -47.24 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -90.26 131.94 35.8 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 105.127 -2.175 . . . . 0.0 105.127 175.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.9 p30 -103.58 67.01 0.89 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.618 -1.301 . . . . 0.0 107.621 177.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.423 HG12 ' H ' ' A' ' 37' ' ' GLY . 20.0 tt -170.48 166.58 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 O-C-N 121.104 -0.998 . . . . 0.0 109.613 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.477 ' O ' HG22 ' A' ' 36' ' ' VAL . 11.5 p -101.35 8.32 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.151 -0.968 . . . . 0.0 109.482 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.423 ' H ' HG12 ' A' ' 35' ' ' ILE . . . 71.56 117.46 0.05 OUTLIER Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.512 ' C ' ' H ' ' A' ' 40' ' ' GLY . 30.5 t0 -48.95 -60.5 2.71 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.214 -1.168 . . . . 0.0 109.301 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.609 ' SG ' ' N ' ' A' ' 42' ' ' SER . 15.0 p -72.65 18.75 0.09 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.359 -0.838 . . . . 0.0 108.928 179.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.512 ' H ' ' C ' ' A' ' 38' ' ' ASP . . . 56.79 10.7 4.89 Favored Glycine 0 N--CA 1.485 1.904 0 N-CA-C 107.786 -2.126 . . . . 0.0 107.786 -178.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.454 ' N ' ' C ' ' A' ' 39' ' ' CYS . . . 89.82 23.77 32.09 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.609 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 17.7 p -98.55 40.6 1.18 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.406 -1.055 . . . . 0.0 109.826 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 42' ' ' SER . . . 42.98 75.79 0.09 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.342 -0.849 . . . . 0.0 110.172 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -166.54 26.01 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.696 -1.252 . . . . 0.0 109.753 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.502 ' O ' ' S1 ' ' A' ' 107' ' ' FES . 3.7 p -162.18 164.17 27.97 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.328 -0.858 . . . . 0.0 110.116 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -95.67 8.79 42.42 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 8.1 m -54.09 -48.37 70.75 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.124 -0.985 . . . . 0.0 110.154 -179.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.546 ' SG ' ' N ' ' A' ' 85' ' ' CYS . 16.6 p -92.74 53.91 2.13 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.891 -1.13 . . . . 0.0 110.397 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.717 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 48.7 t60 -75.94 111.68 11.56 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.28 -0.887 . . . . 0.0 108.634 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -147.34 167.75 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 120.884 -1.135 . . . . 0.0 109.534 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.524 ' OH ' ' NE2' ' A' ' 49' ' ' HIS . 38.0 m-85 -115.68 111.24 20.3 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 121.788 0.804 . . . . 0.0 109.754 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 80.7 t -85.95 132.81 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.763 ' ND2' ' HB3' ' A' ' 55' ' ' ALA . 1.0 OUTLIER -47.96 126.6 10.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.103 -0.998 . . . . 0.0 108.545 179.359 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -56.67 14.13 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.369 -0.832 . . . . 0.0 111.648 -178.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.763 ' HB3' ' ND2' ' A' ' 53' ' ' ASN . . . -101.99 -19.91 15.02 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.56 -1.338 . . . . 0.0 109.681 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -111.54 -10.49 14.14 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.704 -1.247 . . . . 0.0 108.951 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 10.4 p -70.84 -37.39 73.15 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.126 -0.984 . . . . 0.0 110.353 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -84.42 0.33 49.91 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.235 -0.916 . . . . 0.0 110.268 -178.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.448 ' CE ' ' O ' ' A' ' 55' ' ' ALA . 9.0 mttt -112.61 -37.36 4.94 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.4 0.619 . . . . 0.0 109.512 -179.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.742 HG23 HD12 ' A' ' 94' ' ' LEU . 0.4 OUTLIER -81.56 161.67 60.9 Favored Pre-proline 0 N--CA 1.497 1.918 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 179.859 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.734 ' HD2' HG22 ' A' ' 60' ' ' VAL . 5.0 Cg_endo -55.31 90.52 0.04 OUTLIER 'Trans proline' 0 N--CA 1.5 1.905 0 C-N-CA 122.381 2.054 . . . . 0.0 114.348 -176.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.61 104.31 0.64 Allowed 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 177.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.489 ' HB1' ' OE1' ' A' ' 67' ' ' GLU . . . -53.8 149.58 8.51 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.77 0.795 . . . . 0.0 112.561 -178.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.453 ' N ' ' ND2' ' A' ' 64' ' ' ASN . 0.1 OUTLIER -60.74 -172.1 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.308 0.575 . . . . 0.0 110.117 179.678 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -70.14 4.74 1.98 Allowed 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.727 -0.608 . . . . 0.0 112.11 -178.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.4 mtt85 -65.72 -40.28 92.02 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.65 -1.281 . . . . 0.0 108.928 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.489 ' OE1' ' HB1' ' A' ' 63' ' ' ALA . 34.1 mp0 -80.05 -37.66 33.48 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.701 -1.249 . . . . 0.0 109.636 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.454 HD12 ' N ' ' A' ' 68' ' ' ILE . 1.3 mp -46.15 -35.6 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.219 -0.926 . . . . 0.0 109.055 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.39 -28.97 60.73 Favored Glycine 0 N--CA 1.495 2.599 0 C-N-CA 119.365 -1.398 . . . . 0.0 109.619 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.429 ' N ' ' O ' ' A' ' 67' ' ' GLU . 26.6 mtt -79.0 -35.41 42.86 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 178.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 71' ' ' LEU . 74.2 mt -64.98 -24.74 67.6 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 178.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -80.88 5.48 15.98 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.782 -1.198 . . . . 0.0 108.036 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -122.73 25.97 8.46 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.764 -0.585 . . . . 0.0 110.504 -178.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.4 m -96.21 168.97 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.339 0 O-C-N 120.682 -1.261 . . . . 0.0 109.97 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.472 ' OG1' ' CD1' ' A' ' 106' ' ' TRP . 3.1 m -106.57 0.14 24.31 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.429 -0.794 . . . . 0.0 110.824 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.717 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -107.4 169.33 8.64 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.171 -0.956 . . . . 0.0 110.564 -178.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.464 ' O ' ' CG ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -59.76 106.14 0.45 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.569 -0.707 . . . . 0.0 109.478 -179.289 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.9 tp -70.13 152.25 44.53 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 119.933 -1.729 . . . . 0.0 110.303 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 46.3 mmtt -114.73 156.6 44.67 Favored Pre-proline 0 C--N 1.294 -1.828 0 CA-C-N 114.506 -1.225 . . . . 0.0 108.478 -178.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -57.56 -20.36 41.2 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 121.807 1.672 . . . . 0.0 110.4 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -125.22 31.91 5.49 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.734 -0.603 . . . . 0.0 110.775 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 33.4 m -59.44 169.85 1.15 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.653 -1.279 . . . . 0.0 110.473 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.566 ' NH2' ' O ' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -171.91 171.52 5.08 Favored 'General case' 0 N--CA 1.503 2.219 0 CA-C-O 122.479 1.133 . . . . 0.0 111.864 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.476 HD13 ' S1 ' ' A' ' 107' ' ' FES . 47.3 mt -100.87 112.25 24.64 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 178.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.546 ' N ' ' SG ' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -56.7 -11.86 1.58 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.067 -1.02 . . . . 0.0 112.607 -176.554 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 28.3 p -87.54 -39.9 14.74 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 119.896 -1.752 . . . . 0.0 110.932 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -81.29 42.83 0.69 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.802 -1.186 . . . . 0.0 110.573 -178.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.8 mt -130.67 157.56 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 O-C-N 121.124 -0.985 . . . . 0.0 108.494 179.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 36.9 mm -132.46 128.52 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 O-C-N 121.391 -0.818 . . . . 0.0 109.763 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.493 ' SD ' HD21 ' A' ' 23' ' ' LEU . 3.6 tpt -88.62 161.54 16.84 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.969 -1.082 . . . . 0.0 109.657 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.5 p -155.04 148.83 18.83 Favored Pre-proline 0 C--N 1.3 -1.58 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -55.91 -37.7 95.59 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 121.651 1.567 . . . . 0.0 111.874 -178.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -65.13 -27.32 68.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.213 -0.929 . . . . 0.0 109.305 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.742 HD12 HG23 ' A' ' 60' ' ' VAL . 15.7 mt -96.66 24.73 5.73 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.322 -0.861 . . . . 0.0 109.459 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -64.2 138.06 58.26 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.651 -0.655 . . . . 0.0 110.055 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 108.03 8.87 29.02 Favored Glycine 0 N--CA 1.505 3.251 0 N-CA-C 110.669 -0.973 . . . . 0.0 110.669 178.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 16.0 tt -63.2 132.33 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 120.945 -1.326 . . . . 0.0 111.936 -177.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.0 t -104.91 115.33 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.1 t -103.12 133.32 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.898 -1.126 . . . . 0.0 109.01 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -104.71 114.77 29.19 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 23.5 t -102.4 122.18 47.42 Favored Pre-proline 0 N--CA 1.494 1.74 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.455 ' O ' ' NE2' ' A' ' 105' ' ' GLN . 68.5 Cg_endo -83.35 171.17 11.41 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.274 1.983 . . . . 0.0 113.18 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -79.13 -15.24 58.42 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.429 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 2.3 mmp_? -110.75 82.97 1.68 Allowed 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.527 ' H ' ' CD ' ' A' ' 105' ' ' GLN . 14.7 mp0 -83.09 -32.83 26.55 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 120.96 -1.087 . . . . 0.0 108.514 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.472 ' CD1' ' OG1' ' A' ' 75' ' ' THR . 61.6 t-105 . . . . . 0 C--N 1.302 -1.476 0 CA-C-O 117.616 -1.183 . . . . 0.0 110.266 178.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' FES . . . . . 0.502 ' S1 ' ' O ' ' A' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.462 ' CB ' ' SD ' ' A' ' 90' ' ' MET . 1.5 p . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.4 ' H ' ' HB2' ' A' ' 95' ' ' ASP . 25.2 mmtt -92.92 116.36 28.98 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.069 -1.019 . . . . 0.0 109.192 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.579 HG12 ' CE2' ' A' ' 5' ' ' TYR . 57.2 t -114.47 108.61 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 O-C-N 121.351 -0.843 . . . . 0.0 109.573 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.4 t -99.6 129.03 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.267 -0.896 . . . . 0.0 110.849 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.579 ' CE2' HG12 ' A' ' 3' ' ' VAL . 96.5 m-85 -104.86 115.77 30.86 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 177.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 81.0 t -98.24 114.8 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 120.901 -1.125 . . . . 0.0 108.146 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 63.2 p -72.15 -159.92 0.06 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.708 -0.62 . . . . 0.0 109.682 -178.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.605 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -88.02 -46.93 8.92 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -179.882 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.519 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 13.4 p30 -70.75 4.63 2.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.344 -0.848 . . . . 0.0 110.755 -178.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.85 -4.63 65.94 Favored Glycine 0 N--CA 1.498 2.821 0 O-C-N 120.808 -1.182 . . . . 0.0 110.552 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -65.61 126.9 29.8 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.747 -1.443 . . . . 0.0 108.718 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.534 ' CG ' HH11 ' A' ' 12' ' ' ARG . 2.6 mtt-85 -105.52 160.95 14.77 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.474 -0.766 . . . . 0.0 110.84 -178.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -150.83 116.31 5.43 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -101.98 130.87 48.62 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.701 -0.624 . . . . 0.0 111.14 -178.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 30.7 mt -119.4 -165.29 1.13 Allowed 'General case' 0 N--CA 1.504 2.237 0 CA-C-O 122.737 1.256 . . . . 0.0 109.882 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -135.19 97.24 3.67 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 104.62 -2.363 . . . . 0.0 104.62 176.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.704 HG13 ' HB2' ' A' ' 26' ' ' ALA . 3.7 t -104.79 118.62 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.518 0 O-C-N 121.044 -1.035 . . . . 0.0 108.244 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.05 173.34 6.63 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 122.091 0.948 . . . . 0.0 111.693 -177.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -64.63 138.51 58.44 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.988 0.899 . . . . 0.0 111.166 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.9 -14.43 52.72 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 178.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.602 ' HB ' HG12 ' A' ' 17' ' ' VAL . 48.6 t -82.63 140.48 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 O-C-N 120.721 -1.458 . . . . 0.0 108.87 -179.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.471 ' O ' ' N ' ' A' ' 25' ' ' GLN . 35.6 p -92.88 141.05 28.86 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.238 -0.914 . . . . 0.0 109.078 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 57.9 mt -44.48 -36.24 2.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.27 -0.894 . . . . 0.0 109.753 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.405 ' O ' ' SD ' ' A' ' 24' ' ' MET . 4.9 tpt -61.19 -37.84 84.39 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.471 ' N ' ' O ' ' A' ' 22' ' ' SER . 11.8 mm100 -66.82 -58.48 4.95 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.306 -0.871 . . . . 0.0 108.994 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.704 ' HB2' HG13 ' A' ' 17' ' ' VAL . . . -55.29 -30.07 59.44 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.785 -1.197 . . . . 0.0 110.749 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.759 ' HB1' ' H ' ' A' ' 33' ' ' TYR . . . -60.92 -24.58 66.13 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.955 -1.091 . . . . 0.0 109.06 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 89.5 t -86.05 -23.88 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.393 -0.817 . . . . 0.0 109.709 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.34 -28.92 59.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.17 -0.956 . . . . 0.0 108.618 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -108.07 -4.59 17.62 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 178.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 64.1 72.0 0.76 Allowed Glycine 0 N--CA 1.499 2.897 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.2 mt -124.51 -60.3 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.406 -1.056 . . . . 0.0 111.635 -178.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.759 ' H ' ' HB1' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -93.64 -15.19 25.6 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.307 -0.871 . . . . 0.0 109.2 179.267 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.437 ' C ' ' O ' ' A' ' 33' ' ' TYR . 6.8 p-10 -38.67 -43.81 0.93 Allowed 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -178.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.508 HG23 ' O ' ' A' ' 35' ' ' ILE . 19.2 tt -41.76 122.8 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.506 HG12 ' N ' ' A' ' 37' ' ' GLY . 93.4 t 57.46 159.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.309 -0.87 . . . . 0.0 109.577 -178.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.506 ' N ' HG12 ' A' ' 36' ' ' VAL . . . 177.04 111.93 0.3 Allowed Glycine 0 N--CA 1.486 2.007 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.496 ' C ' ' H ' ' A' ' 40' ' ' GLY . 1.0 OUTLIER -88.42 -85.42 0.19 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.004 -1.292 . . . . 0.0 109.99 -178.895 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.533 ' SG ' ' N ' ' A' ' 42' ' ' SER . 11.8 p -65.76 10.36 0.1 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.843 -1.161 . . . . 0.0 110.118 -179.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.496 ' H ' ' C ' ' A' ' 38' ' ' ASP . . . 54.61 7.59 1.0 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 -179.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.494 ' H ' ' C ' ' A' ' 39' ' ' CYS . . . 100.83 84.2 1.79 Allowed Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.533 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 5.1 m -160.3 28.55 0.17 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.274 -1.133 . . . . 0.0 108.922 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.55 ' HB2' ' NE2' ' A' ' 87' ' ' GLN . . . 50.0 66.35 1.16 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.051 -1.03 . . . . 0.0 109.224 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.1 m -159.15 17.16 0.18 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.168 -0.957 . . . . 0.0 109.965 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.442 ' SG ' ' OG1' ' A' ' 47' ' ' THR . 1.5 p -156.49 160.94 40.0 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.2 -0.937 . . . . 0.0 109.899 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.576 ' HB1' HG13 ' A' ' 74' ' ' VAL . . . -95.28 16.74 15.9 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.442 ' OG1' ' SG ' ' A' ' 45' ' ' CYS . 7.3 m -65.43 -54.42 28.82 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.922 -1.111 . . . . 0.0 110.251 -179.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.586 ' SG ' ' N ' ' A' ' 85' ' ' CYS . 17.7 p -82.3 54.42 2.56 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.756 -1.215 . . . . 0.0 110.15 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.716 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 35.8 t60 -77.45 109.67 11.58 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -143.7 164.94 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 120.679 -1.263 . . . . 0.0 109.664 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.546 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 42.4 m-85 -112.52 112.58 24.22 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-O 121.915 0.865 . . . . 0.0 109.747 -179.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.534 HG12 HD22 ' A' ' 53' ' ' ASN . 60.7 t -88.54 132.41 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.669 HD22 ' N ' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -47.73 127.01 11.1 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.076 -1.015 . . . . 0.0 108.646 179.301 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -56.36 14.6 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.252 -0.905 . . . . 0.0 111.297 -178.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.598 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -99.67 -18.0 17.5 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.595 -1.315 . . . . 0.0 109.823 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.617 ' CD2' HD22 ' A' ' 94' ' ' LEU . 30.9 m-85 -116.18 -9.4 11.63 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.977 -1.077 . . . . 0.0 108.38 -179.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.415 HG21 ' OD1' ' A' ' 81' ' ' ASN . 31.2 p -68.44 -43.62 76.71 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.272 -0.893 . . . . 0.0 109.82 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -91.03 19.86 5.36 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 120.179 -0.608 . . . . 0.0 109.731 -179.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.6 mtpt -129.83 -40.83 1.34 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.696 HG22 ' HD2' ' A' ' 61' ' ' PRO . 0.4 OUTLIER -81.06 168.17 26.92 Favored Pre-proline 0 N--CA 1.491 1.599 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 179.254 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.696 ' HD2' HG22 ' A' ' 60' ' ' VAL . 1.1 Cg_endo -59.43 97.68 0.1 Allowed 'Trans proline' 0 N--CA 1.491 1.369 0 CA-C-N 120.123 1.08 . . . . 0.0 113.593 -176.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.84 99.56 3.81 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 178.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.595 ' H ' ' NH1' ' A' ' 83' ' ' ARG . . . -47.03 152.17 0.56 Allowed 'General case' 0 C--N 1.287 -2.121 0 CA-C-O 122.242 1.02 . . . . 0.0 113.129 -178.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -61.1 -169.81 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.618 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -67.68 -3.92 10.58 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.771 -0.58 . . . . 0.0 111.976 -178.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? -62.74 -42.49 99.7 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.539 -1.351 . . . . 0.0 108.442 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.536 ' OE1' ' N ' ' A' ' 67' ' ' GLU . 22.5 mp0 -75.55 -48.1 23.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.446 -0.784 . . . . 0.0 109.937 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 35.3 mt -44.21 -21.83 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.519 -0.738 . . . . 0.0 109.655 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 72' ' ' GLU . . . -80.0 -79.54 0.85 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 9.9 ptp -47.56 -37.81 13.0 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.925 -1.338 . . . . 0.0 108.932 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.448 ' O ' ' CG2' ' A' ' 74' ' ' VAL . 2.5 tm? -56.93 -31.02 64.51 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' A' ' 69' ' ' GLY . 14.5 tt0 -81.88 14.52 2.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.09 -1.007 . . . . 0.0 109.256 178.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -125.51 36.62 4.52 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.225 -0.922 . . . . 0.0 110.083 -179.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.603 ' CG2' HD11 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -98.87 176.09 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 121.058 -1.026 . . . . 0.0 108.522 179.218 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.509 ' OG1' ' CE2' ' A' ' 106' ' ' TRP . 4.9 m -120.05 6.36 10.82 Favored 'General case' 0 N--CA 1.508 2.446 0 O-C-N 121.245 -0.91 . . . . 0.0 111.19 -178.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.716 ' HB3' ' NE2' ' A' ' 49' ' ' HIS . . . -105.78 171.94 7.07 Favored 'General case' 0 N--CA 1.506 2.362 0 O-C-N 120.979 -1.076 . . . . 0.0 109.674 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.546 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -59.0 102.66 0.13 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.23 -0.919 . . . . 0.0 109.641 -179.313 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.603 HD11 ' CG2' ' A' ' 74' ' ' VAL . 2.6 mp -71.81 141.54 49.66 Favored 'General case' 0 C--N 1.293 -1.875 0 O-C-N 120.132 -1.605 . . . . 0.0 110.665 -179.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.556 ' H ' ' HG ' ' A' ' 82' ' ' SER . 45.2 mmtt -104.81 158.52 31.84 Favored Pre-proline 0 C--N 1.288 -2.081 0 CA-C-N 113.786 -1.552 . . . . 0.0 107.845 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -53.4 -16.24 7.06 Favored 'Trans proline' 0 C--N 1.302 -1.901 0 C-N-CA 121.248 1.298 . . . . 0.0 109.873 178.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.415 ' OD1' HG21 ' A' ' 57' ' ' THR . 3.9 p30 -130.55 39.47 3.62 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.993 -0.442 . . . . 0.0 111.03 -179.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.556 ' HG ' ' H ' ' A' ' 79' ' ' LYS . 22.7 m -68.45 150.34 48.23 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 119.978 -1.701 . . . . 0.0 107.554 178.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.595 ' NH1' ' H ' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -165.68 169.47 15.17 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.533 -1.354 . . . . 0.0 110.121 -179.669 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.828 HD22 ' N ' ' A' ' 84' ' ' LEU . 1.1 mm? -85.73 119.78 26.44 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.586 ' N ' ' SG ' ' A' ' 48' ' ' CYS . 0.5 OUTLIER -57.26 -41.84 80.4 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.037 -1.039 . . . . 0.0 111.282 -177.875 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 30.6 p -60.56 -22.92 64.2 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 120.635 -1.29 . . . . 0.0 111.444 -177.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.55 ' NE2' ' HB2' ' A' ' 43' ' ' ALA . 1.6 tp-100 -91.18 33.04 0.98 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.009 -1.057 . . . . 0.0 111.16 -179.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.59 ' C ' HD12 ' A' ' 89' ' ' ILE . 33.8 mt -130.27 144.79 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 O-C-N 120.966 -1.084 . . . . 0.0 108.226 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.59 HD12 ' C ' ' A' ' 88' ' ' ILE . 1.7 mp -122.21 134.96 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.43 0 O-C-N 121.678 -0.639 . . . . 0.0 109.304 -179.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.628 ' SD ' ' N ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -81.16 144.5 31.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.234 -0.917 . . . . 0.0 108.851 -179.651 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.628 ' N ' ' SD ' ' A' ' 90' ' ' MET . 0.5 OUTLIER -129.46 152.54 79.77 Favored Pre-proline 0 N--CA 1.497 1.876 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 177.833 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.24 -34.75 26.66 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 121.671 1.58 . . . . 0.0 110.791 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -70.57 -23.29 62.57 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.584 -0.846 . . . . 0.0 109.8 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.617 HD22 ' CD2' ' A' ' 56' ' ' PHE . 6.7 mt -104.48 30.91 5.0 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.427 -0.796 . . . . 0.0 110.4 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.4 ' HB2' ' H ' ' A' ' 2' ' ' LYS . 11.0 p-10 -64.46 144.75 56.96 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.114 -1.616 . . . . 0.0 109.676 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 105.8 11.75 27.74 Favored Glycine 0 N--CA 1.503 3.112 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 178.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.436 HG13 HD21 ' A' ' 53' ' ' ASN . 15.3 tt -63.62 128.89 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.013 -1.286 . . . . 0.0 111.015 -177.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.478 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 6.6 t -103.84 123.7 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.225 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.2 t -111.44 135.06 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.067 -1.021 . . . . 0.0 109.688 -179.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -108.91 122.48 47.29 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-O 121.712 0.768 . . . . 0.0 109.055 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 35.0 t -110.3 123.27 36.34 Favored Pre-proline 0 N--CA 1.497 1.889 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.442 ' HG3' ' CD2' ' A' ' 49' ' ' HIS . 41.6 Cg_endo -85.94 -178.3 2.83 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.865 2.377 . . . . 0.0 113.486 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -87.01 -20.15 27.64 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.437 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 0.8 OUTLIER -103.78 82.45 2.0 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 179.623 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -81.13 -23.3 38.42 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.444 -0.902 . . . . 0.0 109.68 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.509 ' CE2' ' OG1' ' A' ' 75' ' ' THR . 11.1 t-105 . . . . . 0 C--N 1.305 -1.359 0 O-C-N 120.847 -1.158 . . . . 0.0 110.164 179.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 98.0 p . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.402 ' H ' ' HB2' ' A' ' 95' ' ' ASP . 1.1 mptm? -76.11 111.03 11.09 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.534 HG12 ' CE1' ' A' ' 5' ' ' TYR . 96.5 t -111.9 111.89 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.735 -0.603 . . . . 0.0 110.302 -178.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 24.4 t -98.89 98.85 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.222 -0.924 . . . . 0.0 111.764 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.534 ' CE1' HG12 ' A' ' 3' ' ' VAL . 29.0 m-85 -72.94 111.89 8.47 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 176.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 79.1 t -98.89 117.92 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 75.0 p -73.73 -155.83 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.492 -0.755 . . . . 0.0 109.513 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.598 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -91.54 -50.27 5.87 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.164 -0.96 . . . . 0.0 108.985 -179.727 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.492 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 22.0 p-10 -66.03 2.07 1.24 Allowed 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.509 -0.745 . . . . 0.0 110.734 -179.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.408 ' O ' ' NH1' ' A' ' 12' ' ' ARG . . . 96.74 -4.98 63.92 Favored Glycine 0 N--CA 1.501 3.013 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -62.6 126.52 27.62 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.117 -1.226 . . . . 0.0 108.179 179.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.432 ' NH1' ' CG ' ' A' ' 12' ' ' ARG . 0.5 OUTLIER -112.09 161.1 16.87 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 121.875 0.845 . . . . 0.0 111.577 -178.16 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.5 ttm105 -149.65 118.67 6.71 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -99.46 128.02 45.55 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.39 -0.819 . . . . 0.0 110.427 -178.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.547 HD11 ' CD1' ' A' ' 32' ' ' ILE . 21.6 mt -117.79 -165.54 1.1 Allowed 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 122.972 1.368 . . . . 0.0 109.978 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -138.0 101.73 4.5 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 176.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.49 ' CG2' HG21 ' A' ' 3' ' ' VAL . 12.2 t -104.69 117.07 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.67 179.9 4.5 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-O 122.046 0.927 . . . . 0.0 112.343 -177.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -65.89 134.13 52.37 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.849 0.833 . . . . 0.0 110.548 -179.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.94 -18.01 42.55 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 178.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.416 ' HB ' HG12 ' A' ' 17' ' ' VAL . 46.2 t -83.72 139.63 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 120.848 -1.384 . . . . 0.0 109.889 -178.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.511 ' O ' ' N ' ' A' ' 25' ' ' GLN . 51.4 p -94.84 141.26 28.84 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 178.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.1 mt -45.81 -33.86 3.37 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.362 -0.836 . . . . 0.0 109.611 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.512 ' SD ' ' OD1' ' A' ' 34' ' ' ASP . 2.3 tpt -68.53 -28.46 67.01 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 121.674 0.75 . . . . 0.0 109.165 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.511 ' N ' ' O ' ' A' ' 22' ' ' SER . 7.0 tp-100 -76.55 -62.72 1.53 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.138 -0.976 . . . . 0.0 109.959 -179.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.29 -24.17 53.17 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.689 -1.257 . . . . 0.0 109.995 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.94 -22.21 66.61 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.161 -0.962 . . . . 0.0 109.649 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 99.1 t -86.29 -17.93 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.374 -0.829 . . . . 0.0 109.41 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.97 -30.32 22.85 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.391 -0.818 . . . . 0.0 110.066 -178.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 -94.18 10.64 33.07 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 63.63 70.08 1.15 Allowed Glycine 0 N--CA 1.499 2.864 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 178.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.79 ' O ' ' N ' ' A' ' 34' ' ' ASP . 10.7 mt -124.95 121.64 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.454 -1.027 . . . . 0.0 109.76 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.541 ' O ' ' CD2' ' A' ' 33' ' ' TYR . 76.3 t80 -48.1 49.28 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.423 0 CA-C-O 120.891 0.377 . . . . 0.0 112.002 -177.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.79 ' N ' ' O ' ' A' ' 32' ' ' ILE . 4.2 p30 -96.27 -21.72 17.67 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.195 -0.941 . . . . 0.0 109.821 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.628 ' CG1' ' H ' ' A' ' 36' ' ' VAL . 3.4 tt -54.02 -167.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.422 -0.799 . . . . 0.0 109.996 -178.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.628 ' H ' ' CG1' ' A' ' 35' ' ' ILE . 13.4 t 58.84 99.88 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.285 -0.884 . . . . 0.0 108.729 -178.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -154.22 169.72 32.68 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.503 ' C ' ' H ' ' A' ' 40' ' ' GLY . 23.8 m-20 -87.97 -67.96 0.79 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.111 -1.229 . . . . 0.0 110.079 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.622 ' SG ' ' N ' ' A' ' 42' ' ' SER . 10.2 p -71.05 18.45 0.06 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.045 -1.034 . . . . 0.0 109.563 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.503 ' H ' ' C ' ' A' ' 38' ' ' ASP . . . 50.34 15.26 1.1 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.609 -1.796 . . . . 0.0 108.609 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.475 ' N ' ' C ' ' A' ' 39' ' ' CYS . . . 91.13 21.26 36.12 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 -179.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.622 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 57.9 m -93.77 35.98 1.12 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.437 -1.037 . . . . 0.0 109.991 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.429 ' C ' ' HG ' ' A' ' 44' ' ' SER . . . 44.72 70.58 0.33 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.379 -0.825 . . . . 0.0 110.252 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.429 ' HG ' ' C ' ' A' ' 43' ' ' ALA . 0.7 OUTLIER -163.47 26.6 0.08 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.897 -1.127 . . . . 0.0 110.133 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.455 ' SG ' ' N ' ' A' ' 46' ' ' ALA . 3.4 p -158.9 -159.44 0.78 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.886 -1.134 . . . . 0.0 109.95 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.455 ' N ' ' SG ' ' A' ' 45' ' ' CYS . . . -134.71 3.39 3.25 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.488 HG21 ' H ' ' A' ' 38' ' ' ASP . 62.0 p -49.86 -51.06 43.1 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.434 -0.792 . . . . 0.0 109.458 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.486 ' SG ' ' N ' ' A' ' 85' ' ' CYS . 30.1 p -73.46 54.85 0.46 Allowed 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.869 -1.145 . . . . 0.0 109.405 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.481 ' CE1' ' OH ' ' A' ' 51' ' ' TYR . 50.9 t60 -76.74 106.45 8.41 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -143.84 160.8 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 120.696 -1.253 . . . . 0.0 109.231 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.509 ' OH ' ' O ' ' A' ' 77' ' ' GLU . 39.5 m-85 -108.52 111.42 23.27 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 122.241 1.019 . . . . 0.0 109.953 -179.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.541 HG13 HD11 ' A' ' 97' ' ' ILE . 10.9 t -85.94 133.29 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.576 ' C ' ' H ' ' A' ' 55' ' ' ALA . 1.0 OUTLIER -48.21 127.7 13.04 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.872 -1.143 . . . . 0.0 108.625 -179.852 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -56.35 9.15 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.467 -0.77 . . . . 0.0 111.471 -178.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.576 ' H ' ' C ' ' A' ' 53' ' ' ASN . . . -99.11 -17.38 18.24 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.805 -1.184 . . . . 0.0 109.9 -179.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.627 ' CD2' HD22 ' A' ' 94' ' ' LEU . 48.1 m-85 -115.61 -4.74 12.2 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.1 -1.0 . . . . 0.0 108.808 -179.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 24.8 p -72.95 -41.94 63.93 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.619 -0.676 . . . . 0.0 109.796 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -89.31 15.44 9.05 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 120.204 -0.599 . . . . 0.0 109.886 -179.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.1 mtpt -121.68 -40.86 2.51 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.523 HG22 ' HD2' ' A' ' 61' ' ' PRO . 0.5 OUTLIER -78.86 158.33 75.41 Favored Pre-proline 0 N--CA 1.495 1.82 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.61 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.523 ' HD2' HG22 ' A' ' 60' ' ' VAL . 1.3 Cg_endo -49.47 102.74 0.05 OUTLIER 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 122.222 1.948 . . . . 0.0 113.726 -177.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.463 ' HA ' HH22 ' A' ' 83' ' ' ARG . . . -75.66 101.62 5.05 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 177.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.805 ' H ' HH22 ' A' ' 83' ' ' ARG . . . -65.25 169.58 5.55 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-O 122.211 1.005 . . . . 0.0 112.58 -178.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.422 ' ND2' ' HE ' ' A' ' 66' ' ' ARG . 4.0 p30 -63.24 177.54 0.62 Allowed 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 122.103 0.954 . . . . 0.0 111.428 -178.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -72.23 5.34 2.89 Favored 'General case' 0 N--CA 1.503 2.214 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.523 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.422 ' HE ' ' ND2' ' A' ' 64' ' ' ASN . 10.2 mtm180 -74.16 -50.52 18.96 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 120.37 -1.456 . . . . 0.0 109.185 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.442 ' OE1' ' OE1' ' A' ' 87' ' ' GLN . 82.3 mt-10 -65.58 -16.71 63.97 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.525 -0.734 . . . . 0.0 109.655 179.114 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.563 HD12 ' N ' ' A' ' 68' ' ' ILE . 1.4 mp -75.54 -34.92 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.383 -0.823 . . . . 0.0 108.918 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.81 -20.51 48.21 Favored Glycine 0 N--CA 1.495 2.597 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 3.5 mmt -83.51 -35.42 24.85 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 178.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.484 ' HG ' HD21 ' A' ' 84' ' ' LEU . 59.8 mt -63.75 -21.98 66.68 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -83.82 11.7 7.16 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -131.26 28.13 4.74 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.446 -0.784 . . . . 0.0 109.774 -178.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.604 HG21 HD13 ' A' ' 78' ' ' LEU . 18.0 m -90.92 162.86 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.326 -0.859 . . . . 0.0 110.697 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.524 ' OG1' ' CD2' ' A' ' 106' ' ' TRP . 6.7 m -100.75 -8.7 22.5 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.321 -0.862 . . . . 0.0 109.983 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -107.55 175.33 5.53 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.807 -1.183 . . . . 0.0 110.723 -178.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.509 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -61.46 108.71 1.0 Allowed 'General case' 0 N--CA 1.503 2.21 0 CA-C-O 121.372 0.606 . . . . 0.0 110.967 -178.843 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.604 HD13 HG21 ' A' ' 74' ' ' VAL . 9.2 tp -72.92 156.67 38.62 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 119.547 -1.97 . . . . 0.0 110.101 179.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.6 mmtm -118.03 155.76 50.94 Favored Pre-proline 0 C--N 1.293 -1.856 0 CA-C-N 115.105 -0.952 . . . . 0.0 108.534 -178.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.99 -24.26 79.21 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 121.674 1.582 . . . . 0.0 109.261 178.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.44 ' OD1' ' O ' ' A' ' 81' ' ' ASN . 1.4 p30 -112.9 21.69 15.21 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.013 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.476 ' HB3' HD22 ' A' ' 71' ' ' LEU . 3.7 m -52.07 158.26 1.13 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 120.306 -1.496 . . . . 0.0 109.067 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.805 HH22 ' H ' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -156.69 148.22 22.48 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.061 -1.055 . . . . 0.0 111.924 -178.28 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.787 HD22 ' N ' ' A' ' 84' ' ' LEU . 2.2 mm? -85.48 121.66 28.51 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 177.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.486 ' N ' ' SG ' ' A' ' 48' ' ' CYS . 0.2 OUTLIER -70.64 -5.09 26.9 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.867 -1.146 . . . . 0.0 113.183 -175.708 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 27.9 p -93.93 -37.7 11.56 Favored 'General case' 0 N--CA 1.506 2.354 0 CA-C-N 120.438 1.472 . . . . 0.0 111.004 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.669 HE22 ' NH1' ' A' ' 83' ' ' ARG . 5.0 pp0? -84.91 24.74 1.02 Allowed 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.214 -0.929 . . . . 0.0 110.39 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.447 HD11 ' HB3' ' A' ' 83' ' ' ARG . 47.3 mt -108.09 148.3 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 O-C-N 121.131 -0.981 . . . . 0.0 108.651 179.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 33.5 mm -127.68 124.35 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.518 ' SD ' HG21 ' A' ' 97' ' ' ILE . 2.7 tpt -91.14 160.77 15.39 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.301 -0.874 . . . . 0.0 109.928 -178.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 70.9 p -149.38 147.61 23.86 Favored Pre-proline 0 N--CA 1.49 1.532 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -57.1 -29.58 83.71 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 121.46 1.44 . . . . 0.0 111.616 -179.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -67.83 -29.54 68.72 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.19 -0.944 . . . . 0.0 109.938 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.627 HD22 ' CD2' ' A' ' 56' ' ' PHE . 6.4 mt -98.1 31.04 2.85 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.578 -0.701 . . . . 0.0 109.863 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.402 ' HB2' ' H ' ' A' ' 2' ' ' LYS . 5.5 p-10 -62.63 138.51 58.51 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.169 -0.957 . . . . 0.0 110.17 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 111.8 9.1 21.49 Favored Glycine 0 N--CA 1.505 3.281 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 178.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.584 HD12 ' N ' ' A' ' 98' ' ' VAL . 0.1 OUTLIER -67.07 125.94 25.58 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 O-C-N 121.604 -0.939 . . . . 0.0 110.838 -178.213 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.584 ' N ' HD12 ' A' ' 97' ' ' ILE . 2.6 t -101.97 121.51 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.367 -0.833 . . . . 0.0 109.594 178.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.3 t -105.88 134.02 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 120.894 -1.129 . . . . 0.0 108.849 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -108.16 119.83 40.59 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 121.864 0.84 . . . . 0.0 109.015 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 23.7 t -107.27 122.94 39.76 Favored Pre-proline 0 N--CA 1.496 1.846 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.423 ' HG3' ' CD2' ' A' ' 49' ' ' HIS . 69.2 Cg_endo -83.57 177.69 6.15 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.703 2.269 . . . . 0.0 113.594 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -84.38 -15.26 46.96 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -112.05 80.4 1.32 Allowed 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.465 ' NE2' ' O ' ' A' ' 106' ' ' TRP . 2.2 pp0? -80.55 -20.43 43.46 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.724 -1.235 . . . . 0.0 109.659 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.524 ' CD2' ' OG1' ' A' ' 75' ' ' THR . 67.4 t-105 . . . . . 0 C--N 1.302 -1.475 0 CA-C-O 117.83 -1.081 . . . . 0.0 110.24 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_